{
  "graph": {
    "directed": false,
    "type": "BEL-V1.0",
    "label": "PGE2-2.0-Hs",
    "metadata": {
      "description": "The PGE2 network depicts the pathways exerting regulatory control of PGE2 in the context of cellular proliferation. The network includes cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation.",
      "species_common_name": "Human",
      "version": "2.0",
      "boundary_conditions": "The human model sets represent early COPD (GOLD stage I and II) processes. If supporting literature from early COPD studies were not available, stage-independent COPD studies were used. If COPD studies were not found, we expanded our inclusion criteria to studies from healthy context and incorporated mechanisms active in processes implicated in COPD into the disease models. Literature describing processes active in acute exacerbation in COPD patients was excluded from supporting edges of the network models. We prioritized data collected from studies of lung and COPD-relevant cell types, but excluded literature related to asthma or bronchitis. Human-specific connections were preferred, but rat and mouse were also included where human data was not available."
    },
    "nodes": [
      {
        "id": "kin(p(SFAM:\"AKT Family\"))",
        "label": "kin(p(SFAM:\"AKT Family\"))",
        "metadata": {
          "coordinate": [
            0.6792181261027022,
            0.7862919003521586
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532c0"
        }
      },
      {
        "id": "a(SCHEM:Epoprostenol)",
        "label": "a(SCHEM:Epoprostenol)",
        "metadata": {
          "coordinate": [
            0.42431980685300397,
            0.5671709925655406
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532c1"
        }
      },
      {
        "id": "cat(p(HGNC:PTGER1))",
        "label": "cat(p(HGNC:PTGER1))",
        "metadata": {
          "coordinate": [
            0.8412573126566998,
            0.4276118429633494
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532c2"
        }
      },
      {
        "id": "p(HGNC:IL1A)",
        "label": "p(HGNC:IL1A)",
        "metadata": {
          "coordinate": [
            0.727969170767945,
            0.4784791965566714
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532c3"
        }
      },
      {
        "id": "cat(p(HGNC:PTGER2))",
        "label": "cat(p(HGNC:PTGER2))",
        "metadata": {
          "coordinate": [
            0.4582133902869347,
            0.46500152167297076
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532c4"
        }
      },
      {
        "id": "cat(p(HGNC:PTGER3))",
        "label": "cat(p(HGNC:PTGER3))",
        "metadata": {
          "coordinate": [
            0.7521125452688272,
            0.2641406895352376
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532c5"
        }
      },
      {
        "id": "p(HGNC:FGF7)",
        "label": "p(HGNC:FGF7)",
        "metadata": {
          "coordinate": [
            0.6425387686879005,
            0.5097821833833311
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532c6"
        }
      },
      {
        "id": "p(HGNC:VIPR1)",
        "label": "p(HGNC:VIPR1)",
        "metadata": {
          "coordinate": [
            0.10163432073544433,
            0.3280509543063345
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532c7"
        }
      },
      {
        "id": "cat(p(HGNC:PTGER4))",
        "label": "cat(p(HGNC:PTGER4))",
        "metadata": {
          "coordinate": [
            0.15270684371807966,
            0.5197817486196252
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532c8"
        }
      },
      {
        "id": "cat(p(HGNC:PTGS2))",
        "label": "cat(p(HGNC:PTGS2))",
        "metadata": {
          "coordinate": [
            0.5083573219426131,
            0.25761923394635017
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532c9"
        }
      },
      {
        "id": "p(HGNC:PTGS1)",
        "label": "p(HGNC:PTGS1)",
        "metadata": {
          "coordinate": [
            0.3133531432816417,
            0.08936567975305422
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532ca"
        }
      },
      {
        "id": "a(CHEBI:celecoxib)",
        "label": "a(CHEBI:celecoxib)",
        "metadata": {
          "coordinate": [
            0.41921255455474044,
            0.20805617147080563
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532cb"
        }
      },
      {
        "id": "p(HGNC:VEGFA)",
        "label": "p(HGNC:VEGFA)",
        "metadata": {
          "coordinate": [
            0.4939641563747795,
            0.36500586931003
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532cc"
        }
      },
      {
        "id": "gtp(p(SFAM:\"RAS Family\"))",
        "label": "gtp(p(SFAM:\"RAS Family\"))",
        "metadata": {
          "coordinate": [
            0.8472931562819203,
            0.5367375331507326
          ],
          "bel_function_type": "gtpBoundActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532cd"
        }
      },
      {
        "id": "cat(p(HGNC:PTGES))",
        "label": "cat(p(HGNC:PTGES))",
        "metadata": {
          "coordinate": [
            0.8287213297427801,
            0.32892048171818616
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532ce"
        }
      },
      {
        "id": "p(SFAM:\"TGFB Family\")",
        "label": "p(SFAM:\"TGFB Family\")",
        "metadata": {
          "coordinate": [
            0.5566440709443774,
            0.4602191209077866
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532cf"
        }
      },
      {
        "id": "p(HGNC:PTGER3)",
        "label": "p(HGNC:PTGER3)",
        "metadata": {
          "coordinate": [
            0.8189711208097316,
            0.1806660579974784
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532d0"
        }
      },
      {
        "id": "p(HGNC:VIP)",
        "label": "p(HGNC:VIP)",
        "metadata": {
          "coordinate": [
            0.05427616306063701,
            0.4110908221381679
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532d1"
        }
      },
      {
        "id": "kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "label": "kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "metadata": {
          "coordinate": [
            0.6230383508218034,
            0.716729707404026
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532d2"
        }
      },
      {
        "id": "p(HGNC:NPPA)",
        "label": "p(HGNC:NPPA)",
        "metadata": {
          "coordinate": [
            0.38160460581298167,
            0.6615147167514456
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532d3"
        }
      },
      {
        "id": "p(HGNC:TIAM1)",
        "label": "p(HGNC:TIAM1)",
        "metadata": {
          "coordinate": [
            0.4024979106695143,
            0.9545454545454547
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532d4"
        }
      },
      {
        "id": "gtp(p(HGNC:RAP1A))",
        "label": "gtp(p(HGNC:RAP1A))",
        "metadata": {
          "coordinate": [
            0.350496796359922,
            0.7962914655884527
          ],
          "bel_function_type": "gtpBoundActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532d5"
        }
      },
      {
        "id": "p(HGNC:PDGFRA)",
        "label": "p(HGNC:PDGFRA)",
        "metadata": {
          "coordinate": [
            0.7061472745844554,
            0.5593452458588757
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532d6"
        }
      },
      {
        "id": "p(HGNC:RAP1A)",
        "label": "p(HGNC:RAP1A)",
        "metadata": {
          "coordinate": [
            0.4433559290556226,
            0.8497674014173296
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532d7"
        }
      },
      {
        "id": "p(HGNC:PTGES2)",
        "label": "p(HGNC:PTGES2)",
        "metadata": {
          "coordinate": [
            0.6077165939270127,
            0.08284422416416679
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532d8"
        }
      },
      {
        "id": "a(SCHEM:\"cyclic AMP\")",
        "label": "a(SCHEM:\"cyclic AMP\")",
        "metadata": {
          "coordinate": [
            0.34817531804252944,
            0.5258684405025869
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532d9"
        }
      },
      {
        "id": "p(HGNC:RAPGEF3)",
        "label": "p(HGNC:RAPGEF3)",
        "metadata": {
          "coordinate": [
            0.5176432352121831,
            0.7754228077040128
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532da"
        }
      },
      {
        "id": "gtp(p(HGNC:HRAS))",
        "label": "gtp(p(HGNC:HRAS))",
        "metadata": {
          "coordinate": [
            0.6258241248026744,
            0.2680535628885701
          ],
          "bel_function_type": "gtpBoundActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532db"
        }
      },
      {
        "id": "cat(p(HGNC:RAPGEF3))",
        "label": "cat(p(HGNC:RAPGEF3))",
        "metadata": {
          "coordinate": [
            0.4582133902869347,
            0.7023825051084736
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532dc"
        }
      },
      {
        "id": "gtp(p(HGNC:RAC1))",
        "label": "gtp(p(HGNC:RAC1))",
        "metadata": {
          "coordinate": [
            0.20238647971027948,
            0.752380331289944
          ],
          "bel_function_type": "gtpBoundActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532dd"
        }
      },
      {
        "id": "p(HGNC:PTGER1)",
        "label": "p(HGNC:PTGER1)",
        "metadata": {
          "coordinate": [
            0.950366793574148,
            0.4089170036085388
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532de"
        }
      },
      {
        "id": "tscript(p(HGNC:CREB1))",
        "label": "tscript(p(HGNC:CREB1))",
        "metadata": {
          "coordinate": [
            0.2650663942798774,
            0.34631102995521934
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532df"
        }
      },
      {
        "id": "p(HGNC:TGFB2)",
        "label": "p(HGNC:TGFB2)",
        "metadata": {
          "coordinate": [
            0.576608784473953,
            0.36674492413373333
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532e0"
        }
      },
      {
        "id": "p(HGNC:CREB1,pmod(P,S,133))",
        "label": "p(HGNC:CREB1,pmod(P,S,133))",
        "metadata": {
          "coordinate": [
            0.2562447766737858,
            0.22327290117820964
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532e1"
        }
      },
      {
        "id": "p(SFAM:\"MEK1/2 Family\")",
        "label": "p(SFAM:\"MEK1/2 Family\")",
        "metadata": {
          "coordinate": [
            0.8394001300027858,
            0.7302073822877266
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532e2"
        }
      },
      {
        "id": "p(HGNC:HRAS)",
        "label": "p(HGNC:HRAS)",
        "metadata": {
          "coordinate": [
            0.6996471352957563,
            0.16414503717229686
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532e3"
        }
      },
      {
        "id": "bp(GOBP:\"cell proliferation\")",
        "label": "bp(GOBP:\"cell proliferation\")",
        "metadata": {
          "coordinate": [
            0.2933884297520661,
            0.6823833746358854
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532e4"
        }
      },
      {
        "id": "cat(p(HGNC:VIPR1))",
        "label": "cat(p(HGNC:VIPR1))",
        "metadata": {
          "coordinate": [
            0.16384993964156372,
            0.41587322290335205
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532e5"
        }
      },
      {
        "id": "kin(p(SFAM:\"RAF Family\"))",
        "label": "kin(p(SFAM:\"RAF Family\"))",
        "metadata": {
          "coordinate": [
            0.9447952456124059,
            0.6502108603973741
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532e6"
        }
      },
      {
        "id": "p(HGNC:PTGS2)",
        "label": "p(HGNC:PTGS2)",
        "metadata": {
          "coordinate": [
            0.40528368465038533,
            0.3163123342463371
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532e7"
        }
      },
      {
        "id": "a(CHEBI:\"arachidonic acid\")",
        "label": "a(CHEBI:\"arachidonic acid\")",
        "metadata": {
          "coordinate": [
            0.47167796452781124,
            0.13153775922785968
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532e8"
        }
      },
      {
        "id": "a(SCHEM:Dinoprostone)",
        "label": "a(SCHEM:Dinoprostone)",
        "metadata": {
          "coordinate": [
            0.6374315163896369,
            0.42369896961001696
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532e9"
        }
      },
      {
        "id": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "label": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "metadata": {
          "coordinate": [
            0.7850775373758009,
            0.8193339420025216
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532ea"
        }
      },
      {
        "id": "p(SFAM:\"MAPK Erk1/2 Family\")",
        "label": "p(SFAM:\"MAPK Erk1/2 Family\")",
        "metadata": {
          "coordinate": [
            0.7613984585383973,
            0.91019955654102
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532eb"
        }
      },
      {
        "id": "cat(p(HGNC:PTGS1))",
        "label": "cat(p(HGNC:PTGS1))",
        "metadata": {
          "coordinate": [
            0.40528368465038533,
            0.045454545454545456
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532ec"
        }
      },
      {
        "id": "kin(p(SFAM:\"MEK1/2 Family\"))",
        "label": "kin(p(SFAM:\"MEK1/2 Family\"))",
        "metadata": {
          "coordinate": [
            0.9169375058036957,
            0.7745532802921612
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532ed"
        }
      },
      {
        "id": "a(SCHEM:Colforsin)",
        "label": "a(SCHEM:Colforsin)",
        "metadata": {
          "coordinate": [
            0.284102516482496,
            0.46413199426111906
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532ee"
        }
      },
      {
        "id": "cat(p(HGNC:VAV2))",
        "label": "cat(p(HGNC:VAV2))",
        "metadata": {
          "coordinate": [
            0.2204940105859411,
            0.8471588191817747
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532ef"
        }
      },
      {
        "id": "p(HGNC:PTGES)",
        "label": "p(HGNC:PTGES)",
        "metadata": {
          "coordinate": [
            0.9206518711115238,
            0.27848789183079
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532f0"
        }
      },
      {
        "id": "cat(p(HGNC:PTGES2))",
        "label": "cat(p(HGNC:PTGES2))",
        "metadata": {
          "coordinate": [
            0.6040022286191847,
            0.1854484587626625
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532f1"
        }
      },
      {
        "id": "p(HGNC:CCND1)",
        "label": "p(HGNC:CCND1)",
        "metadata": {
          "coordinate": [
            0.18010028786331134,
            0.26761879918264425
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532f2"
        }
      },
      {
        "id": "p(HGNC:VAV2)",
        "label": "p(HGNC:VAV2)",
        "metadata": {
          "coordinate": [
            0.12670628656328348,
            0.8636798400069562
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532f3"
        }
      },
      {
        "id": "p(SFAM:\"RAS Family\")",
        "label": "p(SFAM:\"RAS Family\")",
        "metadata": {
          "coordinate": [
            0.9545454545454545,
            0.5249989130907352
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532f4"
        }
      },
      {
        "id": "a(SCHEM:\"Cyclic GMP\")",
        "label": "a(SCHEM:\"Cyclic GMP\")",
        "metadata": {
          "coordinate": [
            0.3421394744173089,
            0.6028216164514586
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532f5"
        }
      },
      {
        "id": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\")",
        "label": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\")",
        "metadata": {
          "coordinate": [
            0.6095737765809267,
            0.9041128646580585
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532f6"
        }
      },
      {
        "id": "p(HGNC:PTGES3)",
        "label": "p(HGNC:PTGES3)",
        "metadata": {
          "coordinate": [
            0.5566440709443774,
            0.6354288943958958
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532f7"
        }
      },
      {
        "id": "p(SFAM:\"RAF Family\")",
        "label": "p(SFAM:\"RAF Family\")",
        "metadata": {
          "coordinate": [
            0.8519361129167053,
            0.6341246032781184
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532f8"
        }
      },
      {
        "id": "cat(p(HGNC:TIAM1))",
        "label": "cat(p(HGNC:TIAM1))",
        "metadata": {
          "coordinate": [
            0.3133531432816417,
            0.8910699534802836
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532f9"
        }
      },
      {
        "id": "p(HGNC:CREB1)",
        "label": "p(HGNC:CREB1)",
        "metadata": {
          "coordinate": [
            0.3124245519546847,
            0.27109690883005083
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532fa"
        }
      },
      {
        "id": "p(HGNC:RAC1)",
        "label": "p(HGNC:RAC1)",
        "metadata": {
          "coordinate": [
            0.0979199554276163,
            0.7236859266988392
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532fb"
        }
      },
      {
        "id": "p(HGNC:PTGER4)",
        "label": "p(HGNC:PTGER4)",
        "metadata": {
          "coordinate": [
            0.045454545454545456,
            0.5354332420329551
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532fc"
        }
      },
      {
        "id": "p(SFAM:\"AKT Family\")",
        "label": "p(SFAM:\"AKT Family\")",
        "metadata": {
          "coordinate": [
            0.721469031479246,
            0.693687230989957
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532fd"
        }
      },
      {
        "id": "cat(p(HGNC:PTGES3))",
        "label": "cat(p(HGNC:PTGES3))",
        "metadata": {
          "coordinate": [
            0.5696443495217755,
            0.5549976087996175
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532fe"
        }
      },
      {
        "id": "p(HGNC:TGFB3)",
        "label": "p(HGNC:TGFB3)",
        "metadata": {
          "coordinate": [
            0.6713250998235676,
            0.347180557367071
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c340532ff"
        }
      },
      {
        "id": "p(HGNC:PTGER2)",
        "label": "p(HGNC:PTGER2)",
        "metadata": {
          "coordinate": [
            0.38067601448602467,
            0.4145689317855745
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c34053300"
        }
      },
      {
        "id": "p(HGNC:TGFB1)",
        "label": "p(HGNC:TGFB1)",
        "metadata": {
          "coordinate": [
            0.7335407187296871,
            0.3993522020781705
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c34053301"
        }
      },
      {
        "id": "p(SFAM:\"PRKA Family\")",
        "label": "p(SFAM:\"PRKA Family\")",
        "metadata": {
          "coordinate": [
            0.1457424087659021,
            0.6206469283944176
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c34053302"
        }
      },
      {
        "id": "kin(p(SFAM:\"PRKA Family\"))",
        "label": "kin(p(SFAM:\"PRKA Family\"))",
        "metadata": {
          "coordinate": [
            0.24603027207725878,
            0.5771705578018347
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b351ad3fbfd4c34053303"
        }
      },
      {
        "id": "cat(p(SFAM:\"PDE4 Family\"))",
        "label": "cat(p(SFAM:\"PDE4 Family\"))",
        "metadata": {
          "coordinate": [
            0.515078406555149,
            0.730434305840374
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "benwong1999",
          "nodeId": "52cb7d81bf21ca05bcfa1daf"
        }
      },
      {
        "id": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "metadata": {
          "coordinate": [
            0.185073904779308,
            0.955456119475633
          ],
          "bel_function_type": "pathology",
          "createdBy": "benwong1999",
          "nodeId": "52cb80aabf21ca05bcfa2492"
        }
      },
      {
        "id": "p(HGNC:PDE4A)",
        "label": "p(HGNC:PDE4A)",
        "metadata": {
          "coordinate": [
            0.662353825132527,
            0.864675220504718
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "tndror",
          "nodeId": "52ef5ea189e3620e445e995d"
        }
      },
      {
        "id": "p(HGNC:PDE4C)",
        "label": "p(HGNC:PDE4C)",
        "metadata": {
          "coordinate": [
            0.301056746999294,
            0.997095205354083
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "tndror",
          "nodeId": "52ef5f2089e3620e445e9ea2"
        }
      },
      {
        "id": "p(HGNC:CXCL8)",
        "label": "p(HGNC:CXCL8)",
        "metadata": {
          "coordinate": [
            0.390944081074998,
            0.931586942137958
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "pirxtrurl",
          "nodeId": "5511865c89e3620b9c6acab0"
        }
      }
    ],
    "edges": [
      {
        "source": "p(SFAM:\"MEK1/2 Family\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"MEK1/2 Family\"))",
        "directed": false,
        "label": "p(SFAM:\"MEK1/2 Family\") actsIn kin(p(SFAM:\"MEK1/2 Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053288",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"MEK1/2 Family\") actsIn kin(p(SFAM:\"MEK1/2 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Dinoprostone)",
        "relation": "decreases",
        "target": "p(HGNC:PDGFRA)",
        "directed": false,
        "label": "a(SCHEM:Dinoprostone) decreases p(HGNC:PDGFRA)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532b7",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Dinoprostone) decreases p(HGNC:PDGFRA)",
              "summary_text": "PGE2 downregulated PDGF-Ralpha protein and messenger RNA expression",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 1999 Mar 20(3) 433-40",
                "id": "10030841"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc1e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "relation": "increases",
        "target": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "directed": false,
        "label": "kin(p(SFAM:\"PIK3C Class IA Family\")) increases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405329c",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"PIK3C Class IA Family\")) increases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc3f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "directed": false,
        "label": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\") actsIn kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405329a",
          "evidences": [
            {
              "bel_statement": "complex(SCOMP:\"p85/p110 PI3Kinase Complex\") actsIn kin(p(SFAM:\"PIK3C Class IA Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc44"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CREB1)",
        "relation": " hasModification",
        "target": "p(HGNC:CREB1,pmod(P,S,133))",
        "directed": false,
        "label": "p(HGNC:CREB1)  hasModification p(HGNC:CREB1,pmod(P,S,133))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532af",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(SFAM:\"MAPK Erk1/2 Family\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "directed": false,
        "label": "p(SFAM:\"MAPK Erk1/2 Family\") actsIn kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405329d",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"MAPK Erk1/2 Family\") actsIn kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd3c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:VIPR1))",
        "relation": "increases",
        "target": "a(SCHEM:\"cyclic AMP\")",
        "directed": false,
        "label": "cat(p(HGNC:VIPR1)) increases a(SCHEM:\"cyclic AMP\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405327e",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:VIPR1)) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "VIP/VPAC1 interaction is associated with a cAMP increase and activation of a cAMP/p38 MAPK pathway, which regulates MMP-9, CD35, and CD11b exocytosis, and a cAMP/EPAC/PI-3K/ERK pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2008 Apr 83(4) 972-81",
                "id": "18174366"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"PRKA Family\"))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:CREB1))",
        "directed": false,
        "label": "kin(p(SFAM:\"PRKA Family\")) directlyIncreases tscript(p(HGNC:CREB1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532b4",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"PRKA Family\")) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "aken together, these data provide strong evidence that PKA is the enzyme responsible for phosphorylating CREB at S133 in response to PTH and that PKA activity is required for PTH-induced c-fos expression.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1999 Mar 140(3) 1255-61",
                "id": "10067851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:TIAM1))",
        "relation": "directlyIncreases",
        "target": "gtp(p(HGNC:RAC1))",
        "directed": false,
        "label": "cat(p(HGNC:TIAM1)) directlyIncreases gtp(p(HGNC:RAC1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053284",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:TIAM1)) directlyIncreases gtp(p(HGNC:RAC1))",
              "summary_text": "Tiam1 and Ras-GRF1 are guanine nucleotide exchange factors (GEFs) that activate the Rac GTPase.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(12) 4073-85",
                "id": "12024021"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd7d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NPPA)",
        "relation": "increases",
        "target": "cat(p(HGNC:RAPGEF3))",
        "directed": false,
        "label": "p(HGNC:NPPA) increases cat(p(HGNC:RAPGEF3))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532b5",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NPPA) increases cat(p(HGNC:RAPGEF3))",
              "summary_text": "The recently described cAMP-dependent guanine nucleotide exchange factor (GEF) Epac activates small GTPase Rap1, which results in activation of small GTPase Rac-specific GEFs Tiam1 and Vav2 and Rac-mediated EC barrier protective responses. Our results show that ANP stimulated protein kinase A and the Epac/Rap1/Tiam/Vav/Rac cascade",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd89"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:RAPGEF3))",
        "relation": "directlyIncreases",
        "target": "gtp(p(HGNC:RAP1A))",
        "directed": false,
        "label": "cat(p(HGNC:RAPGEF3)) directlyIncreases gtp(p(HGNC:RAP1A))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532b1",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:RAPGEF3)) directlyIncreases gtp(p(HGNC:RAP1A))",
              "summary_text": "From CST pathway map for GPCR Signaling to ERK. ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Endocrinol Metab 2006 Sep 17(7) 276-83",
                "id": "16890451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de0f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "gtp(p(HGNC:HRAS))",
        "relation": "increases",
        "target": "cat(p(HGNC:PTGS2))",
        "directed": false,
        "label": "gtp(p(HGNC:HRAS)) increases cat(p(HGNC:PTGS2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053281",
          "evidences": [
            {
              "bel_statement": "gtp(p(HGNC:HRAS)) increases cat(p(HGNC:PTGS2))",
              "summary_text": "Cyclooxygenase (COX)-2 and the subsequent production of prostaglandin E2 (PGE2) were also induced by H-Ras",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2006 Oct 15 119(8) 1767-75",
                "id": "16721810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de3a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Cyclic GMP\")",
        "relation": "decreases",
        "target": "bp(GOBP:\"cell proliferation\")",
        "directed": false,
        "label": "a(SCHEM:\"Cyclic GMP\") decreases bp(GOBP:\"cell proliferation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532a9",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Cyclic GMP\") decreases bp(GOBP:\"cell proliferation\")",
              "summary_text": "Endothelialderived relaxing factors, such as NO or prostacyclin (PGI2), relax blood vessels and inhibit the proliferation and migration of SMCs by increasing the synthesis of the cyclic nucleotides cAMP or cGMP.",
              "citation": {
                "type": "PubMed",
                "name": "J Smooth Muscle Res 2003 Aug 39(4) 67-86",
                "id": "14692693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de51"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PTGES)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:PTGES))",
        "directed": false,
        "label": "p(HGNC:PTGES) actsIn cat(p(HGNC:PTGES))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532bf",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PTGES) actsIn cat(p(HGNC:PTGES))",
              "summary_text": "Cell-specific prostaglandin synthases convert PGH2 into a series of prostaglandins, including PGI2, PGF2alpha, PGD2 and PGE2 (Fig. 1).   Fig. 1 Legend - Pathway of prostaglandin production. Arachidonic acid is liberated from membranes by phospholipase A2. The cyclooxygenase enzymes (COX-1 and COX-2) produce prostaglandin H2 (PGH2) from arachidonic acid. PGH2 is acted upon by prostaglandin synthases to produce PGI2, PGD2, PGE2 and PGF2alpha. PGD2 is metabolized to 15-deoxy-12,14-PGJ2 (15-d-PGJ2). ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2002 Mar 23(3) 144-50",
                "id": "11864843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGES) actsIn cat(p(HGNC:PTGES))",
              "summary_text": "PGH2 are metabolized to PGE2, PGI2, PGD2, PGF2alpha, and thromboxane A2 (TXA2) by respective actions of PGE2 synthase (PGES), PGI2 synthase (PGIS), PGD2 synthase (PGDS), PGF2 synthase (PGFS), and thromboxane synthase. ",
              "citation": {
                "type": "PubMed",
                "name": "Immune Netw 2011 Dec 11(6) 364-7",
                "id": "22346776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbe9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGES) actsIn cat(p(HGNC:PTGES))",
              "summary_text": "Treatment of HCA-7 cells with an mPGES-1 inhibitor or antisense oligonucleotide attenuated, whereas overexpression of mPGES-1 accelerated, PGE2 production and cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 19396-405",
                "id": "12626523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dba4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:PTGES))",
        "relation": "increases",
        "target": "a(SCHEM:Dinoprostone)",
        "directed": false,
        "label": "cat(p(HGNC:PTGES)) increases a(SCHEM:Dinoprostone)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532be",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:PTGES)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "Cell-specific prostaglandin synthases convert PGH2 into a series of prostaglandins, including PGI2, PGF2alpha, PGD2 and PGE2 (Fig. 1).   Fig. 1 Legend - Pathway of prostaglandin production. Arachidonic acid is liberated from membranes by phospholipase A2. The cyclooxygenase enzymes (COX-1 and COX-2) produce prostaglandin H2 (PGH2) from arachidonic acid. PGH2 is acted upon by prostaglandin synthases to produce PGI2, PGD2, PGE2 and PGF2alpha. PGD2 is metabolized to 15-deoxy-12,14-PGJ2 (15-d-PGJ2). ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2002 Mar 23(3) 144-50",
                "id": "11864843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de8b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGES)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "PGH2 are metabolized to PGE2, PGI2, PGD2, PGF2alpha, and thromboxane A2 (TXA2) by respective actions of PGE2 synthase (PGES), PGI2 synthase (PGIS), PGD2 synthase (PGDS), PGF2 synthase (PGFS), and thromboxane synthase. ",
              "citation": {
                "type": "PubMed",
                "name": "Immune Netw 2011 Dec 11(6) 364-7",
                "id": "22346776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de1e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGES)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "Treatment of HCA-7 cells with an mPGES-1 inhibitor or antisense oligonucleotide attenuated, whereas overexpression of mPGES-1 accelerated, PGE2 production and cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 19396-405",
                "id": "12626523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:PTGS2))",
        "relation": "decreases",
        "target": "a(CHEBI:\"arachidonic acid\")",
        "directed": false,
        "label": "cat(p(HGNC:PTGS2)) decreases a(CHEBI:\"arachidonic acid\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405329f",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) decreases a(CHEBI:\"arachidonic acid\")",
              "summary_text": "Cell-specific prostaglandin synthases convert PGH2 into a series of prostaglandins, including PGI2, PGF2alpha, PGD2 and PGE2 (Fig. 1).   Fig. 1 Legend - Pathway of prostaglandin production. Arachidonic acid is liberated from membranes by phospholipase A2. The cyclooxygenase enzymes (COX-1 and COX-2) produce prostaglandin H2 (PGH2) from arachidonic acid. PGH2 is acted upon by prostaglandin synthases to produce PGI2, PGD2, PGE2 and PGF2alpha. PGD2 is metabolized to 15-deoxy-12,14-PGJ2 (15-d-PGJ2). ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2002 Mar 23(3) 144-50",
                "id": "11864843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deb2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) decreases a(CHEBI:\"arachidonic acid\")",
              "summary_text": "FACL4 and COX-2 synergistically inhibit apoptosis by reducing the intracellular level of free arachidonic acid. Here, we report that expression of FACL4 is significantly increased in colon adenocarcinoma",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Dec 1 61(23) 8429-34",
                "id": "11731423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de2e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Dinoprostone)",
        "relation": "directlyIncreases",
        "target": "cat(p(HGNC:PTGER1))",
        "directed": false,
        "label": "a(SCHEM:Dinoprostone) directlyIncreases cat(p(HGNC:PTGER1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532bb",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Dinoprostone) directlyIncreases cat(p(HGNC:PTGER1))",
              "summary_text": "PGE2 acts via EP1 and EP2 receptor subtypes to stimulate both the PKC and PKA pathways. ",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1996 Dec 137(12) 5739-42",
                "id": "8940410"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dec5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:VEGFA)",
        "relation": "increases",
        "target": "a(SCHEM:Dinoprostone)",
        "directed": false,
        "label": "p(HGNC:VEGFA) increases a(SCHEM:Dinoprostone)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532a1",
          "evidences": [
            {
              "bel_statement": "p(HGNC:VEGFA) increases a(SCHEM:Dinoprostone)",
              "summary_text": "VEGF induced cyclooxygenase (COX) -2 mRNA expression in HUVECs and increased the PGE2 concentration in the medium. PGE2 treatment enhanced the expression of VEGF mRNA",
              "citation": {
                "type": "PubMed",
                "name": "Vascul Pharmacol 2006 Jun 44(6) 411-6",
                "id": "16651031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:IL1A)",
        "relation": "increases",
        "target": "a(SCHEM:Dinoprostone)",
        "directed": false,
        "label": "p(HGNC:IL1A) increases a(SCHEM:Dinoprostone)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053293",
          "evidences": [
            {
              "bel_statement": "p(HGNC:IL1A) increases a(SCHEM:Dinoprostone)",
              "summary_text": " PGE2 synthesis was drastically increased by IL-1alpha from the basal level (45  8 pg/well) to 280  29 pg/well (n = 3).",
              "citation": {
                "type": "PubMed",
                "name": "J Inflamm (Lond) 2006 3 4",
                "id": "16569220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "gtp(p(HGNC:HRAS))",
        "relation": "increases",
        "target": "a(SCHEM:Dinoprostone)",
        "directed": false,
        "label": "gtp(p(HGNC:HRAS)) increases a(SCHEM:Dinoprostone)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053282",
          "evidences": [
            {
              "bel_statement": "gtp(p(HGNC:HRAS)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "Cyclooxygenase (COX)-2 and the subsequent production of prostaglandin E2 (PGE2) were also induced by H-Ras",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2006 Oct 15 119(8) 1767-75",
                "id": "16721810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df12"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"PRKA Family\"))",
        "relation": "increases",
        "target": "gtp(p(HGNC:RAC1))",
        "directed": false,
        "label": "kin(p(SFAM:\"PRKA Family\")) increases gtp(p(HGNC:RAC1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532b3",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"PRKA Family\")) increases gtp(p(HGNC:RAC1))",
              "summary_text": "Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df1c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:CREB1))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CCND1)",
        "directed": false,
        "label": "tscript(p(HGNC:CREB1)) directlyIncreases p(HGNC:CCND1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532ad",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:CREB1)) directlyIncreases p(HGNC:CCND1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Dinoprostone)",
        "relation": "increases",
        "target": "kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "directed": false,
        "label": "a(SCHEM:Dinoprostone) increases kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532ba",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Dinoprostone) increases kin(p(SFAM:\"PIK3C Class IA Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df3f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:VEGFA)",
        "relation": "increases",
        "target": "p(HGNC:PTGS2)",
        "directed": false,
        "label": "p(HGNC:VEGFA) increases p(HGNC:PTGS2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532a2",
          "evidences": [
            {
              "bel_statement": "p(HGNC:VEGFA) increases p(HGNC:PTGS2)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df49"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TGFB3)",
        "relation": "increases",
        "target": "a(SCHEM:Dinoprostone)",
        "directed": false,
        "label": "p(HGNC:TGFB3) increases a(SCHEM:Dinoprostone)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405328b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TGFB3) increases a(SCHEM:Dinoprostone)",
              "summary_text": "All TGFbeta isoforms stimulated PGE2 synthesis; TGFbeta3 was approximately twice as potent as TGFbeta1 and TGFbeta2, each of which had similar effects",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1997 Feb 1 321 ( Pt 3) 639-43",
                "id": "9032448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfa9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:PTGS1))",
        "relation": "decreases",
        "target": "a(CHEBI:\"arachidonic acid\")",
        "directed": false,
        "label": "cat(p(HGNC:PTGS1)) decreases a(CHEBI:\"arachidonic acid\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053295",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:PTGS1)) decreases a(CHEBI:\"arachidonic acid\")",
              "summary_text": "Cell-specific prostaglandin synthases convert PGH2 into a series of prostaglandins, including PGI2, PGF2alpha, PGD2 and PGE2 (Fig. 1).   Fig. 1 Legend - Pathway of prostaglandin production. Arachidonic acid is liberated from membranes by phospholipase A2. The cyclooxygenase enzymes (COX-1 and COX-2) produce prostaglandin H2 (PGH2) from arachidonic acid. PGH2 is acted upon by prostaglandin synthases to produce PGI2, PGD2, PGE2 and PGF2alpha. PGD2 is metabolized to 15-deoxy-12,14-PGJ2 (15-d-PGJ2). ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2002 Mar 23(3) 144-50",
                "id": "11864843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e010"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:RAPGEF3))",
        "relation": "increases",
        "target": "kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "directed": false,
        "label": "cat(p(HGNC:RAPGEF3)) increases kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532b2",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:RAPGEF3)) increases kin(p(SFAM:\"PIK3C Class IA Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e068"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"MEK1/2 Family\"))",
        "relation": "directlyIncreases",
        "target": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "directed": false,
        "label": "kin(p(SFAM:\"MEK1/2 Family\")) directlyIncreases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053289",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"MEK1/2 Family\")) directlyIncreases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e081"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PTGES3)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:PTGES3))",
        "directed": false,
        "label": "p(HGNC:PTGES3) actsIn cat(p(HGNC:PTGES3))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053299",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PTGES3) actsIn cat(p(HGNC:PTGES3))",
              "summary_text": "Cell-specific prostaglandin synthases convert PGH2 into a series of prostaglandins, including PGI2, PGF2alpha, PGD2 and PGE2 (Fig. 1).   Fig. 1 Legend - Pathway of prostaglandin production. Arachidonic acid is liberated from membranes by phospholipase A2. The cyclooxygenase enzymes (COX-1 and COX-2) produce prostaglandin H2 (PGH2) from arachidonic acid. PGH2 is acted upon by prostaglandin synthases to produce PGI2, PGD2, PGE2 and PGF2alpha. PGD2 is metabolized to 15-deoxy-12,14-PGJ2 (15-d-PGJ2). ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2002 Mar 23(3) 144-50",
                "id": "11864843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dde1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGES3) actsIn cat(p(HGNC:PTGES3))",
              "summary_text": "Prostaglandin E synthase (PGES) is a terminal prostanoid synthase and can catalyse the isomerization of the COX product PGH2 to PGE2, including microsomal PGES-1 (mPGES-1), cytosolic PGES (cPGES) and mPGES-2.",
              "citation": {
                "type": "PubMed",
                "name": "Zygote 2005 May 13(2) 103-8",
                "id": "16128405"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0e2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "embryonic tissue"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Epoprostenol)",
        "relation": "increases",
        "target": "a(SCHEM:\"Cyclic GMP\")",
        "directed": false,
        "label": "a(SCHEM:Epoprostenol) increases a(SCHEM:\"Cyclic GMP\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532ab",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Epoprostenol) increases a(SCHEM:\"Cyclic GMP\")",
              "summary_text": "Endothelialderived relaxing factors, such as NO or prostacyclin (PGI2), relax blood vessels and inhibit the proliferation and migration of SMCs by increasing the synthesis of the cyclic nucleotides cAMP or cGMP.",
              "citation": {
                "type": "PubMed",
                "name": "J Smooth Muscle Res 2003 Aug 39(4) 67-86",
                "id": "14692693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e100"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NPPA)",
        "relation": "increases",
        "target": "kin(p(SFAM:\"PRKA Family\"))",
        "directed": false,
        "label": "p(HGNC:NPPA) increases kin(p(SFAM:\"PRKA Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532b6",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NPPA) increases kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The recently described cAMP-dependent guanine nucleotide exchange factor (GEF) Epac activates small GTPase Rap1, which results in activation of small GTPase Rac-specific GEFs Tiam1 and Vav2 and Rac-mediated EC barrier protective responses. Our results show that ANP stimulated protein kinase A and the Epac/Rap1/Tiam/Vav/Rac cascade",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e111"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:NPPA) increases kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Our results show that, in addition to significant elevation of intracellular cGMP levels, ANP treatment of human pulmonary EC induced time-dependent increases in intracellular cAMP concentrations (Fig. 1A,B) and activation of cAMP-dependent protein kinase (PKA, Fig. 1C).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:CREB1))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:PTGS2)",
        "directed": false,
        "label": "tscript(p(HGNC:CREB1)) directlyIncreases p(HGNC:PTGS2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532ae",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:CREB1)) directlyIncreases p(HGNC:PTGS2)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e13f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:PTGS2))",
        "relation": "increases",
        "target": "a(SCHEM:Dinoprostone)",
        "directed": false,
        "label": "cat(p(HGNC:PTGS2)) increases a(SCHEM:Dinoprostone)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405329e",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "Cell-specific prostaglandin synthases convert PGH2 into a series of prostaglandins, including PGI2, PGF2alpha, PGD2 and PGE2 (Fig. 1).   Fig. 1 Legend - Pathway of prostaglandin production. Arachidonic acid is liberated from membranes by phospholipase A2. The cyclooxygenase enzymes (COX-1 and COX-2) produce prostaglandin H2 (PGH2) from arachidonic acid. PGH2 is acted upon by prostaglandin synthases to produce PGI2, PGD2, PGE2 and PGF2alpha. PGD2 is metabolized to 15-deoxy-12,14-PGJ2 (15-d-PGJ2). ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2002 Mar 23(3) 144-50",
                "id": "11864843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df4a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "Mechanisms of cancer promotion by COX-2 are not fully understood, but signaling through prostaglandin (PG)E2 receptors is a contributing factor. The major PGE2 receptors on epithelial cells, EP2 and EP4, increase cAMP production, which promotes growth and inhibits apoptosis in some cell types.  To explore the hypothesis that PGE2-stimulated cAMP  is a key intracellular mediator of COX-2-dependent antiapoptosis and define the underlying mechanisms, we used the T84 human colon epithelial cell line, which exhibits inducible apoptosis and is responsive to PGE2  stimulation (31, 34, 35). The major PGE2 receptors on colon epithelial cells are EP2 and EP4  (25), a finding we confirmed by RT-PCR of T84 cells (data not shown). Both EP2 and EP4 receptors activate adenylyl cyclase and increase cAMP as a second messenger, suggesting that cAMP mediates antiapoptotic functions in epithelial cells. Consistent with this idea, we found that a membrane-permeant  cAMP analog, 8-CPT-cAMP, and CTX, which catalyzes the ADP-ribosylation of Gs regulatory protein, leading to the activation of adenylyl  cyclase, also inhibited Fas- and staurosporine-promoted apoptosis  (Fig. 1 A). These findings were confirmed by evidence that CTX and 8-CPT-cAMP also inhibited the formation of apoptosis-associated DNA laddering in T84 cells (Fig. 1B and data not shown). We obtained similar results with the normal rat intestinal epithelial  cell line, RIE-1 (Fig. 1C). Thus, the antiapoptotic response to increases in cAMP in intestinal epithelial cells is independent of their state of transformation and conserved across at least two species.\\\"From full text\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jul 22 100(15) 8921-6",
                "id": "12837940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd8a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "Prostaglandins, particularly prostaglandin E2 (PGE2), play an important role during inflammation. This is exemplified by the clinical use of cyclooxygenase 2 inhibitors, which interfere with PGE2 synthesis, as effective antiinflammatory drugs. In human purified naive T cells, PGE2 acts via prostaglandin receptor EP2- and EP4-mediated signaling and cyclic AMP pathways to up-regulate IL-23 and IL-1 receptor expression. ",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2009 Mar 16 206(3) 535-48",
                "id": "19273625"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e03c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "naive T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "in both benign and malignant mouse intestinal tumors, stromal expression of COX2 results in elevated PGE2 levels that stimulate, in turn, cell surface receptor EP2, followed by induction of VEGF and angiogenesis",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2004 Aug 25(4) 581-611",
                "id": "15294883"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd84"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "COX-2 synthesizes prostaglandin E2 (PGE2) which stimulates bcl-2 and inhibits apoptosis, and induces interleukin-6 (IL-6) which enhances haptoglobin synthesis. PGE2 is associated with tumor metastases, IL-6 with cancer cell invasion, and haptoglobin with implantation and angiogenesis",
              "citation": {
                "type": "PubMed",
                "name": "Ann Clin Lab Sci 2000 Jan 30(1) 3-21",
                "id": "10678579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e146"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "These data suggest that H2O2 stimulates CFTR Cl(-) channel-mediated Cl(-) secretion through cyclooxygenase- and mPGES-1-dependent release of PGE2 and subsequent activation of PKA.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2007 Nov 293(5) F1571-6",
                "id": "17699556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "renal medulla"
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "To test whether the PGE2 produced was through COX-2, a COX-2-selective inhibitor NS398 was used (51). At 300 nM, there was complete inhibition of TNF-induced PGE2 production, suggesting a key role for COX-2 in the PGE2 response to TNF in this system (Fig. 1B).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Aug 17(11) 1411-21",
                "id": "12890694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e053"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "These results indicate that PGE(2) synthetic capacity in AECs is predominantly COX-2-dependent under both basal and stimulated conditions",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2002 Dec 27(6) 752-8",
                "id": "12444036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de31"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "The elevated PGE2 production by metastatic cancer cells was due to COX-2 activity since dual COX-1/2 inhibitor indomethacin and selective COX-2 inhibitor NS-398 equally suppressed both basal and inducible (by IFN-gamma/LPS or Ca2+-ionophores) PGE2 accumulation.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Oct 1 289(2) 265-74",
                "id": "14499627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dde9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "Cyclooxygenase-2 (COX-2) antagonists, by blocking prostaglandin production, might inhibit this pathway 149.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Feb 2(2) 101-12",
                "id": "12635173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGS2)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "Cyclooxygenase-2 (COX-2) is a crucial enzyme in the conversion of arachidonicacid to prostaglandin E2 (PGE(2)) and is significantly upregulated in many typesof adenocarcinomas.",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2003 Dec 1010 504-9",
                "id": "15033780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcd7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Dinoprostone)",
        "relation": "directlyIncreases",
        "target": "cat(p(HGNC:PTGER2))",
        "directed": false,
        "label": "a(SCHEM:Dinoprostone) directlyIncreases cat(p(HGNC:PTGER2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532bc",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Dinoprostone) directlyIncreases cat(p(HGNC:PTGER2))",
              "summary_text": "PGE(2) acts through different receptors (EP1-4). (EP1=PTGER1, EP2=PTGER2..etc.) ....EP1, EP2, EP3, and EP4 were expressed on human platelets and megakaryocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2011 Feb 336(2) 391-402",
                "id": "21059804"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Dinoprostone) directlyIncreases cat(p(HGNC:PTGER2))",
              "summary_text": "PGE2 acts via EP1 and EP2 receptor subtypes to stimulate both the PKC and PKA pathways. ",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1996 Dec 137(12) 5739-42",
                "id": "8940410"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e16d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Dinoprostone) directlyIncreases cat(p(HGNC:PTGER2))",
              "summary_text": "Work in our laboratory (13) and others (14) has shown that the inhibitory actions of PGE2 in lung fibroblasts are a result of increases in cAMP, mediated through the Gas-coupled EP2 receptor;",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 Oct 39(4) 482-9",
                "id": "18421013"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddd5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:PTGES3))",
        "relation": "increases",
        "target": "a(SCHEM:Dinoprostone)",
        "directed": false,
        "label": "cat(p(HGNC:PTGES3)) increases a(SCHEM:Dinoprostone)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053298",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:PTGES3)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "Cell-specific prostaglandin synthases convert PGH2 into a series of prostaglandins, including PGI2, PGF2alpha, PGD2 and PGE2 (Fig. 1).   Fig. 1 Legend - Pathway of prostaglandin production. Arachidonic acid is liberated from membranes by phospholipase A2. The cyclooxygenase enzymes (COX-1 and COX-2) produce prostaglandin H2 (PGH2) from arachidonic acid. PGH2 is acted upon by prostaglandin synthases to produce PGI2, PGD2, PGE2 and PGF2alpha. PGD2 is metabolized to 15-deoxy-12,14-PGJ2 (15-d-PGJ2). ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2002 Mar 23(3) 144-50",
                "id": "11864843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e193"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGES3)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "Prostaglandin E synthase (PGES) is a terminal prostanoid synthase and can catalyse the isomerization of the COX product PGH2 to PGE2, including microsomal PGES-1 (mPGES-1), cytosolic PGES (cPGES) and mPGES-2.",
              "citation": {
                "type": "PubMed",
                "name": "Zygote 2005 May 13(2) 103-8",
                "id": "16128405"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0b5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "embryonic tissue"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Dinoprostone)",
        "relation": "increases",
        "target": "gtp(p(SFAM:\"RAS Family\"))",
        "directed": false,
        "label": "a(SCHEM:Dinoprostone) increases gtp(p(SFAM:\"RAS Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532b8",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Dinoprostone) increases gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "we found that PGE2 stimulated the activation of Ras and ERK, but not Akt, and reduced matrix deprivation-induced apoptosis, in untransformed epithelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2007 Dec 46(12) 958-70",
                "id": "17477350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FGF7)",
        "relation": "increases",
        "target": "a(SCHEM:Dinoprostone)",
        "directed": false,
        "label": "p(HGNC:FGF7) increases a(SCHEM:Dinoprostone)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053294",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FGF7) increases a(SCHEM:Dinoprostone)",
              "summary_text": "We conclude that in this coculture system, IL-1alpha secretion by ATII cells is one factor that stimulates PGE2 production by lung fibroblasts, thereby inhibiting fibroblast proliferation. In addition, these studies demonstrate that KGF enhances ATII cell PGE2 production through an IL-1alpha-independent pathway",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2006 Feb 290(2) L307-16",
                "id": "16169897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "gtp(p(SFAM:\"RAS Family\"))",
        "relation": "directlyIncreases",
        "target": "kin(p(SFAM:\"RAF Family\"))",
        "directed": false,
        "label": "gtp(p(SFAM:\"RAS Family\")) directlyIncreases kin(p(SFAM:\"RAF Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405327c",
          "evidences": [
            {
              "bel_statement": "gtp(p(SFAM:\"RAS Family\")) directlyIncreases kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Moreover, Erbin inhibits the Erk activation by active Ras, while it fails to do so in the presence of active Raf-1. Erbin associates with active Ras, but not inactive Ras nor Raf. Consistently, Erbin interferes with the interaction between Ras and Raf both in vivo and in vitro. Erbin associates with active Ras, but not inactive Ras nor Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 10 278(2) 1108-14",
                "id": "12379659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(SFAM:\"RAS Family\")) directlyIncreases kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e257"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(SFAM:\"RAS Family\")) directlyIncreases kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(SFAM:\"RAS Family\")) directlyIncreases kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Because Raf binds tightly to the GTP-bound form of Ras but not to the GDP-bound form, such differential affinity can be used to determine the GTP-bound status of Ras. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31981-6",
                "id": "10542228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"cyclic AMP\")",
        "relation": "directlyIncreases",
        "target": "cat(p(HGNC:RAPGEF3))",
        "directed": false,
        "label": "a(SCHEM:\"cyclic AMP\") directlyIncreases cat(p(HGNC:RAPGEF3))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532a7",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"cyclic AMP\") directlyIncreases cat(p(HGNC:RAPGEF3))",
              "summary_text": "Stimulation of phosphoinositide-hydrolysing phospholipase C (PLC) generating inositol-1,4,5-trisphosphate is a major calcium signalling pathway used by a wide variety of membrane receptors, activating distinct PLC-beta or PLC-gamma isoforms. Here we report a new PLC and calcium signalling pathway that is triggered by cyclic AMP (cAMP) and mediated by a small GTPase of the Rap family. Activation of the adenylyl cyclase-coupled beta2-adrenoceptor expressed in HEK-293 cells or the endogenous receptor for prostaglandin E1 in N1E-115 neuroblastoma cells induced calcium mobilization and PLC stimulation, seemingly caused by cAMP formation, but was independent of protein kinase A (PKA). We provide evidence that these receptor responses are mediated by a Rap GTPase, specifically Rap2B, activated by a guanine-nucleotide-exchange factor (Epac) regulated by cAMP, and involve the recently identified PLC-epsilon isoform.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Nov 3(11) 1020-4",
                "id": "11715024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df06"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:\"cyclic AMP\") directlyIncreases cat(p(HGNC:RAPGEF3))",
              "summary_text": "Two principal effector proteins for cAMP are protein kinase A (PKA) and EPAC (exchange protein directly activated by cAMP), a Rap guanosine 5'-diphosphate (GDP) exchange factor.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Apr 1 103(7) 2661-7",
                "id": "14615375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e276"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"cyclic AMP\")",
        "relation": "directlyIncreases",
        "target": "kin(p(SFAM:\"PRKA Family\"))",
        "directed": false,
        "label": "a(SCHEM:\"cyclic AMP\") directlyIncreases kin(p(SFAM:\"PRKA Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532a6",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"cyclic AMP\") directlyIncreases kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Insulin also profoundly inhibits lipolysis in adipocytes, primarily through inhibition of the enzyme hormone sensitive lipase71. This enzyme is acutely regulated by control of its phosphorylation state, which is activated by PKA-dependent phosphorylation, and inhibited as a result of a combination of kinase inhibition and phosphatase activation. Insulin inhibits the activity of the lipase primarily through reductions in cAMP levels, owing to the activation of a cAMP-specific phosphodiesterase in fat cells72.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Adipose Tissue"
              }
            },
            {
              "bel_statement": "a(SCHEM:\"cyclic AMP\") directlyIncreases kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Because Rap1b is one of the proteins that become phosphorylated by PKA upon elevation of intracellular cAMP levels, we evaluated the effect of the absence of Rap1b in platelets on cAMP-induced inhibition of AYPGKF peptide-induced platelet aggregation (Figure ?(Figure4C).4C).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2005 Mar 115(3) 680-7",
                "id": "15696195"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2b4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:\"cyclic AMP\") directlyIncreases kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Cyclic AMP activates PKA, therefore we expect to see an increased difference between active and inactive PKA when cAMP levels are physiologically high. ",
              "citation": {
                "type": "PubMed",
                "name": "BMC Syst Biol 2009 3 70",
                "id": "19607691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:\"cyclic AMP\") directlyIncreases kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Hepatic gluconeogenesis is essential for maintenance of normal blood glucose concentrations and is regulated by opposing stimulatory (cyclic adenosine monophosphate, cAMP) and inhibitory (insulin) signaling pathways. The cAMP signaling pathway leads to phosphorylation of cAMP response element-binding (CREB) protein, resulting in recruitment of the coactivators CREB-binding protein (CBP) and p300 and subsequent activation of gluconeogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2004 Jun 10(6) 633-7",
                "id": "15146178"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TGFB2)",
        "relation": "increases",
        "target": "a(SCHEM:Dinoprostone)",
        "directed": false,
        "label": "p(HGNC:TGFB2) increases a(SCHEM:Dinoprostone)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405328a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TGFB2) increases a(SCHEM:Dinoprostone)",
              "summary_text": "All TGFbeta isoforms stimulated PGE2 synthesis; TGFbeta3 was approximately twice as potent as TGFbeta1 and TGFbeta2, each of which had similar effects",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1997 Feb 1 321 ( Pt 3) 639-43",
                "id": "9032448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PTGER1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:PTGER1))",
        "directed": false,
        "label": "p(HGNC:PTGER1) actsIn cat(p(HGNC:PTGER1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405327d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PTGER1) actsIn cat(p(HGNC:PTGER1))",
              "summary_text": "11d-16dm PGE(2) and 17-phenyltrinor PGE(2) (EP3 > EP1 agonist) at nanomolar concentrations counteracted PGE(1)-induced VASP phosphorylation and induced platelet microaggregates and P-selectin expression",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2011 Feb 336(2) 391-402",
                "id": "21059804"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e136"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER1) actsIn cat(p(HGNC:PTGER1))",
              "summary_text": "After overnight smoking cessation, basal and prostaglandin E1-induced phosphorylation state of intraplatelet VASP was compared between smokers and non-smokers. Furthermore, the ability of several concentrations of ADP to induce surface expression of P-selectin was assessed",
              "citation": {
                "type": "PubMed",
                "name": "Platelets 2010 21(8) 596-603",
                "id": "20822337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e12c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER1) actsIn cat(p(HGNC:PTGER1))",
              "summary_text": "PGE(2) and agonists of EP(1) and EP(2) significantly increased aromatase activity levels, which were decreased by the corresponding antagonists.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2003 Jun 88(6) 2810-6",
                "id": "12788892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "stroma"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER1) actsIn cat(p(HGNC:PTGER1))",
              "summary_text": "Antigen-evoked secretion of interferon-gamma (IFN-gamma) by sperm whale myoglobin-specific Th1 cells of DBA/2 mouse I-Ed-restricted clones, that express EP3Rs and EP4Rs, was enhanced a maximum of 3-fold by 10(-10) to 10(-8) M PGE2 and 2.5-fold each for the EP1R/EP3R-directed agonist sulprostone (10(-8) and 10(-7) M) and for the EP4R/EP3R/EP2R agonist misoprostol (10(-9) M). ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Immunol 1999 May 25 194(1) 21-7",
                "id": "10357877"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER1) actsIn cat(p(HGNC:PTGER1))",
              "summary_text": "PGE2 acts via EP1 and EP2 receptor subtypes to stimulate both the PKC and PKA pathways. ",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1996 Dec 137(12) 5739-42",
                "id": "8940410"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e316"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER1) actsIn cat(p(HGNC:PTGER1))",
              "summary_text": "Consistent with our findings using PKC inhibition by Ro-31-8425, blocking the EP1 receptors by AH6809 notably suppressed the PGE2-dependent Erk phosphorylation (Fig. 5B).  ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jul 15 65(14) 6275-81",
                "id": "16024629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER1) actsIn cat(p(HGNC:PTGER1))",
              "summary_text": "PGE(2) exerts its actions via four transmembrane receptors, EP(1), EP(2), EP(3), and EP(4)",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2003 Jun 88(6) 2810-6",
                "id": "12788892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df01"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER1) actsIn cat(p(HGNC:PTGER1))",
              "summary_text": "EP1/EP3 agonist, sulprostone.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 16 278(20) 17977-81",
                "id": "12637575"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de4e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER1) actsIn cat(p(HGNC:PTGER1))",
              "summary_text": "The EP1 receptor is functionally connected to Gq, a G protein that increases Ca2+i. ",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2008 Nov 24 205(12) 2791-801",
                "id": "18955568"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc3c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER1) actsIn cat(p(HGNC:PTGER1))",
              "summary_text": "Prostaglandin E(2) (PGE(2)) is the most abundant prostaglandin in the human body. It has a large number of biological actions that it exerts via four types of receptors, EP1-4",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2007 Sep 59(3) 207-24",
                "id": "17878511"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "gtp(p(HGNC:RAP1A))",
        "relation": "increases",
        "target": "cat(p(HGNC:TIAM1))",
        "directed": false,
        "label": "gtp(p(HGNC:RAP1A)) increases cat(p(HGNC:TIAM1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053285",
          "evidences": [
            {
              "bel_statement": "gtp(p(HGNC:RAP1A)) increases cat(p(HGNC:TIAM1))",
              "summary_text": "The recently described cAMP-dependent guanine nucleotide exchange factor (GEF) Epac activates small GTPase Rap1, which results in activation of small GTPase Rac-specific GEFs Tiam1 and Vav2 and Rac-mediated EC barrier protective responses. Our results show that ANP stimulated protein kinase A and the Epac/Rap1/Tiam/Vav/Rac cascade",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e32c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "gtp(p(HGNC:RAP1A)) increases cat(p(HGNC:TIAM1))",
              "summary_text": "Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Epoprostenol)",
        "relation": "increases",
        "target": "a(SCHEM:\"cyclic AMP\")",
        "directed": false,
        "label": "a(SCHEM:Epoprostenol) increases a(SCHEM:\"cyclic AMP\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532aa",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Epoprostenol) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "The major antiplatelet agents secreted by endothelial cells are prostacyclin (PGI2) and nitric oxide (NO) (Cines et al., 1998). Both synergistically increasecAMPcontent in platelets, hence preventing their aggregation (de Graaf et al., 1992).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2003 Sep 196(3) 430-43",
                "id": "12891700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e11a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Epoprostenol) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Endothelial cells convert arachidonic acid into prostacyclin with the help of cyclooxygenase-1 or cyclooxygenase-2 (COX-1 or COX-2) and prostacyclin synthase. COX-2 appears to be important in prostacyclin synthesis, on the basis of the effects of selective COX-2 inhibitors on the excretion of prostacyclin metabolites.19-21 Prostacyclin inhibits platelet function by elevating intracellular cyclic AMP levels.22",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2007 Dec 13 357(24) 2482-94",
                "id": "18077812"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deb3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Epoprostenol) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Endothelialderived relaxing factors, such as NO or prostacyclin (PGI2), relax blood vessels and inhibit the proliferation and migration of SMCs by increasing the synthesis of the cyclic nucleotides cAMP or cGMP.",
              "citation": {
                "type": "PubMed",
                "name": "J Smooth Muscle Res 2003 Aug 39(4) 67-86",
                "id": "14692693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de29"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Epoprostenol) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "antimitogenic effects of NO and PGI2 on SMCs have been demonstrated in vitro and in vivo acting via production of the intracellular messengers cGMP and cAMP, respectivley",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2001 Jun 280(6) C1375-86",
                "id": "11350732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e338"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Epoprostenol) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e00e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"cyclic AMP\")",
        "relation": "decreases",
        "target": "bp(GOBP:\"cell proliferation\")",
        "directed": false,
        "label": "a(SCHEM:\"cyclic AMP\") decreases bp(GOBP:\"cell proliferation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532a8",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"cyclic AMP\") decreases bp(GOBP:\"cell proliferation\")",
              "summary_text": "Figure 2 shows that different cAMP elevating agents inhibit the growth of MDA-MB-231 cells. Cells were incubated for 48 h with increasing (from 10-9 to 10-4 M) concentrations of forskolin (A), or (from 0.05 to10 mM) 8-Br-cAMP (B), or (from 0.05, to 5 mM ) IBMX (C); then cell proliferation was calculated by a conventional tetrazolium-based (MTT) assay. As shown in Figure 2, all cAMP elevating compounds induced anti-proliferative effects",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 2009 Jun 8(12) 1183-90",
                "id": "19662684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e19b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:\"cyclic AMP\") decreases bp(GOBP:\"cell proliferation\")",
              "summary_text": "Endothelialderived relaxing factors, such as NO or prostacyclin (PGI2), relax blood vessels and inhibit the proliferation and migration of SMCs by increasing the synthesis of the cyclic nucleotides cAMP or cGMP.",
              "citation": {
                "type": "PubMed",
                "name": "J Smooth Muscle Res 2003 Aug 39(4) 67-86",
                "id": "14692693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de95"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "a(SCHEM:\"cyclic AMP\") decreases bp(GOBP:\"cell proliferation\")",
              "summary_text": "Gaumond et al demonstrated in rat vascular smooth muscle cells that augmentation of cAMP levels or activation of PKA inhibited proliferation",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Mar 18(3) 568-70",
                "id": "14715700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd6e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:\"cyclic AMP\") decreases bp(GOBP:\"cell proliferation\")",
              "summary_text": "Cyclic AMP analogues inhibited proliferation, as well as other treatments that increased intracellular cAMP. The cAMP-induced inhibition could be reversed after 24 h by the removal of dibutyryl-cAMP from the culture medium and readdition of IL6. In the absence of IL6, cAMP induced a slow loss of viable cells.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2001 Apr 15 265(1) 73-9",
                "id": "11281645"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbc3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:\"cyclic AMP\") decreases bp(GOBP:\"cell proliferation\")",
              "summary_text": "Gaumond et al demonstrated in rat vascular smooth muscle cells that augmentation of cAMP levels or activation of PKA inhibited proliferation",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Mar 18(3) 568-70",
                "id": "14715700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e340"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "a(SCHEM:\"cyclic AMP\") decreases bp(GOBP:\"cell proliferation\")",
              "summary_text": "Forskolin, a cAMP-elevating agent, or 8-Bromo-cAMP (8-B-cAMP), a cell permeable cAMP analogue, inhibited the cell proliferation and markedly enhanced apoptosis induced by transforming growth factor-beta1, but completely suppressed serum deprivation-induced apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Int J Biochem Cell Biol 2005 Jul 37(7) 1483-95",
                "id": "15833279"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e186"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"PIK3C Class IA Family\"))",
        "relation": "increases",
        "target": "kin(p(SFAM:\"AKT Family\"))",
        "directed": false,
        "label": "kin(p(SFAM:\"PIK3C Class IA Family\")) increases kin(p(SFAM:\"AKT Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405329b",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"PIK3C Class IA Family\")) increases kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e341"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Dinoprostone)",
        "relation": "directlyIncreases",
        "target": "cat(p(HGNC:PTGER3))",
        "directed": false,
        "label": "a(SCHEM:Dinoprostone) directlyIncreases cat(p(HGNC:PTGER3))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532bd",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Dinoprostone) directlyIncreases cat(p(HGNC:PTGER3))",
              "summary_text": "PGE(2) acts through different receptors (EP1-4). (EP1=PTGER1, EP2=PTGER2..etc.) ....EP1, EP2, EP3, and EP4 were expressed on human platelets and megakaryocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2011 Feb 336(2) 391-402",
                "id": "21059804"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e344"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Dinoprostone) directlyIncreases cat(p(HGNC:PTGER3))",
              "summary_text": "PGE2 exerted its action by activating EP3 receptors. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pain 2007 3 22",
                "id": "17692121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e00b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:PTGER2))",
        "relation": "increases",
        "target": "a(SCHEM:\"cyclic AMP\")",
        "directed": false,
        "label": "cat(p(HGNC:PTGER2)) increases a(SCHEM:\"cyclic AMP\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053290",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:PTGER2)) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Mechanisms of cancer promotion by COX-2 are not fully understood, but signaling through prostaglandin (PG)E2 receptors is a contributing factor. The major PGE2 receptors on epithelial cells, EP2 and EP4, increase cAMP production, which promotes growth and inhibits apoptosis in some cell types.  To explore the hypothesis that PGE2-stimulated cAMP  is a key intracellular mediator of COX-2-dependent antiapoptosis and define the underlying mechanisms, we used the T84 human colon epithelial cell line, which exhibits inducible apoptosis and is responsive to PGE2  stimulation (31, 34, 35). The major PGE2 receptors on colon epithelial cells are EP2 and EP4  (25), a finding we confirmed by RT-PCR of T84 cells (data not shown). Both EP2 and EP4 receptors activate adenylyl cyclase and increase cAMP as a second messenger, suggesting that cAMP mediates antiapoptotic functions in epithelial cells. Consistent with this idea, we found that a membrane-permeant  cAMP analog, 8-CPT-cAMP, and CTX, which catalyzes the ADP-ribosylation of Gs regulatory protein, leading to the activation of adenylyl  cyclase, also inhibited Fas- and staurosporine-promoted apoptosis  (Fig. 1 A). These findings were confirmed by evidence that CTX and 8-CPT-cAMP also inhibited the formation of apoptosis-associated DNA laddering in T84 cells (Fig. 1B and data not shown). We obtained similar results with the normal rat intestinal epithelial  cell line, RIE-1 (Fig. 1C). Thus, the antiapoptotic response to increases in cAMP in intestinal epithelial cells is independent of their state of transformation and conserved across at least two species.\\\"From full text\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jul 22 100(15) 8921-6",
                "id": "12837940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db86"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGER2)) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Work in our laboratory (13) and others (14) has shown that the inhibitory actions of PGE2 in lung fibroblasts are a result of increases in cAMP, mediated through the Gas-coupled EP2 receptor;",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 Oct 39(4) 482-9",
                "id": "18421013"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGER2)) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Activation of the adenylyl cyclase-coupled beta2-adrenoceptor expressed in HEK-293 cells or the endogenous receptor for prostaglandin E1 in N1E-115 neuroblastoma cells induced calcium mobilization and PLC stimulation, seemingly caused by cAMP formation,",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Nov 3(11) 1020-4",
                "id": "11715024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e379"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGER2)) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e02c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGER2)) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2001 Dec 79(5) 950-8",
                "id": "11739606"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df3a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGER2)) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Stimulation of EP2 and EP4 is linked with cyclic adenosine 3', 5'-monophosphate (cAMP)-dependent protein kinase A (PKA). specific agonists of these receptors induced growth inhibition with an accompanying increase in cAMP production.",
              "citation": {
                "type": "PubMed",
                "name": "J Lab Clin Med 2002 Aug 140(2) 92-102",
                "id": "12228765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:VAV2)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:VAV2))",
        "directed": false,
        "label": "p(HGNC:VAV2) actsIn cat(p(HGNC:VAV2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532a3",
          "evidences": [
            {
              "bel_statement": "p(HGNC:VAV2) actsIn cat(p(HGNC:VAV2))",
              "summary_text": "We found that CD36 contributes to activation of Vav-1, -2, and -3 in aortae from hyperlipidemic mice and that oxidatively modified LDL (oxLDL) induces activation of macrophage Vav in vitro in a CD36 and Src family kinase-dependent manner. CD36-dependent uptake of oxLDL in vitro and foam cell formation in vitro and in vivo was significantly reduced in Vav null macrophages. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2011 Mar 4 286(9) 7010-7",
                "id": "21209086"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e37c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VAV2) actsIn cat(p(HGNC:VAV2))",
              "summary_text": "The recently described cAMP-dependent guanine nucleotide exchange factor (GEF) Epac activates small GTPase Rap1, which results in activation of small GTPase Rac-specific GEFs Tiam1 and Vav2 and Rac-mediated EC barrier protective responses. Our results show that ANP stimulated protein kinase A and the Epac/Rap1/Tiam/Vav/Rac cascade",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e30f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:VAV2) actsIn cat(p(HGNC:VAV2))",
              "summary_text": "# Ariadne: During the course of our studies, Bustelo and colleagues ( 18 ) showed that Vav2 was an activator of RhoA, RhoB, and RhoG but not Rac1 or Cdc42 in vitro . [Regulation] Vav and Vav2 are members of the Dbl family of proteins that act as guanine nucleotide exchange factors (GEFs) for Rho family proteins.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10141-9",
                "id": "10744696"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e20f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VAV2) actsIn cat(p(HGNC:VAV2))",
              "summary_text": "Stimulation of EC with PGE2 or beraprost induced site-specific tyrosine phosphorylation of Vav2 in a time-dependent manner (Figure 2B, left panels), which along with Vav2 membrane translocation (Figure 2B, right panels) is essential for a full activation of Vav2 nucleotide exchange activity [33,37].",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfa1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VAV2) actsIn cat(p(HGNC:VAV2))",
              "summary_text": "First, we determined that RhoG was regulated by guanine nucleotide exchange factors that also activate Rac and/or Cdc42. Vav2 (which activates RhoA, Rac1, and Cdc42) and to a lesser degree Dbs (which activates RhoA and Cdc42) activated RhoG in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47810-7",
                "id": "12376551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df3e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VAV2) actsIn cat(p(HGNC:VAV2))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VAV2) actsIn cat(p(HGNC:VAV2))",
              "summary_text": "Vav proteins thus regulate an NF-kappaB-dependent survival signal in naive B cells and are required for NF-kappaB function after BCR cross-linking.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Oct 1 106(7) 2391-8",
                "id": "15941910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407decf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VAV2) actsIn cat(p(HGNC:VAV2))",
              "summary_text": "Vav2 phosphorylation observed in these experiments reflects the activation of Rac-specific Vav2 nucleotide exchange activity (Aghazadeh et al., 2000).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dea9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VAV2) actsIn cat(p(HGNC:VAV2))",
              "summary_text": "We further show that Vav2 and the ubiquitously expressed Rac1 guanine nucleotide exchange factor Tiam1 are phosphorylated in tyrosine residues in cells transfected with active and oncogenic Src.Moreover, phosphorylation of Tiam1 in cells treated with pervanadate, a potent inhibitor of tyrosine phosphatases, was partially inhibited by the Src inhibitor SU6656.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 5 278(36) 34339-46",
                "id": "12810717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd3f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VAV2) actsIn cat(p(HGNC:VAV2))",
              "summary_text": "FIGURE 1. Hyperlipidemic conditions induce CD36-dependent activation of Vav-family members in vivo. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2011 Mar 4 286(9) 7010-7",
                "id": "21209086"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e043"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VAV2) actsIn cat(p(HGNC:VAV2))",
              "summary_text": "Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcaa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:VAV2) actsIn cat(p(HGNC:VAV2))",
              "summary_text": "Vav proteins thus regulate an NF-kappaB-dependent survival signal in naive B cells and are required for NF-kappaB function after BCR cross-linking.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Oct 1 106(7) 2391-8",
                "id": "15941910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc7f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "gtp(p(HGNC:RAP1A))",
        "relation": "decreases",
        "target": "bp(GOBP:\"cell proliferation\")",
        "directed": false,
        "label": "gtp(p(HGNC:RAP1A)) decreases bp(GOBP:\"cell proliferation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053286",
          "evidences": [
            {
              "bel_statement": "gtp(p(HGNC:RAP1A)) decreases bp(GOBP:\"cell proliferation\")",
              "summary_text": "inhibition of fibroblast proliferation was mediated exclusively by activation of Epac-1. PGE(2) and Epac-1 inhibited cell proliferation through activation of the small GTPase Rap1, since decreasing Rap1 activity by transfection with Rap1GAP or the dominant-negative Rap1N17 prevented, and transfection with the constitutively active Rap1V12 mimicked, the anti-proliferative effects of PGE(2)",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 Oct 39(4) 482-9",
                "id": "18421013"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e37e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:VIPR1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:VIPR1))",
        "directed": false,
        "label": "p(HGNC:VIPR1) actsIn cat(p(HGNC:VIPR1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405327f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:VIPR1) actsIn cat(p(HGNC:VIPR1))",
              "summary_text": "Furthermore, ZO-1 expression (mRNA, protein) assessed in HT29-Cl.16E, was significantly increased after submucosal neuron activation by EFS. These effects on ZO-1 expression were blocked by TTX and VIPra and reproduced by VIP.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2003 Nov 285(5) G1028-36",
                "id": "12881224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:VIPR1) actsIn cat(p(HGNC:VIPR1))",
              "summary_text": "The PAC1 receptor is more selective for PACAP while the VPAC1 and VPAC2 receptors can be potently activated by VIP or PACAP .",
              "citation": {
                "type": "PubMed",
                "name": "BMC Neurosci 2006 7 15",
                "id": "16483357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e38b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VIPR1) actsIn cat(p(HGNC:VIPR1))",
              "summary_text": "VPAC2 activation enhances glucose-induced insulin release while VPAC1 activation elevates glucose output.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 21 278(12) 10273-81",
                "id": "12525492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VIPR1) actsIn cat(p(HGNC:VIPR1))",
              "summary_text": "Their actions have been shown to be mediated by three different receptor subtypes: PAC1-R, which has exclusive affinity for PACAP, and VPAC1-R and VPAC2-R, which have equal affinity for PACAP and VIP.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2005 Feb 146(2) 744-50",
                "id": "15514088"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e062"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VIPR1) actsIn cat(p(HGNC:VIPR1))",
              "summary_text": "We synthesized a VIP analog that combines mutations that decrease the affinity for the VPAC1 receptor but maintain a high affinity for the VPAC2 receptor with an amino-terminal hexanoylation that increases the affinity for the VPAC2 receptor with a limited decrease in the affinity of the VPAC1 receptor. ",
              "citation": {
                "type": "PubMed",
                "name": "Peptides 2004 Feb 25(2) 275-8",
                "id": "15063009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e02d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VIPR1) actsIn cat(p(HGNC:VIPR1))",
              "summary_text": "VIP has been shown to down-regulate interleukin 8 (IL-8) secretion significantly in MDM after LPS stimulation.....The high VPAC1 expression in AM may reflect the chronic pro-inflammatory environment found in the lung of COPD patients. ",
              "citation": {
                "type": "PubMed",
                "name": "Peptides 2010 Apr 31(4) 603-8",
                "id": "20026142"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddc4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VIPR1) actsIn cat(p(HGNC:VIPR1))",
              "summary_text": "The VPAC1 antagonist, but not PACAP6?38, reversed the inhibitory activity of VIP on NF-?B binding and on the changes in the composition of the Ets-2-binding complexes (Fig.6). This is in accordance with the fact that the VPAC1 agonist showed a similar effect than that of VIP on NF-?B- and Ets-2-binding complexes (Fig. 6).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31930-40",
                "id": "10542221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VIPR1) actsIn cat(p(HGNC:VIPR1))",
              "summary_text": "VIP/VPAC1 interaction is associated with a cAMP increase and activation of a cAMP/p38 MAPK pathway, which regulates MMP-9, CD35, and CD11b exocytosis, and a cAMP/EPAC/PI-3K/ERK pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2008 Apr 83(4) 972-81",
                "id": "18174366"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:VIPR1) actsIn cat(p(HGNC:VIPR1))",
              "summary_text": "Megakaryocytes and platelets express the Gs-coupled VPAC1 receptor, for which the pituitary adenylyl cyclase-activating peptide (PACAP) and the vasointestinal peptide (VIP) are agonists. ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Feb 15 111(4) 1885-93",
                "id": "18000164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "megakaryocyte",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"RAF Family\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"RAF Family\"))",
        "directed": false,
        "label": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053277",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "To elucidate the role of MAPKs in keratinocyte differentiation, activation of ERK, JNK, and p38 in response to stimulation with extracellular calcium was analyzed. We provide evidence that calcium-induced differentiation of keratinocytes is associated with rapid and transient activation of the Raf/MEK/ERK pathway. Stimulation of keratinocytes with extracellular calcium resulted in activation of Raf isozymes and their downstream effector ERK within 10-15 min, but did not increase JNK or p38 activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 29 275(52) 41011-7",
                "id": "11018025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfbb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Ariadne: Thus, the major components of the AP-1 in MEK-DD-transformed CEFs were shown to be Fra-2 and c-Jun, and Fra-2 was highly phosphorylated, as reported in CEFs transformed by v- src , Ha- ras , and activated raf (17 , 22) . [Regulation] Here, we report that the transcriptional activity of Fra-2/c-Jun heterodimer was greatly enhanced by cotransfecting a constitutively active mutant of MEK1 gene (MEK-DD) into F9 cells, indicating that Fra-2 was converted into an active transactivator after phosphorylation by MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 May 10(5) 333-42",
                "id": "10359014"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc84"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Oncogenic Ras decreases Rac activity through sustained Raf/MAP kinase signaling, which causes transcriptional downregulation of Tiam1, an activator of Rac in epithelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 May 15 149(4) 775-82",
                "id": "10811819"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Moreover, Erbin inhibits the Erk activation by active Ras, while it fails to do so in the presence of active Raf-1. Erbin associates with active Ras, but not inactive Ras nor Raf. Consistently, Erbin interferes with the interaction between Ras and Raf both in vivo and in vitro. Erbin associates with active Ras, but not inactive Ras nor Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 10 278(2) 1108-14",
                "id": "12379659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "we found that PGE2 stimulated the activation of Ras and ERK, but not Akt, and reduced matrix deprivation-induced apoptosis, in untransformed epithelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2007 Dec 46(12) 958-70",
                "id": "17477350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Ras R115777 (tipifarnib) Phase III treatment (194-197) SCH 66336 (lonafarnib; Sarasar) Phase I treatment (194,195,198) BMS-214662 Phase I treatment (194,195,198) L-744,832 Preclinical development (199-202) L-778,123 Phase I treatment (203,204) XR-3054 Preclinical development (205) Raf Bay 43-9006 Phase II treatment (206,207) ISIS 5132 Phase II treatment (208-211)",
              "citation": {
                "type": "PubMed",
                "name": "J Mammary Gland Biol Neoplasia 2003 Jan 8(1) 45-73",
                "id": "14587863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Growth factor and other survival signals are transduced through receptor tyrosine kinases via adaptor proteins (such as GRB2 and the guanine-nucleotide exchange factor SOS) and activate Ras and its downstream targets, Raf and MEK1/2, which results in the activation of ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2008 Sep 118(9) 3003-6",
                "id": "18725993"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcb7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "he independent signaling competence of Tnfr1 and Tnfr2 was further confirmed in the studies of various kinases of the Erk/Mapk signal transduction cascade; Erk1, Erk2, Raf-1, Raf-B, Mek-1, Mekk, and p90rsk all were found to be activated independently by Tnfr1 as well as Tnfr2. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 8 271(45) 28097-104",
                "id": "8910423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dca3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Because Raf binds tightly to the GTP-bound form of Ras but not to the GDP-bound form, such differential affinity can be used to determine the GTP-bound status of Ras. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31981-6",
                "id": "10542228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "hKSR-2 selectively inhibited the Cot-mediated activation of MEK by  60%. In contrast, hKSR-2 up-regulated the Rafmediated MEK activation by up to 70%.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 47089-97",
                "id": "12975377"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e263"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "inhibition of LPAAT-beta inhibits signaling in both the Ras/Raf/Erk and PI3K/Akt pathway",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2003 Oct 2(10) 1067-78",
                "id": "14578472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e21a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Rap-1 antagonizes Ras in T cells42 but activates the Raf-ERK cascade, as does Ras, in PC12 cells43 and contributes to the integrin-mediated adhesion of T lymphocytes and embryonic fibroblasts.44,45",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2002 Nov 1 91(9) 769-75",
                "id": "12411390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "STAT3 inhibited myogenic differentiation induced by low serum or MyoD as efficiently as the Ras/mitogen-activated protein kinase cascade",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2003 Dec 24(12) 659-66",
                "id": "14644140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e027"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "The RasRafMek pathway is involved in signaling downstream from EGFR and in other pathways leading to the growth of cancer cells and tumor progression (Fig. 2).",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2008 Sep 25 359(13) 1367-80",
                "id": "18815398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfa6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "from full text - Figure 1 ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jul 35(1) 3-9",
                "id": "16484682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de9f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de09"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "The abundance of cyclin D1 is induced by a variety of oncogenic and growth factor signaling pathways, including activating mutations of Ras, Src, Rac, and erbB2 (HER-2/neu)",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd1c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "whereas p27kip-1 and other inhibitors of cyclin-dependent kinases (cdk) are negatively regulated.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Finally, disruption of microtubule polymerization by 2-methoxyoestradiol (2ME2) has also been shown to result in decreased HIF-1a levels and decreased VEGF mRNA expression in cultured cells88.In vivo, 2ME2 decreases tumour-xenograft growth and vascularization.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Oct 3(10) 721-32",
                "id": "13130303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db9d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "three members of the Raf family of protein-serine/threonine kinases have been identified (Raf-1, A-Raf, and B-Raf), whose activation is linked to receptor protein-tyrosine kinases by Ras (24).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Aug 19(8) 5308-15",
                "id": "10409722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db79"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:PTGER4))",
        "relation": "increases",
        "target": "a(SCHEM:\"cyclic AMP\")",
        "directed": false,
        "label": "cat(p(HGNC:PTGER4)) increases a(SCHEM:\"cyclic AMP\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405328e",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:PTGER4)) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Mechanisms of cancer promotion by COX-2 are not fully understood, but signaling through prostaglandin (PG)E2 receptors is a contributing factor. The major PGE2 receptors on epithelial cells, EP2 and EP4, increase cAMP production, which promotes growth and inhibits apoptosis in some cell types.  To explore the hypothesis that PGE2-stimulated cAMP  is a key intracellular mediator of COX-2-dependent antiapoptosis and define the underlying mechanisms, we used the T84 human colon epithelial cell line, which exhibits inducible apoptosis and is responsive to PGE2  stimulation (31, 34, 35). The major PGE2 receptors on colon epithelial cells are EP2 and EP4  (25), a finding we confirmed by RT-PCR of T84 cells (data not shown). Both EP2 and EP4 receptors activate adenylyl cyclase and increase cAMP as a second messenger, suggesting that cAMP mediates antiapoptotic functions in epithelial cells. Consistent with this idea, we found that a membrane-permeant  cAMP analog, 8-CPT-cAMP, and CTX, which catalyzes the ADP-ribosylation of Gs regulatory protein, leading to the activation of adenylyl  cyclase, also inhibited Fas- and staurosporine-promoted apoptosis  (Fig. 1 A). These findings were confirmed by evidence that CTX and 8-CPT-cAMP also inhibited the formation of apoptosis-associated DNA laddering in T84 cells (Fig. 1B and data not shown). We obtained similar results with the normal rat intestinal epithelial  cell line, RIE-1 (Fig. 1C). Thus, the antiapoptotic response to increases in cAMP in intestinal epithelial cells is independent of their state of transformation and conserved across at least two species.\\\"From full text\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jul 22 100(15) 8921-6",
                "id": "12837940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e225"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGER4)) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Activation of the adenylyl cyclase-coupled beta2-adrenoceptor expressed in HEK-293 cells or the endogenous receptor for prostaglandin E1 in N1E-115 neuroblastoma cells induced calcium mobilization and PLC stimulation, seemingly caused by cAMP formation,",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Nov 3(11) 1020-4",
                "id": "11715024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGER4)) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGER4)) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Stimulation of EP2 and EP4 is linked with cyclic adenosine 3', 5'-monophosphate (cAMP)-dependent protein kinase A (PKA). specific agonists of these receptors induced growth inhibition with an accompanying increase in cAMP production.",
              "citation": {
                "type": "PubMed",
                "name": "J Lab Clin Med 2002 Aug 140(2) 92-102",
                "id": "12228765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TIAM1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:TIAM1))",
        "directed": false,
        "label": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053279",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "Tiam1 (T-lymphoma invasion and metastasis 1) is one of the known guanine nucleotide (GDP/GTP) exchange factors (GEFs) for Rho GTPases (e.g., Rac1) and is expressed in breast tumor cells (e.g., SP-1 cell line).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Jul 10 150(1) 177-91",
                "id": "10893266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "The Rac exchange factor Tiam1 (ref. 7) binds directly to the carboxy-terminal region of Par-3, and knockdown of Tiam1 enhances tight junction formation in cells lacking Par-3.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2005 Mar 7(3) 262-9",
                "id": "15723052"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e11f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "Tiam1 and Ras-GRF1 are guanine nucleotide exchange factors (GEFs) that activate the Rac GTPase.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(12) 4073-85",
                "id": "12024021"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "Tiam1 is a ubiquitous guanine nucleotide exchange factor (GEF) that activates the Rac GTPase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 18833-41",
                "id": "12531897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "The recently described cAMP-dependent guanine nucleotide exchange factor (GEF) Epac activates small GTPase Rap1, which results in activation of small GTPase Rac-specific GEFs Tiam1 and Vav2 and Rac-mediated EC barrier protective responses. Our results show that ANP stimulated protein kinase A and the Epac/Rap1/Tiam/Vav/Rac cascade",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd62"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "We demonstrated previously that colon tumor cells biologically selected for increased migration were increased in Tiam1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Metastasis 2006 23(5-6) 301-13",
                "id": "17086355"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "We further show that Vav2 and the ubiquitously expressed Rac1 guanine nucleotide exchange factor Tiam1 are phosphorylated in tyrosine residues in cells transfected with active and oncogenic Src.Moreover, phosphorylation of Tiam1 in cells treated with pervanadate, a potent inhibitor of tyrosine phosphatases, was partially inhibited by the Src inhibitor SU6656.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 5 278(36) 34339-46",
                "id": "12810717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e34f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "nm23H1 negatively regulates Tiam1 and inhibits Rac1 activation in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Apr 10 98(8) 4385-90",
                "id": "11274357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e238"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "Rac activators such as Tiam1, Sos, Vav, and PIX ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 19 274(47) 33587-93",
                "id": "10559246"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e227"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "Depletion of PAR-3 causes the formation of multiple filopodia- and lamellipodia-like dendritic protrusions - a phenotype similar to neurons expressing activated Rac. PAR-3 regulates spine formation by binding the Rac guanine nucleotide-exchange factor (GEF) TIAM1, and spatially restricting it to dendritic spines. Thus, a balance of PAR-3 and TIAM1 is essential to modulate Rac-GTP levels and to allow spine morphogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2006 Mar 8(3) 227-37",
                "id": "16474385"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e202"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "Phosphatidylinositol 3-kinase (PI3K) is recruited to the membrane by intact E-cadherin adhesion junctions, where it generates phosphatidylinositol-(3,4,5)- triphosphate (PIP3), resulting in the activation of the RHO-GEF TIAM1 and subsequently of RAC1 and CDC42.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Feb 4(2) 118-32",
                "id": "14964308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e182"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "Here we demonstrate that Tiam1, a Rac-specific GEF, preferentially associates with activated GTP-bound Ras through a Ras-binding domain. Furthermore, activated Ras and Tiam1 cooperate to cause synergistic formation of Rac-GTP in a PI(3)K-independent manner. Thus, Tiam1 can function as an effector that directly mediates Ras activation of Rac.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Aug 4(8) 621-5",
                "id": "12134164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dda2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TIAM1) actsIn cat(p(HGNC:TIAM1))",
              "summary_text": "PI3 kinase inhibition (LY294002) attenuated S1P-induced Tiam1 association with S1P1, Tiam1/Rac1 activation, alpha-actinin-1/4 recruitment, and EC barrier enhancement.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2005 Oct 19(12) 1646-56",
                "id": "16195373"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db7d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            }
          ]
        }
      },
      {
        "source": "gtp(p(HGNC:RAP1A))",
        "relation": "increases",
        "target": "cat(p(HGNC:VAV2))",
        "directed": false,
        "label": "gtp(p(HGNC:RAP1A)) increases cat(p(HGNC:VAV2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053287",
          "evidences": [
            {
              "bel_statement": "gtp(p(HGNC:RAP1A)) increases cat(p(HGNC:VAV2))",
              "summary_text": "The recently described cAMP-dependent guanine nucleotide exchange factor (GEF) Epac activates small GTPase Rap1, which results in activation of small GTPase Rac-specific GEFs Tiam1 and Vav2 and Rac-mediated EC barrier protective responses. Our results show that ANP stimulated protein kinase A and the Epac/Rap1/Tiam/Vav/Rac cascade",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "gtp(p(HGNC:RAP1A)) increases cat(p(HGNC:VAV2))",
              "summary_text": "Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e352"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PTGS1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:PTGS1))",
        "directed": false,
        "label": "p(HGNC:PTGS1) actsIn cat(p(HGNC:PTGS1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053296",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PTGS1) actsIn cat(p(HGNC:PTGS1))",
              "summary_text": "On the other hand, the mRNA for cyclooxygenase-2, which produces PGH2 and participates in the production of prostanoids in inflammation, was expressed in both the resident and BCG-elicited macrophages but barely in the casein-elicited cells.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1997 Jun 9 409(2) 242-6",
                "id": "9202154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2f7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS1) actsIn cat(p(HGNC:PTGS1))",
              "summary_text": "where CO takes over the roles of NO under conditions of oxidative stress (Maines, 1997). Therefore, HO activity is important in controlling the activity of heme proteins, such as cytochromes P450, COX, guanylyl cyclase, and NOS, not only at the level of the intracellular heme pool available for the apo-heme proteins (Kappas and Drummond, 1986) but possibly also at the level of HO's downstream effector molecule CO by interactions with the heme group (Haider et al., 2002). ",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2003 Sep 55(3) 551-71",
                "id": "12869663"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS1) actsIn cat(p(HGNC:PTGS1))",
              "summary_text": "There was a significant increase in IL-5 and IL-13 mRNA in the OVA-COX-1 inhibitor group, OVA-COX-2 inhibitor group, and OVA-indomethacin group compared with the untreated OVA group, with the OVA- COX-2 inhibitor group and OVA-indomethacin groups showing greater expression of these cytokines than the OVA- COX-1 inhibitor group.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2002 Apr 15 165(8) 1154-60",
                "id": "11956061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd6f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS1) actsIn cat(p(HGNC:PTGS1))",
              "summary_text": "The production of prostaglandins begins with the liberation of arachidonic acid from membrane phospholipids by phospholipase A2 in response to inflammatory stimuli. Arachidonic acid is converted to PGH2 by the cyclooxygenase enzymes COX-1 and COX-2 (known formally as prostaglandin endoperoxide H synthases). ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2002 Mar 23(3) 144-50",
                "id": "11864843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd06"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS1) actsIn cat(p(HGNC:PTGS1))",
              "summary_text": "The elevated PGE2 production by metastatic cancer cells was due to COX-2 activity since dual COX-1/2 inhibitor indomethacin and selective COX-2 inhibitor NS-398 equally suppressed both basal and inducible (by IFN-gamma/LPS or Ca2+-ionophores) PGE2 accumulation.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Oct 1 289(2) 265-74",
                "id": "14499627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS1) actsIn cat(p(HGNC:PTGS1))",
              "summary_text": "Pleckstrin phosphorylation and serotonin secretion in human platelets stimulated with vWF are blocked by the cyclooxygenase inhibitor acetylsalicylic acid",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 13 276(28) 26022-9",
                "id": "11344169"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1d1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS1) actsIn cat(p(HGNC:PTGS1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2001 Jan 24(1) 44-48",
                "id": "11152649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e06f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS1) actsIn cat(p(HGNC:PTGS1))",
              "summary_text": "Sulindac sulfide,  but not sulindac sulfone, inhibits cyclooxygenase (COX) enzyme activities,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 28 278(48) 47762-75",
                "id": "14506281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e00d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS1) actsIn cat(p(HGNC:PTGS1))",
              "summary_text": "The defect in PDGF-induced PGE2 release occurs prior to action of prostaglandin H synthase/cyclooxygenase as release of arachadonic acid (in response to PDGF) does not occur in the superoxide dismutase-overexpressing clones.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 1995 Sep 10 322(1) 31-8",
                "id": "7574691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc53"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Colforsin)",
        "relation": "increases",
        "target": "a(SCHEM:\"cyclic AMP\")",
        "directed": false,
        "label": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053297",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "The TSH-induced increase in cathepsin B mRNA concentrations (approximately fivefold over that in untreated cells) was partially mimicked by forskolin (approximately threefold) and ionomycin, while phorbol ester decreased cathepsin B mRNA concentrations. Similar changes were observed for thyroglobulin and actin mRNA concentrations.... These results demonstrate (1) that cathepsin B expression in the thyroid is regulated in parallel with that of thyroglobulin and actin, and (2) that cyclic AMP- and Ca2+-dependent processes stimulate gene expression, while phorbol ester treatment inhibits gene expression in FRTL5 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Endocrinol 1989 May 2(3) 207-12",
                "id": "2751829"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0bb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "The increase in cellular cAMP concentration during 10-min incubation of rat hepatocytes with glucagon or forskolin was enhanced markedly when the hepatocytes had been cultured for several hours with herbimycin A",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1999 Mar 260(2) 398-408",
                "id": "10095774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e258"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "HGF secretion by the cells was markedly stimulated by the cAMP-elevating agents, forskolin, cholera toxin, prostaglandin E2 (PGE2), and 3-isobutyl-1-methylxanthine, as well as by the membrane-permeable cAMP analogues, 8-bromo-cAMP and dibutyryl cAMP. ",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 1994 Feb 210(2) 326-35",
                "id": "7507855"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e12e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "the cardiac fibroblasts expressed SMA following exposure to TGFbeta (10 ng/ml for 6 hours at 37C) (Figures 5D and G [lane 4]), which was markedly attenuated in the presence of forskolin (Figures 5E and G [lane 5]).",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2007 Dec 56(12) 4120-31",
                "id": "18050204"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e096"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "In the osteoblastic cell line, MC3T3-E1, continuous treatment with cAMP elevating agents inhibited both osteoblastic differentiation based on alkaline phosphatase assay and DNA binding ability of Cbfa1 based on a gel retardation assay. Cbfa1 inhibition was paralleled by an inhibitory effect of forskolin on Cbfa1-regulated genes. Northern and Western blot analyses suggested that the inhibition of Cbfa1 by forskolin was mainly at the protein level.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 8 274(41) 28875-9",
                "id": "10506130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "However, when expressed in vitro, VACM-1 attenuates basal and vasopressin- and forskolin-induced cAMP production.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Dec 285(6) C1386-96",
                "id": "12917106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3d3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Treatment with forskolin increased the steady-state levels of ATA1 and ATA2 mRNAs, but decreased that of ATA3 mRNA.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Sep 14 505(2) 317-20",
                "id": "11566196"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Sodium nitroprusside inhibited PDE3 activity and augmented forskolin- and isoproterenol-stimulated cAMP levels; PDE3 inhibition was reversed by blockade of cGMP synthesis.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Mar 282(3) C508-17",
                "id": "11832336"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e112"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "FSK, a cyclic adenosine 3#,5#-monophosphate activator, strongly induced Nurr1 expression consistent with the inhibitor study.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2009 Sep 30(9) 1606-13",
                "id": "19570744"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dff5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Direct activation of adenylyl cyclase with forskolin stimulated a magnitude of ERK activation and cAMP accumulation similar to that seen with 5-CT (Table 1 and Fig. 1b).",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2003 Dec 87(5) 1076-85",
                "id": "14622088"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df7e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Elevated levels of cAMP induced by forskolin mimicked the effects of relaxation on the regulation of Cyr61, CTGF and Nov.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Apr 1 1691(1) 33-40",
                "id": "15053922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de04"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Incubation of cultured VSMCs with a PDE4-selective inhibitor, Ro 20-1724, markedly potentiated both the antimigratory effect and the increase in cAMP caused by forskolin.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 1998 May 4 82(8) 852-61",
                "id": "9576105"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Phagocytosis and accumulation of PDE-4 and PKA near adherent zymosan were inhibited by elevating cAMP levels with forskolin or rolipram",
              "citation": {
                "type": "PubMed",
                "name": "Cell Biochem Biophys 1998 28(2-3) 251-75",
                "id": "9515168"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Additionally, RGS4 and RGS10 significantly inhibited forskolin-stimulated cAMP production in both cell lines",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Jun 16(6) 711-21",
                "id": "15093612"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc1d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Colforsin) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "phosphorylation of CREB at Ser-133 is induced 6-fold in vivo, following treatment of PC12 cells with forskolin.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1989 Nov 17 59(4) 675-80",
                "id": "2573431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc14"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PTGER4)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:PTGER4))",
        "directed": false,
        "label": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405328d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Mechanisms of cancer promotion by COX-2 are not fully understood, but signaling through prostaglandin (PG)E2 receptors is a contributing factor. The major PGE2 receptors on epithelial cells, EP2 and EP4, increase cAMP production, which promotes growth and inhibits apoptosis in some cell types.  To explore the hypothesis that PGE2-stimulated cAMP  is a key intracellular mediator of COX-2-dependent antiapoptosis and define the underlying mechanisms, we used the T84 human colon epithelial cell line, which exhibits inducible apoptosis and is responsive to PGE2  stimulation (31, 34, 35). The major PGE2 receptors on colon epithelial cells are EP2 and EP4  (25), a finding we confirmed by RT-PCR of T84 cells (data not shown). Both EP2 and EP4 receptors activate adenylyl cyclase and increase cAMP as a second messenger, suggesting that cAMP mediates antiapoptotic functions in epithelial cells. Consistent with this idea, we found that a membrane-permeant  cAMP analog, 8-CPT-cAMP, and CTX, which catalyzes the ADP-ribosylation of Gs regulatory protein, leading to the activation of adenylyl  cyclase, also inhibited Fas- and staurosporine-promoted apoptosis  (Fig. 1 A). These findings were confirmed by evidence that CTX and 8-CPT-cAMP also inhibited the formation of apoptosis-associated DNA laddering in T84 cells (Fig. 1B and data not shown). We obtained similar results with the normal rat intestinal epithelial  cell line, RIE-1 (Fig. 1C). Thus, the antiapoptotic response to increases in cAMP in intestinal epithelial cells is independent of their state of transformation and conserved across at least two species.\\\"From full text\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jul 22 100(15) 8921-6",
                "id": "12837940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Among various prostanoids affected by NSAIDs, prostaglandin E2 (PGE2), in particular, seems to play critical roles in IBD via the EP4 receptor, one of the four PGE2 receptor subtypes (EP1-4). An EP4 agonist for example, when topically applied, has been reported to ameliorate typical colitis symptoms by suppressing the production of cytotoxic cytokines in the dextran sodium sulfate (DSS)-induced colitis model. EP4 agonists are also known, however, for their ability to protect epithelial cells from apoptosis in vitro, which may contribute to the protection of mucosal barrier functions. To investigate this potential application, we have tested another EP4-selective agonist in the DSS-indomethacin mouse colitis model.",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2007 Jan 320(1) 22-8",
                "id": "17008451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dde0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Crohn",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Among various prostanoids affected by NSAIDs, prostaglandin E2 (PGE2), in particular, seems to play critical roles in IBD via the EP4 receptor, one of the four PGE2 receptor subtypes (EP1-4). An EP4 agonist for example, when topically applied, has been reported to ameliorate typical colitis symptoms by suppressing the production of cytotoxic cytokines in the dextran sodium sulfate (DSS)-induced colitis model. EP4 agonists are also known, however, for their ability to protect epithelial cells from apoptosis in vitro, which may contribute to the protection of mucosal barrier functions. To investigate this potential application, we have tested another EP4-selective agonist in the DSS-indomethacin mouse colitis model.",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2007 Jan 320(1) 22-8",
                "id": "17008451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Crohn",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Using flow cytometry, we found that human platelets expressed EP4 receptor protein. A selective EP4 agonist (ONO AE1-329) potently inhibited the platelet aggregation as induced by ADP or collagen. This effect could be completely reversed by an EP4 antagonist, but not by PGI(2), PGD(2), and thromboxane receptor antagonists or cyclooxygenase inhibition. Moreover, an EP4 antagonist enhanced the PGE(2)-induced stimulation of platelet aggregation, indicating a physiological antiaggregatory activity of EP4 receptors.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2010 Dec 30(12) 2416-23",
                "id": "21071691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "(1) selective EP4 antagonist AH-23848B effectively inhibited migration of both C3L5 and MDA-MB-231 cells in a dose-dependent manner; (2) exogenous PGE2 and EP4 agonist PGE1 alcohol increased migration of C3L5 cells; (3) forskolin, a potent activator of adenylate cyclase, as well as membrane-permeable analogues of cAMP (8-bromo-cAMP, dibutyryl-cAMP) stimulated migration of C3L5 cells; and (4) Rp-cAMPS, a selective protein kinase A inhibitor, reduced migration of C3L5 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Oct 1 289(2) 265-74",
                "id": "14499627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbb6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Consistent with mRNA expression of the G(s)-coupled EP4- and G(i)-coupled EP3-PGE receptor subtypes, P-815 cell adhesion was accelerated by treatment with a selective EP4 agonist",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 16 278(20) 17977-81",
                "id": "12637575"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e230"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasms",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Prostaglandin E(2) (PGE(2)) is the most abundant prostaglandin in the human body. It has a large number of biological actions that it exerts via four types of receptors, EP1-4",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2007 Sep 59(3) 207-24",
                "id": "17878511"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e15e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "PGE2-EP4 signaling thus facilitates initiation of skin immune responses by promoting the migration and maturation of Langerhans cells.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2003 Jun 9(6) 744-9",
                "id": "12740571"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e13b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "They are in the family of G-protein coupled receptors and both receptors were initially characterized as coupling to Gs and increasing intracellular cAMP formation. Recently, however, we have shown that both receptors can stimulate T-cell factor (Tcf) mediated transcriptional activity",
              "citation": {
                "type": "PubMed",
                "name": "Life Sci 2003 Dec 5 74(2-3) 143-53",
                "id": "14607241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e103"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Stimulation of EP2 and EP4 is linked with cyclic adenosine 3', 5'-monophosphate (cAMP)-dependent protein kinase A (PKA). specific agonists of these receptors induced growth inhibition with an accompanying increase in cAMP production.",
              "citation": {
                "type": "PubMed",
                "name": "J Lab Clin Med 2002 Aug 140(2) 92-102",
                "id": "12228765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e082"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Antigen-evoked secretion of interferon-gamma (IFN-gamma) by sperm whale myoglobin-specific Th1 cells of DBA/2 mouse I-Ed-restricted clones, that express EP3Rs and EP4Rs, was enhanced a maximum of 3-fold by 10(-10) to 10(-8) M PGE2 and 2.5-fold each for the EP1R/EP3R-directed agonist sulprostone (10(-8) and 10(-7) M) and for the EP4R/EP3R/EP2R agonist misoprostol (10(-9) M). ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Immunol 1999 May 25 194(1) 21-7",
                "id": "10357877"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e063"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "(1) selective EP4 antagonist AH-23848B effectively inhibited migration of both C3L5 and MDA-MB-231 cells in a dose-dependent manner; (2) exogenous PGE2 and EP4 agonist PGE1 alcohol increased migration of C3L5 cells; (3) forskolin, a potent activator of adenylate cyclase, as well as membrane-permeable analogues of cAMP (8-bromo-cAMP, dibutyryl-cAMP) stimulated migration of C3L5 cells; and (4) Rp-cAMPS, a selective protein kinase A inhibitor, reduced migration of C3L5 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Oct 1 289(2) 265-74",
                "id": "14499627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e047"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Based on our observations we speculate that PGE1 exerts its effect on VEGF-1 via interaction via EP2 and_or EP4 PG receptors both of which increase intracellular cAMP levels, whereas we hypothesize that neither EP1 nor EP3 receptors play a role in this effect since they lead to a rise in intracellular calcium or to a decrease in intracellular cAMP, respectively",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Apr 36(4) 539-46",
                "id": "15081313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df03"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "EP3 inhibits adenylate cyclase,  whereas both EP2 and EP4 stimulate adenylate cyclase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 30 275(26) 19819-23",
                "id": "10749873"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dec3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Activation of the adenylyl cyclase-coupled beta2-adrenoceptor expressed in HEK-293 cells or the endogenous receptor for prostaglandin E1 in N1E-115 neuroblastoma cells induced calcium mobilization and PLC stimulation, seemingly caused by cAMP formation,",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Nov 3(11) 1020-4",
                "id": "11715024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dead"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Our findings of a PGE2-mediated induction of EGR-1 expression by the EP4 receptor is interesting light of recent studies with knockout mice that show a potential involvement of the EP4 receptor with colon cancer and rheumatoid arthritis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 4 278(14) 12151-6",
                "id": "12566441"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "PGE(2) exerts its actions via four transmembrane receptors, EP(1), EP(2), EP(3), and EP(4)",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2003 Jun 88(6) 2810-6",
                "id": "12788892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e36a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 25 276(21) 18075-81",
                "id": "11278548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e302"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 50081-6",
                "id": "12401798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e20c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "PGE(2)  stimulates IL-6  secretion by activation of EP4 receptors, present in macrophages. ",
              "citation": {
                "type": "PubMed",
                "name": "J Vasc Surg 2003 Aug 38(2) 354-9",
                "id": "12891120"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e205"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "This stimulation of reporter gene activity was accompanied by a PGE(2)-dependent increase in the phosphorylation of both glycogen synthase kinase-3 (GSK-3) and Akt kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 25 277(4) 2614-9",
                "id": "11706038"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "TNF-alpha production was inhibited 50-70% at 2-24 h by EP4/2 agonists, whereas IL-6 was enhanced up to approximately 220%.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2004 Jul 76(1) 227-36",
                "id": "15075356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1d4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "EP4 and EP2 agonists both inhibited IL-1-induced IL-6 production.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Immunol 2001 Feb 123(2) 323-30",
                "id": "11207665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e181"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "EP2 and EP4 are coupled to Gs and stimulate cAMP production which leads to gene regulation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Oncol 2011 2011",
                "id": "20953410"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e160"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "PGE2 stimulates differentiation of osteoblast progenitor cells through the EP4 receptor in an autocrine manner, and the PDE4 inhibitor potentiates the differentiation by inhibiting hydrolysis of cyclic AMP in the cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Bone Miner Res 2003 Aug 18(8) 1471-7",
                "id": "12929936"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e098"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "from full text - Table 5 PGE2-induced or AE1-329-decreased genes not associated with differentiation",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Sep 24 322(3) 911-7",
                "id": "15336550"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df80"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Prostaglandins, such as PGE2, stimulate renin release and synthesis via an increase in intracellular cAMP in JG cells [59, 60, 61, 62], probably by EP4 receptors present in the glomerulus [63, 64, 65]. (see Figure 1, PGE2=Dinoprostone; EP4=PTGER4)",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Med 2000 78(3) 130-9",
                "id": "10868475"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd11"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Juxtaglomerular Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 27 277(52) 50828-33",
                "id": "12393872"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcdc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "EP2 receptors directly inhibit T cell proliferation while EP2 and EP4 receptors regulate antigen presenting cells functions.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2001 Oct 108(8) 1229-35",
                "id": "11602631"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcbe"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Only PGE(2) and PGE1 alcohol completely abolished CD36 induction",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2005 Apr 1 66(1) 141-9",
                "id": "15769457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Our data indicate that in R2C cells the COX-2-derived prostaglandin E2 (PGE2) binds the PGE2 receptor EP4 and activates protein kinase A (PKA) and ultimately CREB. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Oct 16 284(42) 28905-16",
                "id": "19679653"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "We conclude that EP4 maintains intestinal homeostasis by keeping mucosal integrity and downregulating immune response.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2002 Apr 109(7) 883-93",
                "id": "11927615"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbdd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "The compound potentiated the osteoblast differentiation through accumulation of cyclic AMP after autocrine stimulation of EP4 receptor by PGE2 in pro-osteoblastic cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Bone Miner Res 2003 Aug 18(8) 1471-7",
                "id": "12929936"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbd4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER4) actsIn cat(p(HGNC:PTGER4))",
              "summary_text": "An antagonistic effect of EP3 against EP4 through the modulation of cyclic AMP level is required for PGE2-mediated activation of Ras signal pathway in A549 cells.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2002 May 8 518(1-3) 154-8",
                "id": "11997037"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbc9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CREB1,pmod(P,S,133))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:CREB1))",
        "directed": false,
        "label": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532b0",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "Their minimum consensus sequence Hyd-X-R-X-X-(S/T) (where Hyd is any hydrophobic amino acid), determined through peptide studies, provides only a rough template common to many protein kinases (11). Additional specificity is provided by residues adjacent to the phosphorylation site of the substrate, producing differences in substrate preference among these kinases. The differences can have important transcriptional implications; for example, although all three can phosphorylate CREB on the activating site Ser-133, only CaMKII phosphorylates an additional inhibitory site, Ser-142 (13). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 2 276(5) 2975-8",
                "id": "11096122"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "Moreover, PP1 was shown to act as a major CTD phosphatase in nuclear extracts and to affinity-purify with RNA polymerase II. Both PP1 and the nuclear regulator NIPP1 have also been identified as components of the Tat-associated RNA polymerase II complex, which regulates transcription from the human immunodeficiency virus type 1 promoter (40, 275). The transcription factor CREB mediates the expression of cAMP-induced genes by binding to a conserved cAMP-responsive element. Phosphorylation of CREB on Ser-133, e.g., by PKA, promotes the recruitment of the histone acetyltransferase CBP, which facilitates access of the promoter region to the transcriptional machinery.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2004 Jan 84(1) 1-39",
                "id": "14715909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "We found that the intracellular domain of Notch2 interacted with a phosphorylated form of the transcription factor CREB1, and together these proteins bound the transcriptional coactivator p300 to form a complex on the promoter of the gene encoding granzyme B. Our results suggest that the highly regulated, dynamic control of T cell cytotoxicity depends on the integration of Notch2 and CREB1 signals.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2008 Oct 9(10) 1140-7",
                "id": "18724371"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dba8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "LDL promotes cAMP response element binding protein (CREB) activation (phosphorylation in Ser133). In transfection assays a dominant-negative of CREB inhibits NOR-1 promoter activity, while mutation of specific (cAMP response element) CRE sites in the NOR-1 promoter abolishes LDL-induced NOR-1 promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2004 Apr 24(4) 697-702",
                "id": "14962944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "aken together, these data provide strong evidence that PKA is the enzyme responsible for phosphorylating CREB at S133 in response to PTH and that PKA activity is required for PTH-induced c-fos expression.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1999 Mar 140(3) 1255-61",
                "id": "10067851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "Mutation of the CREB-binding site reduced cyclin D2 promoter activity 5-10-fold. CREB-1 is phosphorylated at serine 133, a critical site for activity, in both T cells and Epstein-Barr virus immortalized B cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Apr 6 25(15) 2170-80",
                "id": "16301994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e09d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "Mutation of the CREB-binding site reduced cyclin D2 promoter activity 5-10-fold. CREB-1 is phosphorylated at serine 133, a critical site for activity, in both T cells and Epstein-Barr virus immortalized B cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Apr 6 25(15) 2170-80",
                "id": "16301994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dece"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "We found that, in contrast to Akt1 that induces CREB phosphorylation at Ser-133 and CREB target gene expression, Akt2 was unable to induce CREB phosphorylation at Ser-133 in vivo and CREB target gene expression. This difference is specific to CREB as both Akt1 and Akt2 similarly inhibits FoxO1 mediated gene expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 Mar 23 354(4) 1061-6",
                "id": "17276404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "A constitutive active mutant of PKD1 stimulates GAL4-CREB-mediated transcription in a Ser-133-dependent manner, activates CRE-responsive promoters, and increases the expression of CREB target genes. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 May 18 282(20) 14777-87",
                "id": "17389598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "Protein kinase A phosphorylation of CREB at serine 133 facilitates transcription from cellular CREs by recruiting CBP/p300 via its KIX domain. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 29 282(26) 18750-7",
                "id": "17449469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "As shown in Fig. 6, TPA and the presence of caPKD1 clearly augmented Nur77 transcript levels. The PKD1-induced increase of Nur77 expression is mediated through CREB, as co-transfection with the dominant negative A-CREB or K-CREB resulted in reduced PKD1-induced Nur77 expression (Fig. 6).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 May 18 282(20) 14777-87",
                "id": "17389598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e362"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "CREB activation via phosphorylation at serine 133 and resulting CREB mediated gene expression is a critical event which can have a significant effect on many cellular processes, including cell survival and plasticity.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2009 Jan 30 379(1) 1-5",
                "id": "19070599"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "The induction of CREB-mediated transcription was Ser-133-dependent, because caPKD1 failed to stimulate GAL4-CREBS133A-driven transcription. Similar results were obtained with co-transfection studies in COS-1 cells (results not shown), indicating that PKD1-induced CREB activation is not cell-specific.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 May 18 282(20) 14777-87",
                "id": "17389598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e298"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "Inactivating the kinase A phosphorylation site by in vitro mutagenesis of the cloned CREB cDNA at Ser-133 completely abolished CREB transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1989 Nov 17 59(4) 675-80",
                "id": "2573431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e22e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "CaMKIV, and p38 MAPK were also the kinases involved in CREB Ser(133) phosphorylation induced by CD3/CD28.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 284-92",
                "id": "11123304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e17c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "MSK1 is localized in the nucleus of unstimulated or stimulated cells, and phosphorylates CREB at Ser133 with a Km value far lower than PKA, MAPKAP-K1(p90Rsk) and MAPKAP-K2.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Aug 3 17(15) 4426-41",
                "id": "9687510"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1,pmod(P,S,133)) directlyIncreases tscript(p(HGNC:CREB1))",
              "summary_text": "pp60(v-src) induction of CREB was blocked by the p38 inhibitor SB203580 or by mutation of CREB at Ser133.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Mar 12 274(11) 7341-50",
                "id": "10066798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfb7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAP1A)",
        "relation": "actsIn",
        "target": "gtp(p(HGNC:RAP1A))",
        "directed": false,
        "label": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053283",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "A phospholipase C inhibitor, U73122, abrogated Rap1 activation triggered by both the TCR and SDF-1 (CXCL12). PLC-gamma1-deficient Jurkat T cells showed a marked reduction of TCR-triggered Rap1 activation and adhesion to intercellular adhesion molecule-1 (ICAM-1) mediated by LFA-1. In contrast, SDF-1-triggered Rap1 activation and adhesion were not affected in these cells. Transfection of these cells with an expression plasmid encoding PLC-gamma1 restored Rap1 activation by the TCR and the ability to adhere to ICAM-1, accompanied by polarized LFA-1 surface clustering colocalized with regulator of adhesion and polarization enriched in lymphoid tissues (RAPL).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Mar 19 279(12) 11875-81",
                "id": "14702343"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "Page 54 - \\\"The SH3 domain of Crk family members binds to proline-rich domains found in C3G, a guanine nucleotide exchange factor that activates the GTPase Rap1, a member of the Ras superfamily (98). Crk family members also bind Dock180, which binds to and activates the Rac GTPase via an unknown mechansim. Both Rap1 and Rac are activated by HGF/SF-Met signaling presumably via the Crk-mediated mechansims just described.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Cytokine Growth Factor Rev 2002 Feb 13(1) 41-59",
                "id": "11750879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de8a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "as shown in Figure 2.95-98 In essence, the activation status of Raf depends on the integration of both activating and inhibitory stimuli, the net result of which determines the downstream messages. THE RAF FAMILY OF GENES AND PROTEINS The raf family of genes was first identified as oncogenes in retroviruses that are the causative vectors of tumors in mice and chicken.99,100 The first raf gene to be identified, v-raf, the transforming gene of the mouse sarcoma virus 3611, induces fibrosarcomas and erythroleukemia in newborn mice, and C-raf (also called raf-1) is its proto-oncogene homolog.101,102 A-raf was found next by screening a mouse spleen cDNA library at low stringency with a v-raf probe. Next, v-Rmil was identified as the transforming gene in the avian retrovirus Mill Hill No. 2 (MH2) from a spontaneous ovarian tumor and found to be homologous to v-raf.99 C-Rmil corresponded to a third mammalian raf gene, B-raf, which was also shown to be an oncogene.103,104 However, initial attempts to identify activated versions of raf in human cancers failed to demonstrate unique DNA rearrangements in any specific tumor type, which, in retrospect, can be attributed to the lack of requisite sensitivity of early assays to detect single point mutations. Furthermore, most early efforts were directed at C-raf, rather than at the more oncogenic B-raf. The mammalian raf family consists of the following three genes: A-raf, B-raf, and C-raf, which are located on chromosomes Xp11, 7q32, and 3p25, respectively. The raf proto-oncogenes encode three 68- to 74-kd cytosolic proteins, termed A-Raf, B-Raf, and C-Raf (Raf-1), which share highly conserved amino-terminal regulatory regions and catalytic domains at the carboxyl terminus (Fig 4).10 As serine/threonine kinases, Raf proteins phosphorylate serine and threonine residues on essential modulatory proteins downstream of Ras. Each Raf species has a distinct expression profile in tissues, which suggests that individual Raf isoforms perform clearly defined functions.4 C-Raf is ubiquitously expressed in most tissues. Both A- and B-Raf have more restricted expression profiles than C-Raf, with A-Raf overexpressed in urogenital tissues (eg, kidney, ovary, prostate, and epididymis) and B-Raf overexpressed in neural, testicular, splenic, and hematopoietic tissues.105 Unlike A-raf and C-raf, B-raf undergoes differential splicing in exons 8b and 10a, and its spliced variants are translated into 10 B-Raf isoforms.106,107 Both A-Raf and C-Raf undergo localization to the mitochondria, which supports the notion that Raf regulates apoptosis, but the specific proportions of Raf isoforms that are localized to the mitochondria are not known.108-112 This localization may be a result of isoform-specific lipid- or protein-binding partners, which recruit Raf to distinct membrane rafts. From a functional standpoint, although all Raf proteins are serine/threonine kinases and capable of activating the MAPK cascade, they have distinct downstream phosphorylation targets and play unique roles in signaling.113 Their distinct roles are supported by Raf knockout studies, in which mice lacking each of the three Raf proteins have disparate phenotypes.113,114 B-raf knockouts die in utero by day 12, usually as a result of massive internal hemorrhage, whereas A-raf and C-raf knockouts die postpartum with extensive intestinal distension (A-raf knockout) or failure of lung maturation (C-raf knockout). Additional support for the diverse functionality of Raf family members is provided by the disparate responses of B-Raf and C-Raf to identical stimuli, as well as the distinct messages that each isoform relays downstream to Rap1, which is a small GTPase that functions as both an activator and repressor of Raf.115 For example, Rap1- mediated stimulation of B-Raf by cyclic adenosine monophosphate (cAMP) phosphorylates ERK, whereas stimulation of C-Raf inhibits ERK phosphorylation.115",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddd9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "inhibition of fibroblast proliferation was mediated exclusively by activation of Epac-1. PGE(2) and Epac-1 inhibited cell proliferation through activation of the small GTPase Rap1, since decreasing Rap1 activity by transfection with Rap1GAP or the dominant-negative Rap1N17 prevented, and transfection with the constitutively active Rap1V12 mimicked, the anti-proliferative effects of PGE(2)",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 Oct 39(4) 482-9",
                "id": "18421013"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc49"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "Insulin stimulation of Chinese hamster ovary cells expressing the human insulin receptor resulted in a time-dependent decrease in the amount of GTP bound to Rap1.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 May 1 17(9) 2554-65",
                "id": "9564038"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "CD98hc constitutively and specifically associates with beta1 integrins and accumulating evidence indicates that CD98hc plays a significant role in regulatin integrin-mediated functions in cancer cells cross-linking CD98hc promotes activation of PI3K and Rap1 and enhances beta1 integrin-mediated cell adhesion in a number of cancer cells, including breast and small cell lung cancer",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 24 279(52) 54731-41",
                "id": "15485886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e129"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "In addition, the small GTPase Rap1, which is activated by cAMP specifically through Epac2 in pancreatic beta cells, mediates cAMP-induced insulin secretion in a protein kinase A-independent manner. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2007 Dec 4 104(49) 19333-8",
                "id": "18040047"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e119"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "Here, we report that Crkl mediates the formation of protein complexes that include C3G and Bcr/Abl. These complexes contain highly elevated levels of tyrosine-phosphorylated C3G and P130Cas, a scaffolding protein. Moreover, the presence of Rap1 further promoted tyrosine phosphorylation of C3G and Cas. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Aug 12 333(4) 1276-83",
                "id": "15982636"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e025"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "In the original characterization of GAP1IP4BP, it was shown that it possesses not only Ras-GAP activity but is also able to enhance the intrinsic GTPase activity of the Ras-related protein, Rap1. Recently, this understanding has been extended through the demonstration that CAPRI and RASAL also possess such dual activity ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Soc Trans 2006 Nov 34(Pt 5) 846-50",
                "id": "17052212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "Our results show an ANP-induced transient activation of Rap1 detected by in vitro Rap1 activation assay (Fig. 2E).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "we found increased activity of endogenous Rap1 in NIH3T3 cells after stimulation with the neuropeptide growth factor bombesin in a concentration- and time-dependent manner.  The activity of endogenous Ras was unaffected However, MAPK/Erk-phosphorylation and the proliferation rate was increased",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Sep 18 273(38) 24297-300",
                "id": "9733713"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dec0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "The recently described cAMP-dependent guanine nucleotide exchange factor (GEF) Epac activates small GTPase Rap1, which results in activation of small GTPase Rac-specific GEFs Tiam1 and Vav2 and Rac-mediated EC barrier protective responses. Our results show that ANP stimulated protein kinase A and the Epac/Rap1/Tiam/Vav/Rac cascade",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd1f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "cAMP-dependent but A-kinase independent signaling can involve activation of guanine nucleotide exchange factors for the GTP-binding protein, Rap.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2005 Jan 288(1) H69-76",
                "id": "15345481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "Thus, the interaction between Epac2 and Ras appears to be necessary for efficient activation of Rap1 by Epac2 following cAMP elevation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Dec 28(23) 7109-25",
                "id": "18824540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "Challenge with Fskn/IBMX, CPTcAMP or 8-CPT-2Me-cAMP increased the level of Rap1 immunoreactivity associated with RalGDS-RBD, indicative of Rap1 activation in these treated Jurkat T-cells (Fig. 1b).",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2005 Sep 10 309(1) 161-73",
                "id": "15963501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e395"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "Treatment of pulmonary EC with PGE2 or beraprost induced rapid activation of Rap1 (Figure 5A).",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e36c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "The cAMP-specific type 4 family phosphodiesterase inhibitor rolipram potentiated the rate of activation of both Rap1A and Rap1B by forskolin challenge of Rat1 cells. Challenge of Rat1 cells with rolipram alone was able to elicit the phosphorylation of CREB but not activation of either Rap1A or Rap1B.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2000 Jul 21 477(3) 213-8",
                "id": "10908723"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e364"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "Following platelet-derived growth factor treatment, this receptor induces persistent activation of ectopically expressed PLC epsilon through activation of Ras and Rap1.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Nov 21 21(53) 8105-13",
                "id": "12444546"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e23a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "As shown in Fig. 9, butaprost caused a marked, rapid, but transient activation of Rap1.",
              "citation": {
                "type": "PubMed",
                "name": "Naunyn Schmiedebergs Arch Pharmacol 2008 Dec 378(6) 617-30",
                "id": "18648773"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e09f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "First, we tested whether activation of Rap1 results in increased adhesion to FN, which is mediated by beta1 integrins. Indeed, upon stimulation with the phorbol ester PMA, which is a strong stimulus for Rap1 (39), these cells rapidly adhered to FN.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 22 279(43) 44889-96",
                "id": "15302884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e064"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "and of Rap1 in a Ca2+-dependent manner.94,95",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1998 Apr 15 91(8) 2645-57",
                "id": "9531572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e03d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "This results in the IFN-gamma-dependent activation of Rap1, a protein known to exhibit tumor suppressor activity and mediate growth inhibitory responses. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Feb 15 164(4) 1800-6",
                "id": "10657627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e015"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "expression of Val12Rap1a was sufficient to induce a 3.3-   1.5-fold increase in SOCS-3 levels over vector-transfected controls in the presence of proteasome inhibitor (Fig. 7C).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Sep 26(17) 6333-46",
                "id": "16914720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dff8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "RasGRP2 also catalyzes nucleotide exchange on Rap1, but this RapGEF activity is less potent than that associated with CalDAG-GEFI. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 13 275(41) 32260-7",
                "id": "10918068"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfa0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "Moreover, roflumilast treatment for 30 min activated GTP-Rap1 by ~2.5-fold compared to unstimulated cells without affecting total Rap1 level. 8CPT- 2Me-cAMP also activated GTP-Rap1 (Fig. 4B).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 May 20(5) 803-14",
                "id": "18276108"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df93"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "The data in Figs. 1 and 2 provide strong evidence that the Epac/Rap/PLCepsilon pathway contributes to betaAR signaling in the heart.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Feb 23 282(8) 5488-95",
                "id": "17178726"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dee4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "and of Rap1 in a Ca2+-dependent manner.94,95",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1998 Apr 15 91(8) 2645-57",
                "id": "9531572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "From CST pathway map for GPCR Signaling to ERK. ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Endocrinol Metab 2006 Sep 17(7) 276-83",
                "id": "16890451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddb3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "AND-34 displays GEF activity on RalA, Rap1A, and R-Ras but not Ha-Ras GTPases in cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 29 275(39) 30118-23",
                "id": "10896938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "We observed that 8-Br-cAMP augmented cell adhesion and activated Rap1 in a concentration-dependent manner to fibronectin (EC50, ~ 0.20.5 mM) (Fig. 1, A and B).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2003 Feb 17 160(4) 487-93",
                "id": "12578910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcb0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "The results presented here delineate a novel signaling pathway from HGF to the GTPase Rap1 which depends on the interaction of the adapter protein CRKL with the exchange factor C3G and could be linked to cell migration.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 14 275(15) 10772-8",
                "id": "10753869"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "Treatment with forskolin or 8-pCPT-2Me-cAMP led to increased GTP-loading of Rap1 and Rap2, the main downstream effectors of Epac (Fig. 2B, C). ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Oct 20(10) 1715-24",
                "id": "18565730"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc30"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "ARMS is rapidly tyrosine phosphorylated after binding of neurotrophins to Trk receptors and provides a docking site for the CrkL-C3G complex, resulting in Rap1-dependent sustained ERK activation. (CRKL= #1399; KIDINS220 = #57498; RAPGEF = #2889)",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Jun 16 23(12) 2358-68",
                "id": "15167895"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc16"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "We had previously found that induction of the SOCS-3 gene following EPAC and Rap1 activation in HUVECs is dependent on activation of C/EBP transcription factors, particularly C/EBPbeta (10).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jun 26 284(26) 17391-403",
                "id": "19423709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbf1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "Following transfection of H1299 cells with Epac2, total Rap1-GTP levels were elevated as expected.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 3 281(5) 2506-14",
                "id": "16316996"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db73"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAP1A) actsIn gtp(p(HGNC:RAP1A))",
              "summary_text": "activation of Rap1 or Map3k2 is sufficient to stimulate ERK5, while inhibition of either Rap1 or Map3k2 attenuates BDNF activation of ERK5.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 26",
                "id": "17003042"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db72"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PTGER3)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:PTGER3))",
        "directed": false,
        "label": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053291",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "Prostaglandin E(2) (PGE(2)) is the most abundant prostaglandin in the human body. It has a large number of biological actions that it exerts via four types of receptors, EP1-4",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2007 Sep 59(3) 207-24",
                "id": "17878511"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "An agonist of EP(3), an inhibitory pathway, antagonized activity levels induced by PGE(2).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2003 Jun 88(6) 2810-6",
                "id": "12788892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "stroma"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "These results indicate that PGE2 rapidly down-regulates at least GABAA alpha2 protein levels within the POA via EP3 receptor. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Apr 18 283(16) 11064-71",
                "id": "18292084"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3ff"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "Antigen-evoked secretion of interferon-gamma (IFN-gamma) by sperm whale myoglobin-specific Th1 cells of DBA/2 mouse I-Ed-restricted clones, that express EP3Rs and EP4Rs, was enhanced a maximum of 3-fold by 10(-10) to 10(-8) M PGE2 and 2.5-fold each for the EP1R/EP3R-directed agonist sulprostone (10(-8) and 10(-7) M) and for the EP4R/EP3R/EP2R agonist misoprostol (10(-9) M). ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Immunol 1999 May 25 194(1) 21-7",
                "id": "10357877"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "an EP3 receptor antagonist inhibited tumor growth and angiogenesis in WT, but not in EP3(-/-).",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2003 Jan 20 197(2) 221-32",
                "id": "12538661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1ea"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "EP1/EP3 agonist, sulprostone.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 16 278(20) 17977-81",
                "id": "12637575"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1c9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "Treatment with 5 microM of an EP(3) selective agonist, ONO-AE-248, resulted in a 30% decrease in viable cell numbers in the HCA-7 human colon cancer cell line in which EP(3) was expressed.",
              "citation": {
                "type": "PubMed",
                "name": "Gut 2004 Aug 53(8) 1151-8",
                "id": "15247185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 1999 Jun 40(6) 1045-52",
                "id": "10357836"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "exogenous PGE(2) and the specific EP(3) receptor agonist, MB28767, reduced constitutive alpha(v) integrin mRNA expression to half normal values.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Pathol 2004 May 57(5) 553-5",
                "id": "15113870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e194"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "PGE(2) exerts its actions via four transmembrane receptors, EP(1), EP(2), EP(3), and EP(4)",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2003 Jun 88(6) 2810-6",
                "id": "12788892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e187"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "Top 20 genes with signal intensities that were significantly decreased in AE248-treated mice compared with those in vehicle treated mice.",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy Clin Immunol 2009 Oct 124(4) 809-18.e2",
                "id": "19541354"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e05c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "PGE(2) acts through different receptors (EP1-4). (EP1=PTGER1, EP2=PTGER2..etc.) ....EP1, EP2, EP3, and EP4 were expressed on human platelets and megakaryocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2011 Feb 336(2) 391-402",
                "id": "21059804"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfdf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "the selective EP(3) agonist, MB28767",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Pathol 2004 May 57(5) 553-5",
                "id": "15113870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df90"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "using metabolic inhibitors demonstrated that the agonist caused neutrophil death via the activation of protein kinase C in the presence of intracellular ATP.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2000 Aug 68(2) 187-93",
                "id": "10947062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "EP3 inhibits adenylate cyclase,  whereas both EP2 and EP4 stimulate adenylate cyclase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 30 275(26) 19819-23",
                "id": "10749873"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407def7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2002 May 8 518(1-3) 154-8",
                "id": "11997037"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de42"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "VEGF-expression in the stroma was markedly reduced in EP3(-/-)",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2003 Jan 20 197(2) 221-32",
                "id": "12538661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddfe"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "stroma"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "Misoprostol, an EP3 agonist, inhibited glucose-induced insulin secretion from islets, an event that was prevented by preincubation with pertussis toxin, by decreasing cAMP.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2002 Jun 51(6) 1772-8",
                "id": "12031964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dddc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "PGE2 exerted its action by activating EP3 receptors. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pain 2007 3 22",
                "id": "17692121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddb6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "we examined PGE2-induced gene expression changes at single-cell resolution in preoptic neurons expressing EP3. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Apr 18 283(16) 11064-71",
                "id": "18292084"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbf2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER3) actsIn cat(p(HGNC:PTGER3))",
              "summary_text": "This study shows that among the four PGE2 receptors (EP1-EP4), activation of EP3 is sufficient to mediate the proaggregatory actions of low PGE2 concentration",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2001 Mar 107(5) 603-10",
                "id": "11238561"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TGFB1)",
        "relation": "increases",
        "target": "a(SCHEM:Dinoprostone)",
        "directed": false,
        "label": "p(HGNC:TGFB1) increases a(SCHEM:Dinoprostone)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405328c",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TGFB1) increases a(SCHEM:Dinoprostone)",
              "summary_text": "All TGFbeta isoforms stimulated PGE2 synthesis; TGFbeta3 was approximately twice as potent as TGFbeta1 and TGFbeta2, each of which had similar effects",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1997 Feb 1 321 ( Pt 3) 639-43",
                "id": "9032448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e403"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAPGEF3)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:RAPGEF3))",
        "directed": false,
        "label": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053275",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "Stimulation of phosphoinositide-hydrolysing phospholipase C (PLC) generating inositol-1,4,5-trisphosphate is a major calcium signalling pathway used by a wide variety of membrane receptors, activating distinct PLC-beta or PLC-gamma isoforms. Here we report a new PLC and calcium signalling pathway that is triggered by cyclic AMP (cAMP) and mediated by a small GTPase of the Rap family. Activation of the adenylyl cyclase-coupled beta2-adrenoceptor expressed in HEK-293 cells or the endogenous receptor for prostaglandin E1 in N1E-115 neuroblastoma cells induced calcium mobilization and PLC stimulation, seemingly caused by cAMP formation, but was independent of protein kinase A (PKA). We provide evidence that these receptor responses are mediated by a Rap GTPase, specifically Rap2B, activated by a guanine-nucleotide-exchange factor (Epac) regulated by cAMP, and involve the recently identified PLC-epsilon isoform.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Nov 3(11) 1020-4",
                "id": "11715024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "inhibition of fibroblast proliferation was mediated exclusively by activation of Epac-1. PGE(2) and Epac-1 inhibited cell proliferation through activation of the small GTPase Rap1, since decreasing Rap1 activity by transfection with Rap1GAP or the dominant-negative Rap1N17 prevented, and transfection with the constitutively active Rap1V12 mimicked, the anti-proliferative effects of PGE(2)",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 Oct 39(4) 482-9",
                "id": "18421013"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e408"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "The recently described cAMP-dependent guanine nucleotide exchange factor (GEF) Epac activates small GTPase Rap1, which results in activation of small GTPase Rac-specific GEFs Tiam1 and Vav2 and Rac-mediated EC barrier protective responses. Our results show that ANP stimulated protein kinase A and the Epac/Rap1/Tiam/Vav/Rac cascade",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e23d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "We show here that in COS1 cells stimulation with the EPACselective cyclic AMP analogue, 8-pCPT-2'-O-Me-cyclic AMP (8Me), is sufficient to induce expression of SOCS-3 (Fig. 1a).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jun 26 284(26) 17391-403",
                "id": "19423709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e233"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "agonist activation of the Gs-coupled receptor for PGE1 endogenously expressed in N1E-115 neuroblastoma cells induced activation of R-Ras by about 2-fold, similar to treatment of the cells with 8-pCPT-2Me-cAMP (Fig. 5B). Again, expression of R279K Epac1 suppressed activation of R-Ras by PGE1 and the Epac-specific cyclic AMP analog.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Aug 4 281(31) 21837-47",
                "id": "16754664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e01c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "More importantly, these data strongly suggest EPAC rather than PKA as the relevant effector of cAMP-mediated inhibition of proliferation of HASM cells.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Jan 294(1) L131-8",
                "id": "17993585"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "VIP/VPAC1 interaction is associated with a cAMP increase and activation of a cAMP/p38 MAPK pathway, which regulates MMP-9, CD35, and CD11b exocytosis, and a cAMP/EPAC/PI-3K/ERK pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2008 Apr 83(4) 972-81",
                "id": "18174366"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbbd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "We had previously found that induction of the SOCS-3 gene following EPAC and Rap1 activation in HUVECs is dependent on activation of C/EBP transcription factors, particularly C/EBPbeta (10).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jun 26 284(26) 17391-403",
                "id": "19423709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db66"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "Treatment with forskolin or 8-pCPT-2Me-cAMP led to increased GTP-loading of Rap1 and Rap2, the main downstream effectors of Epac (Fig. 2B, C).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Oct 20(10) 1715-24",
                "id": "18565730"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e337"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "The data in Figs. 1 and 2 provide strong evidence that the Epac/Rap/PLCepsilon pathway contributes to betaAR signaling in the heart.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Feb 23 282(8) 5488-95",
                "id": "17178726"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e241"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "Thus, nuclear/cytoplasmic translocation of DNA-PK is under dual control by cAMP, with EPAC activation promoting nuclear exit while PKA promotes its nuclear entry (Fig. 1F).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2008 Sep 2 105(35) 12791-6",
                "id": "18728186"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "Two principal effector proteins for cAMP are protein kinase A (PKA) and EPAC (exchange protein directly activated by cAMP), a Rap guanosine 5'-diphosphate (GDP) exchange factor.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Apr 1 103(7) 2661-7",
                "id": "14615375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e19d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "Treatment of HEK-293 cells with the membrane-permeable Epac-specific cyclic AMP analog, 8-pCPT-2Me-cAMP (100 uM) (43), induced a robust and rather long lasting activation R-Ras, with a maximum at 510 min (Fig. 4A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Aug 4 281(31) 21837-47",
                "id": "16754664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e15a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "From CST pathway map for GPCR Signaling to ERK. ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Endocrinol Metab 2006 Sep 17(7) 276-83",
                "id": "16890451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e057"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "Whereas overexpression of wild-type Epac1 enhanced the phosphorylation of ERK1/2 induced by the beta2-AR, the receptor response was almost fully blunted (n = 4; p < 0.003) by expression of R279K Epac1 (Fig. 5A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 5 279(45) 46497-508",
                "id": "15319437"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e035"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "Epac1, on the contrary, strongly promoted cell adhesion, which was decreased upon cotransfection of the receptor (Figure 8C, D).",
              "citation": {
                "type": "PubMed",
                "name": "J Proteome Res 2007 Jan 6(1) 287-97",
                "id": "17203972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e013"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "Significant enhancement of CREB phosphorylation was observed only upon transfection of Epac1 and treatment of cells with cAMP analogue 8-pCPT.",
              "citation": {
                "type": "PubMed",
                "name": "J Proteome Res 2007 Jan 6(1) 287-97",
                "id": "17203972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dda1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAPGEF3) actsIn cat(p(HGNC:RAPGEF3))",
              "summary_text": "In summary, our data indicate that Gi-coupled receptors can inhibit PLC-epsilon, most likely by suppressing formation of cyclic AMP required for Epac-mediated Rap2B activation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Aug 16(8) 921-8",
                "id": "15157671"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PTGER2)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:PTGER2))",
        "directed": false,
        "label": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405328f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "Mechanisms of cancer promotion by COX-2 are not fully understood, but signaling through prostaglandin (PG)E2 receptors is a contributing factor. The major PGE2 receptors on epithelial cells, EP2 and EP4, increase cAMP production, which promotes growth and inhibits apoptosis in some cell types.  To explore the hypothesis that PGE2-stimulated cAMP  is a key intracellular mediator of COX-2-dependent antiapoptosis and define the underlying mechanisms, we used the T84 human colon epithelial cell line, which exhibits inducible apoptosis and is responsive to PGE2  stimulation (31, 34, 35). The major PGE2 receptors on colon epithelial cells are EP2 and EP4  (25), a finding we confirmed by RT-PCR of T84 cells (data not shown). Both EP2 and EP4 receptors activate adenylyl cyclase and increase cAMP as a second messenger, suggesting that cAMP mediates antiapoptotic functions in epithelial cells. Consistent with this idea, we found that a membrane-permeant  cAMP analog, 8-CPT-cAMP, and CTX, which catalyzes the ADP-ribosylation of Gs regulatory protein, leading to the activation of adenylyl  cyclase, also inhibited Fas- and staurosporine-promoted apoptosis  (Fig. 1 A). These findings were confirmed by evidence that CTX and 8-CPT-cAMP also inhibited the formation of apoptosis-associated DNA laddering in T84 cells (Fig. 1B and data not shown). We obtained similar results with the normal rat intestinal epithelial  cell line, RIE-1 (Fig. 1C). Thus, the antiapoptotic response to increases in cAMP in intestinal epithelial cells is independent of their state of transformation and conserved across at least two species.\\\"From full text\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jul 22 100(15) 8921-6",
                "id": "12837940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e150"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "The EP2 receptor agonist butaprost inhibited [3H]-thymidine incorporation in a concentrationdependent manner, maximally by about 75% and with an IC50 of 2.3 nM (Fig. 2). In the presence of 1% FCS, basal [3H]-thymidine incorporation was increased about fourfold (Fig. 2a), but the inhibitory effect of butaprost was very similar to that in the absence of FCS (Fig. 2b and c).",
              "citation": {
                "type": "PubMed",
                "name": "Naunyn Schmiedebergs Arch Pharmacol 2008 Dec 378(6) 617-30",
                "id": "18648773"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e410"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "They are in the family of G-protein coupled receptors and both receptors were initially characterized as coupling to Gs and increasing intracellular cAMP formation. Recently, however, we have shown that both receptors can stimulate T-cell factor (Tcf) mediated transcriptional activity",
              "citation": {
                "type": "PubMed",
                "name": "Life Sci 2003 Dec 5 74(2-3) 143-53",
                "id": "14607241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "PGE(2) acts through different receptors (EP1-4). (EP1=PTGER1, EP2=PTGER2..etc.) ....EP1, EP2, EP3, and EP4 were expressed on human platelets and megakaryocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2011 Feb 336(2) 391-402",
                "id": "21059804"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e127"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "This stimulation of reporter gene activity was accompanied by a PGE(2)-dependent increase in the phosphorylation of both glycogen synthase kinase-3 (GSK-3) and Akt kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 25 277(4) 2614-9",
                "id": "11706038"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e117"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "PGE(2) and agonists of EP(1) and EP(2) significantly increased aromatase activity levels, which were decreased by the corresponding antagonists.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2003 Jun 88(6) 2810-6",
                "id": "12788892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "stroma"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "EP3 inhibits adenylate cyclase,  whereas both EP2 and EP4 stimulate adenylate cyclase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 30 275(26) 19819-23",
                "id": "10749873"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df1a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "Only PGE(2) and PGE1 alcohol completely abolished CD36 induction",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2005 Apr 1 66(1) 141-9",
                "id": "15769457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407def3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "PGE2 appears to signal through EP2 receptors. Butaprost (EP2 agonist) but not sulprostone (EP3 agonist) inhibited IL-6-stimulated proliferation. In addition, an EP2 antagonist (AH6809) alleviated the anti-proliferative effects of PGE2.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Feb 15 370(Pt 1) 315-21",
                "id": "12429018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407debf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd86"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "Based on our observations we speculate that PGE1 exerts its effect on VEGF-1 via interaction via EP2 and_or EP4 PG receptors both of which increase intracellular cAMP levels, whereas we hypothesize that neither EP1 nor EP3 receptors play a role in this effect since they lead to a rise in intracellular calcium or to a decrease in intracellular cAMP, respectively",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Apr 36(4) 539-46",
                "id": "15081313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db89"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "After overnight smoking cessation, basal and prostaglandin E1-induced phosphorylation state of intraplatelet VASP was compared between smokers and non-smokers. Furthermore, the ability of several concentrations of ADP to induce surface expression of P-selectin was assessed",
              "citation": {
                "type": "PubMed",
                "name": "Platelets 2010 21(8) 596-603",
                "id": "20822337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "Antigen-evoked secretion of interferon-gamma (IFN-gamma) by sperm whale myoglobin-specific Th1 cells of DBA/2 mouse I-Ed-restricted clones, that express EP3Rs and EP4Rs, was enhanced a maximum of 3-fold by 10(-10) to 10(-8) M PGE2 and 2.5-fold each for the EP1R/EP3R-directed agonist sulprostone (10(-8) and 10(-7) M) and for the EP4R/EP3R/EP2R agonist misoprostol (10(-9) M). ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Immunol 1999 May 25 194(1) 21-7",
                "id": "10357877"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e342"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "Stimulation of EP2 and EP4 is linked with cyclic adenosine 3', 5'-monophosphate (cAMP)-dependent protein kinase A (PKA). specific agonists of these receptors induced growth inhibition with an accompanying increase in cAMP production.",
              "citation": {
                "type": "PubMed",
                "name": "J Lab Clin Med 2002 Aug 140(2) 92-102",
                "id": "12228765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e321"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "Activation of the adenylyl cyclase-coupled beta2-adrenoceptor expressed in HEK-293 cells or the endogenous receptor for prostaglandin E1 in N1E-115 neuroblastoma cells induced calcium mobilization and PLC stimulation, seemingly caused by cAMP formation,",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Nov 3(11) 1020-4",
                "id": "11715024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e30d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "Prostaglandin E(2) (PGE(2)) is the most abundant prostaglandin in the human body. It has a large number of biological actions that it exerts via four types of receptors, EP1-4",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2007 Sep 59(3) 207-24",
                "id": "17878511"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "The selective EP2 receptor agonist butaprost, but not the EP1/EP3 agonist sulprostone, suppressed IFN-gamma synthesis and exclusively competed with PGE2 for receptor binding on NK cells.",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2004 Mar 111(3) 298-305",
                "id": "15009430"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e212"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "natural killer cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 31 278(44) 43146-56",
                "id": "12939279"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e032"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "PGE2 acts via EP1 and EP2 receptor subtypes to stimulate both the PKC and PKA pathways. ",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1996 Dec 137(12) 5739-42",
                "id": "8940410"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df6f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2001 Dec 79(5) 950-8",
                "id": "11739606"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "Among prostaglandin E (EP) receptor-selective synthetic agonists, EP2 and EP4 agonists caused down-regulation of the zymosan-induced TNFalpha production, but up-regulation on the IL-10 production",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2001 May 1 61(9) 1153-60",
                "id": "11301049"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de9c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "in both benign and malignant mouse intestinal tumors, stromal expression of COX2 results in elevated PGE2 levels that stimulate, in turn, cell surface receptor EP2, followed by induction of VEGF and angiogenesis",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2004 Aug 25(4) 581-611",
                "id": "15294883"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 50081-6",
                "id": "12401798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dddd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "EP2 and EP4 are coupled to Gs and stimulate cAMP production which leads to gene regulation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Oncol 2011 2011",
                "id": "20953410"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddcd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "PGE(2) exerts its actions via four transmembrane receptors, EP(1), EP(2), EP(3), and EP(4)",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2003 Jun 88(6) 2810-6",
                "id": "12788892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd9e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "Work in our laboratory (13) and others (14) has shown that the inhibitory actions of PGE2 in lung fibroblasts are a result of increases in cAMP, mediated through the Gas-coupled EP2 receptor;",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 Oct 39(4) 482-9",
                "id": "18421013"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc9f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "TNF-alpha production was inhibited 50-70% at 2-24 h by EP4/2 agonists, whereas IL-6 was enhanced up to approximately 220%.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2004 Jul 76(1) 227-36",
                "id": "15075356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc91"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGER2) actsIn cat(p(HGNC:PTGER2))",
              "summary_text": "PGE(2) caused a rapid increase in StAR expression that involves activation of the EP2 receptor-coupled protein kinase A pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2003 Sep 144(9) 3934-42",
                "id": "12933667"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc37"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PTGS2)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:PTGS2))",
        "directed": false,
        "label": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532a0",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "A COX-2-selective inhibitor, NS-398 (10 M), was used to determine whether COX-2 was responsible for the observed increases in PGE2 synthesis by CSE-treated fibroblasts (62). Two different strains of human lung fibroblasts were pretreated with NS-398 for 1 h before treatment with 1% CSE for 24 h, and supernatants were analyzed for PGE2. As shown in Fig. 2, the fibroblast strains incubated with 1% CSE had a three- to fourfold induction in PGE2 synthesis over basal levels after 24 h, depending on the strain. However, cells treated with both CSE and NS-398 had significantly decreased PGE2 levels relative to fibroblasts treated with CSE alone, supporting the idea that the elevated PGE2 levels are a result of COX-2 activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2004 Nov 287(5) L981-91",
                "id": "15234907"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "One of the several genes that were highly up-regulated by over expressed Cox-2 was MDR1. MDR1 or P-glycoprotein (P-gp), the product of the MDR1 gene, is implicated as the primary cause of multidrug resistance (MDR) in tumors where it acts as an efflux pump for chemotherapeutic agents. It is also expressed in normal tissues of the liver and kidney where it functions to actively transport lipophilic xenobiotics. Reverse transcriptase-PCR analysis confirmed the results of the microarray, showing increased mRNA levels for MDR1 in Cox-2 overexpressing cells.e again confirm that Cox-2 overexpressing RMC have increased MDR1 expression. We also observed that the addition of NS398 blocked the up-regulation of the MDR1 protein, consistent with the R123 efflux assay showing reduced MDR1 activity. These additional results show that the Cox-2-mediated MDR1 response is dependent on Cox-2 activity. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38915-20",
                "id": "12138126"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cultured myometrial cells expressed low levels of Cox-2 mRNA under baseline conditions, but interleukin-1beta (IL-1beta) caused a 17-fold induction of expression of the Cox-2 transcript after incubation for 6 h. IL-1beta also induced expression of biologically active Cox-2 protein, as detected by immunofluorescence, Western blot analysis, and measuring the conversion of arachidonic acid to prostanoids in the presence and absence of a Cox-2-selective inhibitor, NS-398.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2000 Sep 85(9) 3468-75",
                "id": "10999850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e387"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "myometrium"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Several anticancer therapies target, albeit indirectly, the PI3K/ Akt1 axis and cause inhibition of Akt1 phosphorylation and induction of apoptosis. Examples include herceptin, which inhibits ErbB2 in breast cancer cells; cyclooxygenase-2 (COX-2) inhibitors, which inhibit COX-2 and PDK1 in colon and prostate cancer; gefitnib (Iressa), which targets mutant epidermal growth factor receptor in lung cancer cells; and imatinib mesylate (Gleevec, STI- 571), which targets bcr-abl in leukemia. Conversely, inhibition of anoikis, which contributes to metastasis by trkB or TWIST, involves Akt activation. Given that Akt1 binds to Par-4 in diverse cell types, the action of these therapeutic agents may involve regulation of Par-4 function via Akt1.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Mar 15 66(6) 2889-92",
                "id": "16540633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e329"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "was able to prevent the development of N-methylnitrosurea-induced prostate and mammary carcinomas in rats by 50% (REF. 38). Celecoxib, an inhibitor of the inducible prostaglandin G/H synthase COX2, was able to reduce the number of colorectal polyps in patients with familial adenomatous polyposis (FAP). Patients with FAP are at high risk of developing colorectal neoplasias39.COX2 inhibitors are anti-inflammatory agents with anti-angiogenic activities that downregulate the expression of the pro-angiogenic factors FGF and VEGF40.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Jun 3(6) 401-10",
                "id": "12778130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "The PI3K pathway is negatively regulated by PTEN (phosphatase and TENsin homolog), which converts PIP3 in PIP2, preventing PKB activation and Bad phosphorylation/sequestration. Thus PTEN is considered as a tumor suppressor gene. It has been shown that NS-398 was able to increase the level of PTEN in human gastric carcinoma cell line MKN45 [114]. ",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cell Biol 2010 2010 215158",
                "id": "20339581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Mechanisms of cancer promotion by COX-2 are not fully understood, but signaling through prostaglandin (PG)E2 receptors is a contributing factor. The major PGE2 receptors on epithelial cells, EP2 and EP4, increase cAMP production, which promotes growth and inhibits apoptosis in some cell types.  To explore the hypothesis that PGE2-stimulated cAMP  is a key intracellular mediator of COX-2-dependent antiapoptosis and define the underlying mechanisms, we used the T84 human colon epithelial cell line, which exhibits inducible apoptosis and is responsive to PGE2  stimulation (31, 34, 35). The major PGE2 receptors on colon epithelial cells are EP2 and EP4  (25), a finding we confirmed by RT-PCR of T84 cells (data not shown). Both EP2 and EP4 receptors activate adenylyl cyclase and increase cAMP as a second messenger, suggesting that cAMP mediates antiapoptotic functions in epithelial cells. Consistent with this idea, we found that a membrane-permeant  cAMP analog, 8-CPT-cAMP, and CTX, which catalyzes the ADP-ribosylation of Gs regulatory protein, leading to the activation of adenylyl  cyclase, also inhibited Fas- and staurosporine-promoted apoptosis  (Fig. 1 A). These findings were confirmed by evidence that CTX and 8-CPT-cAMP also inhibited the formation of apoptosis-associated DNA laddering in T84 cells (Fig. 1B and data not shown). We obtained similar results with the normal rat intestinal epithelial  cell line, RIE-1 (Fig. 1C). Thus, the antiapoptotic response to increases in cAMP in intestinal epithelial cells is independent of their state of transformation and conserved across at least two species.\\\"From full text\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jul 22 100(15) 8921-6",
                "id": "12837940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dda9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Our results show that tobacco smoke led to increased generation of reactive oxygen species with an increase in NF-kB activation.Gel shift analysis also revealed the elevated level of the oxidative stress sensitive proinflammatory nuclear transcription factor-kappa B and activator protein-1 in different regions of the brain of cigarette smoke exposed mice. Tobacco smoke led to activation of COX-2 in all the regions of the brain. Activation of mitogen activated protein kinase and c-Jun N-terminal kinase were also observed in various regions of brain of ETS exposed mice.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 May 28 71(11) 1602-9",
                "id": "16569398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd60"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "JAK/STATs C225 Phase I treatment (47) AG490 Preclinical treatment (48-51) #----------------------------------------------------------------- Table II. Chemopreventive Agents for Targeting Signal Transduction Pathways Target Drug Phase of Testing Reference Cox-2 Celecoxib Preclinical treatment (164,174-177) and prevention Nimesulide, Valdecoxib, Preclinical treatment (178) Parecoxib, Etoricoxib, Lumaricoxib Sulindac Phase II treatment (179-181) Exisulind Phase I treatment",
              "citation": {
                "type": "PubMed",
                "name": "J Mammary Gland Biol Neoplasia 2003 Jan 8(1) 45-73",
                "id": "14587863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc06"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cigarette smoke up-regulates experimentally the production of cytokines, such as interleukin (IL)-1b, and the Th-1 cytokines, which increase cyclooxygenase (COX)-2 enzymatic activity and can promote an inflammatory response through lymphocytes, resulting in an overproduction of cytokines, such as IL-6, IL-8, and IL- 10.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Am Thorac Soc 2008 Dec 1 5(8) 842-7",
                "id": "19017739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e406"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "immune cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": " Inhibition of cyclooxygenase-2 activity by specific chemical inhibitor or siRNA attenuates the H(2)O(2)-induced increase of senescence associated beta-galactosidase positive cells and attenuates growth arrest. In this work, p38(MAPK) activation and increased DNA binding activities of ATF-2 and p53 are shown to mediate cyclooxygenase-2 overexpression in premature senescence.",
              "citation": {
                "type": "PubMed",
                "name": "Biogerontology 2009 Jun 10(3) 291-8",
                "id": "19082758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "# sentences for pubmedID=12970159: # GeneRif: COX-2 exerts a negative feedback on the expression of cathepsin D to reduce the generation of the antiangiogenic factor angiostatin, hence promoting a proangiogenic environment. # Pubmed:gene: Cyclooxygenase-2 overexpression inhibits cathepsin D-mediated cleavage of plasminogen to the potent antiangiogenic factor angiostatin.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2003 Dec 144(12) 5322-8",
                "id": "12970159"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "ANXA1 inhibits the expression and/or activity of other inflammatory enzymes like inducible nitric oxide synthase (iNOS) in macrophages and inducible cyclooxygenase (COX2) in activated microglia.",
              "citation": {
                "type": "PubMed",
                "name": "Inflamm Res 2004 Apr 53(4) 125-32",
                "id": "15060718"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "PGH2 are metabolized to PGE2, PGI2, PGD2, PGF2alpha, and thromboxane A2 (TXA2) by respective actions of PGE2 synthase (PGES), PGI2 synthase (PGIS), PGD2 synthase (PGDS), PGF2 synthase (PGFS), and thromboxane synthase. ",
              "citation": {
                "type": "PubMed",
                "name": "Immune Netw 2011 Dec 11(6) 364-7",
                "id": "22346776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "These results indicate that PGE(2) synthetic capacity in AECs is predominantly COX-2-dependent under both basal and stimulated conditions",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2002 Dec 27(6) 752-8",
                "id": "12444036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2a0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cultured myometrial cells expressed low levels of Cox-2 mRNA under baseline conditions, but interleukin-1beta (IL-1beta) caused a 17-fold induction of expression of the Cox-2 transcript after incubation for 6 h. IL-1beta also induced expression of biologically active Cox-2 protein, as detected by immunofluorescence, Western blot analysis, and measuring the conversion of arachidonic acid to prostanoids in the presence and absence of a Cox-2-selective inhibitor, NS-398.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2000 Sep 85(9) 3468-75",
                "id": "10999850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e286"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "in both benign and malignant mouse intestinal tumors, stromal expression of COX2 results in elevated PGE2 levels that stimulate, in turn, cell surface receptor EP2, followed by induction of VEGF and angiogenesis",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2004 Aug 25(4) 581-611",
                "id": "15294883"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e235"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Carrageenin-induced acute lung inflammation was also exacerbated in Nrf2?/? mice compared with Nrf2+/+ mice (Mochizuki et al., 2005). A selective COX-2 inhibitor (NS-398) suppressed the antiinflammatory 15-deoxy-delta (12,14)-prostaglandin J2 (15d-PGJ2) accumulation and ARE responsiveness, and caused greater lung injury in Nrf2?/? mice than in Nrf2+/+ mice (Mochizuki et al., 2005).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2009 Jul 29",
                "id": "19646463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1c5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Prostaglandins, particularly prostaglandin E2 (PGE2), play an important role during inflammation. This is exemplified by the clinical use of cyclooxygenase 2 inhibitors, which interfere with PGE2 synthesis, as effective antiinflammatory drugs. In human purified naive T cells, PGE2 acts via prostaglandin receptor EP2- and EP4-mediated signaling and cyclic AMP pathways to up-regulate IL-23 and IL-1 receptor expression. ",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2009 Mar 16 206(3) 535-48",
                "id": "19273625"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e18c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "naive T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Macrophage activation promotes the secretion of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta), and of secondary mediators (through activation of Cox2), leukotrienes and prostaglandins (PGs) such as PGE2. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Sep 16 21(18) 4831-40",
                "id": "12234923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e172"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Theseeffects were reversed by NS398, a COX-2-specific inhibitor, suggesting thatlipopolysaccharide-mediated inhibition of CUGBP2 is a PG-dependent mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Sep 21 101(38) 13873-8",
                "id": "15358864"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e168"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Overexpressing of COX-2 showed reduced DR-4 and DR-5 mRNA and protein expression. COX-2-overexpressing cells were treated with 20micro M sulindac sulfide  for 24h, which increased both DR-4 and DR-5 mRNA levels in HCT-15 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Sep 1 62(17) 4903-8",
                "id": "12208739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e15b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "To test whether the PGE2 produced was through COX-2, a COX-2-selective inhibitor NS398 was used (51). At 300 nM, there was complete inhibition of TNF-induced PGE2 production, suggesting a key role for COX-2 in the PGE2 response to TNF in this system (Fig. 1B).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Aug 17(11) 1411-21",
                "id": "12890694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e124"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "we did IL-6-specific ELISA on supernatants of COX-2-S and COX-2-AS cells and showed that IL-6 is significantly increased in COX-2-S",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2005 Nov 1 11(21) 7674-82",
                "id": "16278387"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e114"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Recent experiments have demonstrated that COX-2 promotes tumor angiogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Mar 4 1654(1) 51-67",
                "id": "14984767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "FACL4 and COX-2 synergistically inhibit apoptosis by reducing the intracellular level of free arachidonic acid. Here, we report that expression of FACL4 is significantly increased in colon adenocarcinoma",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Dec 1 61(23) 8429-34",
                "id": "11731423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "A substantial body of literature indicates that endothelial COX-2 activity is upregulated by a number of cytokines and mitogenic stimuli, including Interleukin-1 alpha and beta (IL-l alpha and beta), tumour necrosis factor alpha (TNFa), transforming growth factor beta (TGFbeta), phorbol ester, lipolysaccharide (LPS) and interferon gamma (IFNy) I2 13.",
              "citation": {
                "type": "PubMed",
                "name": "Dig Liver Dis 2001 Dec 33 Suppl 2 S12-20",
                "id": "11827357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Dexamethasone and niflumic acid, a cyclooxygenase-2 inhibitor, both inhibited haptoglobin release. There was release of haptoglobin by both isolated adipocytes and the adipose tissue matrix remaining after collagenase digestion of human adipose tissue",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2004 Mar 45(3) 536-42",
                "id": "14657203"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Adipose Tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Interestingly,  expression of the proapoptotic proteins Bax and Bcl-x L was reduced in Cox-2- expressing tumors. Cox-2-induced tumor tissue expressed reduced levels of the proapoptotic proteins Bax and Bcl-x(L) and an increase in the anti-apoptotic protein Bcl-2, suggesting that decreased apoptosis of mammary epithelial cells contributes to tumorigenesis. \\\"From full text\\\"",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 25 276(21) 18563-9",
                "id": "11278747"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df73"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Pleckstrin phosphorylation and serotonin secretion in human platelets stimulated with vWF are blocked by the cyclooxygenase inhibitor acetylsalicylic acid",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 13 276(28) 26022-9",
                "id": "11344169"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ded5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "The expression of cyclooxygenase (COX)-2 is induced by growth factors, tumor promoters and cytokines, and is correlated with carcinogenesis, tumor progression and inhibition of apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2005 Feb 26(2) 353-60",
                "id": "15645119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deaa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "nonsteroidal antiinflammatory drugs up-regulate the synthesis of LTB(4), supporting the shunt hypothesis from COX to 5-LOX.",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2004 Dec 50(12) 3925-33",
                "id": "15593193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dea4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "LPS upregulated COX-2 expression 2.8-fold and alpha(v) integrin expression twofold. The COX-2 inhibitor celecoxib increased alpha(v) integrin mRNA expression twofold. Both exogenous PGE(2) and the specific EP(3) receptor agonist, MB28767, reduced constitutive alpha(v) integrin mRNA expression to half normal values",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Pathol 2004 May 57(5) 553-5",
                "id": "15113870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de98"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "These results confirm the importance of COX-2 activity in prolonged PGI2 release in response to thrombin",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 28 281(17) 11792-804",
                "id": "16467309"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "In the present study, we demonstrated that COX-2 inhibits genotoxic stress-induced apoptosis by using an adenoviral COX-2 overexpression system. In addition, we found that COX-2 regulates the transcription function of p53 as evidenced by suppression of p53 target gene induction by COX-2 cotransfection. Furthermore, COX-2 interacted with p53 in vitro and in vivo, which was inhibited by the treatment with NS-398.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Mar 25 328(4) 1107-12",
                "id": "15707991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "To test whether the PGE2 produced was through COX-2, a COX-2-selective inhibitor NS398 was used (51). At 300 nM, there was complete inhibition of TNF-induced PGE2 production, suggesting a key role for COX-2 in the PGE2 response to TNF in this system (Fig. 1B).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Aug 17(11) 1411-21",
                "id": "12890694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de57"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "in fact, eicosanoids produced by macrophages expressing COX-2 are known to have proinflammatory effects increasing vascular permeability, promoting chemotaxis and favouring cell proliferation and cholesterol ester retention.",
              "citation": {
                "type": "PubMed",
                "name": "Dig Liver Dis 2001 Dec 33 Suppl 2 S12-20",
                "id": "11827357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "A prostate apoptosis response 4 (Par-4) gene was up-regulated after NSAID treatment. Par-4 was first isolated from prostate carcinoma cells undergoing apoptosis, and expression of Par-4 sensitized cancer cells to apoptotic stimuli. ",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2000 Jun 118(6) 1012-7",
                "id": "10833474"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Prostanoids are lipid mediators generated from AA by the enzymatic action of the cyclooxygenases (COX) 1 and 2 to form the intermediate PGH 2 , with subsequent metabolism to specifi c prostanoid species (e.g., PGD 2 , PGE 2 , PGF 2  , PGI 2 , and thromboxane) by prostaglandin synthases",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2008 Nov 24 205(12) 2791-801",
                "id": "18955568"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "the JNK2/c-jun/COX-2 pathway functions upstream of PI3-K and Nrf2 (26) in the signaling cascade",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Sep 27 102(39) 14010-5",
                "id": "16172382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "We report that overexpression of human (h) cyclooxygenase-2 h(COX-2) in the brain of a transgenic mouse line leads to selective induction of endogenous complement component C1qB expression in neurons. No detectable induction of the C3 and C4 complement components in the brain was found. Chronic treatment of mice with the selective COX-2 inhibitor nimesulide reduced the hCOX-2-mediated induction of hippocampal C1qB mRNA expression.",
              "citation": {
                "type": "PubMed",
                "name": "Acta Neuropathol (Berl) 2002 Feb 103(2) 157-62",
                "id": "11810182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "The production of prostaglandins begins with the liberation of arachidonic acid from membrane phospholipids by phospholipase A2 in response to inflammatory stimuli. Arachidonic acid is converted to PGH2 by the cyclooxygenase enzymes COX-1 and COX-2 (known formally as prostaglandin endoperoxide H synthases). ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2002 Mar 23(3) 144-50",
                "id": "11864843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcc0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Incubation with NS-398, a COX-2 inhibitor, blocked the effect of AA, but not of ethanol, on COL1A2 expression suggesting that CYP2E1 activates COX-2 expression, and the oxidation of AA by COX-2 is responsible for the increase in COL1A2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 30 275(26) 20136-45",
                "id": "10770928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbc0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "The defect in PDGF-induced PGE2 release occurs prior to action of prostaglandin H synthase/cyclooxygenase as release of arachadonic acid (in response to PDGF) does not occur in the superoxide dismutase-overexpressing clones.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 1995 Sep 10 322(1) 31-8",
                "id": "7574691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbb9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "where CO takes over the roles of NO under conditions of oxidative stress (Maines, 1997). Therefore, HO activity is important in controlling the activity of heme proteins, such as cytochromes P450, COX, guanylyl cyclase, and NOS, not only at the level of the intracellular heme pool available for the apo-heme proteins (Kappas and Drummond, 1986) but possibly also at the level of HO's downstream effector molecule CO by interactions with the heme group (Haider et al., 2002). ",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2003 Sep 55(3) 551-71",
                "id": "12869663"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Conversely, calcium ionophore greatly enhanced SR-A up-regulation This enhancement was dependent upon concurrent up-regulation of SMC cyclooxygenase-2 expression and activity and was blocked by the cyclooxygenase-2 inhibitors NS-398 and Resveratrol",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 9 275(23) 17661-70",
                "id": "10837497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e413"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "The elevated PGE2 production by metastatic cancer cells was due to COX-2 activity since dual COX-1/2 inhibitor indomethacin and selective COX-2 inhibitor NS-398 equally suppressed both basal and inducible (by IFN-gamma/LPS or Ca2+-ionophores) PGE2 accumulation.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Oct 1 289(2) 265-74",
                "id": "14499627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "COX-2 synthesizes prostaglandin E2 (PGE2) which stimulates bcl-2 and inhibits apoptosis, and induces interleukin-6 (IL-6) which enhances haptoglobin synthesis. PGE2 is associated with tumor metastases, IL-6 with cancer cell invasion, and haptoglobin with implantation and angiogenesis",
              "citation": {
                "type": "PubMed",
                "name": "Ann Clin Lab Sci 2000 Jan 30(1) 3-21",
                "id": "10678579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e397"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "tumor growth (sarcoma-180, Lewis lung carcinoma) was markedly suppressed in EP3(-/-), in which tumor-associated angiogenesis was also reduced.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2003 Jan 20 197(2) 221-32",
                "id": "12538661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e386"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "To confirm that COX-2 was the source of peroxides in the K-rasV12 transfected cells, we treated the cells with COX-2- specific inhibitor, SC58125.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2004 Nov 25(11) 2231-7",
                "id": "15284181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e36d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "E4BP4 is a negative regulator of the cyclooxygenase-2 (COX-2) pathway that drives the expression of both Runx2 and Osterix...Runx2 and Osterix as major osteoblast transcriptional activators",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2008 Oct 1 14(19) 6081-91",
                "id": "18829486"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e361"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Otolaryngol 2003 Aug 32(4) 226-9",
                "id": "14587561"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e353"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cyclooxygenase-2 (COX-2) is a crucial enzyme in the conversion of arachidonicacid to prostaglandin E2 (PGE(2)) and is significantly upregulated in many typesof adenocarcinomas.",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2003 Dec 1010 504-9",
                "id": "15033780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e31b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "COX-2 inhibition prevented ETS-1 expression in response to ANG II, suggesting that COX-2 is required for ETS-1 induction.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2008 May 294(5) F1094-100",
                "id": "18337545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e296"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "These results indicate that the COX-2 pathway contributes to Nrf2 activation in the acute phase (i.e. 6 h) following exposure to L-flow. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 27244-50",
                "id": "15917255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e28b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Ariadne: PGE 2 inhibits S14 gene transcription in primary hepatocytes  To examine the effects of PGE 2 on parenchymal cell gene transcription, primary hepatocytes were transiently transfected with either an S14 CAT reporter gene (S170) or RSVCAT (R100).",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 1999 Jun 40(6) 1045-52",
                "id": "10357836"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1bc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Nonsteroidal antiinflammatory drugs, which inhibit COX-2, prevent colon cancer and cause apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 10 97(21) 11280-5",
                "id": "11005842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e164"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Tumor COX-2 overexpression seems to affect numerous cellular pathways;...37 genes were increased (Fig. 1C; Table 1) and eight genes were decreased (data not shown) in both A549-S and H157-S cell lines.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2005 Nov 1 11(21) 7674-82",
                "id": "16278387"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e153"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Inhibition of COX-2 by acetyl salicylic acid (1 mM), NS-398 (5 microM), or celecoxib (3 microM) abolished the increase in cAMP and markedly reduced alpha(2C)-AR induction in response to serum stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2005 Jan 288(1) H69-76",
                "id": "15345481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e14f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "nonsteroidal antiinflammatory drugs up-regulate the synthesis of LTB(4), supporting the shunt hypothesis from COX to 5-LOX.",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2004 Dec 50(12) 3925-33",
                "id": "15593193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e14e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "There was a significant increase in IL-5 and IL-13 mRNA in the OVA-COX-1 inhibitor group, OVA-COX-2 inhibitor group, and OVA-indomethacin group compared with the untreated OVA group, with the OVA- COX-2 inhibitor group and OVA-indomethacin groups showing greater expression of these cytokines than the OVA- COX-1 inhibitor group.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2002 Apr 15 165(8) 1154-60",
                "id": "11956061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e10c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "TGF? can also suppress gastrointestinal inflammatory activity by stimulating the expression of the prostaglandin-degrading enzyme 15-PGDH, which antagonizes the proinflammatory action of COX2 (Yan et al., 2004).",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2008 Jul 25 134(2) 215-30",
                "id": "18662538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0a4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Other pathways underlying nAChR-induced cell proliferation include activation of NF-kB, Src, the 5-lipooxygenase pathway [36], Akt, HIF-1a [37,38] and COX-2 [19,26,33].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Pharmacol Sci 2008 Mar 29(3) 151-8",
                "id": "18262664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e09a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "LPS caused dose- and time-dependent release of arachidonate and only cyclooxygenase products",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol 1988 Jun 254(6 Pt 1) C809-15",
                "id": "3132045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e088"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2000 Jul 21(7) 1403-9",
                "id": "10874020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e085"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "COX-2-specific inhibitor, NS-398,",
              "citation": {
                "type": "PubMed",
                "name": "J Rheumatol 2002 Mar 29(3) 546-53",
                "id": "11908571"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e02f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Treatment with a COX-2 inhibitor, celecoxib... beta 3Gal-T5 and ST3Gal III and IV expression was inhibited by celecoxib and was enhanced by prostaglandin E(2) treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Mar 1 62(5) 1567-72",
                "id": "11888937"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfb8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Sulindac sulfide,  but not sulindac sulfone, inhibits cyclooxygenase (COX) enzyme activities,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 28 278(48) 47762-75",
                "id": "14506281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407defa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Ku70 and Ku80 expression is mediated by constitutively activated NF-kappaB and constitutively expressed COX-2 in gastric cancer cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 46093-100",
                "id": "12324457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de48"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Ku70 and Ku80 expression is mediated by constitutively activated NF-kappaB and constitutively expressed COX-2 in gastric cancer cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 46093-100",
                "id": "12324457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de40"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol 1998 Apr 274(4 Pt 2) F673-9",
                "id": "9575890"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de37"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Overexpression of the COX2 gene in COS-1 cells significantly inhibited StAR promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2003 Aug 144(8) 3368-75",
                "id": "12865315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de0a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "COX-2-mediated down-regulation of PPARgamma2 and C/EBPalpha",
              "citation": {
                "type": "PubMed",
                "name": "J Biosci Bioeng 2010 Mar 109(3) 297-303",
                "id": "20159581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dde2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "COX-2 inhibitors...in the vasculature prevents the accumulation of COX-2- derived 15d-PGJ2, which is associated with the atheroprotective nature of laminar flow.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Sep 27 102(39) 14010-5",
                "id": "16172382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddb9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 50081-6",
                "id": "12401798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dda7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "The enzymatic activity of 15-PGDH as a COX-2 antagonist, plus the observed loss of 15-PGDH expression in colon cancer, suggested that 15-PGDH might have tumor suppressor activity.  From full text",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Dec 14 101(50) 17468-73",
                "id": "15574495"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dda5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cyclooxygenase-2 (COX-2) is up-regulated in human colon carcinomas, and its inhibition is associated with a reduction in tumorigenesis and a promotion of apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Dec 15 65(24) 11447-58",
                "id": "16357153"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd9c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "PGD2, is synthesized from arachidonic acid via the catalytic activities of COX in epithelial cells and mast cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy (Cairo) 2012 2012 372384",
                "id": "22500183"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd1d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "",
                "tissue": "Lung airway"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Both transforming growth factor-alpha and amphiregulin were released in response to over-expression of cyclooxygenase-2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Sep 19(9) 1956-63",
                "id": "17572069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Resveratrol was found to act as a competitive inhibitor of purified 5-lipoxygenase and 15-lipoxygenase and prostaglandin H synthase",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1999 Oct 1 265(1) 27-34",
                "id": "10491155"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2001 Aug 21 104(8) 921-7",
                "id": "11514380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dccf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "These data suggest that H2O2 stimulates CFTR Cl(-) channel-mediated Cl(-) secretion through cyclooxygenase- and mPGES-1-dependent release of PGE2 and subsequent activation of PKA.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2007 Nov 293(5) F1571-6",
                "id": "17699556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcb3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "renal medulla"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2001 Sep 44(9) 2078-83",
                "id": "11592370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "# Ariadne: Indeed, we found that HDL and APOE suppress aortic smooth muscle cell cycle progression by stimulating Cox-2 expression, leading to prostacyclin synthesis and an IP-dependent inhibition of the cyclin A gene. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2004 Feb 113(4) 609-18",
                "id": "14966570"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc89"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Inhibition of COX-2 caused apoptosis of the anergy-resistant lupus T cells by augmenting Fas signaling and markedly decreasing the survival molecule c-FLIP (cellular homolog of viral FLICE inhibitory protein).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2004 Apr 10(4) 411-5",
                "id": "14991050"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cyclooxygenase-2 (COX-2) antagonists, by blocking prostaglandin production, might inhibit this pathway 149.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Feb 2(2) 101-12",
                "id": "12635173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "# Ariadne: Indeed, we found that HDL and APOE suppress aortic smooth muscle cell cycle progression by stimulating Cox-2 expression, leading to prostacyclin synthesis and an IP-dependent inhibition of the cyclin A gene. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2004 Feb 113(4) 609-18",
                "id": "14966570"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc65"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Using NS398 or small interferent RNA specifically targeting COX-2 attenuated the appearance of the SA-beta-Gal activity and growth arrest in both stress situations.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Aug 15 313(14) 3046-56",
                "id": "17560572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc5a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Cyclooxygenase (COX)-2 and the subsequent production of prostaglandin E2 (PGE2) were also induced by H-Ras",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2006 Oct 15 119(8) 1767-75",
                "id": "16721810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc48"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Inhibition of the enzyme inducible cyclooxygenase (COX-2) and the transcription factor nuclear factor-kappaB (NF-kappaB) significantly diminished the free radicals' signal intensity, implicating these factors in the formation of free radicals",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Aug 52(8) 1994-9",
                "id": "12882915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc3b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Herein, we demonstrate that 15-PGDH is active in vivo as a highly potent suppressor of colon neoplasia development and acts in the colon as a required physiologic antagonist of the prostaglandin-synthesizing activity of the cyclooxygenase 2 (COX-2) oncogene.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Aug 8 103(32) 12098-102",
                "id": "16880406"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbfd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "COX-2 protein and activity clearly decreased in cells transfected with -catenin after treatment compared to cells transfected with non-specific siRNA (Fig. 4A, B).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2007 Jun 21(8) 1831-43",
                "id": "17317723"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbb8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Inhibition of COX-2 by acetyl salicylic acid (1 mM), NS-398 (5 microM), or celecoxib (3 microM) abolished the increase in cAMP and markedly reduced alpha(2C)-AR induction in response to serum stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2005 Jan 288(1) H69-76",
                "id": "15345481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGS2) actsIn cat(p(HGNC:PTGS2))",
              "summary_text": "Administration of the cyclooxygenase 2 inhibitor NS-398 to mice with carrageenan-induced pleurisy caused persistence of neutrophil recruitment and, in macrophages, attenuated the 15d-PGJ(2) accumulation and PrxI expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jan 24(1) 36-45",
                "id": "14673141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db80"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:HRAS)",
        "relation": "actsIn",
        "target": "gtp(p(HGNC:HRAS))",
        "directed": false,
        "label": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053280",
          "evidences": [
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "This result indicates that activation of MEK1, which is located downstream of the pathway, is able to cancel the induction of CNTF expression by Gap1 m .Human: The protein encoded by this gene is member of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. This particular family member has a perinuclear localization and is an inositol 1,3,4,5-tetrakisphosphate-binding protein; a compound suggested to function as a second messenger. Rat: activates Ras GTPase [RGD]",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2001 Apr 77(2) 700-3",
                "id": "11299332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e405"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Schwann cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, expression of mGFP-H-RasG12V resulted in a substantial increase both in the extent of mRFP-Gal-1 clustering (Figure 1A), and in the total amount of mRFP-Gal-1 recruited to the plasma membrane. To validate this interpretation plasma membrane sheets from cells co-expressing mGFP-H-RasG12V and mRFP-Gal-1 were co-labeled with different sized gold particles. The bivariate K-function analysis of the resulting 2nm / 6nm point 7 pattern shows that H-RasG12V and Gal-1 co-localize in nanoscale clusters on the inner leaflet of the plasma membrane.These results formally demonstrate that Gal-1 is a component of GTP-H-Ras signaling nanoclusters.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2008 Jan 30",
                "id": "18234837"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Activation of RET, either by ligand or through specific mutations, results in phosphorylation of multiple tyrosine residues that, in turn, interact with specific adaptor molecules to trigger downstream signaling. Four of the tyrosines phosphorylated on RET activation, tyrosines 905, 1015, 1062, and 1096, have been well characterized, and are known to interact with a number of adaptor molecules to stimulate signaling through phosphatidylinositol kinase (PI3K)/AKT, PLC-gamma, RAS/extracellular signal-regulated kinase (ERK), p38MAPK, JNK and ERK5.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Jul 1 64(13) 4453-63",
                "id": "15231654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e380"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The zinc finger transcription factor GLI1, which mediates Sonic hedgehog signaling during development, is expressed in several human cancers, including basal cell carcinoma, medulloblastoma, and sarcomas. We identified 147 genes whose levels of expression were significantly altered in RNA obtained from cells demonstrating a transformed phenotype with stable GLI1 expression or stable Ha-ras expression. Comparison of expression profiles from GLI1- and Ha-ras-expressing cells established a set of genes unique to GLI1-induced cell transformation. Thirty genes were altered by stable GLI1 expression, and 124 genes were changed by stable Ha-ras expression. Seven genes had altered expression levels in both GLI1- and Ha-ras-expressing cells. Genes whose expression was altered by GLI1 included cell cycle genes, cell adhesion genes, signal transduction genes, and genes regulating apoptosis. GLI1 consensus DNA-binding sequences were identified in the 5' regions of cyclin D2, IGFBP-6, osteopontin, and plakoglobin, suggesting that these genes represent immediate downstream targets. Gel shift analysis confirmed the ability of the GLI1 protein to bind these sequences. Up-regulation of cyclin D2 and down-regulation of plakoglobin were demonstrated in GLI1-amplified compared with non-amplified human rhabdomyosarcoma cells. Many of the GLI1 targets with known function identified in this study increase cell proliferation, indicating that GLI1-induced cell transformation occurs through multiple downstream pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 15 277(7) 5548-55",
                "id": "11719506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e371"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Therefore, the apoptotic effects of cytotoxic chemotherapy on proliferating vascular endothelium could contribute to the anti-tumor efficacy of chemotherapy in vivo. While it is relatively simple, however, to study chemotherapy-induced apoptosis of endothelial cells or tumor cells separately in vitro, it is not trivial to analyze apoptosis in these two populations when they are crowded together in a tumor. Browder et al. approached this problem by carrying out animal experiments in which the apoptotic effect of cytotoxic chemotherapy on endothelial cells in a tumor bed was dissociated from the apoptotic effect of cytotoxic chemotherapy on tumor cells supported by these endothelial cells [35]. Browder et al. hypothesized, that the tradition of administering chemotherapy at maximum tolerated dose (MTD), required a treatment-free interval to allow recovery of the bone marrow and gastrointestinal tract. During the treatment-free interval, microvascular endothelial cells in the tumor bed could resume their proliferation and support tumor regrowth. When tumor-bearing mice were treated with cyclophosphamide at a conventional maximum tolerated dose followed by a 21-day interval to rescue bone marrow, ('conventional schedule'), tumors recurred after each cycle. All animals eventually died of large tumors which had a diminished response to cyclophosphamide after each cycle, i.e. the tumors developed acquired drug resistance. In contrast, if cyclophosphamide was administered more frequently and at lower doses ('antiangiogenic schedule'), without a prolonged treatment-free interval, all tumors regressed and all animals survived without bone marrow suppression or other toxicity. Then the tumors were made drug-resistant to cyclophosphamide. On the 'conventional schedule', animals died even more rapidly with large tumors as drug resistant tumor cells continued to proliferate unaffected by cyclophosphamide. However, the 'antiangiogenic schedule' significantly inhibited tumor growth, but there was still very slow tumor growth. It was not possible to raise the low dose of cyclophosphamide to a level sufficient to induce apoptosis of the remaining endothelial cells in the tumor bed, without provoking bone marrow suppression. Therefore, a low dose of a pure angiogenesis inhibitor, TNP-470 was added. This inhibitor by itself could not slow this tumor by more than 65%. However, when combined with cyclophosphamide on the antiangiogenic schedule, there was complete tumor regression and long-term survival in all but one animal. Immunohistochemical analysis (Fig. 3) revealed extensive endothelial apoptosis that preceded tumor cell apoptosis by 4-5 days, despite the fact that the tumor cells were resistant to cyclophosphamide and not directly affected by TNP-470. This experiment reveals an endothelial-dependence of cytotoxic chemotherapy that is concealed before tumor cells have acquired drug resistance. Klement et al. obtained similar results by administering continuous low dose vinblastine to tumor-bearing mice in combination with a VEGF receptor antibody [36]. Furthermore, these results might also help to explain why some patients who receive long-term maintenance or even palliative chemotherapy have stable disease beyond the time that the tumor would have been expected to develop drug resistance. Patients with slow-growing cancers who are on 'antiangiogenic scheduling' of chemotherapy involving continuous infusion 5-fluorouracil [37-39], weekly paclitaxel [40,41], or daily oral etoposide [42-44], have shown an improved outcome--despite the fact that in some of these patients the tumors had already become drug resistant to conventional chemotherapy. Antiangiogenic chemotherapy has also been called 'metronomic' therapy [45], but the two terms do not have precisely the same meaning. 'Antiangiogenic chemotherapy' signifies that the target of the chemotherapy is microvascular endothelium in the tumor b...",
              "citation": {
                "type": "PubMed",
                "name": "Semin Cancer Biol 2003 Apr 13(2) 159-67",
                "id": "12654259"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e315"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Oncogene-induced senescence is a cellular response that may be crucial for protection against cancer development1, 2, but its investigation has so far been restricted to cultured cells that have been manipulated to overexpress an oncogene. Here we analyse tumours initiated by an endogenous oncogene, ras, and show that senescent cells exist in premalignant tumours but not in malignant ones. Senescence is therefore a defining feature of premalignant tumours that could prove valuable in the diagnosis and prognosis of cancer.  We used a mouse model for cancer initiation in humans: the animals have a conditional oncogenic K-rasV12 allele that is activated only by the enzyme Cre recombinase3, causing them to develop multiple lung adenomas (premalignant tumours) and a few lung adenocarcinomas (malignant tumours). Senescence markers previously identified in cultured cells were used to detect oncogene-induced senescence in lung sections from control mice (expressing Cre) and from K-rasV12-expressing mice (expressing Cre and activated K-rasV12). We analysed p16INK4a, an effector of in vitro oncogene-induced senescence1, and de novo markers that we identified by using DNA microarray analysis of in vitro oncogene-induced senescence (see supplementary information). These de novo markers are p15INK4b (also known as CDKN2B), Dec1 (BHLHB2) and DcR2 (TNFRSF10D). In addition, we looked for two features evident in cultured senescent cells, namely the expression of senescence-associated beta-galactosidase4 and the presence of senescence-associated heterochromatin foci5.  Staining with antibodies against p16INK4a, p15INK4b, Dec1 and DcR2 revealed abundant positive cells in adenomas, whereas adenocarcinomas were essentially negative (Fig. 1a).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2005 Aug 4 436(7051) 642",
                "id": "16079833"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "adenoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, p70S6K inhibition by rapamycin did not preclude the transactivation of the UCP-1-CAT construct induced by IGF-I but partly inhibited IGF-I induced UCP-1 mRNA expression (Valverde et al. 1997a). In addition, RAS proteins seem to be involved in insulin/IGF-I-induced UCP-1 expression. In fact, transient transfection of primary brown adipocytes with a dominant-negative form of p21ras completely abolished insulin-induced UCP-1-CAT transactivation (Lorenzo et al. 1996).",
              "citation": {
                "type": "PubMed",
                "name": "Mini Rev Med Chem 2005 Mar 5(3) 269-78",
                "id": "15777261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "J. Adaptors Adaptors are molecules that are devoid of intrinsic catalytic activity; after binding to the PDGF receptors through their SH2 domains, they connect the receptor with downstream effector molecules. The regulatory subunits of PI 3-kinase and Grb2, which form complexes with the catalytic subunit of PI 3-kinase and Sos, respectively, are examples of adaptor molecules that have been discussed already. Other adaptor molecules that bind to PDGF receptors are Shc, Grb7, Nck, and Crk.  After binding of Shc to the PDGF receptors, it becomes phosphorylated on Tyr-317, which can be recognized by Grb2/Sos and thus contributes to Ras activation (398), as well as on Tyr-239 and Tyr-240, which initiates another signaling pathway leading to induction of c-myc (148).",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 1999 Oct 79(4) 1283-316",
                "id": "10508235"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e277"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The RET gene encodes a transmembrane tyrosine kinase (TK) receptor whose expression and function is normally restricted to a subset of cells derived from the neural crest. In thyroid follicular cells, RET activation occurs through chromosomal recombination resulting in illegitimate expression of a fusion protein consisting of the intracellular TK domain of RET coupled to the N-terminal fragment of a heterologous gene. The promoter region of the partner gene drives constitutive expression of the chimeric gene.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2005 Apr 115(4) 1068-81",
                "id": "15761501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e26e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "thyroid"
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "To confirm that binding of Sin1 to H-Ras is also specific for the activated form,GSTSin1 beadswere incubated with lysates of HEK293 cells expressing either wild-type GFPH-Ras or constitutively activated GFPH-RasG12V. The beads were analysed by immunoblot using anti-GFP, which showed that GSTSin1 bound to GFPH-RasG12V (Fig. 3E, GFPH-RasG12V) but not GFPH-Ras (Fig. 3A, GFPH-Ras). These data indicate that Sin1 binds preferentially to the activated (GTP-bound) form of H- and K-Ras.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Jun 19(6) 1279-89",
                "id": "17303383"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We found that oncogenic Ras upregulates PML expression, and overexpression of PML induces senescence in a p53-dependent manner. p53 is acetylated at lysine 382 upon Ras expression, an event that is essential for its biological function. Ras induces re-localization of p53 and the CBP acetyltransferase within the PML nuclear bodies and induces the formation of a trimeric p53-PML-CBP complex. Lastly, Ras-induced p53 acetylation, p53-CBP complex stabilization and senescence are lost in PML-/- fibroblasts. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2000 Jul 13 406(6792) 207-10",
                "id": "10910364"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e17b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "To test whether eNOS promoted tumour growth through nitrosylation of Ras in pancreatic cancer cells, we determined which Ras family members were inactivated by eNOS shRNA in CFPac-1 and MIAPaCa-2 cells. Not surprisingly, GTP-bound KRas was unchanged on knockdown of eNOS (Fig. 4c and Supplementary Fig. 9), as KRas is mutated to remain active in these two cell lines19,20. Consistent with this, oncogenic KRas harbouring the C118S mutation remained tumorigenic (Supplementary Fig. 10), pointing towards wild-type Ras proteins as the target of eNOS signalling. Indeed, GTP-bound endogenous wild-type HRas and NRas were reduced upon shRNA knockdown of eNOS.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2008 Apr 3 452(7187) 646-9",
                "id": "18344980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "These results imply that FRS2 and Shp2 are in a BDNF signaling pathway. Shp2 is required for complete MAPK activation by BDNF, as expression of a dominant negative Shp2 in cells attenuates BDNF-induced activation of MAPK. Moreover, expression of a dominant negative Shp2 attenuates Ras activation showing that the protein tyrosine phosphatase is required for complete activation of MAPKs by BDNF. In conclusion, Shp2 regulates BDNF signaling through the MAPK pathway by regulating either Ras directly or alternatively, by signaling components upstream of Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2006 May 97(3) 834-45",
                "id": "16573649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e016"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "INTRODUCTION The ras family of oncogenes and encoded proteins has been evaluated as a putative target for anticancer therapeutic development. These efforts have resulted in new insights into Rasmediated cell signaling as it relates to human cancer. Ras plays a central role in an intricate array of signal transduction pathways, characterized by cross talk, feedback loops, and multicomponent signaling complexes.1-3 One strategy to overcome the challenges inherent in developing therapeutics against signaling elements situated in redundant pathways is to target elements downstream of convergence points of critical signaling modules. This reasoning has led, in part, to interest in Raf kinase, which is one of several downstream effectors of Ras, as a target for therapeutic development against cancer. The Raf serine/threonine kinases are the principal effectors of Ras in the mitogenactivated protein kinase (MAPK) pathway (Fig 1). Raf activation occurs immediately downstream of membrane and cytoplasmic receptors that relay mitogenic signals.4 Although principally activated by Ras,",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df0f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, it is p27 that seems to be the primary target of SKP2, given that Skp2 ko mice show a marked accumulation of p27 (REF. 24), and that prominent cellular phenotypes apparent in Skp2 00 mice (see Supplementary information S1 (table)) including nuclear enlargement, polyploidy and an increased number of centrosomes that are probably caused by overreplication of chromosomes and centrosomes disappear in Skp2 ko p27 ko double mutant mice. The oncogenic potential of SKP2 has also been shown in transgenic mouse models 35,36. Furthermore, Ras signalling induces SKP2 expression through the binding of GA-binding protein, an Ets-family transcription factor, to the SKP2 promoter37. Such evidence supports the notion that SKP2 is a growth promoter and an oncoprotein.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2006 May 6(5) 369-81",
                "id": "16633365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dedc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Oncogenic Ras induces the transcription activity of NF-kappaB that confers cell survival. Oncogenic Ras also down-modulates the expression of Par-4, a transcriptional repressor protein, that is essential but not sufficient on its own to induce apoptosis. Here we show that reintroduction of Par-4 by transient transfection leads to apoptosis in cells expressing oncogenic Ras but not in those that lack oncogenic Ras expression. Par-4 abrogates oncogenic Ras-inducible NF-kappaB transcription activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 29976-83",
                "id": "10514481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddbe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "our data suggests that in N/N1003A cells, calcimycin treatment leads to RAS activation mainly through RAS-GRF2. Calcimycin not only induces translocation of the RAS-GRF2 from cytosol to plasma membrane but also causes the direct binding of RAS-GRF2 to RAS (Figure 6). Moreover, AB-crystallin that substantially blocks calcimycin-induced activation of RAS also suppresses the translocation of RAS-GRF2. Thus, through activation of the calcium-triggered RAS-GRF2, calcium can indirectly activated RAS in rabbit lens epithelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Sep 16(9) 4437-53",
                "id": "16000378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The ERF protein is also hyperphosphorylated in cells transformed by the activated Ha-ras and v-src genes and the transcription repressor activity of ERF is decreased after co-transfection with activated Ha-ras or the kinase domain of the c-Raf-1 gene, indicating that ERF activity is probably regulated by the ras/MAPK pathway.......These data suggest that the repression ability of ERF may be regulated, at least partially, by phosphorylation of Thr526 (Substitution of Thr526 for glutamic acid also decreases the repression ability of ERF).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Oct 2 14(19) 4781-93",
                "id": "7588608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd10"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "From text: To determine whether the MLC-2v-ras construct would be capable of directing the expression of a functional, constitutively active Ras protein, co-transfections were performed in cultured ventricular muscle cells with an ANF luciferase reporter gene which is up-regulated by the parental Ha-ras vector, as it is by other defined hypertrophic stimuli. The studies employing the MLC-ras construct induced a 4.2  0.6-fold (mean  S.E.) increase in luciferase activity compared to the vector alone,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Sep 29 270(39) 23173-8",
                "id": "7559464"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbf5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Despite remarkable progress in dissecting the signaling pathways that are crucial for the metabolic effects of insulin, the molecular basis for the specificity of its cellular actions is not fully understood. One clue might lie in the spatial and temporal aspects of signaling. Recent evidence suggests that signaling molecules and pathways are localized to discrete compartments in cells by specific protein interactions. Also, the rapid termination of tyrosine or lipid phosphorylation by phosphatases or serine kinases might tightly control the strength of a signaling pathway, thus determining its effect on growth, differentiation and metabolism. Insulin is the most potent anabolic hormone known, promoting the synthesis and storage of carbohydrates, lipids and proteins and inhibiting their degradation and release back into the circulation. Decreased secretion of insulin, coupled with resistance to its actions, results in type 2 diabetes, a devastating disease that is reaching epidemic proportions [1]. Even in the absence of diabetes, insulin resistance is often associated with central obesity, hypertension, polycystic ovarian syndrome, dyslipidemia and atherosclerosis. At the cellular level, insulin action is characterized by diverse effects, including changes in vesicle trafficking, stimulation of protein kinases and phosphatases, promotion of cellular growth and differentiation and activation or repression of transcription. This complexity suggests that insulin action must involve multiple signaling pathways that diverge at or near the activation of its tyrosine kinase receptor. In fact, it is likely that even individual effects of the hormone require multiple signaling inputs. Evidence is emerging that the coordination of these pathways might be governed by their intracellular compartmentalization or duration of action. Here, we consider how temporal and spatial aspects of signal transduction play a crucial role in determining the specificity of insulin action, focusing on signal initiation from the receptor that is spatially segregated into discrete domains of the plasma membrane, as well as the mechanisms that determine the duration of individual signaling pathways. Together, these factors help to differentiate insulin from other hormones that share some of the same overall signaling properties. Divergent signaling pathways are initiated by insulin receptor substrates. The insulin receptor is a tyrosine kinase that catalyzes the phosphorylation of several intracellular substrates, including the insulin receptor substrate (IRS) proteins [2], GAB-1 [3], Shc [4], APS [5], p60DOK [6], SIRPS [7] and c-Cbl [8] (Fig. 1). Each of these substrates recruits a distinct subset of signaling proteins containing Src homology 2 (SH2) domains, which interact specifically with sequences surrounding the phosphotyrosine residue. Moreover, each of these substrates can be confined to distinct locations in the cell by specific sequences that direct interactions with other proteins or lipids. Most attention in the field of insulin receptor substrates has focused on the IRS family of proteins. Mice lacking the IRS-1 protein are insulin resistant but do not develop overt diabetes [9,10]. By contrast, animals lacking IRS-2 exhibit both impaired glucose tolerance and diabetes [11], which appears to result from a defect in insulin secretion as well as insulin resistance, presumably owing to decreased b-cell proliferation in the pancreas in the face of increased demand for insulin. Despite the similarity in structure and function, the apparent differences in phenotype between IRS1 and IRS2 knockout mice underscore a specific signaling specificity that probably results from their tissue distribution, subcellular location, activation&ndash;inactivation kinetics and combinatorial interactions with downstream effectors [12]. The tyrosine phosphorylation of IRS family members generates docking sites for sev...",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cell Biol 2002 Feb 12(2) 65-71",
                "id": "11849969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In situ end-labeling detection showed that apoptotic cell death was significantly increased in cells with 5-day treatment of antisense H-ras oligodeoxynucleotide (34.0 +/- 4.5%) in comparing with cells without treatment (2.5 +/- 1.2%, t = 13.434, P < 0.01) or treated with non-specific antisense oligodeoxynucleotide (4.8 +/- 1.4%, t = 12.453, P < 0.01) at the corresponding time. ",
              "citation": {
                "type": "PubMed",
                "name": "Hepatogastroenterology 47(32) 365-70",
                "id": "10791191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Whether this model represents an accelerated version of normal cancer progression, or simply a bypass of the premalignant stages, is still unclear. Human tumours that bypass premalignant stages have not been described. The importance of the angiogenic switch was also recently demonstrated by Weinberg and colleagues55. They showed that expression of the SV40 early region, TERT and activated RAS were sufficient to transform primary epithelial cells in vitro. However, the ability to grow in vivo depended on the level of HRAS expression - cells that expressed low levels of RAS were dormant and non-angiogenic, whereas cells that expressed high levels of RAS developed into full-blown tumours.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Jun 3(6) 401-10",
                "id": "12778130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "H1299 cells transfected with FLAG-Epac2 showed predominantly cytosolic staining (Fig. 4B). However, upon coexpression with GFP-H-RasLeu-61 (Fig. 4, C and D), the GEF was predominantly redistributed to the plasmamembrane (Fig. 4D)where it colocalized with Ras (Fig. 4C). Similar findings were subsequently observed upon co-expression of Epac2 with activated K- and N-Ras (Fig. 5) but not M-RasLeu-71 (Fig. 4F).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 3 281(5) 2506-14",
                "id": "16316996"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We then examined the levels of DNMT1 and methylated DNA-binding protein 2 (MBD2) expressions in these cells to determine whether this reduction in uPA expression is associated with changes in the DNA methylation machinery.  Our results showed that ectopic expression of RAS induced DNMT1 expression and activity and inhibited MBD2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2005 Mar 26(3) 557-64",
                "id": "15618232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Expression of CD151 specifically attenuated adhesion-dependent activation of Ras. Furthermore, activation of PKB/c-Akt and ERK1/2, downstream targets in the Ras signaling pathway, was also diminished in cells expressing CD151. In contrast, adhesion-dependent activation of FAK and c-Src were not affected by CD151.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 18 278(29) 26323-6",
                "id": "12782641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2b5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "DOC-2/DAB2 and DIP1/2 complex represent a negative feedback machinery for several exogenous stimuli-elicited signal cascade. PKC can phosphorylate the N-terminal domain of DOC-2/DAB2 (serine 24) that recruits DIP1/2 to inactivate Ras protein. On the other hand, shortly after the treatment of peptide growth factors, the C terminus of DOC-2/DAB2 (proline-rich domain) competes with SOS for Grb 2 binding, which leads to the inactivation of the MAP pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31981-6",
                "id": "10542228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We show that RanBPM can induce GTP-Ras association and Erk phosphorylation and elevate serum response element-luciferase (SRE-LUC) expression, indicating that RanBPM can activate the Ras-Erk-SRE pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36216-22",
                "id": "12147692"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "p38, but not ERK or JNK, was found in a complex with Gadd45 proteins. The region of interaction was mapped to amino acids 71 to 96, and the central portion (amino acids 71 to 124) of Gadd45a was required for p38 MAPK activation in the presence of H-ras.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jun 23(11) 3859-71",
                "id": "12748288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e27f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Thus, one function of Rho A may be to regulate cytoskeletal organization and integrin clustering rather than integrin affinity.92 Expression of activated R-Ras increases integrin-mediated adhesion in some cells,93 but its presence in platelets has not been demonstrated. Thrombin stimulation of platelets causes GTP loading of H-Ras in a PKC-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1998 Apr 15 91(8) 2645-57",
                "id": "9531572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e248"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Here we demonstrate that Tiam1, a Rac-specific GEF, preferentially associates with activated GTP-bound Ras through a Ras-binding domain. Furthermore, activated Ras and Tiam1 cooperate to cause synergistic formation of Rac-GTP in a PI(3)K-independent manner. Thus, Tiam1 can function as an effector that directly mediates Ras activation of Rac.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Aug 4(8) 621-5",
                "id": "12134164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e239"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "cells were first subjected to retroviral-mediated gene transfer with a dominant-negative mutant of Ras (N17Ras). This resulted in a marked inhibition of PDGF-induced FAK tyrosine phosphorylation together with the expected reduction of PDGF-induced extracellular signal-regulated kinase activity (ERK).",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2000 Jan 31(1) 131-40",
                "id": "10613738"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e216"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Assays for GTP loading and H-Ras interactions with the Ras-binding domain on Raf-1 demonstrated a decrease in H-Ras activity in the presence of NO*. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Jul 15 397(2) 329-36",
                "id": "16569214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In this study, we found that H-Ras interacted with ASK1 to cause the inhibition of both ASK1 activity and ASK1-induced apoptosis in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Cell Res 2004 Apr 14(2) 148-54",
                "id": "15115616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Upon stimulation with epidermal growth factor, similar translocation of ectopically expressed PLCepsilon is observed, which is inhibited by coexpression of dominant negative Ha Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jan 26 276(4) 2752-7",
                "id": "11022048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e155"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "IGF1 binding activates the IGF1 receptor (IGFR), a receptor tyrosine kinase. The IGFR subsequently recruits the insulin receptor substrate (IRS1), which results in the activation of two signaling pathways: the RasRaf MEK ERK pathway  and the PI3K Akt pathway",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2003 Aug 9(8) 344-50",
                "id": "12928036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e147"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Stably transfected C2C12-RasV12 myoblasts actively proliferated as indicated by the sustained expression of proliferating cell nuclear antigen and retinoblastoma at the hyperphosphorylated state and failed to express differentiation markers. ",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2008 Feb 149(2) 793-801",
                "id": "17962350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e141"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Accordingly, acute expression of H-Ras(V12) or of a constitutively active MEK1 also blocked TSH-induced expression of Tg and NIS.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jul 10 22(28) 4406-12",
                "id": "12853977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e13c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "expression of H-ras.V12 caused a 2- to 3-fold elevation in the level of RalA-GTP",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Sep 15 104(6) 1679-87",
                "id": "15166036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e123"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Previous studies have shown that a constitutively active isoform of Ras is able to produce superoxide radical (O2(-))....ESR spin trapping measurements showed that Ras(+) cells generated more hydroxyl radical ((.)OH), O2(-) radical, and Cr(V) than Ras(-) cells following Cr(VI) stimulation. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2004 Jan 255(1-2) 119-27",
                "id": "14971653"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e10d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Prostatic Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "HER2/Neu overexpression stimulates the ability of p300 to acetylate ER81, likely by inducing phosphorylation of p300 through the Ras--Raf--mitogen-activated protein kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Sep 23(17) 6243-54",
                "id": "12917345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e101"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "hDAB2IP (human DAB2 (also known as DOC-2) interactive protein) is a novel GTPase-activating protein for modulating the Ras-mediated signal pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 31 278(5) 3121-30",
                "id": "12446720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "An antagonistic effect of EP3 against EP4 through the modulation of cyclic AMP level is required for PGE2-mediated activation of Ras signal pathway in A549 cells.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2002 May 8 518(1-3) 154-8",
                "id": "11997037"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Germline expression of the endogenous H-RasG12V oncogene, even in homozygosis, resulted in hyperplasia of the mammary gland.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2008 Jun 118(6) 2169-79",
                "id": "18483625"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0f5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "When c-H-ras expression was induced with heavy metal ions there was a marked reduction in the expression of two glycosylphosphatidylinositol (GPI) anchored proteins, TAP/Ly-6A.2 and Thy-1, on the plasma membrane of the transformed cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1991 Aug 6(8) 1445-51",
                "id": "1679532"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfd0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Site-directed mutagenesis replaced each of the serine residues within this region with alanine and demonstrated that serine 916 is a major site of in vivo phosphorylation of Ras-GRF1 in both COS-7 cells and NIH-3T3 fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 24 274(52) 37379-84",
                "id": "10601308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfc3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "#WB-F344 rat liver epithelial (WB)# H-Ras induced the invasive and migrative phenotypes of WB cells with a selective up-regulation of matrix metalloproteinase (MMP)-9, but not MMP-2. Cyclooxygenase (COX)-2 and the subsequent production of prostaglandin E2 (PGE2) were also induced by H-Ras. ",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2006 Oct 15 119(8) 1767-75",
                "id": "16721810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df62"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, overexpression of v-Ha-ras in HaCaT cells resulted in a three to five-fold decrease in the steady-state mRNA level of EF-1 delta.",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 18(1A) 385-92",
                "id": "9568107"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Here we report that in fibroblasts, activated H-Ras and Raf-1 oncogenes decrease biosynthesis, association with beta1 integrins, and surface expression of tTG because of down-regulation of tTG mRNA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 12 278(37) 35609-19",
                "id": "12832399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df48"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, unlike Raf-1, the phosphorylation of B-Raf at Ser(445) was constitutive and was only moderately increased by expression of constitutively active H-Ras or constitutively active PAK1. These data demonstrate that B-Raf activity is autoregulated, that constitutive phosphorylation of Ser(445) primes B-Raf for activation, and that a key feature of phosphorylation within the activation loop or of oncogenic mutations within this region is to block autoinhibition.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 22 280(16) 16244-53",
                "id": "15710605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df34"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Caco-2 cells were transfected with homer-6 a control vector(Caco-2-H), Ha-ras gene (Caco-2-T) and Py-MT gene (Caco-2-MT\\\") to constitutively activate c-SRC, observed that the level of the PKC-alpha transcript was 4-fold higher in Caco-2-T and Caco-2-MT cells than in Caco-2-H cells. And also Caco-2-T and Caco-2-MT cells exhibited a 3-fold increase in the level of immunoreactive PKC-alpha and tended to display a higher  PKC specific activity than the cytosolic fractions.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1993 Jun 15 53(12) 2762-70",
                "id": "8504416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df15"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Many angiogenic growth factors, including bFGF and VEGF, stimulate endothelial cell invasion (51) through transmembrane protein kinase receptor dimerization and phosphorylation (11, 53), leading to the activation of phospholipase Cg (PLCg) and Ras, both of which ultimately result in activation of cPLA2",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Mar 18(3) 568-70",
                "id": "14715700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deb0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Expression of dominant active Ras or dominant active MEKK1 alone can also stimulate NF-kappaB activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 2 276(5) 3650-9",
                "id": "11062239"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Here, we examined whether NO could activate NF-kappaB in cells harboring a mutant, inactive p21(35) . As seen in Fig. 4, upper panel, wild type parental cells responded to sodium nitroprusside by translocating NF-kappaB to the nucleus. In contrast, the p21-defective cells did not respond to sodium nitroprusside. Thus, p21 is necessary for NO-induced cellular activation signals. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Mar 31 270(13) 7017-20",
                "id": "7706235"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Using a mutant ErbB4 receptor, which lacks kinase activity, we demonstrated that the Ras-mediated ErbB4 phosphorylation depends on the kinase activity of the receptor and facilitates ligand-independent neurite outgrowth in PC12-ErbB4 cells. These experiments demonstrate a novel mechanism controlling ErbB receptor activation. Ras induces ErbB4 receptor phosphorylation in a non-autocrine manner and this activation depends on multiple Ras effector pathways and on ErbB4 kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2006 Aug 15 98(6) 1482-94",
                "id": "16518842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de73"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We compared human fibroblasts malignantly transformed by overexpression of H-Ras(V12) oncogene to their nontransformed parental cells and found that the malignant cells express a high level of Spry2. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jan 25 283(4) 2002-9",
                "id": "18048363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de6f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Kit and other RTKs will activate the MAP kinase signaling pathway and has been reported both to increase the transcriptional activity of Mitf as well as down-regulate Mitf protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Jul 15 14(14) 1712-28",
                "id": "10898786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de65"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Although inhibitors of PKC had no effect on this suppression, MAPK inhibitors completely prevented the TPA effect. RasGRP1 activates the MAPK pathway through activation of the small G protein H-Ras. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2007 Dec 11 104(50) 20120-5",
                "id": "18077438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de52"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "kidney epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The levels of cyclin D1 were elevated in tumors resulting from high levels of ornithine decarboxylase activity and the expression of v-Ha-ras. There appeared to be a cooperative effect of ornithine decarboxylase and v-Ha-ras in causing the accumulation of G1-related cyclin D1. Histone or Rb-associated kinase activities of cyclin complexes was elevated.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 Nov 10(11) 739-48",
                "id": "10593650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dde4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Our results show that invasive cell lines which overexpress the c-Ha-ras gene also have increased epidermal EGF-R expression.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1991 Aug 15 51(16) 4486-91",
                "id": "1868471"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd80"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "These results were consistently found when using K-rasV12 mice carrying Cre transgenic alleles that were expressed either inducibly by tamoxifen (Cre-ER) or constitutively (CMV-Cre)3; 5-10 mice were analysed for each marker. The results have also been confirmed by immunoblotting and by quantitative real-time polymerase chain reaction with reverse transcription (see supplementary information; these analyses also included p19ARF, an effector of senescence-associated -galactosidase6). ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2005 Aug 4 436(7051) 642",
                "id": "16079833"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "V12S35 transformed NIH-3T3 cells showed enhanced Erk1/2 activity which led to increase in tumorigenicity and metastasis.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Jul 21 95(15) 8773-8",
                "id": "9671754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd74"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "ras Oncogene triggers up-regulation of cIAP2 and XIAP in intestinal epithelial cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 11 280(45) 37383-92",
                "id": "16115895"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd66"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "EGF induced Ha-Ras activation in the PANC-1 cells but neurotensin could not increase Ha-Ras activation in these cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 May 15 63(10) 2379-87",
                "id": "12750255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras Our results suggest that cAKI may act as a mediator of ras and erbB-2 oncogene action in human breast cells and that interference with cAKI action provides a potential tool for inhibiting the growth-promoting effects of these oncogenes.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 1993 Feb 1 53(3) 438-43",
                "id": "8094073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In this report we have demonstrated that MEKK1 is also a potential Ras effector and selectively binds to Ras in a GTP-stimulated manner. This finding supports at a biochemical level the observation that MEKK1 is activated in a Ras-dependent manner in response to growth factors in PC12 pheochromocytoma cells (16)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 May 19 270(20) 11757-60",
                "id": "7744823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd5a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "insulin stimulates the mitogen-activated protein (MAP) kinase extracellular signalregulated kinase (ERK) (Fig. 2). This pathway involves the tyrosine phosphorylation of IRS proteins and/or Shc, which in turn interact with the adapter protein Grb2, recruiting the Son-of-sevenless (SOS) exchange protein to the plasma membrane for activation of Ras.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "IRK1 in HEK 293 cells leads to the appearance of a potassium current with strong inward rectifying properties, coexpression of the constitutively active form of Ras (Ras-L61) results in a significant reduction of the mean current density",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 5 277(14) 12158-63",
                "id": "11809752"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd01"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Overexpression of RREB-1 protein in TT cells confers the ability to mediate increased transactivation of the CT gene promoter-reporter construct during Ras- or Raf-induced differentiation. These data suggest that RREB-1 may play a role in Ras and Raf signal transduction in medullary thyroid cancer and other cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Oct 16(10) 5335-45",
                "id": "8816445"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc03"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We show that PREL1 directly binds to Ena/VASP proteins and co-localizes with them at lamellipodia tips and at focal adhesions in response to Ras activation. Moreover, PREL1 directly binds to activated Ras in a phosphoinositide-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2005 Jan 17 579(2) 455-63",
                "id": "15642358"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway. The data indicate that a protein kinase C, Ras, MEKK1, p38 MAPK signaling pathway plays a major role for the transcriptional up-regulation of Prx I gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45419-34",
                "id": "12960165"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbbe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "3) H(2)O(2) rapidly activated Ras (peak at 2-5 min), which preceded p90RSK activation (peak at 20 min).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 21 275(3) 1739-48",
                "id": "10636870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e41f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In addition, the Y716(P) peptide significantly decreased the amount of GTP bound to Ras [Ras activation] in response to PDGF",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Oct 14(10) 6715-26",
                "id": "7935391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e414"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Aug 22(15) 5281-95",
                "id": "12101225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e412"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Both ras- and trk-transformed cell lines were less sensitive to cisplatin (CDDP) and doxorubicin (DXR) than the wild type. ",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 1993 May 28 54(3) 450-5",
                "id": "8509220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e40b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Apr 29 269(17) 12741-8",
                "id": "8175686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3f5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Transformation by human K-Ras or H-Ras (S12 and V12 point mutations, respectively) results in a 10-fold increase in ST6Gal I mRNA, but no alteration in the expression of related sialyltransferases.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2004 Sep 271(18) 3623-34",
                "id": "15355339"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3e9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "e show here that oncogenic forms of Ha-Ras activate NF-kappaB, not through induced nuclear translocation, but rather through the activation of the transcriptional function of the NF-kappaB RelA/p65 subunit. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Sep 26 272(39) 24113-6",
                "id": "9305854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3e5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Sep 29 270(39) 23007-12",
                "id": "7559439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Supplementary Figure 3 Cluster of upregulated genes that correlate with INK4A locus [inactivation].",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jun 1 65(11) 4530-43",
                "id": "15930270"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Ras induces the sequential activation of PI3 kinase, Rho, and ROCK, leading to activation of Myc through phosphorylation; phosphorylation of Myc via this mechanism enables it to repress Tsp-1 expression",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 219-31",
                "id": "12676581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "# Ariadne: First, we showed that the expression of transgelin is  abolished at the level of transcription by oncogenic Ras in NIH 3T3 mouse  fibroblasts, RIE-1 rat intestinal epithelial cells, and HT1080 human  fibrosarcoma cells. [Expression] # Ariadne: We further  characterized transgelin as a gene whose expression was abolished by Ras. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 22 277(12) 9790-9",
                "id": "11773051"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3a4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Feb 17 19(7) 961-4",
                "id": "10702805"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e39d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 Jun 27 417(6892) 949-54",
                "id": "12068308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e39b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The activation of Ras by the guanine nucleotide-exchange factor Son of sevenless (Sos) constitutes the rate-limiting step in the transduction process that links receptor tyrosine kinases to Ras-triggered intracellular signalling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2007 Jun 9(6) 706-12",
                "id": "17486115"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e398"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "overexpression of v-Ha-ras in HaCaT cells resulted in a three to five-fold decrease in the steady-state mRNA level of EF-1 delta.",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 18(1A) 385-92",
                "id": "9568107"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e383"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "activated Ha-Ras expression inhibits both the binding of cyclin E to Fbw7 and cyclin E ubiquitination",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Jul 5 102(27) 9649-54",
                "id": "15980150"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e36e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "dominant negative S17N Rap2B (n = 36; p < 0.002). In addition, expression of this Rap2B mutant suppressed activation of H-Ras induced by the beta2-AR (Fig. 6D).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 5 279(45) 46497-508",
                "id": "15319437"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e36b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "phosphorylated IRS1 also stimulates the Ras-Raf-MEK-ERK pathway, a MAPK pathway",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2004 Aug 3 2004(244) re11",
                "id": "15292521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e366"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "GnT-V  transcription was stimulated by several oncogenes including src , her -2/ neu ,  H- ras , and v- sis (9 , 10 , 11) , and this overexpression was regulated  through the ras-raf-ets pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jan 12 276(2) 1555-63",
                "id": "11029459"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e357"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Phosphorylated Shc binds to Grb2 which forms a complex with Sos guanine nucleotide exchange factor for p21ras.",
              "citation": {
                "type": "PubMed",
                "name": "Endocr J 2000 Aug 47(4) 373-81",
                "id": "11075717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e356"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "TNF- induced binding of Ras to beads conjugated to the Ras binding domain (RBD) of Raf, indicative of Ras activation (Figure 2A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Jun 28(6) 762-9",
                "id": "12600818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e349"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 4 274(23) 16377-86",
                "id": "10347197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e348"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In addition, pleiotrophin activates both the Ras-MAPK and the PI3K-Akt signaling axes ( 18 ), and both pathways are implicated in glial tumorigenesis",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 19 277(16) 14153-8",
                "id": "11809760"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e33a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In this study, we show that JunD, a member of the AP-1 family of transcription factors, reduces tumor angiogenesis by limiting Ras-mediated production of ROS.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Sep 17 118(6) 781-94",
                "id": "15369676"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e309"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Inhibitors of both Ha-Ras and mitogen-activated protein kinase kinase completely abolished the mob-5 expression in ras transformed cells, with concomitant loss of the transformation phenotype.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 11 275(32) 24436-43",
                "id": "10825166"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2f2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "from full text: H-Ras and K-Ras isoforms are activated in response to ethanol in a TNF-dependent mechanism,",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2004 Mar 39(3) 721-31",
                "id": "14999690"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2e9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "heparin inhibits phosphorylation of EGFR on the Src-dependent site Tyr(845), but not the autophosphorylation of Tyr(1173), and decreases Ras activation and Erk phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2007 Apr 211(1) 205-12",
                "id": "17226785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2000 Jul 17 192(2) 171-82",
                "id": "10899904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1997 Jan 138(1) 114-20",
                "id": "8977393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e29a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Both G-CSF and GM-CSF caused activation of p21 ras in neutrophils",
              "citation": {
                "type": "PubMed",
                "name": "Leuk Res 2005 Jan 29(1) 73-8",
                "id": "15541478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e28c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In the case of the Ras proteins, carboxyl methylation is important for targeting of the proteins to the plasma membrane.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2004 Feb 113(4) 539-50",
                "id": "14966563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e289"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We found that TPO stimulation or Ha-Ras  G12V expression led to up-regulation of cyclin D1, cyclin D2, and cyclin D3  expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Feb 25 275(8) 5553-9",
                "id": "10681535"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e284"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "By  contrast, H-ras G12V augmented CD14 and CD33 expression and reduced GPA  expression in K562/ras/PU.1.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2000 Oct 1 96(7) 2440-50",
                "id": "11001896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e269"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 25 278(17) 14753-61",
                "id": "12584202"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e268"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Overexpression of active Ras or Raf represses PEPCK gene transcription (28)",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes. 2001 May;50(5):937-46",
                "id": "11334436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e262"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "the results suggest that the loss of NM23 expression that is commonly observed during tumor progression could lead to increased potency of oncogenic Ras proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jul 15 63(14) 4089-94",
                "id": "12874011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e24b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Shc phosphorylation and Ras activity were inhibited by expression of PTEN",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 1998 Nov 30 143(5) 1375-83",
                "id": "9832564"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e23b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Oct 4 20(45) 6531-7",
                "id": "11641777"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e236"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Phosphorylation of Shc produces its binding to the adaptor protein Grb2, causing activation of the protooncogene ras, which is also upstream of the MAP kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2001 Feb 23 104(4) 517-29",
                "id": "11239409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e229"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Additionally, KLF6 inhibits cellular transformation induced by several oncogenes (c-sis/PDGF-B, v-src, H-Ras, and EGFR) that are components of signaling cascades implicated in GBM.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jun 24 23(29) 5077-83",
                "id": "15064720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Studies on mice lacking these exchange factors revealed that both p140 Ras-GRF1 and p130 Ras-GRF2 couple NMDA glutamate receptors (NMDARs) to the activation of the Ras/Erk signaling cascade...",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Apr 7 23(7) 1567-75",
                "id": "15029245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1f3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Collectively these results indicate that H-Ras up- regulates the glut1 promoter, at least in part, by increasing HIF-1alpha  protein levels leading to transactivation of promoter through the HIF-1 binding  site.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem. 2001 Mar 23;276(12):9519-25",
                "id": "11120745"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Following platelet-derived growth factor treatment, this receptor induces persistent activation of ectopically expressed PLC epsilon through activation of Ras and Rap1.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Nov 21 21(53) 8105-13",
                "id": "12444546"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Experiments with a C-terminal-truncated Ras or a farnesyltransferase inhibitor demonstrate that the CAAX motif of Ras is essential for apoptotic signaling and Bcl-2 association.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 5775-85",
                "id": "12477721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "A mutant form of p21(ras), in which Cys118 was changed to a serine residue and termed p21(ras)C118S, was not S-nitrosylated. NO-related species stimulated guanine nucleotide exchange on wild-type p21(ras), resulting in an active form, but not on p21(ras)C118S. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Feb 14 272(7) 4323-6",
                "id": "9020151"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e16f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In this report, we show that growth factor-induced transcriptional activation of Egr-1 gene is downregulated by chronic expression of oncogenic H-Ras in NIH3T3 fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Mar 8 25(5) 1093-103",
                "id": "16456537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e06d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "B , activated H-Ras also represses the SRG3 promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 21 279(21) 21903-15",
                "id": "15016814"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e05d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Thus, while p120 and NF1 (neurofibromatosis-related protein 1) are clearly Ras-specific and do not enhance the catalytic activity of Rap, RASA1 (p120-RASGAP)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Soc Trans 2006 Nov 34(Pt 5) 846-50",
                "id": "17052212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e05b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Dec 15 61(24) 8909-16",
                "id": "11751416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e033"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Oncogenic transformation of ovarian epithelial cells with H-Ras(V12) or expression of Bcr-Abl in hematopoietic cells causes elevated ROS generation and renders the malignant cells highly sensitive to PEITC",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Sep 10(3) 241-52",
                "id": "16959615"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e020"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "KLF5 in mediating cellular transformation caused by oncogenic H-Ras.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2005 Aug 29 579(21) 4757-62",
                "id": "16102754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e01b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Induction of H-Ras(G12V) down-regulates caveolin-1 protein  expression and caveolin-1 promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 32333-41",
                "id": "10542274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e014"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We report here that oncogenic Ras (H-Ras) downregulates Fas expression and renders cells of fibroblastic and epitheloid origin resistant to Fas ligand-induced apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Apr 1 18(7) 1824-31",
                "id": "10202146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dffd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The mutant and, to a lesser extent, the normal ras gene caused reduction of the AFP mRNA but not the albumin mRNA level in transfected HuH-7 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1990 Apr 10(4) 1461-9",
                "id": "1690841"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dff2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Grb2 constitutively associates with Sos, the guanine nucleotide exchange factor for plasma membrane-bound Ras (36). Docking of Grb2 to IRS proteins recruits Sos to Ras, resulting in activation of its GTPase Following insulin stimulation, Grb2 binds to both IRS proteins and to Shc, and it is not clear which pathway is more important for its activity (37, 38)",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 1999 Apr 103(7) 931-43",
                "id": "10194465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfe6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Molecular cloning and biological activity of a novel Ha-Ras suppressor gene",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 32192-7",
                "id": "10542256"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfe4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Ariadne: In this study, we show that H-Ras, N-Ras, K-Ras, EGFR and ErbB2 but not v-Src suppress RhoB promoter transcriptional activity in NIH3T3 cells and human cancer cell lines derived from lung (A-549), pancreatic (Panc-1) and cervical (C33A) tumors. [Expression]",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Feb 5 23(5) 1136-45",
                "id": "14647415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfc9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Table 2. Alteration of Gene Expression Specially Associated with H-ras Status in Skin Tumorigenesis #[JL] constituitively active HRAS",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2005 Oct 3(10) 563-74",
                "id": "16254190"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfb3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Of potential functional relevance, the expression of Par-4 allows TNFalpha to induce apoptosis in NIH-3T3 cells. In addition, the down-regulation of Par-4 levels by oncogenic Ras sensitizes cells to TNFalpha-induced NF-kappaB activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 9 274(28) 19606-12",
                "id": "10391896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfb0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": " The agent that we have employed is R115777, which is an orally bioavailable imidazole analog that blocks prenylation of Ha-ras, but not Ki-ras and N-ras (6).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Jul 27(7) 1420-31",
                "id": "16403772"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jun 1 60(11) 3031-8",
                "id": "10850453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfa2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We found that oncogenic Ras (61L), but not a dominant negative allele (17N), induced strong rpS6 phosphorylation at Ser235/236 (Fig. 2B). This stimulation was strongly inhibited by U0126 (Fig. 2C), indicating that ERK signaling is required for rpS6 phosphorylation under mTOR-independent conditions.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 May 11 282(19) 14056-64",
                "id": "17360704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Lysates of 293T cells transfected with either H-RasG12V alone, or with RASSF1A, were subjected to immune complex kinase assays with the immobilized c-Jun bead as a JNK substrate. HRasG12V expression enhanced c-Jun phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2006 Dec 29(6) 1541-7",
                "id": "17088994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Indirect confocal immunofluorescence of transfected PC12 cells using antibody 2152 demonstrated reactivity only under conditions in which Ras-GRF1 was phosphorylated at Ser(916/898).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 11 278(15) 13278-85",
                "id": "12538592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df53"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1990 Jul 5(7) 1037-43",
                "id": "2197591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df4f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Cancer research 2001 Sep 1;61(17):6340-4",
                "id": "11522622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ded8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Recently, we and others identified phospholipase C (PLC) epsilon as an effector of Ras.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Dec 15 64(24) 8808-10",
                "id": "15604236"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deb8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1993 Apr 1 53(7) 1625-9",
                "id": "8453633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deb1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Activated Src and p21ras were able to induce CD69 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Apr 28 270(17) 9833-9",
                "id": "7730364"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dea0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In vitro studies have delineated two primary intracellular pathways that appear to mediate the effects of IGF-I in skeletal muscle: the Ras-ERK pathway and the phosphoinositide-3 kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2004 Jan 96(1) 203-10",
                "id": "12959952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de6b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Different signalling molecules such as the ?-subunit of G-proteins, Ha-Ras, Src-kinases, eNOS, EGF receptors and some protein kinase-C isoenzymes bind directly to the scaffolding domain of caveolins. This binding results in the inactivation of these molecules (Casey, 1994, Feron et al., 1998 and Li et al., 1996);",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2005 Dec 21 245(1-2) 128-37",
                "id": "16368181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de4d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Oncogenic ras induces upregulation of the transcriptional repressor SLUG",
              "citation": {
                "type": "PubMed",
                "name": "Surgery 2005 Aug 138(2) 306-12",
                "id": "16153441"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de3c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Although there are now four known adenosine receptors, and the nomenclature has been changed and refined, the early classification scheme still mirrors the generally accepted profile of adenosine receptor G protein coupling (Table 1)",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2003 Sep 15(9) 813-27",
                "id": "12834807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The oncoprotein p21ras further activates transcription of the cyclin D1 gene, through sites within the promoter that bind the transcriptional regulators Ets or CREB.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1999 Apr 1 398(6726) 422-6",
                "id": "10201372"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddd8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Ras inhibits ME promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 18 274(25) 17997-8004",
                "id": "10364249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddd0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In addition, we found that Rheb inhibits the association of B-Raf with H-Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 1 281(35) 25447-56",
                "id": "16803888"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddc6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Stable transfection of activated Ha-ras into a number of murine cells correlated with a down-regulation of the expression of the NF1 genes NF1/CTF and NF1/X.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Mar 11 269(10) 7371-8",
                "id": "8125955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddb8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In previous studies we have shown that oncogenic Ras inhibits the expression of Fas (CD95) and renders Ras-transformed cells resistant to Fas-induced death",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jan 15 62(2) 450-8",
                "id": "11809695"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Table 2 Summary of genes regulated by H-Ras V12, RhoA QL, Rac1 QL and Cdc42 QL [activated forms]",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 May 1 22(17) 2689-97",
                "id": "12730683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd98"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Co-transfection with a Ha-Ras expression vector stimulated galectin-3 promoter activity approximately 10-fold",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2003 Jun 17 1641(1) 13-23",
                "id": "12788225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The adapter protein Grb2 can directly associate with phosphorylated Y703 and Y936 in c-Kit",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Oct 61(19-20) 2535-48",
                "id": "15526160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd4d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "in NIH 3T3 cells transient expression of constitutively activated forms of the small GTP-binding proteins Ras or Rac1 leads to a significant increase in intracellular ROS",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1996 Sep 1 318 ( Pt 2) 379-82",
                "id": "8809022"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd40"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Biosensors &amp; bioelectronics 2004 Oct 15;20(3):448-53",
                "id": "15494224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd23"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We have found that v-H-ras can induce the expression of CD5 on two CD5+ pre-B-cell lines established from murine bone marrow.",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 1997 Jan 90(1) 30-7",
                "id": "9038709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd05"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In previous studies we found that the GTPase p21 Harvey-Ras (Ha-Ras) stimulates the production of reactive oxygen species and induces apoptosis by oxidative stress",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Neurosci 2007 Dec 26(11) 3261-6",
                "id": "18005061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "GEF activity of Ras-GRF1 toward Ha-Ras, as defined by in vitro GDP binding and release assays, was augmented after tyrosine phosphorylation by ACK1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 22 275(38) 29788-93",
                "id": "10882715"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dce7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "GST-DIP1/2 fusion protein containing the minimal Ras GAP domain (23), and either this fusion protein or GST protein was incubated with human recombinant [gamma -32P]GTP-bound Ha-Ras protein. The increasing amounts of GST-DIP1/2 (ranging from 0.2 to 1 g) stimulated Ras GTPase activity in a dose-dependent manner ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 12 277(15) 12622-31",
                "id": "11812785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dce2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "These data suggest that H-ras participates in pathways that regulate cyclin B1 expression and therefore controls the G2/M checkpoint in a p53-independent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 2002 Oct 31 508(1-2) 49-58",
                "id": "12379461"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dce0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "While T29 cells, stably transfected with SV40 T/t antigens and hTERT, are fully immortalized, only the addition of oncogenic RAS leads to the malignant transformation of T29H cells as demonstrated by the capability of anchorage-independent growth and tumor formation in nude mice.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Sep 8 24(40) 6174-84",
                "id": "15940260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcde"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "MPD is known to furnish prenyl groups required for prenylation, protein modification that is essential for the activity of many proteins including p21(Ras) (Ras).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Mar 21 302(4) 735-42",
                "id": "12646231"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcd6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Inducible Ha-Ras(V12) increases the production of PGI(2) through the coordinate up-regulation of cPLA(2), COX-2, and prostacyclin synthase (PGIS).",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2004 Nov 127(5) 1391-400",
                "id": "15521009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcd5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jan 15 60(2) 400-8",
                "id": "10667594"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dccd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "activated V12-H-Ras can induce the p21 promoter through the same region of the p21 promoter by a p53-independent mechanism in NIH3T3 cells E2F1 is required for induction of the p21 promoter by activated Ras",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Feb 17 19(7) 961-4",
                "id": "10702805"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcc7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Activation of NF-kappaB by osteopontin depended on the small GTP-binding protein Ras and the tyrosine kinase Src,",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 1998 May 18 141(4) 1083-93",
                "id": "9585425"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcb4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcb1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "On the other hand, prostate cancer cells LNCaP or normal prostatic epithelial cells that were resistant to apoptosis by Par-4 did not show Fas or FasL trafficking. Par-4 is down-regulated by oncogenic-Ras, -Raf, or -Src.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Oct 1 61(19) 7255-63",
                "id": "11585763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc9d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In in vitro cell culture study, 5-day continuous suppression of H-ras expression by antisense H-ras oligodeoxynucleotide resulted in significant inhibition of the proliferation of LCI-D20 cells (t = 31.529, P < 0.01). ",
              "citation": {
                "type": "PubMed",
                "name": "Hepatogastroenterology 47(32) 365-70",
                "id": "10791191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Recently, Crk has also been shown to bind to IRS-1 in an insulin-dependent manner (44). Crk uses its SH3 domains to bind to the guanine nucleotide exchange factors Sos and C3G, the latter of which activates the c-Jun kinase, leading to induction of transformation",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 1999 Apr 103(7) 931-43",
                "id": "10194465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc8b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, H-Ras-inducible cells transfected with the nonphosphorylatable mutant FAK Y861F showed decreased migration/invasion, focus forming activity and anchorage-independent growth, compared with either wild-type or kinase-defective FAK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 9 279(28) 29060-5",
                "id": "15123632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc78"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "14-3-3 beta isoform has been shown to bind to the product of the protooncogene cRaf-1 and to facilitate its activation by Ras.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 1999 Aug 18(8) 653-61",
                "id": "10463061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc74"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Nov 18 18(48) 6635-40",
                "id": "10597268"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Infecting HUVECs with a dominant negative H-Ras mutant (Ras(S17N)) interferes bFGF-mediated cadherin downregulation, and the result suggests that bFGF attenuates surface cadherin expression on HUVECs via FGFR1 and intracellular Ras-JNK signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2008 Feb 1 314(3) 421-9",
                "id": "18164704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc55"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Additionally, KLF6 inhibits cellular transformation induced by several oncogenes (c-sis/PDGF-B, v-src, H-Ras, and EGFR) that are components of signaling cascades implicated in GBM.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jun 24 23(29) 5077-83",
                "id": "15064720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Oncogenic Ras as well as serum growth factors that activate endogenous Ras can induce mob-1 expression",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1994 Dec 20 91(26) 12515-9",
                "id": "7809069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc4d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Cyclooxygenase (COX)-2 and the subsequent production of prostaglandin E2 (PGE2) were also induced by H-Ras",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2006 Oct 15 119(8) 1767-75",
                "id": "16721810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc3a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, sustained Ha-ras oncogene expression attenuates glucocorticoid-triggered induction of the alpha B crystallin gene completely.",
              "citation": {
                "type": "PubMed",
                "name": "Verh Dtsch Ges Pathol 1994 78 34-5",
                "id": "7534008"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc2e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Grx2 significantly activated the Ras/phosphoinositide 3-kinase/Akt/NF-kappaB cascade in parallel to the Jun N-terminal kinase (JNK)/AP1 cascade.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 21618-26",
                "id": "11290748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "It has long been known that excessive mitotic activity due to H-Ras can block keratinocyte differentiation and cause skin cancer.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2008 Sep 9 14(3) 212-25",
                "id": "18772111"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc27"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The Ras-GRF1 exchange factor, which is regulated by increases in intracellular calcium and the release of G beta gamma subunits from heterotrimeric G proteins, plays a critical role in the activation of neuronal Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 11 278(15) 13278-85",
                "id": "12538592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc19"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1994 Feb 1 91(3) 873-7",
                "id": "7508123"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 12 278(37) 35609-19",
                "id": "12832399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dba2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "phosphorylation of RhoE correlates with its activity in inducing stress fibre disruption and inhibiting Ras-induced transformation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Mar 23 24(6) 1170-80",
                "id": "15775972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We report that in the CML cell line K562 Ras induces p21Cip1 expression through the Raf-MEK-ERK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1112-22",
                "id": "15528212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db6f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "75-Ras-GRF1 expression occurred with a concomitant increase in activated Ras (GTP bound), and the activation of Ras was significantly inhibited by antisense Ras-GRF1 oligomers.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Apr 25(8) 3324-37",
                "id": "15798216"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db60"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CREB1)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:CREB1))",
        "directed": false,
        "label": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532ac",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Mutational analysis in transient transfection assays uncovered an important role for an Ets-binding motif located between -77 and -74 and a cAMP-response-element (CRE)-like motif located between -68 and -62 in mediating high-level expression in endothelial cells. A second Ets site (-63 to -60) as well as a novel 6-bp palindromic sequence (-58 to -53) were found to inhibit expression. In DNase footprint analyses, both the Ets-binding motifs were protected specifically in endothelial cells, while the CRE-like element and palindrome were protected in endothelial and nonendothelial cells alike.",
              "citation": {
                "type": "PubMed",
                "name": "J Vasc Res 39(2) 148-59",
                "id": "12011586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The human PGC-1-alpha promoter contains a CRE between 133 and 116 that is crucial for PGC-1-alpha  induction by cAMP in the liver (24). Similarly, a very conserved putative CRE can be identified in the mouse PGC-1-alpha  promoter at approximately the same distance (between 146 and 129) from the transcriptional start site (Fig. 1B). The functional role of this CRE was tested by using a mutated promoter (Fig. 1B), followed by a 10-h stimulation of cells with the cAMP-stimulating agent forskolin. As shown in Fig. 1C, mutagenesis of the CRE site abolished induction of the mouse PGC-1-alpha  promoter by forskolin, as expected. Importantly, expression of the CRE PGC-1-alpha  promoter also showed a dramatically impaired response to CaMKIV alone or the combination of CaMKIV and CnA (Fig. 1C), indicating a key role for CREB in the induction of PGC-1-alpha expression by these mediators of calcium signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jun 10 100(12) 7111-6",
                "id": "12764228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2f0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "fibrosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "FOLLISTATIN IS NECESSARY TO MEDIATE THE EFFECTS OF TSA AND COUNTERACTS MYOSTATIN ACTIVITY To test the hypothesis that follistatin is required to mediate the effects exerted by TSA, we employed five different and complementary experimental approaches. Skeletal myoblasts were first infected with an adenovirus expressing the dominant-negative A-CREB (Herzig et al., 2001) and then exposed to TSA. Consistent with a positive role of CREB in mediating the transcriptional effects of TSA (Figure 5), cells infected with A-CREB displayed a reduced expression of endogenous follistatin (Figure 6A) and did not form hypernucleated myotubes (Figure 6B) after TSA treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2004 May 6(5) 673-84",
                "id": "15130492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2d9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "myoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Using cultured human amnion fibroblasts, we found that the induction of COX-2 mRNA expression by cortisol was a glucocorticoid receptor (GR)-dependent process requiring ongoing transcription. Upon transfection of a COX-2 promoter-driven reporter gene into the amnion fibroblasts, cortisol stimulated the COX-2 promoter activity. This was abolished by mutagenesis of a cAMP response element (CRE) at -53 to approximately -59bp as well as by cotransfection of a plasmid expressing dominant-negative CRE-binding protein (CREB). The phosphorylation level of CREB-1 was significantly increased by cortisol treatment of the amnion fibroblasts.Chromatin immunoprecipitation (ChIP) assay revealed that the binding of CREB-1 to the CRE of the COX-2 promoter was increased by cortisol treatment of the amnion fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2009 Nov 23(11) 1839-49",
                "id": "19797430"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e29d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The brca2 gene encodes a nuclear protein which is mainly involved in DNA repair and, when mutated, is responsible for some of the hereditary breast cancers. However, brca2 expression is also deregulated in sporadic breast tumors. In the mouse brca2 gene we had earlier identified a region of 148bp upstream of the transcription start site sufficient to activate its expression. In the present report, we show that the -92 to -40bp region is essential for the transcription of brca2 in murine mammary cells and that this nucleotide sequence contains one putative CREB/ATF consensus site (cAMP responsive element: CRE). We demonstrated that the mutation of this binding site led to a highly significant reduction of the mouse brca2 transcription, and that CREB, CREM, and/or ATF-1 functionally bound to and regulated this promoter. Therefore, the regulation of the promoter of the mouse brca2 gene is driven by this family of transcription factors.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Dec 19 312(3) 702-7",
                "id": "14680822"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e26c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Using the adenovirus E1A oncoprotein, we show that p300/CBP acts as a coactivator in the USF2-dependent activation of the Cox5b Inr. We also demonstrate that although expression of multifunctional regulatory factor, Yin Yang 1 (YY1), can stimulate transcription of the Cox5b Inr to a modest extent, expression of YY1 together with USF2 greatly reduces the level of activation of the Cox5b Inr. Furthermore, we show that the transcription factor, Sp1, represses both the YY1- and the USF2-dependent activation of the Cox5b Inr, indicating competition among Sp1, YY1, and USF2.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2000 Dec 15 1517(1) 119-27",
                "id": "11118624"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e242"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Supporting Table 7. The lists of cAMP responsive genes from HEK293T and MIN6 cells, hepatocytes, and pancreatic islets based on gene profiling using Affymetrix arrays. The values are lower bounds of the 90% confidence intervals of fold changes. In other words, if the lower bound value is 1, one can say with 90% probability that the gene expression is increased (fold change  1). Gene expression induced by cAMP treatment (forskolin) is shown in \\\"FSK induction\\\" columns; inhibition by dominant negative A-CREB is shown in \\\"A-CREB inhibition\\\" columns. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Mar 22 102(12) 4459-64",
                "id": "15753290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1ca"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "FOLLISTATIN HAS EFFECTS SIMILAR TO THOSE EXERTED BY TSA ON SKELETAL MUSCLE CELLS We evaluated whether follistatin may have effects similar to those exerted by TSA on muscle cells by enforcing its expression in skeletal myoblasts. Cells expressing exogenous follistatin (Figure 4A) displayed increased number of nuclei and cell size (Figure 4B) and increased fusion index (Figure 4E). To continue investigating whether follistatin has properties similar to those of TSA, skeletal muscle cells were exposed to recombinant follistatin at different stages of differentiation. As for TSA treatment, follistatin did not increase the size of preformed myotubes (Figures 4C, rFS on myotubes, and 4E). In contrast, myoblasts cultured in the presence of follistatin and prompted to differentiate formed hyper-nucleated myotubes with increased size, due to enhanced fusion (Figures 4D, rFS on myoblasts, and 4E). The effects exerted by TSA on myoblasts are unlikely to be mediated by IL-4 (Figure 2). To evaluate whether follistatin could indirectly activate IL-4 expression, we performed an RT-PCR assay on RNA isolated from C2C12 expressing myc-follistatin and found no signs of IL-4 induction (Figure 4F). Therefore, it appears that the effects exerted by follistatin on muscle cells are similar to those exerted by HDAC inhibitors.  MYOD, CREB, AND NFAT MEDIATE THE TRANSCRIPTIONAL ACTIVATION OF THE FOLLISTATIN PROMOTER INDUCED BY TSA To investigate the effects of TSA on follistatin transcription, the follistatin promoter linked to luciferase (FS-luc) was transfected in skeletal myoblasts. TSA activated transcription of FS-luc (Figure 5A). Within the follistatin proximal promoter, there are an E box, a CRE element, and a consensus site for NFAT (Figure 5B). To ascertain whether MyoD, CREB, and NFAT could activate FS-luc, we transfected murine fibroblasts with the FS-luc reporter and expression vectors for MyoD, a form of constitutively active CREB (CREB Y134F) (Du et al., 2000) and NFATc2. Either MyoD or CREBY134F activated FS-luc transcription (Figure 5C, lanes 2 and 3, respectively) and their cotransfection had an additive effect (Figure 5C, lane 4).",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2004 May 6(5) 673-84",
                "id": "15130492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1be"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Here, we find that overexpression of Nipsnap2 caused a 45% increase in currents though L-type Ca(2+) channels in a neuronal cell line, while siRNA knockdown of Nipsnap2 greatly reduced L-type currents. The increased influx through L-type Ca(2+) channels due to Nipsnap2 overexpression led to increased phosphorylation of the transcription factor cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) along with enhanced expression of several transcription factors and CREB target genes.",
              "citation": {
                "type": "PubMed",
                "name": "Channels (Austin) 6(2) 94-102",
                "id": "22627147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e17a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "siRNA silencing of either PKCepsilon or Akt in MCF-7 cells, which overexpress Akt, decreased Bcl-2 protein and mRNA levels. However, knockdown of PKCepsilon, but not Akt, led to the decrease in Bcl-2 at both protein and mRNA levels in MDA-MB-231 breast cancer cells, which overexpress PKCepsilon but contain little constitutively-active Akt. Knockdown of PKCepsilon decreased phosphorylation of cAMP response element-binding protein (CREB) at Ser133 in MDA-MB-231 cells, and depletion of CREB by siRNA decreased Bcl-2 at both the protein and mRNA levels",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2010 Apr 36(4) 883-8",
                "id": "20198332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e167"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "\\\"Glucocorticoids stimulate CREB binding to a cyclic-AMP response element in the rat serine dehydratase gene.\\\" Here we have demonstrated by DNaseI footprinting and site-directed mutagenesis that the phosphorylated cAMP response element binding protein (CREB) binds to a cAMP response element different from that described previously. While the amount of CREB in the extracts is unaltered by hormone treatment, more CREB is capable of binding the response element upon addition of dexamethasone (Dex). These studies suggest that synergistic induction of the SDH gene by cAMP and Dex is through a CRE and is due, in part, to regulation of CREB-DNA binding by treatment of the cells with glucocorticoids.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 1999 Feb 15 362(2) 317-24",
                "id": "9989941"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e149"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The ability of Tpl2 to regulate COX-2 expression depends on ERK signals that activate p90Rsk and Msk1, which in turn phosphorylate CREB, a key regulator of COX-2 transcription. The ERK phosphorylates p90Rsk at serine-364, 381 and threonine-360, which in turn phosphorylates Creb1 at serine-133 in cells treated by the LPS. The ERK mediated phosphorylation of p90Rsk was abrogated in Tpl2-/- cells. {Tpl2 Official Gene Symbol: MAP3K8, p90Rsk Official Gene Symbol: Rps6ka1, Msk1 Official Gene Symbol: Rps6ka5}",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Sep 16 21(18) 4831-40",
                "id": "12234923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e11e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Mobility shift assays revealed that HSP60 induced NF-kappaB and CRE binding activity, while CCAAT/enhancer binding protein (C/EBP), which binds to NF-IL-6, was constitutively active in the cells. CREB and c-Jun bind CRE regulatory regions in responsive gene promoters. HSP60, like LPS, readily activated CRE in macrophages. Both c-Jun and CRE binding protein (CREB) bound to the CRE, while C/EBP-beta bound to NF-IL-6. These data indicate that NF-kappaB, C/EBP-beta, c-Jun, and CREB are important in HSP60-induced expression of COX-2.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Oct 283(4) C1267-77",
                "id": "12225989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0e5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "This was investigated initially by cotransfecting 293 cells with a pEFNeo vector encoding wtDYRK3 (or empty pEFNeo as a control) plus a pCRE-Luc transcriptional reporter. pCRE-Luc was reproducibly stimulated 45-fold by wtDYRK3, and DYRK3-Y331E/ Y333E likewise proved to efficiently activate pCRE-Luc (Fig. 5A). Interestingly, yet somewhat unexpectedly, pCRE-Luc was also stimulated significantly by the kinase-inactive construct DYRK3-K202R (Fig. 5B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47052-60",
                "id": "12356771"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Mobility shift assays revealed that HSP60 induced NF-kappaB and CRE binding activity, while CCAAT/enhancer binding protein (C/EBP), which binds to NF-IL-6, was constitutively active in the cells. CREB and c-Jun bind CRE regulatory regions in responsive gene promoters. HSP60, like LPS, readily activated CRE in macrophages. Both c-Jun and CRE binding protein (CREB) bound to the CRE, while C/EBP-beta bound to NF-IL-6. These data indicate that NF-kappaB, C/EBP-beta, c-Jun, and CREB are important in HSP60-induced expression of COX-2.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Oct 283(4) C1267-77",
                "id": "12225989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0ad"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "We thus examined the effects of TGF-beta on activation of the cAMP regulatory element binding protein CREB, a nuclear transcription factor which mediates transcription of genes containing CRE recognition sequences in their promoters.   We examined the ability of TGF-beta-treated murine embryonic palate mesenchymal (MEPM) cells to phosphorylate CREB on the amino acid residue serine 133, phosphorylation of which is indispensable for transcriptional activation. TGF-beta treatment led to increased phosphorylation of CREB ser-133 in a time- and dose-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 1997 Feb 25 231(1) 96-103",
                "id": "9056415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df18"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "embryonic tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Supporting Table 7. The lists of cAMP responsive genes from HEK293T and MIN6 cells, hepatocytes, and pancreatic islets based on gene profiling using Affymetrix arrays. The values are lower bounds of the 90% confidence intervals of fold changes. In other words, if the lower bound value is 1, one can say with 90% probability that the gene expression is increased (fold change  1). Gene expression induced by cAMP treatment (forskolin) is shown in \\\"FSK induction\\\" columns; inhibition by dominant negative A-CREB is shown in \\\"A-CREB inhibition\\\" columns. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Mar 22 102(12) 4459-64",
                "id": "15753290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de53"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "In the present study, we focused on the molecular events involved in tumor necrosis factor-alpha (TNF-alpha) production in response to the amyloidogenic 105-amino acid carboxyl-terminal fragment (CT105) of amyloid precursor protein, a candidate alternative toxic element in Alzheimer's disease pathology, and the mechanisms by which cyclic AMP regulates the relating inflammatory signal cascades. CT105 at nanomolar concentrations strongly activated multiple signaling pathways involving tyrosine kinase-dependent extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Moreover, phosphatidylinositol 3-kinase/Akt signal was required for excess TNF-alpha production in human macrophages derived from THP-1 cells. Interferon-gamma significantly potentiated the induction of the CT105-mediated signal cascade. These multiple signaling pathways in turn converged, at least in part, at the nuclear transcription factor known as cAMP response element binding protein (CREB), which acts on the TNF-alpha gene promoter through the cAMP response element. The cell-permeable cAMP analog dibutyryl cAMP partially and almost simultaneously suppressed all of these CT105-induced signaling pathways through excessive CREB phosphorylation, which led to decreased CREB DNA binding activity and reduced TNF-alpha expression. Furthermore, dibutyryl cAMP decreased the interaction of the p65 nuclear factor-kappa B with CREB binding protein, thus further inhibiting CT105-mediated TNF-alpha expression. Collectively, the detailed molecular mechanisms of amyloidogenic CT-induced TNF-alpha production as negatively regulated by cAMP may advance the possibility of targeted treatment in Alzheimer's disease.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2003 Mar 63(3) 690-8",
                "id": "12606779"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Activation is abolished when either CRE or SRE are removed/mutated. Furthermore, mutation of CRE abolishes SREBP-dependent activation after overexpression of SREBP-1a and CRE binding protein (CREB). This shows that CRE is essential, and that under ex vivo conditions CREB and SREBP cooperate in transactivating CYP51. Interestingly, protein kinase A shows a marked stimulation of the CYP51 promoter activity when overexpressed together with SREBP-1a but not when overexpressed with CREB, suggesting phosphorylation of SREBP-1a. Using a DNA probe containing all three regulatory elements, it is found that SREBP-1a, a CREB-like factor, and specificity protein (Sp1) all probably bind the CYP51 promoter. While SREBP-1a and the CRE-bound proteins are essential for the SREBP-dependent response, Sp1 apparently functions only to maximize sterol regulation of CYP51.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2002 Aug 16(8) 1853-63",
                "id": "12145339"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddf8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd67"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Several recognition sites are present on the promoter of the cytochrome c gene, including the cAMP response element binding-protein (CREB) and nuclear respiratory factor 1 (NRF-1). Both these transcription factors are activated by phosphorylation of serine residues (Figs. 1b, 2). In BALB/3T3 cells, cAMP leads to activation of PKA, which, in turn, activates the transcription factor CREB and up-regulates the cytochrome c gene [29].",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2006 Jun 63(11) 1236-48",
                "id": "16568236"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd42"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd38"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "[from text]  Indeed, although both CaMKI/CaMKIV and CaMKII branches of the CaMK family are established Ca2+/cAMP-response element-binding protein (CREB) phosphorylating kinases (11, 31-37), we show here, using transcriptional readout assays, that CL1/CL2/CLr kinases were unlikely to target CREB but rather inhibited CRE-dependent gene expression by a dominant mechanism that bypassed CREB and was mediated by phosphorylated transducer of regulated CREB activity (TORC) 2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jul 21 281(29) 20427-39",
                "id": "16684769"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd1e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "\\\"Glucocorticoids stimulate CREB binding to a cyclic-AMP response element in the rat serine dehydratase gene.\\\" Here we have demonstrated by DNaseI footprinting and site-directed mutagenesis that the phosphorylated cAMP response element binding protein (CREB) binds to a cAMP response element different from that described previously. While the amount of CREB in the extracts is unaltered by hormone treatment, more CREB is capable of binding the response element upon addition of dexamethasone (Dex). These studies suggest that synergistic induction of the SDH gene by cAMP and Dex is through a CRE and is due, in part, to regulation of CREB-DNA binding by treatment of the cells with glucocorticoids.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 1999 Feb 15 362(2) 317-24",
                "id": "9989941"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcc3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Cells synchronized by serum starvation and then returned to serum-containing growth conditions showed a rapid induction of high levels of transcription of the hRRM2 gene. To clarify whether expression of hRRM2 mRNA was regulated at a transcriptional level, several transcription factors, including AP-1, Sp1, AP-2, CREB, NF-kappa B, and OCT1, were examined by gel-shift assay...  Each clone demonstrated a unique pattern of transcription factor binding that may play a vital role in the mechanism of drug resistance.",
              "citation": {
                "type": "PubMed",
                "name": "Cytogenet Cell Genet 2001 95(1-2) 34-42",
                "id": "11978967"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The DNA response elements that control the induction of ART-27 gene expression were also characterized. The major cis-acting element corresponds to a consensus cAMP-responsive element (CRE) and binds the CRE-binding protein (CREB) as shown by EMSA and chromatin immunoprecipitation assays. Furthermore, ART-27 promoter activity is induced upon CREB overexpression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2007 Dec 21(12) 2864-76",
                "id": "17761951"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "embryonic kidney cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Their minimum consensus sequence Hyd-X-R-X-X-(S/T) (where Hyd is any hydrophobic amino acid), determined through peptide studies, provides only a rough template common to many protein kinases (11). Additional specificity is provided by residues adjacent to the phosphorylation site of the substrate, producing differences in substrate preference among these kinases. The differences can have important transcriptional implications; for example, although all three can phosphorylate CREB on the activating site Ser-133, only CaMKII phosphorylates an additional inhibitory site, Ser-142 (13). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 2 276(5) 2975-8",
                "id": "11096122"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Moreover, PP1 was shown to act as a major CTD phosphatase in nuclear extracts and to affinity-purify with RNA polymerase II. Both PP1 and the nuclear regulator NIPP1 have also been identified as components of the Tat-associated RNA polymerase II complex, which regulates transcription from the human immunodeficiency virus type 1 promoter (40, 275). The transcription factor CREB mediates the expression of cAMP-induced genes by binding to a conserved cAMP-responsive element. Phosphorylation of CREB on Ser-133, e.g., by PKA, promotes the recruitment of the histone acetyltransferase CBP, which facilitates access of the promoter region to the transcriptional machinery.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2004 Jan 84(1) 1-39",
                "id": "14715909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbfe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "In human osteoblast-like Saos2 cells, PTH (human 1-34 PTH, 10 nM) increased BSP mRNA and protein levels at 3 h. From transient transfection assays, 2- to 2.5-fold increase in transcription by PTH was observed at 3 and 6 h in -184, -211, -428, -868, and -927 luciferase constructs that included the human BSP gene promoter. Effect of PTH was abrogated by 2 bp mutations in either the CRE1 (-79 to -72) or CRE2 (-674 to -667). Luciferase activities induced by PTH were blocked by protein kinase A inhibitor H89 and tyrosine kinase inhibitor herbimycin. The CRE1-protein and CRE2-protein complexes were disrupted by CRE binding protein 1 (CREB1) antibodies and supershifted by phospho-CREB1 antibody. ChIP assays detected binding of CREB1 and phospho-CREB1 to a chromatin fragment containing CRE1 and CRE2, and increased binding of phospho-CREB1 to the both sites.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2009 Mar 1 106(4) 618-25",
                "id": "19127545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Electrophoretic mobility shift assay confirmed that transcription factors Ets-1 and CREB bind to the Cdc2L2 promoter elements, indicating their potential role in the transcriptional regulation of Cdc2L2 gene. More importantly, Ets-1, CREB and phosphorylated CREB were found binding to the endogenous Cdc2L2 promoter using chromatin immunoprecipitation (CHIP) assay. Our results provide the foundation for further studies into the regulation of Cdc2L2 gene expression in normal homeostasis and cancer.",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2004 Apr 14 330 75-84",
                "id": "15087126"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db95"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The induction of CREB-mediated transcription was Ser-133-dependent, because caPKD1 failed to stimulate GAL4-CREBS133A-driven transcription. Similar results were obtained with co-transfection studies in COS-1 cells (results not shown), indicating that PKD1-induced CREB activation is not cell-specific.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 May 18 282(20) 14777-87",
                "id": "17389598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e40e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "This kinase can activate the transcription factor CREB, which promotes cell survival through transcriptional up-regulation of anti-apoptotic Bcl-2, Bcl-XL, and Bcl-1 proteins. Increased CREB phosphorylation on S133 was observed, in agreement with phosphorylation of p90RSK (Group II in Table 1).",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(11) e13805",
                "id": "21072193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e334"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Hepatic gluconeogenesis is essential for maintenance of normal blood glucose concentrations and is regulated by opposing stimulatory (cyclic adenosine monophosphate, cAMP) and inhibitory (insulin) signaling pathways. The cAMP signaling pathway leads to phosphorylation of cAMP response element-binding (CREB) protein, resulting in recruitment of the coactivators CREB-binding protein (CBP) and p300 and subsequent activation of gluconeogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2004 Jun 10(6) 633-7",
                "id": "15146178"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e310"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "ATF1 and CREB can be phosphorylated by Rsk2 which is a protein kinase directly activated by Erk MAP kinase.  These results suggest a signaling pathway in which Erk MAP kinase activates the c-fos enhancer by direct phosphorylation of p62TCF and by activation of Rsk related kinases that phosphorylate ATF1 and CREB.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Mar 9 19(11) 1379-85",
                "id": "10723128"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Ariadne: These data demonstrate that CREB is the mediator of the CRF-induced MIF gene transcription in pituitary cells through an identified CRE in the proximal region of the MIF promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 1998 May 12(5) 698-705",
                "id": "9605932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e26f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Our results demonstrate that CREB promotes abnormal proliferation and survival of myeloid cells in vitro and in vivo through upregulation of specific target genes. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2005 Apr 7(4) 351-62",
                "id": "15837624"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e234"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myeloid Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Coexpression of SRF mutant or an Elk1 mutant significantly repressed TNF-a-induced FRA-1 promoter activity (Fig. 8C). Ectopic expression of the ATF1 and CREB mutants had a similar effect on reporter gene expression (Fig. 8D).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Nov 15 177(10) 7193-202",
                "id": "17082637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e215"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "We found that the phosphorylation of cAMP-response element (CRE)-binding protein (CREB) preceded AR transcription after PTH treatment. Moreover, luciferase reporter assays revealed that the binding of phosphorylated CREB to a conserved CRE site in the AR promoter plays an important role in basal, PTH-induced, and prostaglandin E2 (PGE2)-induced AR expression in osteoblastic cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2005 Oct 15 96(3) 632-40",
                "id": "16088955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "This activates the transcription factor cAMP-response-element-binding protein (CREB) and increases the expression of aromatase, which catalyses the conversion of ovarian androgens to oestrogens.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Feb 2(2) 101-12",
                "id": "12635173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e142"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "We have shown recently that decreased cAMP-responsive element (CRE)-dependent transcription contributes to the loss of hRFC gene expression in multiple antifolate-resistant cell lines. This was associated with markedly decreased levels of phosphorylated cAMP response element-binding protein 1 (pCREB-1) and CRE-binding. Consistent with the autoregulation of CREB-1 gene expression by pCREB-1, prominently decreased CREB-1 mRNA levels were observed in antifolate-resistant cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2004 Dec 66(6) 1536-43",
                "id": "15340044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e13a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Constitutively active CREB constructs induced expression of PPARgamma2, fatty acid synthase, GLUT-4, and leptin both in control and prenylation inhibitors-treated cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 27 276(30) 28430-5",
                "id": "11375992"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e12a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The incretin hormone GLP1 promotes islet-cell survival via the second messenger cAMP.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jul 1 17(13) 1575-80",
                "id": "12842910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e122"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "FGFR1(SP-/NLS) transactivated CRE, up-regulated phosphorylation and transcriptional activity of CREB and stimulated the activity of CBP several-fold",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2003 Mar 84(6) 1296-312",
                "id": "12614330"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "aken together, these data provide strong evidence that PKA is the enzyme responsible for phosphorylating CREB at S133 in response to PTH and that PKA activity is required for PTH-induced c-fos expression.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1999 Mar 140(3) 1255-61",
                "id": "10067851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "This indicates that ERK1/2, reported to be located downstream of PKA, participates in the PKA-mediated CREB phosphorylation elicited by glucose. In ERK1/2-downregulated MIN6 cells by siRNA, glucose-stimulated CREB phosphorylation was highly reduced and CREB protein content was decreased by 60%.% blockade of ERK1/2 activity with PD98059 caused a significant decrease in CREB protein level",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Aug 55(8) 2220-30",
                "id": "16873684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0d5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "RHA was found to cooperate with CBP in mediating target gene activation via the CAMP responsive factor CREB",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1997 Sep 19 90(6) 1107-12",
                "id": "9323138"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "confirmed interaction of members of the Ets, AP-1 and CREB families of transcription factors with PGDH-DE mutation of the Ets site of the distal element reduced basal promoter activity. CREB activated the PGDH-DE construct through the CREB1 site. These results defined the distal element as an integrator of transcriptional regulation by AP-1, Ets and CREB proteins.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Endocrinol 2003 Aug 31(1) 105-21",
                "id": "12914529"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e055"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Salt-inducible kinase (SIK), a serine/threonine protein kinase expressed at an early stage of adrenocorticotropic hormone (ACTH) stimulation in Y1 mouse adrenocortical tumor cells, repressed the cAMP-responsive element (CRE)-dependent gene transcription by acting on the basic leucine zipper domain of the CRE-binding protein",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 1 277(44) 42334-43",
                "id": "12200423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df76"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Pharmacologic inhibition of protein kinase C (PKC) and protein kinase A (PKA), which are involved in hexosamine-mediated matrix production, blocked the CREB phosphorylation and fibronectin synthesis seen in HG and GlcN conditions.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Oct 50(10) 2355-62",
                "id": "11574420"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df5a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Studies in our laboratory have demonstrated that SRCAP functions as a coactivator for CREB-mediated transcription of a number of promoters, including that of the PEPCK gene.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2003 Dec 17(12) 2519-28",
                "id": "14500758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df50"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "These observations indicated that NF-kappaB and/or CREB are crucial for butyrate-dependent activation of CD86 gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2003 Mar 108(3) 375-83",
                "id": "12603604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Gel shift and supershift assays also demonstrated specific binding of transcription factors to their putative binding sites. Furthermore, overexpression of either CREB or ATF4 enhanced the activation of the HEC1 promoter and overexpression of both of them had an additive effect on the activation of the HEC1 transcription.  ",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 1769(9-10) 593-602",
                "id": "17822787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df4d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Epidermal growth factor, which activates CREB via phosphorylation, also induces ART-27 expression, whereas a reduction in CREB phosphorylation or expression blocks this induction in prostate cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2007 Dec 21(12) 2864-76",
                "id": "17761951"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "CREB activation via phosphorylation at serine 133 and resulting CREB mediated gene expression is a critical event which can have a significant effect on many cellular processes, including cell survival and plasticity.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2009 Jan 30 379(1) 1-5",
                "id": "19070599"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df38"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Transient transfection studies performed in SK-N-DZ and A431-PKD1 cells revealed that coexpression of caPKD1, but not dnPKD1, stimulated GAL4- CREB-dependent transcription (Fig. 4A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 May 18 282(20) 14777-87",
                "id": "17389598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df2e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "CREB and NFkappaB were activated most likely in response to an observed elevation in cytosolic calcium",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 5 279(45) 46748-54",
                "id": "15326191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "CKLiK kinase activity was dependent on Ca(++) and calmodulin as analyzed by in vitro phosphorylation of cyclic adenosine monophosphate responsive element modulator (CREM). these results  demonstrate that CKLiK is regulated by Ca ++ /calmodulin and that active CKLiK  can directly phosphorylate CREM and activate CREB, enhancing its  transactivation capacity.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2000 Nov 1 96(9) 3215-23",
                "id": "11050006"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407def0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Using this system, both Dob (Fig. 2C) and ISO (Fig. 2D) caused significant induction of CREB-Gal4-mediated luciferase activity. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 24 284(30) 20375-86",
                "id": "19509284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Pharmacologic and genetic inhibition of alpha-CaMKII by using trifluoperazine, KN93, and alpha-CaMKII small interfering RNA decreases the phosphorylation of ERK and of cAMP-response element-binding protein, leading to a significant decrease in the transactivation of serum response element and cAMP-response element. Inhibition of alpha-CaMKII decreases the expression of c-fos, AP-1 transactivation, and AP-1 DNA binding activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 25 280(8) 7049-59",
                "id": "15590632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "stimulation of ET(B)-R with ET-1 induces phosphorylation of cAMP response element-binding protein (CREB).",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2001 Nov 15 21(22) 8842-53",
                "id": "11698596"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dea5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The induction of PGC-1alpha and its mitochondrial target genes is triggered by a burst of intracellular calcium, which causes an increase in cAMP-response-element-binding protein and transducer of regulated cAMP-response-element-binding proteins actions on the PGC-1alpha promoter {cAMP-response-element-binding protein is CREB1}.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2007 May 8 104(19) 7933-8",
                "id": "17470778"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Cotransfection of A-CREB, a dominant negative to CREB, inhibited stimulation of PGDH-2368/luc3 by PEA3 in myometrial SMC, whereas treatment with 8-bromo-cAMP moderately enhanced promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2000 Feb 141(2) 581-97",
                "id": "10650939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Several enzymes involved in gluconeogenesis are down-regulated in the C/EBP knockout mice and the CREB transgenic mice (48, 50), including phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-phosphatase, pyruvate carboxylase (PC), and glycogen synthase (GS) (Fig. 2).",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2003 Feb 24(1) 91-101",
                "id": "12588811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de30"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "HEK293 cells were transfected with dnPKD or caPKD and GAL4-CREB, GAL4-CREM, or GAL4- ATF-1. The transcriptional activity of all the tested CREB family members was induced in the presence of caPKD, albeit with different amplitude, CREB being most responsive to caPKD1 (Fig. 4D).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 May 18 282(20) 14777-87",
                "id": "17389598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de25"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Ariadne: Schematic showing the possible mechanisms by which CREB or related cAMP-inducible proteins and bHLH proteins activate the transferrin promoter. Ariadne: The presence of a nearly conserved PRII site in the mouse transferrin promoter suggests that this PRII site is a potential candidate in regulating FSH and cAMP-induced mouse transferrin gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1999 Mar 140(3) 1262-71",
                "id": "10067852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddb1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Electrophoretic mobility shift assays showed that CRE-binding protein (CREB)-1 and activating transcription factor (ATF)-1 bound to CRE. The activity of the OAT3 promoter was increased through the phosphorylation of CREB-1 and ATF-1 by treatment with 8-bromo-cAMP.",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2006 Oct 319(1) 317-22",
                "id": "16809478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd94"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Activated p90rsk phosphorylates several transcription factors including Elk and the cAMP-response element-binding protein (CREB) and the activating protein 1 family of c-Jun, c-fos and activating transcription factor (Pearson et al. 2001).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "IGF-1 significantly enhanced DHPR alpha(1S) transcription in those constructs carrying cAMP-response element-binding protein (CREB) binding site but not in CREB core binding site mutants.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 27 277(52) 50535-42",
                "id": "12407098"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd87"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "In response to pancreatic glucagon and adrenal cortisol, the cAMP-responsive transcription factor CREB activates gluconeogenic and fatty acid oxidation programmes by stimulating expression of the nuclear hormone receptor coactivator PGC-1",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 Nov 13 426(6963) 190-3",
                "id": "14614508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd69"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Moreover, the phosphatidylinositol 3 (PI3)-kinase inhibitor (wortmannin) and p38(MAPK) inhibitor (SB203580) inhibited the EGF-induced CREB phosphorylation and the expression of NF-IL6beta gene in cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Jul 16(7) 3365-76",
                "id": "15901830"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd65"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "increase in cyclin D1 mRNA (Altucci et al. 1996, Prall et al. 1997), indicating that cyclin D1 is directly regulated by ER. However, the cyclin D1 promoter region does not contain a classical ERE. Instead, induction by ER has been mapped to a cAMP response element (CRE) close to the transcription start site (Sabbah et al. 1999, Castro-Rivera et al. 2001) and a more distal Sp1 site bound by both ER and Sp1 in chromatin immunoprecipitation assays",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Relat Cancer 2003 Jun 10(2) 179-86",
                "id": "12790780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd29"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "E2 increased the enhancer activity of CRE-like element and theamount of phosphorylated cAMP response element binding protein (CREB) bindingthis element, and the increases were suppressed by H-89, an inhibitor ofcAMP-dependent protein kinase A. H-89 also suppressed E2-induced cyclin D2expression, proliferation, and bromodeoxyuridine incorporation in keratinocytes.Antisense oligonucleotide against G-protein-coupled receptor",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2004 Aug 123(2) 319-28",
                "id": "15245432"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "binding of transcription factors Sp1, Sp2, and Sp3 to GC boxes 1 and 6, Sp1 and Sp2 to GC boxes 2 and 5, NF-Y to CCAAT boxes, and CREB, ATF1, and CREM to CRE. In addition, transfection studies involving Sp1, Sp2, Sp3, CREB, and NFY (dominant negative form) provided evidence that these proteins are promoter activators",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 17 278(42) 41047-58",
                "id": "12893819"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dced"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "CYP1B1 luciferase reporters respond selectively to cAMP and TCDD in adrenal Y-1 cells (only cAMP), testis MA10 cells (cAMP>TCDD), and C3H10T1/2 mouse embryo fibroblasts (only TCDD). In Y-1 cells, which lack AhR, cAMP induction is totally dependent on the FUER, including absolute requirements for upstream and downstream halves of this region, and for CREB activity at a CRE sequence located at the 3(')-end.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2003 Aug 1 416(1) 53-67",
                "id": "12859982"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc41"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "LDL promotes cAMP response element binding protein (CREB) activation (phosphorylation in Ser133). In transfection assays a dominant-negative of CREB inhibits NOR-1 promoter activity, while mutation of specific (cAMP response element) CRE sites in the NOR-1 promoter abolishes LDL-induced NOR-1 promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2004 Apr 24(4) 697-702",
                "id": "14962944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc36"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The cAMP-responsive element-binding protein (CREB) was phosphorylated via these pathways in response to OxPAPC treatment and expression of a dominant-negative mutant of CREB inhibited OxPAPC-induced activity of a human heme oxygenase-1 promoter-driven luciferase reporter construct.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 19 278(51) 51006-14",
                "id": "14523007"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc10"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "We found that, in contrast to Akt1 that induces CREB phosphorylation at Ser-133 and CREB target gene expression, Akt2 was unable to induce CREB phosphorylation at Ser-133 in vivo and CREB target gene expression. This difference is specific to CREB as both Akt1 and Akt2 similarly inhibits FoxO1 mediated gene expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 Mar 23 354(4) 1061-6",
                "id": "17276404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbf8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Here, we show that Transducer of Regulated CREB activity (TORC1), the human co-activator of cAMP response element-binding protein (CREB), but not a dominant-negative CREB mutant, significantly up-regulates the GCMa promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2008 Jun 36(11) 3834-46",
                "id": "18495750"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e420"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "These results suggest that ERK2 has a regulatory role in activating CREB in vivo in lung neutrophils after hemorrhage or endotoxemia. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 522-30",
                "id": "11123332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e41c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "These observations suggest that CBP/p300 appears to be involved in regulating FSH-mediated activation of the transferrin promoter by linking bHLH and CREB activities.",
              "citation": {
                "type": "PubMed",
                "name": "Biol Reprod 2001 Aug 65(2) 568-74",
                "id": "11466227"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e41b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "MSK1 is localized in the nucleus of unstimulated or stimulated cells, and phosphorylates CREB at Ser133 with a Km value far lower than PKA, MAPKAP-K1(p90Rsk) and MAPKAP-K2.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Aug 3 17(15) 4426-41",
                "id": "9687510"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e417"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "stimulate gene expression by promoting the phosphorylation of CREB (P-CREB), thereby enhancing its association with the histone acetylase paralogs p300 and CBP (CBP/p300)",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2007 Jun 20 26(12) 2880-9",
                "id": "17476304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e411"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "expression of PEPCK, G6Pase and pyruvate carboxylase genes was reduced fourfold in livers of A-CREB mice compared with control mice (Fig. 2b).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Sep 13 413(6852) 179-83",
                "id": "11557984"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e402"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "expression in M-1 mouse collecting duct cells and in H441 human airway epithelium",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2004 Sep 287(3) F460-8",
                "id": "15140762"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "HLA-G promoter contains three CRE/TRE elements with binding affinity for CREB/ATF and Fos/Jun proteins",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39525-31",
                "id": "12183445"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "extravillous cytotrophoblast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Simultaneous addition of dexamethasone and dibutyryl cAMP did not result in a synergistic effect but rather in a competitive one....[break] this cAMP response element sequence plays a prominent role in the transactivation of the annexin A1 promoter by dibutyryl cAMP and that it is involved in the response to glucocorticoids.  ",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2001 Jan 268(1) 62-9",
                "id": "11121103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3df"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Previously we demonstrated that quenching of CREB activity in metastatic melanoma cells by means of a dominant-negative form of CREB (KCREB) led to a decrease in their tumorigenicity and metastatic potential in nude mice.",
              "citation": {
                "type": "PubMed",
                "name": "Crit Rev Immunol 2001 21(1-3) 275-86",
                "id": "11642609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Nurr1 expression was induced by forskolin, an adenylate cyclase activator, via activation of CREB in both N2A and C6 cells",
              "citation": {
                "type": "PubMed",
                "name": "Neuroreport 2004 Jan 19 15(1) 99-102",
                "id": "15106839"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e39f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "MAPK/ERK and CREB are the downstream events of FAK activation",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 May 15 23(10) 4072-80",
                "id": "12764094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e385"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Dec 4 273(49) 32377-9",
                "id": "9829964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e37b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "We found that the intracellular domain of Notch2 interacted with a phosphorylated form of the transcription factor CREB1, and together these proteins bound the transcriptional coactivator p300 to form a complex on the promoter of the gene encoding granzyme B. Our results suggest that the highly regulated, dynamic control of T cell cytotoxicity depends on the integration of Notch2 and CREB1 signals.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2008 Oct 9(10) 1140-7",
                "id": "18724371"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e35f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "LKB1 and its downstream SIK play an important role in silencing CREB activity",
              "citation": {
                "type": "PubMed",
                "name": "FEBS J 2006 Jun 273(12) 2730-48",
                "id": "16817901"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e33d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 20 275(42) 32649-57",
                "id": "10915780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e331"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "In PMA-stimulated HL-60 cells, the PKC/ERKs-dependent CREB activation regulated expression of GM3 synthase, inducing a synthesis of ganglioside GM3 product.",
              "citation": {
                "type": "PubMed",
                "name": "Glycobiology 2005 Mar 15(3) 233-44",
                "id": "15385432"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e32f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) plays a major role in mediating hepatic gluconeogenesis in response to starvation, during which PGC-1 is induced by the cyclic AMP response element binding protein.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Mar 52(3) 642-9",
                "id": "12606503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e32e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Induction of cpg15 expression is significantly diminished in adolescent as well as adult CREB knockout mice.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurobiol 2005 Oct 65(1) 85-96",
                "id": "16010668"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e320"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Tax mutants segregating these two pathways showed that both the NF-kappaB and CREB pathways of Tax are required for maximum activation of a human Bcl-xL promoter, nevertheless, NF-kappaB alone was sufficient for that of a mouse Bcl-xL promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Virus Genes 2001 Jun 22(3) 279-87",
                "id": "11450946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e317"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Beta2-adrenergic receptor stimulation increased CREB phosphorylation, OCA-B expression, and OCA-B binding to the 3'-IgH enhancer in a protein kinase A-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 28 279(22) 23394-404",
                "id": "15024018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e311"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "activation of CREB...in T lymphocytes...requires the stimulation of both CD3 and CD28",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 284-92",
                "id": "11123304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 24 274(52) 37455-60",
                "id": "10601319"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "PTEN also inhibited the transactivation potential of the cyclic AMP-response element-binding protein",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 29 277(13) 11116-25",
                "id": "11799112"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "IFN-gamma caused phosphorylation of CREB, and overexpression of CREB increased IFN-gamma-induced BAFF promoter activity. ",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2008 Jun 83(6) 1431-9",
                "id": "18334541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2a5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "the transactivators RFX, X2BP [CREB] and NFY are required factors for MHC class II gene activation and bind the X1, X2, and Y boxes, respectively",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Oct 21(19) 6495-506",
                "id": "11533238"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e279"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "NSAIDs inhibited the activity of purified RSK2 kinase in vitro and of RSK2 in mammalian cells and suppressed the phosphorylation of RSK2 substrates cAMP response element binding protein (CREB) and I-kappa B alpha in vivo",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Nov 15 163(10) 5608-16",
                "id": "10553090"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e245"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39525-31",
                "id": "12183445"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e22d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "A number of transcription factors, including CCAAT/enhancer-binding protein beta (C/EBPbeta), glucocorticoid receptor, cAMP-response element-binding protein (CREB), and Nopp140, are known to participate in its induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39102-11",
                "id": "12167624"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e211"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "One of the two elements binds to the cyclic adenosine monophosphate (AMP) response element binding protein (CREB) transcription factor, and interfering with CREB or related family members inhibits calcium-dependent BDNF transcription.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2000 Mar 57(3) 394-401",
                "id": "10823240"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e20e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The CREB binding protein (CBP) was first identified as a protein that specifically binds to the active phosphorylated form of the cyclic-AMP response element binding protein (CREB).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Cell Biol 2001 79(3) 253-66",
                "id": "11467739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e20d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 22 276(25) 22685-98",
                "id": "11297548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e20a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "signaling pathways that converge on CREB at the transcriptional level produce different effects on splicing and neuronal gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2003 Jul 86(1) 153-64",
                "id": "12807435"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Furthermore, DDAVP-stimulated VIT32 promoter-reporter activity was inhibited by H89 and by a dominant negative CREB construct.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2004 Sep 287(3) F460-8",
                "id": "15140762"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1f9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "protein kinase A, PKA, and the cAMP response element binding protein, CREB, are downstream targets of Pla2g6, because selective PKA inhibition prevents dsRNA-induced iNOS expression, and the inhibitory actions of BEL on dsRNA-iNOS expression are overcome by the direct activation of PKA",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38449-55",
                "id": "12167650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1d2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Inactivating the kinase A phosphorylation site by in vitro mutagenesis of the cloned CREB cDNA at Ser-133 completely abolished CREB transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1989 Nov 17 59(4) 675-80",
                "id": "2573431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "We identified two mechanisms that explain how overexpression of CREB/ATF-1 contributes to the metastatic phenotype. The first is one in which CREB/ATF-1 play an essential role in invasion by regulating the CRE-dependent expression of the metalloproteinase MMP-2 and the adhesion molecule MCAM/MUC18 genes.",
              "citation": {
                "type": "PubMed",
                "name": "Crit Rev Immunol 2001 21(1-3) 275-86",
                "id": "11642609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The present work provides evidence that cAMP, through PKA-mediated CREB phosphorylation, and phenobarbital induce ALA-S expression at the transcriptional level, while heme represses it.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 1999 Dec 15 372(2) 261-70",
                "id": "10600163"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1b6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "These findings suggest that the NPY Y(1) receptor induces the expression of CRE containing target genes through the CaM kinase-CREB pathway, and inhibits CRE containing genes when cellular cAMP levels are elevated.",
              "citation": {
                "type": "PubMed",
                "name": "Peptides 2002 Jan 23(1) 87-96",
                "id": "11814622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Pgc-1 is indeed a target for creb activity in hepatocytes",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Sep 13 413(6852) 179-83",
                "id": "11557984"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e19e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "As shown in Fig. 2D, the transcription factor, CREB, activated the expression of ska2 directly by binding to its promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Jun 11 396(4) 978-82",
                "id": "20470754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e17f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 4 275(31) 24185-90",
                "id": "10811637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e17e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(3) 1365-77",
                "id": "14729979"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "glucocorticoid receptor (GR) in clonal neurons inhibits the transcriptional activity of the cyclic AMP response element-binding protein (CREB)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 May 16 304(4) 720-3",
                "id": "12727214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2001 Mar 281(5) 1213-9",
                "id": "11243864"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "CREB phosphorylation at serine-133 is essential for its transcriptional activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1997 Mar 27 232(3) 637-42",
                "id": "9126327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e09b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "pp60(v-src) induction of CREB was blocked by the p38 inhibitor SB203580 or by mutation of CREB at Ser133.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Mar 12 274(11) 7341-50",
                "id": "10066798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e08f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Western blot analysis of rat liver cell nuclear extracts and runoff transcription assays of rat liver cell nuclei after two-thirds hepatectomy showed a functional link between the induction of CREB phosphorylation and LAP/C/EBP beta mRNA transcription during liver regeneration.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Jul 17(7) 3600-13",
                "id": "9199295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e08a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Another coactivator TR-binding protein (TRBP; ASC-2; RAP250=NCOA6) ...stimulates transcription of AP1, CREB, NfkB.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2001 Jul 81(3) 1097-142",
                "id": "11427693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e086"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "% Overexpressions of CREB and c-Jun, but not c-Fos, also significantly increased the promoter activity, which suggests that CREB and c-Jun are the crucial transcription factors involved in regulating nectin-2 gene transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2006 Apr 207(1) 144-57",
                "id": "16250013"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e079"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "sertoli cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "These results indicate that CREB and ATF1 act in concert to mediate signals essential for maintaining cell viability during early embryonic development.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Mar 22(6) 1919-25",
                "id": "11865068"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e065"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Analysis of this region by DNase I footprinting and gel retardation assays identified the presence of several DNA elements with SP1 and NF1 recognition site homologies that bound both liver and brain nuclear proteins. However, one 11-nucleotide-long DNA region containing an overlapping consensus binding sequence for CREB and C/EBP-like factors reacted only with the liver nuclear lysate.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 1996 Jun 15(6) 461-73",
                "id": "8672242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e05f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Nov 20 273(47) 31427-36",
                "id": "9813054"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e05e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Furthermore, SUMO-1 overexpression stabilizes CREB in hypoxia and enhances CREB-dependent reporter gene activity",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Feb 4 100(3) 986-91",
                "id": "12552083"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e059"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "1) Band shift and supershift analysis demonstrated the binding of AP-1 and transcription factors of the CRE-binding protein/activating-transcription-factor family to the H3.3B CRE/TRE.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1998 Feb 1 329 ( Pt 3) 609-13",
                "id": "9445389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e04e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "TPA treatment results in phosphorylation of cAMP responsive element binding protein (CREB) and activation of cAMP-dependent protein kinase (PKA) in PC12",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2001 Mar 76(5) 1376-85",
                "id": "11238722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e038"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "CaMKIV activates PGC-1alpha largely through the binding of cAMP response element-binding protein to the PGC-1alpha promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jun 10 100(12) 7111-6",
                "id": "12764228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e036"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2004 Sep 24(9) 1634-9",
                "id": "15242860"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e031"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Collectively, our results demonstrate the induction of rFrp promoter activity by PKA and CREB in vitro, and the binding of CREB and CBP to the rFrp promoter core motif in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jun 19 22(25) 3901-10",
                "id": "12813463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e02b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2000 Dec 21(12) 2175-81",
                "id": "11133806"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e028"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "PDGF-induced CREB phosphorylation was also inhibited by PD98059 (Fig. 5B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 3 281(44) 33467-76",
                "id": "16945922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e012"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "# Pubmed:gene: Muscle induces neuronal expression of acetylcholinesterase in neuron-muscle co-culture: transcriptional regulation mediated by cAMP-dependent signaling. # Ariadne: Moreover, this CRE sequence of human AChE promoter was reported to mediate the cAMP-induced AChE expression in cultured NG108-15 cells ( 27 ). [Expression]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45435-44",
                "id": "12963741"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e00f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "we found that three regions corresponding to CREB, GATA-2 and SOX-5 consensus sequence within the 5'-flanking region of the DHPR alpha(1S) gene are important for DHPR alpha(1S) gene transcription. Antisense oligonucleotides against CREB, GATA-2 and SOX-5 significantly reduced charge movement in C2C12 cells",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2002 Apr 15 540(Pt 2) 397-409",
                "id": "11956331"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e003"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Ubc9 is a novel factor that functionally interacts with RHA and activates the transcription activity of RHA, measured in the CREB-mediated pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2004 Jul 30 341(1) 15-25",
                "id": "15312759"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e000"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The activation of BDNF gene promoter I and III (BDNF-PI and -PIII, respectively) was mediated not only by the CREB but also by the upstream stimulatory factor,",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Sci 2005 Jul 98(3) 212-8",
                "id": "16006741"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dffa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2000 Apr 15 95(8) 2552-8",
                "id": "10753834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfde"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "we report for the first time that CREB-mediated CCN1 transcription is enhanced in hypoxic regions of tumors in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2008 Sep 6(9) 1397-409",
                "id": "18819928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfd6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "FHL2 functioned as a coactivator for CREB-mediated transcription, and inactivation of PP2A further increased FHL2-induced CREB-directed transcription.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2003 Apr 15 65(8) 1317-28",
                "id": "12694872"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfd5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "p34SEI-1 strongly suppressed CREB-mediated transcription",
              "citation": {
                "type": "PubMed",
                "name": "Int J Mol Med 2003 Jun 11(6) 705-12",
                "id": "12736710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfd3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The introduction of an S133A mutant of CREB-1 reduces IL-2 induction of cyclin D2 promoter activity, demonstrating a role for this phosphorylation site in promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Apr 6 25(15) 2170-80",
                "id": "16301994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfc8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "PGE2 can activate prostaglandin E receptors on breast cancer cells, which increase cAMP levels and activate aromatase expression.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Feb 2(2) 101-12",
                "id": "12635173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfc2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The introduction of an S133A mutant of CREB-1 reduces IL-2 induction of cyclin D2 promoter activity, demonstrating a role for this phosphorylation site in promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Apr 6 25(15) 2170-80",
                "id": "16301994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfaf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "this interaction has functional consequences including the inhibition of RSK2-dependent CREB transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 32367-72",
                "id": "12796492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfaa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Here, we report our findings indicating that the cox-2 expression induced by  fluid shear stress was mediated by C/EBP eta, AP-1, and CREB , which bound to  their respective sites on the cox-2 promoter gene in osteoblastic MC3T3-E1  cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 9 276(10) 7048-54",
                "id": "11092885"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfa5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The differentially expressed gene set was integrated with the set of signaling proteins previously shown to be activated by TS: ADAM17 (37), AhR (36, 38), cyclic AMP responsive element binding protein 1 (CREB1; ref. 36), mitogen- activated protein kinase [extracellular signalregulated kinase (ERK)-1/2; ref. 39], protein kinase A catalytic subunit (PRKACA; ref. 36), and SRC.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Prev Res (Phila Pa) 2008 Jul 1(2) 100-11",
                "id": "19138943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "cAMP-driven PDE4D5 up-regulation in hASMs and suggest a CRE-containing, isoform-specific promoter as the primary mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 35980-9",
                "id": "12121997"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "CaMKIV, and p38 MAPK were also the kinases involved in CREB Ser(133) phosphorylation induced by CD3/CD28.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 284-92",
                "id": "11123304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Additionally, forskolin-induced transcription was inhibited by a dominant-negative mutant of CRE-binding protein (CREB) in CATH.a cells.",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res Mol Brain Res 2004 Jul 5 126(1) 22-9",
                "id": "15207912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df52"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The incretin hormone GLP1 promotes islet-cell survival via the second messenger cAMP.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jul 1 17(13) 1575-80",
                "id": "12842910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df40"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "islet cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1999 Aug 11 261(3) 859-63",
                "id": "10441516"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407defd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "PGE(2) treatment induces phosphorylation of cyclic AMP response element binding protein (CREB) at Ser133 residue and CRE-mediated luciferase activity in HCA-7 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Aug 15 313(14) 2969-79",
                "id": "17631291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Cyclic AMP, in turn, regulates a number of these genes through a conserved cAMP response element (CRE). Recently, a nuclear CRE-binding protein, CREB, has been shown to bind to the CRE and stimulate the transcription of cAMP-responsive genes.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Neurosci 1990 May 13(5) 184-8",
                "id": "1693237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de38"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Protein kinase A phosphorylation of CREB at serine 133 facilitates transcription from cellular CREs by recruiting CBP/p300 via its KIX domain. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 29 282(26) 18750-7",
                "id": "17449469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de2a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "These results indicate that PKA phosphorylates CREB and so induces VEGF gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cells 2007 Feb 28 23(1) 23-9",
                "id": "17464208"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de12"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Salt-inducible kinase (SIK), a serine/threonine protein kinase expressed at an early stage of adrenocorticotropic hormone (ACTH) stimulation in Y1 mouse adrenocortical tumor cells, repressed the cAMP-responsive element (CRE)-dependent gene transcription by acting on the basic leucine zipper domain of the CRE-binding protein",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 1 277(44) 42334-43",
                "id": "12200423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de05"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "We found that RA rapidly activates the protein kinase Calpha isozyme and transmits the activation signal to CREB via the Raf/MEK/extracellular signal-regulated kinase/p90 ribosomal S6 kinase (RSK) pathway",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Oct 27(19) 6933-47",
                "id": "17646388"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddf4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2002 Aug 143(8) 2922-9",
                "id": "12130557"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "down-regulated",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Feb 15 64(4) 1338-46",
                "id": "14973073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dde8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "activation of CREB by cAMP/PKA further stimulated HNF-4alpha transactivation in HepG2 cells. c",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2010 Sep 1803(9) 1013-9",
                "id": "20670916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dde6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Real time PCR and immunoblotting indicated that in 3T3-L1 preadipocytes, IBMX-stimulated induction of Pde3b mRNA and protein was markedly inhibited by dominant-negative CREB proteins.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jul 28 281(30) 21096-113",
                "id": "16702214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dde3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "the transcription factor cyclic AMP-responsive element binding protein (CREB1) has been shown to be a regulatory target for AKT in non-haematopoietic cells and PKCtheta in T-cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "GSK-3alpha silencing/inhibition was more robust than GSK-3beta silencing/inhibition in causing cAMP-responsive element- and NF-kappaB-dependent transactivation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 13 281(41) 30479-84",
                "id": "16912034"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddbf"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "overexpression of Oct-1 or its POU domain strongly increases transcriptional activation of cyclin D1 and GAL4 reporter genes that is specifically dependent upon CREB but independent of Oct-1 DNA binding.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Nov 22(22) 7769-79",
                "id": "12391146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddbd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Loss of CREB protein in aortic walls of rats with streptozotocin-induced diabetes is accompanied by an increase in PDGFRalpha content.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2002 Aug 143(8) 2922-9",
                "id": "12130557"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddb4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 16 277(33) 29584-92",
                "id": "12048217"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Here, we present evidence that the PE-1/METS gene is a transcriptional target of the cyclic AMP response element-binding protein-1 (CREB-1)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 23 279(17) 17772-84",
                "id": "14754893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd58"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Overexpression of SIK repressed ACTH-mediated expression of CYP11A- and Steroidogenic acute regulatory (StAR)-genes by inhibiting CREB bound to their promoters.",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Res 2002 Nov 28(4) 315-8",
                "id": "12530631"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd4f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Virol 1998 Aug 72(8) 6902-6",
                "id": "9658143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd2f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Beta2-adrenergic receptor stimulation increased CREB phosphorylation, OCA-B expression, and OCA-B binding to the 3'-IgH enhancer in a protein kinase A-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 28 279(22) 23394-404",
                "id": "15024018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 26 274(48) 34020-8",
                "id": "10567368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcf7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res 1995 Oct 23 696(1-2) 140-4",
                "id": "8574661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcdd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Transient transfection studies performed in SK-N-DZ and A431-PKD1 cells revealed that coexpression of caPKD1, but not dnPKD1, stimulated GAL4- CREB-dependent transcription (Fig. 4A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 May 18 282(20) 14777-87",
                "id": "17389598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcc5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The neonatal hypoglycemia is similar to the phenotype seen in CAAT/enhancer-binding protein alpha (C/EBPbeta)- and beta (C/EBPbeta)-deficient mice (48, 49) and transgenic mice overexpressing a dominant-negative CREB [cAMP regulatory element (CRE)-binding protein] in the liver (50).",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2003 Feb 24(1) 91-101",
                "id": "12588811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcc2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "plasma"
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Jan 24 272(4) 2500-8",
                "id": "8999965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcbc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Overexpression of CREB M1, a mutant in which the serine-133 residue was converted to alanine ( 23 ), inhibited the activation of BDNF promoter I up to ~50% of the control transfected with empty vector (Fig. 9 A ).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 35920-31",
                "id": "12114522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "several other transcription factors are activated by hypoxia, CREB and NFKB",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Jan 2(1) 38-47",
                "id": "11902584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "This study found that TSH induces transcriptional activation of the STAT3 gene through the phosphorylation of STAT3 and CREB activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Jul 15 171(2) 616-27",
                "id": "12847226"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dca0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Salt-inducible kinase-1 represses cAMP response element-binding protein activity both in the nucleus and in the cytoplasm.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2004 Nov 271(21) 4307-19",
                "id": "15511237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc94"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Neutrophils stimulated with FMLP exhibited phosphorylation of the cAMP response element binding protein (CREB), and this reaction was inhibited by SB 203580 and PD 98059.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Oct 15 163(8) 4527-36",
                "id": "10510396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc83"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Furthermore, both forskolin and EGF induced ERK1/2 phosphorylation, but only forskolin-mediated CREB phosphorylation was inhibited by H89, suggesting that PKA regulates CREB indirectly through the MAPK/ERK1/2 pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "Apoptosis 2008 May 13(5) 681-92",
                "id": "18392938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc6e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "LIF-R and IP-R activation induced binding of CREB and/or ATF-1 to C/EBP promoters and CREB-dependent transcription.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2001 Nov 15(11) 2037-49",
                "id": "11682632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "preadipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "NNK upregulated ERK1/2 and CREB/ATF-1 phosphorylation in a PKA-dependent manner in both cell lines. This response was further increased by transient overexpression of the beta 1-AR. Pre-exposure of cells to the selective beta 1-AR antagonist, atenolol, attenuated the stimulatory effects of NNK, suggesting the latter upregulated ERK1/2 and CREB/ATF-1 via this receptor. ",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2006 Oct 1 119(7) 1547-52",
                "id": "16671086"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Fibronectin contains cAMP responsive element (CRE) consensus sequences in its promoter and the phosphorylation of CRE-binding protein (CREB) may regulate its expression. On Western blots, HG and GlcN stimulate two- to threefold the phosphorylation of CREB at Ser 133, whereas CREB protein content was unaltered by either HG or GlcN.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Oct 50(10) 2355-62",
                "id": "11574420"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc56"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The transcription factor CREB (cAMP response element binding protein) was activated with decreasing oxygen tensions in both cell types. This effect was again more marked in A549 cells, demonstrating epithelial cells to be more oxygen sensitive.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Physiol Biochem 2010 25(1) 135-44",
                "id": "20054152"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc51"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "We show here that PRKX exhibits kinase activity towards histone H1 and a peptide containing the PKA consensus recognition sequence. We further showed that a PRKX expression vector can induce CREB-dependent transcriptional activation, presumably by in vivo phosphorylation of CREB.",
              "citation": {
                "type": "PubMed",
                "name": "J Virol 1998 Oct 72(10) 7916-25",
                "id": "9733829"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc42"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Cotransfection assays employing CRE-reporter gene showed that SIK1 could repress the PKA-dependent activation of CRE by acting on the bZIP domain of the CRE-binding protein (CREB), though the target site of SIK1-mediated phosphorylation has yet to be determined.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2004 Mar 31 217(1-2) 109-12",
                "id": "15134808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc1b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "two elements. Band shift experiments identified binding proteins as Oct-1 and factors of the CREB/ATF and AP-1 family, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1997 May 26 408(3) 255-60",
                "id": "9188772"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc15"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "The transcription factors implicated to date in regulation of the Mitf promoter include Pax3, CREB, Sox10, and Lef1 (Fig. 2A), with each factor able to confer on the Mitf promoter the capacity to respond to specific signals.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Jul 15 14(14) 1712-28",
                "id": "10898786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc08"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 1 277(44) 42268-79",
                "id": "12200429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc01"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "in the hippocampus of GCN2(-/-) mice, the expression of ATF4 is reduced and CREB activity is increased",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2005 Aug 25 436(7054) 1166-73",
                "id": "16121183"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbfb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "PGE2 treatment (2.5 M, 1 h) caused a marked enrichment of CREB-1-associated COX-2 promoter DNA but had no effect on C/EBP association with the COX-2 promoter (Fig. 7).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Dec 23(24) 9233-44",
                "id": "14645533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Dominant negative mutants of CREB suppressed PDE4B2 promoter activity and a constitutively active form of CREB robustly stimulated it.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2000 Mar 74(3) 1017-25",
                "id": "10693932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbd3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "FHL2 stimulation of CREB activity",
              "citation": {
                "type": "PubMed",
                "name": "J Bone Miner Res 2006 Jan 21(1) 17-28",
                "id": "16355270"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbb1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "cAMP response unit of the Cpt1a gene is composed of a cAMP-response element motif and a Dr1 sequence located upstream of the transcription start site the coactivator Pgc-1 is involved in the regulation of this gene expression by cAMP in conbination with Hnf4 alpha and Creb",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 37991-8000",
                "id": "12107181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dba9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "It is known that nuclear DNA helicase II (NDH II) links CREB-binding protein directly to RNA polymerase II holoenzyme, and that this interaction is essential for gene activation by CREB",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Aug 5 158(3) 463-73",
                "id": "12163469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dba0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CREB1) actsIn tscript(p(HGNC:CREB1))",
              "summary_text": "Pubmed:gene: The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4 alpha and cAMP-response element-binding protein (CREB).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 37991-8000",
                "id": "12107181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"AKT Family\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"AKT Family\"))",
        "directed": false,
        "label": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532a5",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We found that rictor immunopurifications contain isoforms 1, 2, and 5 (Figure 2C, left panel). mTOR immunopurifications also contain each of these isoforms (data not shown), whereas raptor immunopurifications do not (Figure 2C, right panel). In agreement with these findings, immunopurifications of myc-tagged isoforms 1, 2, and 5 coimmunoprecipitate mTOR and rictor but not raptor (Figure 2D, left panels). Knockdown of mSin1 with these two different shRNAs severely inhibited the phosphorylation of Ser473-Akt/PKB without affecting that of Thr389 of S6K1. We observed the same effect by knocking down rictor, whereas a control shRNA had no effect on Akt/PKB.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2006 Sep 19 16(18) 1865-70",
                "id": "16919458"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e41a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Overexpression of Akt led to upregulation of VEGF, increased production of superoxide ROS, and the switch to a more pronounced glycolytic metabolism ...  and ...  Second, Akt can induce expression of the ROS-generating enzyme NOX4....  From Full text...  We further demonstrated that Akt induced genes associated with resistance to ROS, including Sirt1 and rictor, and activation of the AP-1 subunit JunD....  ....And...  Treatment of this spontaneous melanoma with the Akt inhibitor resulted in significant decreases in 3 genes that may account for this resistance. Sirt1 is a deacetylase that attenuates p53 in the presence of oxidative stress; rictor is a rapamycin-insensitive member of the mammalian target of rapamycin complex; and VEGF is likely the major angiogenic factor in melanoma. Inhibition of Akt led to significant and reproducible decreases in the mRNA levels of all 3 genes.  .... Note: if they didnt not use an inhibitor to verify AKT action, I coded to expression of AKT.  If they used an inhibitor to verify action,  coded to kaof (AKT)",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2007 Mar 117(3) 719-29",
                "id": "17318262"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Activation of RET, either by ligand or through specific mutations, results in phosphorylation of multiple tyrosine residues that, in turn, interact with specific adaptor molecules to trigger downstream signaling. Four of the tyrosines phosphorylated on RET activation, tyrosines 905, 1015, 1062, and 1096, have been well characterized, and are known to interact with a number of adaptor molecules to stimulate signaling through phosphatidylinositol kinase (PI3K)/AKT, PLC-gamma, RAS/extracellular signal-regulated kinase (ERK), p38MAPK, JNK and ERK5.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Jul 1 64(13) 4453-63",
                "id": "15231654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Our previous work strongly links fibroblast responses to ?2?1 integrincollagen interaction with PI3KAkt signal pathway function (2022). We examined activation of the PI3KAkt pathway in response to interaction with collagen in both short-term adhesion and long-term proliferation assays. When serum-starved control fibroblasts attach to monomeric collagen, the level of Akt phosphorylation increases in a time- and PI3K-dependent fashion, along with phosphorylation of the downstream kinase S6K1 (Fig. 2 A).",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2008 Jul 7 205(7) 1659-72",
                "id": "18541712"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In addition to PI3K and Akt, JAK1, JAK2, and the tyrosine 440 STAT1 docking residue of IFNGR1 are required for STAT1 to be phosphorylated on serine. Taken together, these results suggest that the following events lead to the activation of STAT1 upon IFN gamma stimulation: 1) PI3K and Akt are activated by the occupied receptor and Tyr-440 is phosphorylated by the activated JAKs; 2) STAT1 docks to Tyr-440; and 3) Tyr-701 is phosphorylated by the JAKs and Ser-727 is phosphorylated by a kinase downstream of Akt.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Sep 7 276(36) 33361-8",
                "id": "11438544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e365"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "To dissect the biochemical mechanism(s) underlying the ability of these protein kinases to promote the cell division cycle, we used Western blotting to assess the effects of RAF and AKT on the expression of a number of proteins known to be targets of RAF or AKT signaling. Of the various immediate- early targets of RAF signaling that we analyzed (e.g., Fos, Jun, c-Myc, and HB-EGF), none showed evidence of cooperative regulation in response to coactivation of AKT and RAF (data not shown) (11, 33, 34). However, we observed cooperative effects of RAF and AKT on the expression of two key cell cycle regulators, cyclin D1 and p27Kip1. Activation of AKT or RAF alone led to a two- or threefold induction of cyclin D1 expression, respectively (Fig. 2A).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10868-81",
                "id": "15572689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e346"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": ". Since we showed that prokineticin-2 and PKR1 are expressed in adult mouse heart and cardiac cells, we investigated the role of prokineticin-2 on capillary endothelial cell and cardiomyocyte function. In cultured cardiac endothelial cells, prokineticin-2 or overexpression of PKR1 induces vessel-like formation without increasing VEGF levels. In cardiomyocytes and H9c2 cells, prokineticin-2 or overexpressing PKR1 activates Akt to protect cardiomyocytes against oxidative stress. ",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2007 Sep 21(11) 2980-93",
                "id": "17442730"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e328"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PKB/ Akt-dependent signaling controls many essential cellular processes such as cellular metabolism, transcription, cell proliferation, migration and survival [37,73,74]. PKB/Akt is believed to promote endothelial cell survival and angiogenesis via the phosphorylation and inactivation of the pro-apoptotic molecules Bad, Bax, caspase 9, and the Forkhead (FRKH) transcription factor [75], the stimulation of nitric oxide (NO) production [76,77], and the inhibition of the stressactivated kinases p38 and JNK [78].",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Mar 4 1654(1) 51-67",
                "id": "14984767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e319"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "To confirm that increased Akt phosphorylation at S473 and T308 was indicative of increased kinase activity, we measured the phosphorylation of an exogenous peptide substrate, glycogen synthase kinase-3?/? (GSK-3?/?), after nicotine or NNK administration (Figure 2a). Nicotine or NNK increased Akt kinase activity in a PI3K-dependent manner, since the PI3K inhibitor LY294002 (18) inhibited induction of Akt activity by nicotine or NNK.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2003 Jan 111(1) 81-90",
                "id": "12511591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e306"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "annexin 2 depletion attenuated Akt activation, which was associated with increased phosphorylation of VE-cadherin and endothelial barrier leakage. Disrupting homotypic VE-cadherin interactions with EGTA, antibodies to the extracellular domain of VE-cadherin, or gene silencing all resulted in decreased Akt (but not Erk1/2) activation. Furthermore, expression of constitutively active Akt restored reduced endothelial sprouting responses observed with annexin 2 and VE-cadherin knockdown",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Dec 24 285(52) 40624-34",
                "id": "20947498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Effector pathways for PPAR? in NSCLC. PPAR? can increase either expression of enzymatic activity of PTEN. This results in inhibition of Akt activation (pAkt), which may be involved in the growth inhibitory responses seen with PPAR? activation. Decreased Akt activity also can lead to decreased activity of the transcription factor NF-?B. NF-?B is a critical transcription factor in the production of proangiogenic and proinflammatory cytokines such as VEGF, IL-8. Decreased production of these factors would be expected to inhibit recruitment of inflammatory cells such as macrophages, and block tumor angiogenesis. PPAR?-mediated suppression of members of the Snail family of transcription factors, such as Snail, Zeb, or Twist, would lead to derepression of E-cadherin expression and promote the epithelial phenotype, leading to decreased migration and invasiveness. PPAR?-mediated suppression of COX-2 expression in NSCLC has been shown by several investigators. This would result in decreased PGE2 production, which will impact growth. TZDs can inhibit PGE2 production through a PPAR?-independent pathway involving induction of 15-hydroxyprostaglandin dehydrogenase (PGDH). (Figure 2 full text)",
              "citation": {
                "type": "PubMed",
                "name": "PPAR Res 2008 2008 156875",
                "id": "18509496"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "GRP induced Akt activation primarily through c-Src-mediated transactivation of EGFR. Transfection of dominant-negative c-Src abolished GRP-induced EGFR and Akt activation. GRP induced release of amphiregulin, and pre-incubation with human amphiregulin neutralizing antibody eliminated GRP-induced Akt phosphorylation. Pretreatment with phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 completely blocked GRP-initiated Akt phosphorylation. These results suggest that GRP stimulates Akt activation primarily via c-Src activation, followed by extracellular release of the EGFR ligand amphiregulin, leading to the activation of EGFR and PI3K.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Apr 15 313(7) 1361-72",
                "id": "17349623"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e249"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "in mammary epithelium, b4-integrin was found to cooperate with EGF-R in epidermal keratinocytes to enhance proliferation in a Src- but not Rasdependent manner. Signaling-wise this involves mainly the mitogen-activated protein kinase (MAPK) kinase module JNK/c-Jun and contributing activation of signal transducer and activator of transcription 3 (STAT3), whereas the PI3K/Akt kinase survival axis (protein kinase B) was suggested to be activated by b4-integrin and/or RTK alone (see Figure 2",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e244"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We found that expression of Elf5 was induced by FGF7 and FGF10, ligands that primarily bind FGFR2b. To further define the pathways by which FGFs activate Elf5 expression, we cultured E11.5 lung tips in the presence of compounds to inhibit FGF receptors (SU5402), PI3-Kinase/Akt-mediated signaling (LY294002), and MAP Kinase/Erk-mediated signaling (U0126). We found that SU5402 and LY294002 significantly reduced Elf5 expression, whereas U0126 had no effect. LY294002 also reduced Elf5 expression in cultures of purified epithelium. Finally, pAkt was coexpressed with Elf5 in the proximal epithelial airways of E17.5 lungs. These results demonstrate that Elf5 is an FGF-sensitive transcription factor in the lung with a dynamic pattern of expression and that FGF regulation of Elf5 by means of FGFR2b occurs through the PI3-Kinase/Akt pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Dyn 2007 May 236(5) 1175-92",
                "id": "17394208"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e228"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Dexamethasone treatment decreased the ability of insulin to stimulate glucose uptake, glycogen synthesis and glycogen synthase fractional activity. In addition, the dephosphorylation of glycogen synthase by insulin was blocked. These defects were paralleled by reduced insulin-stimulated protein kinase B (PKB) and GSK-3 phosphorylation. We demonstrated that chronic dexamethasone treatment impairs insulin-stimulated PKB and GSK-3 phosphorylation, which may contribute to insulin resistance in skeletal muscles.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetologia 2005 Oct 48(10) 2119-30",
                "id": "16078016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e214"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "FAK appears to play a major role in conveying survival signals from the ECM (50, 51). Because FAK binds PI 3-kinase, the protective effect against anoikis may be the result of PI 3-kinase-mediated activation of protein kinase B/Akt (52). Akt promotes survival, at least in part, by phosphorylating and thereby inactivating two proapoptotic proteins, Bad and caspase-9 (53) (Fig. 4). Inhibition of p53 prevents FAKdeficient cells from undergoing anoikis when deprived of growth factors, suggesting that p53 mediates the death signal under FAK deficiency (51).",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Aug 13 285(5430) 1028-32",
                "id": "10446041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e200"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Overexpression of wild-type SHIP2 (WT-SHIP2) inhibited insulin-induced phosphorylation of Akt at both Thr(308) and Ser(473) in Rat1 fibroblasts expressing insulin receptors. The degree of inhibition was less in the cells expressing either a mutant SHIP2 with R47Q change (R/Q-SHIP2) in the SH2 domain, or a mutant SHIP2 with Y987F change (Y/F-SHIP2) in the C-terminal tyrosine phosphorylation site. However, on addition of a myristoylation signal, WT-SHIP2, R/Q-SHIP2, and Y/F-SHIP2 all efficiently inhibited insulin-induced Akt phosphorylation at both residues, whereas a 5'-phosphatase-defective mutant SHIP2 (deltaIP-SHIP2) with the myristoylation signal did not.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2002 Oct 16(10) 2371-81",
                "id": "12351701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "ROS signals can amplify AKT signaling cascades in the forward direction through transient oxidative inactivation of the phosphatase and tensin homolog (PTEN) and other phosphatases that oppose AKT phosphorylation (21). Accordingly, we utilized the phosphorylation status of AKT as a central marker for signal transduction that can be modulated by H2O2. Accordingly, we utilized the phosphorylation status of AKT as a central marker for signal transduction that can be modulated by H2O2. Initial experiments tested the direct effects of H2O2 on AKT phosphorylation. Serum-starved control HeLa cells do not exhibit increases in pAKT/AKT ratios upon addition of H2O2  (Fig. 2D).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2010 Sep 7 107(36) 15681-6",
                "id": "20724658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Cancer arises from a stepwise accumulation of genetic changes that liberates neoplastic cells from the homeostatic mechanisms that govern normal cell proliferation. In humans, at least four to six mutations are required to reach this state, but fewer seem to be required in mice. By rationalizing the shared and unique elements of human and mouse models of cancer, we should be able to identify the molecular circuits that function differently in humans and mice, and use this knowledge to improve existing models of cancer.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 May 2(5) 331-41",
                "id": "12044009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Here, we describe that COX-2 induction is dependent on PKCalpha/c-Src/EGFR, PDGFR/PI3K/Akt/NF-kappaB signaling in HTSMCs. CSE stimulated the phosphorylation of c-Src, EGFR, PDGFR, and Akt, which were inhibited by pretreatment with the inhibitor of PKCalpha (G?6976 or G?6983), c-Src (PP1), EGFR (AG1478), PDGFR (AG1296), or PI3K (LY294002). Moreover, CSE induced a significant increase in COX-2 expression, which was reduced by pretreatment with these inhibitors or transfection with siRNA of PKCalpha, Src, or Akt. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2009 Nov 297(5) L892-902",
                "id": "19717552"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e191"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "activation of phosphatidylinositol 3-kinase-Akt by insulin induces Foxa-2 phosphorylation, nuclear exclusion, and inhibition of Foxa-2-dependent transcriptional activity. Foxa-2 physically interacts with Akt, a key mediator of the phosphatidylinositol 3-kinase pathway and is phosphorylated at a single conserved site (T156) that is absent in Foxa-1 and Foxa-3 proteins. This Akt phosphorylation site in Foxa-2 is highly conserved from mammals to insects. Mutant Foxa-2T156A is resistant to Akt-mediated phosphorylation, nuclear exclusion, and transcriptional inactivation of Foxa-2-regulated gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Sep 30 100(20) 11624-9",
                "id": "14500912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e180"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Transfection of U87MG and T691 cells with Gab1 and SHP-2 independently with NF-kB-luciferase reporter construct which showed a 9-fold increase in luciferase activity in both U87MG transfected cells and U87MG/T691 compared with the empty vector and cotransfection of Gab1 with SHP-2 resulted in additional upregulation of NF-kB activity. Furthermore, cotransfection with a construct expressing myristoylated Akt increased NF-kB activity in parental and T691 cells by 4 and 3-fold respectively over the empty vector but no change when expressed with mutant Akt. Stimulation with EGF resulted in the robust activation of NFkB and showed a binding complex,suggesting that  p65/p50 were involved in EGFR-mediated signalling.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jan 24(2) 823-36",
                "id": "14701753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e162"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PRAS40 was phosphorylated in vitro by purified Akt on the same site that was phosphorylated in insulin-treated cells. (From Results section) -- To determine whether the predicted Akt consensus phosphorylation site (Thr-246) was in fact the site recognized by the anti-pAkt substrate antibody, a mutant form of the HA-tagged PRAS40 (T246A) was expressed in which this site was changed to Ala. The anti-pAkt substrate did not recognize the mutant PRAS40, even when the constitutively active Akt was co-expressed with this protein (Fig. 5). --",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 21 278(12) 10189-94",
                "id": "12524439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e143"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We next examined the Akt T-loop Thr308 phosphorylation in wild-type and SIN1-/- cells. We found that although Ser473 phosphorylation was completely abolished in the SIN1-/- cells, Thr308 phosphorylation of Akt was not blocked (Figure 3A). These results indicate that SIN1 is not essential for Akt Thr308 phosphorylation and that the Ser473 phosphorylation is not a prerequisite for Thr308 phosphorylation. Akt, Singly Phosphorylated at Thr308, Remains Active and Functional in Response to Growth Factor Stimulation in SIN1-/- Cells Since Akt Thr308 phosphorylation was not dependent on Ser473 phosphorylation in SIN1-/- cells, we then asked whether this Thr308 singly phosphorylated Akt is still active and whether lack of Ser473 phosphorylation would have a global effect on the phosphorylation of Akt targets. Using an in vitro kinase assay, we found that Akt retained a substantial amount of enzymatic activity in SIN1-/- cells, although lower than that in wild-type cells (Figure 3B). Thus, singly phosphorylated (Thr308) Akt is an active but weaker enzyme.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2006 Oct 6 127(1) 125-37",
                "id": "16962653"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e140"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "To examine whether HRG-induced membrane dynamics and beta -catenin nuclear translocation lead to increased beta -catenin/TCFLEF signaling, we examined the effect of HRG on the transcriptional activation from a synthetic LEF/beta -catenin responsive promoter construct containing three LEFTCF binding sites. As shown in Fig. 3A, suppression of PI 3-kinase by LY294002 or a dominant-negative mutant of the p85 subunit of PI 3-kinase (5), as well as its downstream effector AKT, was accompanied by blockade of beta -catenin nuclear signaling-associated transactivation from the LEFTCF promoter in HRG-treated cells. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 27 276(30) 28443-50",
                "id": "11328805"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e10b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "mechanism by which IGF-1 inversely regulates these markers, and found that the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway, which we had previously characterized as being critical for hypertrophy, is also required to be active in order for IGF-1-mediated transcriptional changes to occur. We had recently demonstrated that the IGF1/PI3K/Akt pathway can block dexamethasone-induced up-regulation of the atrophy-induced ubiquitin ligases MuRF1 and MAFbx by blocking nuclear translocation of a FOXO transcription factor.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2737-44",
                "id": "15550386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt phosphorylates and inactivates GSK-3, decreasing the rate of phosphorylation of glycogen synthase, thus increasing its activity state59. Insulin does not activate PP1 globally, but rather specifically targets discrete pools of the phosphatase, primarily increasing PP1 activity localized at the glycogen particle. The compartmentalized activation of PP1 by insulin is due to glycogen-targeting subunits, which serve as 'molecular scaffolds', bringing together the enzyme directly with its substrates glycogen synthase and phosphorylase in a macromolecular complex,",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Downregulation of cathepsin D expression by RNA interference or inhibition of its enzymatic activity increased sensitivity of MYCN-expressing Tet21N cells to doxorubicin. Overexpression of cathepsin D in Tet21N cells attenuated doxorubicin-induced apoptosis. It was accompanied by activation of protein kinase B (Akt) and persistent antiapoptotic activity of Bcl-2. MYCN protein binds to the CTSD promoter and activates its transcription, suggesting a direct link between deregulated MYCN and CTSD mRNA expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2008 Oct 29(10) 1869-77",
                "id": "18566016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Binding of dimerized KitL induces the dimerization of Kit [32]. This leads to the autophosphorylation of Kit on tyrosine and its association with substrates of various kinds. The phophatidylinositol-3-kinase (PI3K)/Akt system is one of the major pathways [33] (fig. 1). PI3K is composed of an 85-kDa regulatory subunit and a 110-kDa catalytic subunit. The 85-kDa regulatory subunit is associated with activated Kit through an SH2 domain, and then is phosphorylated on tyrosine. The 110-kDa catalytic subunit of the activated PI3K produces phosphatidylinositol-3,4-bisphosphate, which in turn is used for phosphorylation of Akt, a serine-threonine kinase. The activated Akt is involved in the inhibition of apoptosis of cells whose survival depends on Kit signaling. A tyrosine kinase inhibitor, imatinib mesylate blocks not only autophosphorylation of Kit but also phosphorylation of Akt [34]. Induction of apoptosis in Kit signaling-dependent cells by imatinib mesylate may be mediated through the inhibition of Akt activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Dec 61(23) 2924-31",
                "id": "15583854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Despite remarkable progress in dissecting the signaling pathways that are crucial for the metabolic effects of insulin, the molecular basis for the specificity of its cellular actions is not fully understood. One clue might lie in the spatial and temporal aspects of signaling. Recent evidence suggests that signaling molecules and pathways are localized to discrete compartments in cells by specific protein interactions. Also, the rapid termination of tyrosine or lipid phosphorylation by phosphatases or serine kinases might tightly control the strength of a signaling pathway, thus determining its effect on growth, differentiation and metabolism. Insulin is the most potent anabolic hormone known, promoting the synthesis and storage of carbohydrates, lipids and proteins and inhibiting their degradation and release back into the circulation. Decreased secretion of insulin, coupled with resistance to its actions, results in type 2 diabetes, a devastating disease that is reaching epidemic proportions [1]. Even in the absence of diabetes, insulin resistance is often associated with central obesity, hypertension, polycystic ovarian syndrome, dyslipidemia and atherosclerosis. At the cellular level, insulin action is characterized by diverse effects, including changes in vesicle trafficking, stimulation of protein kinases and phosphatases, promotion of cellular growth and differentiation and activation or repression of transcription. This complexity suggests that insulin action must involve multiple signaling pathways that diverge at or near the activation of its tyrosine kinase receptor. In fact, it is likely that even individual effects of the hormone require multiple signaling inputs. Evidence is emerging that the coordination of these pathways might be governed by their intracellular compartmentalization or duration of action. Here, we consider how temporal and spatial aspects of signal transduction play a crucial role in determining the specificity of insulin action, focusing on signal initiation from the receptor that is spatially segregated into discrete domains of the plasma membrane, as well as the mechanisms that determine the duration of individual signaling pathways. Together, these factors help to differentiate insulin from other hormones that share some of the same overall signaling properties. Divergent signaling pathways are initiated by insulin receptor substrates. The insulin receptor is a tyrosine kinase that catalyzes the phosphorylation of several intracellular substrates, including the insulin receptor substrate (IRS) proteins [2], GAB-1 [3], Shc [4], APS [5], p60DOK [6], SIRPS [7] and c-Cbl [8] (Fig. 1). Each of these substrates recruits a distinct subset of signaling proteins containing Src homology 2 (SH2) domains, which interact specifically with sequences surrounding the phosphotyrosine residue. Moreover, each of these substrates can be confined to distinct locations in the cell by specific sequences that direct interactions with other proteins or lipids. Most attention in the field of insulin receptor substrates has focused on the IRS family of proteins. Mice lacking the IRS-1 protein are insulin resistant but do not develop overt diabetes [9,10]. By contrast, animals lacking IRS-2 exhibit both impaired glucose tolerance and diabetes [11], which appears to result from a defect in insulin secretion as well as insulin resistance, presumably owing to decreased b-cell proliferation in the pancreas in the face of increased demand for insulin. Despite the similarity in structure and function, the apparent differences in phenotype between IRS1 and IRS2 knockout mice underscore a specific signaling specificity that probably results from their tissue distribution, subcellular location, activation&ndash;inactivation kinetics and combinatorial interactions with downstream effectors [12]. The tyrosine phosphorylation of IRS family members generates docking sites for sev...",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cell Biol 2002 Feb 12(2) 65-71",
                "id": "11849969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e04d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In primary rat neuronal and HT22 cells, FGF1 promoted a time-dependent inactivation of GSK3beta by phosphorylation at serine 9. Blocking FGF1 receptors with heparinase reduced this effect. The effects of FGF1 on GSK3beta were dependent on phosphatidylinositol 3-kinase (PI3K)-protein kinase B (Akt) because inhibitors of this pathway or infection with dominant negative Akt adenovirus blocked inactivation. Furthermore, treatment of neuronal cells with FGF1 resulted in ERK-independent Akt phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 6 277(36) 32985-91",
                "id": "12095987"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e00c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Involvement of Rheb in the insulin TOR S6K signaling pathway was further investigated in mammalian cells. Transient transfection of Rheb1 or Rheb2 in HEK293 cells results in the increase of the phosphorylation of ribosomal S6 kinase (S6K) 25,30-33. Increase of the phosphorylation of S6 as well as 4E-BP1 was observed 30,31,33. In contrast, Rheb did not stimulate Akt phosphorylation 30,33]. The increase of S6K activity by the transient expression of Rheb was inhibited by the addition of rapamycin but not by wortmannin, an inhibitor of PI3K This led to the activation of S6K as detected by its phosphorylation. However, expression of dominant negative Rheb mutant, Rheb1D60K, blocked serum-inducted activation of S6K The overall picture of the involvement of Rheb in the insulin mTOR S6K signaling pathway is shown in Fig. 3. During serum activation of this signaling pathway, insulin or IGF1 is received by their respective receptors at the cell surface. This results in the activation of PI3K, which then phosphorylates Akt. The activated Akt phosphorylates Tsc2 and inhibits the ability of Tsc1 Tsc2 to negatively regulate mTOR. The inhibition of Tsc1 Tsc2 leads to the activation of Rheb, which then causes activation of mTOR. At least two downstream events, activation of p70S6K and phosphorylation of S6, as well as phosphorylation of 4E BP1 contribute to the increase in protein synthesis and progression of cell cycle49.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Oct 16(10) 1105-12",
                "id": "15240005"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df95"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Furthermore, inhibition of PI-3K/Akt by overexpression of Deltap85 or DN-Akt blocked arsenite-induced IKK phosphorylation, IkappaBalpha degradation and cyclin D1 expression, indicating that IKK/NFkappaB is the downstream transducer of arsenite-triggered PI-3K/Akt cascade. Moreover, inhibition of IKKbeta/NFkappaB signal pathway by overexpression of its dominant negative mutant, IKKbeta-KM, also significantly blocked arsenite-induced cyclin D1 expression. [Fig3 shows phosphorylation of both Chuk and IKBKB]",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Apr 27(4) 864-73",
                "id": "16387740"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df87"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "To determine if Src family kinases (SFKs) are involved, we demonstrated that CSF-1 activated Fyn and Lyn in cells expressing wild-type (WT) or DeltaKI receptors. Moreover, CSF-1-induced Akt activity in cells expressing DeltaKI is SFK dependent since Akt activation was prevented by pharmacological or genetic inhibition of SFK activity. The docking protein Gab2 may link SFK to PI3-kinase. CSF-1 induced Gab2 tyrosyl phosphorylation and association with PI3-kinase in cells expressing WT or DeltaKI receptors. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Sep 20(18) 6779-98",
                "id": "10958675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Furthermore, PRAS40 phosphorylation by Akt and association with 14-3-3, a cytosolic anchor protein, are crucial for insulin to stimulate mTOR.  -- (From Results Section) Because insulin stimulates Akt-mediated phosphorylation of PRAS40 at Thr 246 (ref. 26), we considered the possibility that PRAS40 phosphorylation may influence insulin activation of mTOR. Both wild-type PRAS40 and mutant PRAS40T246A expressed in 293T cells inhibited S6K1 phosphorylation and this inhibition was reduced on Akt1 coexpression with wild-type PRAS40 but not PRAS40T246A--",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2007 Mar 9(3) 316-23",
                "id": "17277771"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The connection between TOR and PI3K is revealed by the observation that Akt, which is activated by the PI3K pathway, phosphorylates and inhibits TSC2 (19?21). Furthermore, the understanding of the molecular function of TSC1/2 in regulating TORC1 was significantly advanced when Ras homology enriched in brain (Rheb) was identified as a key component acting downstream of TSC1/2 and upstream of TOR (22?27)... Therefore, a signaling pathway of PI3K-Akt-TSC2-Rheb-TORC1 has been proposed.  (from full text)",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 May 2 103(18) 6811-6",
                "id": "16627617"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In unstimulated cells, GSK3 is active and contributes significantly towards the phosphorylation and inhibition of glycogen synthase [12]. Insulin stimulates glycogen synthesis both by inactivating GSK3 and also by promoting the dephosphorylation of glycogen synthase. The inactivation of GSK3 and GSK3 is achieved through phosphorylation of Ser21 and Ser9, respectively [12], and this is mediated by PKB in a PI3K-dependent fashion. Thus PI3K, PDK, PKB and GSK3 constitute one important arm of the insulin signalling cascade regulating glycogen synthesis. In addition to inducing an increase in glucose transport, over-expression of PKB elicited an inhibition of GSK3 and a concomitant increase in glycogen and protein synthesis a decrease in insulin-stimulated GLUT4 translocation, glucose transport and membrane ruffling, which coincided with reduced phosphorylation of PKB and p70S6K but normal phosphorylation of p42/44 MAPK observed an inhibition of PKB phosphorylation and downstream p70S6K activation, which was attributable to a PP2A-type phosphatase activity Akt phosphorylates and inactivates GSK-3, decreasing the rate of phosphorylation of glycogen synthase",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Mar 16 492(3) 199-203",
                "id": "11257494"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We show that in freshly isolated rat adipocytes, insulin stimulates the phosphorylation of mTOR on serine 2448, a protein kinase B (PKB) consensus phosphorylation site. This site is also phosphorylated by amino acids, which in contrast to insulin do not activate PKB. Moreover, insulin and amino acids have an additive effect on mTOR phosphorylation, indicating that they act via two independent pathways. Importantly, amino acids, notably leucine, permit insulin to stimulate PKB when PI 3-kinase is inhibited",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Dec 18(15) 1894-6",
                "id": "15479767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de8d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In a rat hepatoma cell line, peroxynitrite induced PI3K activation and PKB/Akt phosphorylation, leading to the activation of Nrf2/ARE transcription factor and the upregulated expression of the detoxifying enzyme glutathione-Stransferase (41). A similar conclusion was reached by Li et al, who demonstrated a peroxynitrite-dependent phosphorylation of Akt triggering the activation of Nrf2/ARE, and the subsequent upregulation of the antioxidant and cytoprotective enzyme heme-oxygenase-1 in neural cells, resulting in the limitation of peroxynitrite-mediated apoptosis (42).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de7d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The transcription factor ets-2 was phosphorylated at residue threonine 72 in a colony-stimulating factor 1 (CSF-1)- and mitogen-activated protein kinase-independent manner in macrophages isolated from motheaten-viable (me-v) mice.  The CSF-1 and ets-2 target genes coding for Bcl-x, urokinase plasminogen activator, and scavenger receptor were also expressed at high levels independent of CSF-1 addition to me-v cells.  Akt (protein kinase B) was constitutively active in me-v macrophages, and an Akt immunoprecipitate catalyzed phosphorylation of ets-2 at threonine 72.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Nov 20(21) 8026-34",
                "id": "11027273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de63"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Whereas the function of CKIs as tumour suppressors is well characterized in the nucleus, they also seem to function in the cytoplasm,where they regulate cytoskeletal functions. This occurs through the modulation of the Rho signalling pathway. This cytoplasmic function could be oncogenic, as inhibition of the Rho pathway can result in increased migratory capacity. Phosphorylation of p21 on Thr145 by protein kinase B (PKB)/Akt48 or Pim1 inhibits the nuclear localization of p21. In the cytoplasm, p21 can protect the cell from apoptosis, as well as bind and inhibit the Rho kinases ROCK1 and -2 to modulate actin cytoskeleton organization46,47.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Dec 4(12) 948-55",
                "id": "15573116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de3f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Transient Shb overexpression in RINm5F cells resulted in increased proliferation. Both Shb-overexpressing RINm5F cells and islet cells from transgenic mice (islet Shb) exhibited increased basal tyrosine phosphorylation of IRS-1. Shb overexpression resulted also in the assembly and activation of a multiunit complex consisting of at least Shb, IRS-1, IRS-2, FAK, and PI3K. Consequently, the phosphorylation of Akt was enhanced under basal conditions in Shb overexpressing cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Med 2002 Nov 8(11) 695-704",
                "id": "12520086"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de14"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "To investigate the normal intracellular distribution of 14-3-3 proteins and their ligands, U2OS cells were immunostained with a polyclonal antibody that recognizes all 14-3-3 isotypes (pan-14-3-3) or with a monoclonal antibody generated against the 14-3-3sigma isotype (Fig. 1 A). Upon growth factor stimulation, Akt is activated, directly phosphorylating FKHRL1 at T32 and S253, and to a lesser extent at S315, and resulting in FKHRL1 relocalization from the nucleus to the cytoplasm ....  Similar AKT-dependent changes in subcellular localization have also been observed for the additional FKHRL1 human homologs AFX and FKHR.... Phosphorylation at T32 and S253 causes FKHRL1 to bind to 14-3-3, suggesting that the interaction between FKHRL1 and 14-3-3 may play an important role in regulating the subcellular localization of the complex.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Mar 4 156(5) 817-28",
                "id": "11864996"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddfd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Moreover, we show that the repression of AR activity by LY294002 is mediated through phosphorylation and inactivation of GSK3beta, a downstream substrate of PI3K/Akt, which results in the nuclear accumulation of beta-catenin The activation of Akt results in the phosphorylation of a number of downstream substrates such as glycogen synthase kinase (GSK3) It has been shown that GSK3 plays an important role in the Wnt pathway by regulating the degradation of -catenin Recently, a specific protein-protein interaction between -catenin and AR was identified by us and others (22, 23). Through this interaction, -catenin augments the ligand-dependent activity of AR in prostate cancer cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 23 277(34) 30935-41",
                "id": "12063252"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddf9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Expression of CCN1 protein was detected in normal ovarian epithelial cells and ovarian tumors as well as in ovarian cancer cell lines. Furthermore, estrogen increased CCN1 mRNA and protein levels in ovarian cancer cells. Ectopic expression of CCN1 enhanced the growth of ovarian cancer cells in liquid culture, whereas inhibition of its expression decreased proliferation and increased apoptosis in these cells. The observed changes in cell growth were accompanied with activation of Akt and extracellular signal-regulated kinase (ERK) signaling pathways. Stable expression of CCN1 in SKOV3 cells significantly increased tumorigenicity in nude mice.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2005 Oct 15 11(20) 7243-54",
                "id": "16243794"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddc3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Serum deprived peripheral blood monocytes rapidly undergo apoptosis, but when co-cultured with human SMCs, the monocytes survive 51. This effect was found to be mediated by an increase in Bcl-2 expression and increased activity of the Akt and MAPK pathways. Furthermore, the effect was blocked by a neutralizing antibody to VCAM-1, suggesting that the VCAM-1/VLA4 interaction may be essential 51.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2008 May 28(5) 812-9",
                "id": "18276911"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddb7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Very recent studies have suggested possible connections between Akt, PTEN, and integrin biology. For example, integrin- airlinked kinase (ILK) activation is inhibited by blockade of Akt function (Persad et al., 2000), and PTEN interacts with focal adhesion kinase (FAK) and influences cell migration (Tamura et al., 1999). These interactions affect cell survival, an event influenced by both VEGF and integrins. Also, cell migration and angiogenesis are reg- ulated by Akt and PTEN, and these cellular responses are clearly mediated by integrins (Jiang et al., 2000). By overexpression approaches, we have directly impli- cated Akt and PTEN in the pathway from VEGF to integ- rin activation. Thus, some of the functions of PI 3-kinase, Akt, and PTEN in cell migration may depend upon their role in integrin activation, and engagement of VEGFR2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2000 Oct 6(4) 851-60",
                "id": "11090623"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dda3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "from full text Results - These results were confirmed by IHC analysis of lung sections, which demonstrated increased phospho-Akt- Ser473 staining in vivo in Par-4/ lung alveolar (Figure 3C) and bronchiolar (not shown) cells, as compared with WT controls. Importantly, levels of phospho-Akt-Ser473 were also significantly augmented in Ras-expressing Par-4 KO tumours as compared with WT tumours (Figure 4A and B)          ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Jul 24",
                "id": "18650932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd91"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Lung Neoplasms",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Plasminogen activator inhibitor type-1 (PAI-1), competes with alphavbeta3 integrin for vitronectin (VN) binding. Here we report that PAI-1, in a VN-dependent manner, prevents the cooperation of alphavbeta3 integrin with insulin signaling in NIH3T3 fibroblasts, resulting in a decrease in insulin-induced protein kinase B (PKB) phosphorylation, vascular endothelial growth factor (VEGF) expression and cell migration",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2003 Mar 270(5) 814-21",
                "id": "12603314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Activation of the protein p70s6k by mitogens leads to increased translation of a family of messenger RNAs that encode essential components of the protein synthetic apparatus. Activation of the kinase requires hierarchical phosphorylation at multiple sites, culminating in the phosphorylation of the threonine in position 229 (Thr229), in the catalytic domain. The homologous site in protein kinase B (PKB), Thr308, has been shown to be phosphorylated by the phosphoinositide-dependent protein kinase PDK1. A regulatory link between p70s6k and PKB was demonstrated, as PDK1 was found to selectively phosphorylate p70s6k at Thr229. More importantly, PDK1 activated p70s6k in vitro and in vivo, whereas the catalytically inactive PDK1 blocked insulin-induced activation of p70s6k.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1998 Jan 30 279(5351) 707-10",
                "id": "9445476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Cells producing Y353F ezrin are defective in activation of the protein kinase Akt, a downstream target of PI 3-kinase that protects cells against apoptosis. Furthermore, the apoptotic phenotype of these cells is rescued by production of a constitutively activated form of PI 3-kinase. Taken together, these results establish a novel function for ezrin in determining survival of epithelial cells by activating the PI 3-kinase/Akt pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1999 Jun 22 96(13) 7300-5",
                "id": "10377409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcfb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "kidney epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We next examined the participation of Akt, rather than Erk1/2, to elucidate further the downstream mechanism mediating the enhancement of autonomous motility induced by the mutated K-ras, because Akt was constitutively and highly phosphorylated in HPL-V12 cells, as described above (Figure 1d) . Polyhistidine-tagged Akt or dominant-negative mutant Akt (dnAkt)-transfected clones were generated from HPL-V12 cells. The success of the gene transfections was confirmed by Western blotting for Akt and the polyhistidine tag (His) (Figure 3a) . The dnAkt-transfected HPL-V12 cells (V12/dnAkt) showed significant reductions of the autonomous migration by about 50% compared to the mock-transfected HPL-V12 cells (V12/Emp), while Akt-transfected HPL-V12 cells (V12/Akt) showed increased levels of migration compared to V12/Emp cells ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2004 Jan 164(1) 91-100",
                "id": "14695323"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dce5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Class I PI3K, a heterodimer consisting of a regulatory and a catalytic subunit, is a negative regulator of autophagy that is activated by the insulin receptor and the insulin receptor substrate proteins. Activated class I PI3K mainly uses PtdIns(4,5)P2 as substrate to yield PtdIns(3,4,5)P3 at the plasma membrane, which increases membrane recruitment of both PKB/Akt and its activator phosphoinositide- dependent protein kinase 1, leading to the activation of PKB/Akt, a downstream negative regulator of autophagy. Activated PKB/Akt further activates mTOR through inhibiting a downstream protein complex, the tuberous sclerosis complex 1/2, that represses the small G protein Rheb, causing inhibition of autophagy.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Med Sci 2011 Jun 24",
                "id": "21709535"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dccc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Two-hour exposure to approximately 25 microM H2O2 (generated by adding glucose oxidase to the medium) resulted in disruption of the normal insulin stimulated insulin receptor substrate (IRS)-1 and phosphatidylinositol (PI) 3-kinase cellular redistribution between the cytosol and an internal membrane pool (low density microsomal fraction (LDM)). This was associated with reduced insulin-stimulated IRS-1 and p85-associated PI 3-kinase activities in the LDM (84 and 96% inhibition, respectively). The effect of this finding on the downstream insulin signal was demonstrated by a 90% reduction in insulin stimulated protein kinase B (PKB) serine 473 phosphorylation and impaired activation of PKBalpha and PKBgamma.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Apr 9 274(15) 10595-602",
                "id": "10187855"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc3e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Interestingly, the presence of two additional basic amino acids 6 and 7 residues N-terminal to the phosphorylation site in certain peptide substrates allows phosphorylation by CaMKI/IV equally well with or without activation by a CaMKK (14). This \\\"activation independence\\\" has not yet been demonstrated toward protein substrates. Nonetheless, because CaMKI/IV requires Ca2+/CaM for deinhibition in addition to activation loop phosphorylation, substrates of this type would not be phosphorylated by CaMKI/IV until a Ca2+ signal was initiated and so could represent Ca2+-dependent but activation-independent signaling targets. Subsequent activation by a CaMKK would increase the number of available substrates by enhancing CaMKI/IV activity toward a second set of substrates (Fig. 1).   Does the Cascade Function in Cells? TOP INTRODUCTION Identification and Biochemical... Does the Cascade Function... Is the Cascade Physiologic? Other Transcriptional Targets... Evidence for a CaMK... REFERENCES  The first reconstruction of a CaMK cascade in cells used transient transfection experiments with CREB as the transcriptional target. CaMKI and CaMKIV phosphorylate CREB on its activating Ser-133 in vitro and stimulate Gal4-CREB-dependent transcription in response to a rise in intracellular Ca2+ when cells are cotransfected with Gal4-CREB and a Gal4 reporter gene (15). Additional cotransfection with a CaMKK increases reporter activity more than 10-fold (8, 9). Mutation of the CaMKIV activation loop T to A abolishes CaMKK enhancement.  To be a signaling cascade, kinase activation loop phosphorylation must be dependent upon induction of CaMKK activity. Phosphate incorporation into endogenous CaMKIV in Jurkat cells is induced rapidly following T-cell receptor stimulation and is blocked by chelation of extracellular Ca2+. This is accompanied by 8-14-fold increases in immunoprecipitated CaMKIV activity that is refractory to further activation by exogenous CaMKK and can be reversed by in vitro treatment with PP2A (16). Recombinant CaMKIV transfected into BJAB cells, which lack endogenous CaMKIV, demonstrates similar activation following anti-IgM stimulation that is abrogated by mutating the activation loop T to A (4). Likewise, CaMKI phosphorylation is induced in PC12 cells, coincident with increased CaMKI activity and reduced activation of CaMKI by exogenous CaMKK (17). Collectively, these experiments provide strong evidence for an inducible, Ca2+-dependent activation of CaMKI and CaMKIV in intact cells via activation loop phosphorylation. However, the fact that activation loop phosphorylation requires Ca2+ does not confirm that the physiologic activator is itself Ca2+-dependent, because Ca2+/CaM binding to CaMKI or CaMKIV is required before these enzymes can be phosphorylated by the known CaMKKs.  The issue of subcellular localization is a confounding one for any model of the CaMK cascade regulating transcription. There are several lines of evidence that CaMKK and - are both cytoplasmic. In contrast to an early study using a polyclonal antibody, immunohistochemistry of rat brain slices using monoclonal antibodies able to distinguish between the  and  isoforms found exclusively cytoplasmic immunoreactivity for both (18). Furthermore, green fluorescent protein-tagged CaMKK and - are cytoplasmic in NG108 cells even after depolarizing stimulation (18). This holds true for overexpressed CaMKK in Jurkat and BJAB cells.2 Similarly, CaMKI appears to be excluded from the nucleus in brain slices as well as in cells overexpressing the protein, yet CaMKI immunoreactivity has recently been observed to translocate to the nuclei of hippocampal neurons during long term potentiation (19, 20).3 In contrast, CaMKIV is predominantly nuclear but can also be found in neuronal soma and dendritic processes, where it could interact with a cytoplasmic CaMKK (21).  The CaMK cascade then is well positioned to affect cytoplasmic e...",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 2 276(5) 2975-8",
                "id": "11096122"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Serine 167 in AF1 is also phosphorylated, this time by the 90-kDa ribosomal S6 kinase RSK 89, which is itself activated by ERK1 and ERK2. Another signalling pathway that might have an important role in ER activity is the phosphatidylinositol- 3-OH kinase (PI3K) signalling pathway. The serine/threonine protein kinase AKT (or PKB) is one of the downstream targets of PI3K97. Its activation promotes cellular proliferation and anti-apoptotic responses. ER phosphorylation by AKT occurs at serine 167 and results in ligand-independent activation of ER98,99.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Feb 2(2) 101-12",
                "id": "12635173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbc8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In order to determine if this pathway was also activated by TLR2 in megakaryocytes, lysates treated for up to 1 hour with 1 ?g/mL Pam3CSK4 were also immunoblotted for the phosphorylation of Akt, a downstream target of PI3K. In Figure 1A, there was an increase in the From bloodjournal.hematologylibrary.org at Harvard Libraries on May 6, 2011. For personal use only. 11 phosphorylation of Akt beginning at 30 minutes (139.4%  38.5), which was maintained for up to 1 hour (129.3%  20.1).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2011 Mar 31",
                "id": "21454454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dba7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Elevated growth factors during puberty and persistent growth factor signals due to Western life style stimulate the export of FoxO1 out of the nucleus into the cytoplasm via activation of the phos-phoinositide-3-kinase (PI3K)/Akt pathway. By this mechanism, genes and nuclear receptors involved in acne are derepressed leading to increased androgen receptor-mediated signal transduction, increased cell proliferation of androgen-dependent cells, induction of sebaceous lipogenesis and upregulation of Toll-like-receptor-2-dependent inflammatory cytokines.",
              "citation": {
                "type": "PubMed",
                "name": "J Dtsch Dermatol Ges 2010 Feb 8(2) 105-14",
                "id": "20151947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Hsp27 effectively protected the cells from cisplatin-induced DNA fragmentation. The p38 inhibitors obviously decreased whereas Akt inhibitors markedly increased the apoptotic fraction in cisplatin-treated cells. Overexpression of Hsp27 doubly enhanced the drug-induced Akt activation while substantially depressing the drug-induced activation of ASK1 and p38. Hsp27 endues cells with cisplatin resistance via depression of the drug-induced ASK1/p38 activation and enhancement of the drug-induced Akt activation.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2007 May 15 13(10) 2855-64",
                "id": "17504983"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db78"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PDGF decreased expression of SM alpha-actin. PI3K inhibitor almost completely reversed this inhibition. Expression of activated form of Akt also suppressed SM alpha-actin promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39830-8",
                "id": "12882977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e40c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We have previously found that deguelin, isolated from several plant species, including Mundulea sericea ( Leguminosae ), inhibits the PI3K/Akt pathway and decreases the expression of cyclooxygenase-2, which participates in xenobiotic metabolism, angiogenesis, and inhibition of immune surveillance and apoptosis during tumorigenesis ( 22 ) .",
              "citation": {
                "type": "PubMed",
                "name": "J Natl Cancer Inst 2005 Nov 16 97(22) 1695-9",
                "id": "16288123"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "we performed an immunohistochemical analysis of the PI3K/Akt pathway in lung tissues derived from A/J mice treated with NNK. Active Akt and downstream components were detected in the normal bronchial epithelium, hyperplastic lesions, adenomas, and adenocarcinomas, with the most intense staining observed in adenocarcinomas.",
              "citation": {
                "type": "PubMed",
                "name": "Chest 2004 May 125(5 Suppl) 101S-2S",
                "id": "15136436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Administration of PTEN-specific siRNA reversed PKB/Akt inhibition and mitigated apoptosis in diabetic mouse aortas. These findings therefore suggest that hyperglycaemia may promote apoptosis in endothelial cells through PKB/Akt downregulation, via a peroxynitrite-mediated, LKB1-dependent PTEN activation (46).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3ba"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "diabetes",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Although the growth factors epidermal growth factor (EGF) and neuregulin (NRG) 1 similarly stimulated Erk1/2 in MDA-MB-361 cells, EGF acting through an EGF receptor/ErbB2 heterodimer preferentially stimulated protein kinase C, and NRG1beta acting through an ErbB2/ErbB3 heterodimer preferentially stimulated Akt. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 22 276(25) 22685-98",
                "id": "11297548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e391"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "we identify Ser-166, a site previously reported as an AKT target, and Ser-188, a novel site which is the major site of phosphorylation of MDM2 by AKT in vitro. Analysis of MDM2 in cultured cells confirms that Ser-166 and Ser-188 are phosphorylated by AKT in a physiological context.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2004 Nov 5 577(1-2) 270-6",
                "id": "15527798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e384"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Erlotinib decreased cellular levels of phosphorylated ERK1/2, phosphorylated AKT, Rad51 protein, and mRNA in erlotinib-sensitive H1650, A549, and H1869 cells, leading to cell death via apoptosis     (also Erlotinib decreased Rad51 protein levels by enhancing Rad51 mRNA and protein instability, so will add protein as well as exp)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2009 Aug 7(8) 1378-89",
                "id": "19671683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e37a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The inhibitory effect of Hsp90 on ASK1-p38 activities is diminished when the Akt phosphorylation site on ASK1 (pSer83) is absent or when Akt is genetically deleted in cells, suggesting that Hsp90 and Akt function together to inhibit ASK1-p38 signaling",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jun 2 24(24) 3954-63",
                "id": "15782121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e326"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Ras activates several proteins to initiate human tumour growth, only PI3K, through activation of protein kinase B (PKB; also known as AKT), must remain activated by oncogenic Ras to maintain this growth",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2008 Apr 3 452(7187) 646-9",
                "id": "18344980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Knock-down of LAR induced post-receptor insulin resistance with the insulin-induced activation of PKB/Akt and MAP kinases markedly inhibited.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2005 Jun 6 579(14) 3024-8",
                "id": "15896785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Furthermore, activation of AKT by MAP17 as measured by Thr308 phosphorylation was independent of PI3K activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2007 Dec 28(12) 2443-50",
                "id": "17675338"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2af"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "inhibition of endogenous Akt activity by the PI3K/Akt inhibitor LY294002 abolishes transcriptional cooperativity between the bHLH proteins and p300",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jul 23(13) 4417-27",
                "id": "12808085"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "These results indicate that Akt mediates elevation of cGMP induced by vWF binding to GPIb-IX, and the cGMP signaling pathway is a downstream mediator of Akt in GPIb-IX-dependent platelet activation.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Jan 15 111(2) 658-65",
                "id": "17914025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Here, we demonstrate that nutrients suppress phosphatidylinositol 3 (PI3)-kinase/Akt signaling via Raptor-dependent mTOR (mammalian target of rapamycin)-mediated phosphorylation of insulin receptor substrate 1 (IRS-1). Raptor directly binds to and serves as a scaffold for mTOR-mediated phosphorylation of IRS-1 on Ser636/639",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Jan 26(1) 63-76",
                "id": "16354680"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e29e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Reporter gene assays using pharmacologic and molecular inhibitors of AKT and constitutively active AKT revealed for the first time the ability of AKT to (a) potentiate ERbeta activity and (b) target predominantly the activation function-2 (AF2) domain of the receptor",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8373-81",
                "id": "16951146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e282"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "To confirm these results, we infected BEAS-2B and BEAS-2B/NNK cells with adenoviruses expressing dominant- negative Akt. At lower doses of adenoviral infectivity, immortalized BEAS-2B cells underwent greater apoptosis than did BEAS-2B/NNK cells, but at the higher doses each cell type underwent apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Chest 2004 May 125(5 Suppl) 101S-2S",
                "id": "15136436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e26b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "This represents phosphorylation by the serine/threonine kinase protein kinase B (PKB), since PKB constitutively associates with Gab2, phosphorylates Gab2 on a consensus phosphorylation site, Ser159, in vitro and inhibits Gab2 tyrosine phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Jan 15 21(1-2) 72-82",
                "id": "11782427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e267"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Shc and FRS2 mediates recruitment of Grb2-SOS complexes leading to Ras/ERK stimulation, and of Grb2-GAB1/2 complexes leading to stimulation of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway. ShcC and IRS are required to trigger PI3K/AKT activation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Dec 61(23) 2954-64",
                "id": "15583857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e265"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The PTEN tumor suppressor is a phosphatase that dephosphorylates the phospholipids phosphorylated by PI-3 kinase, thereby opposing the action of PI 3-kinase, and acts as the primary negative regulator of the PI-3 kinase?Akt pathway in the cell",
              "citation": {
                "type": "PubMed",
                "name": "Vitam Horm 2004 67 409-26",
                "id": "15110188"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e264"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "ceramide, diacylglyceride and long chain acyl-coenzyme A esters can also suppress the insulin signaling pathway, as reported for the ceramide induced inhibition of protein kinase B phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Trends Endocrinol Metab 2004 Nov 15(9) 425-31",
                "id": "15519889"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e25c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "GSK-3 activity is inhibited through phosphorylation of serine 21 in GSK-3 alpha and serine 9 in GSK-3 beta. These serine residues of GSK-3 have been previously identified as targets of protein kinase B (PKB/Akt), a serine/threonine kinase located downstream of phosphatidylinositol 3-kinase.      ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 24 97(22) 11960-5",
                "id": "11035810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e25a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "mechanical strain of HASM induced a significant increase in hypoxia-inducible factor-1alpha (HIF-1alpha) mRNA and protein, a transcription factor required for VEGF gene transcription; and 5) mechanical strain of HASM induced HIF-1alpha/VEGF through dual phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) and ERK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2007 Oct 293(4) L1059-68",
                "id": "17693481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e259"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We found that Akt phosphorylates Girdin in response to growth factors such as epidermal growth factor (EGF) in fibroblasts. Furthermore, phosphorylated Girdin accumulates at the leading edge of migrating cells, suggesting its role in Akt-dependent cell migration or tumor invasion.",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2006 Nov 1086 169-84",
                "id": "17185515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e256"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PI3-kinase/AKT may serve as a survival pathway against CYP2E1-dependent toxicity.E47 cells (HepG2 cells transfected with human CYP2E1 cDNA) exposed to 25 microM iron-nitrilotriacetate+5 microM arachidonic acid (AA+Fe) developed higher toxicity than C34 cells (HepG2 cells transfected with empty plasmid). Toxicity was associated with increased oxidative stress and activation of calcium-dependent hydrolases calpain and phospholipase A2.",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2006 Jul 318(1) 360-72",
                "id": "16624972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e254"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "VEGF has been reported to inhibit HUVEC apoptosis by activating the antiapoptotic kinase Akt via a PI3K-dependent pathway",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2001 Jun 280(6) C1375-86",
                "id": "11350732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e253"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "As shown in Figure 3A, blocking of heregulin binding inhibits the constitutive phosphorylation of HER3 as well as Akt downstream in the pathway, suggesting that heregulin functions as an autocrine growth factor in A549.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Jul 10(1) 39-50",
                "id": "16843264"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e252"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The pretreatment of astrocytes with an Akt inhibitor prior to PLGn stimulation resulted in a significant decrease in TGFbeta3 amounts in the CM, suggesting an association of Akt with TGFbeta3 production/secretion",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res 2009 Dec 11 1305 1-13",
                "id": "19765562"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e251"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Here we show that such an activation of PRPK is mediated by another kinase, Akt/PKB, which phosphorylates PRPK at Ser250.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2007 Aug 23",
                "id": "17712528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e24e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "NF-AT activation by vGPCR depended upon signaling through the phosphatidylinositol 3-kinase-Akt-glycogen synthetase kinase 3 (PI3-K/Akt/GSK-3) pathway and resulted in increased expression of NF-AT-dependent cell surface molecules (CD25, CD29, Fas ligand), proinflammatory cytokines (interleukin-2 [IL-2], IL-4), and proangiogenic factors (granulocyte-macrophage colony-stimulating factor GMCSF and TNF alpha)",
              "citation": {
                "type": "PubMed",
                "name": "J Virol 2003 May 77(10) 5759-73",
                "id": "12719569"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e243"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt (PKB) directly phosphorylates multiple protein targets of relevance to apoptosis (Figure 2B), suppressing cell death clearly within the intrinsic pathway (e.g., BAD inactivation, human caspase-9 suppression) and possibly also the extrinsic pathway (e.g., FasL expression) in some types of cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Jan 3(1) 17-22",
                "id": "12559172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e240"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Studies in mouse BMMCs have suggested that AKT activation leads to cytokine production by regulating transcription from the NF?B, NFAT and AP-1 binding regions in the IL-2 and TNF-? promoter sites [75]. These studies also indicated that GSK3? might be involved in the regulation of NFAT and AP-1 activity leading to mast cell cytokine production.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2008 Oct 29(10) 493-501",
                "id": "18775670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e23e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Interaction of p27kip1 with JAB1/CNS5 or phosphorylation of serine 10 (S10) by the hKIS kinase promotes p27kip1 export from the nucleus, whereas phosphorylation of threonine 157 (T157) by the protein kinase B/AKT (AKT) impairs its import.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2005 Mar 166(3) 737-49",
                "id": "15743786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e23c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt/phosphoinositide 3-kinase (PI3-kinase) pathway with LY294002 and wortmannin prevents the ability of ET-1 to induce alpha-SMA, ezrin, paxillin, and moesin and to promote matrix contraction.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2004 Jun 15(6) 2707-19",
                "id": "15047866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e22b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Furthermore, GH induced rapid, time- and dose-dependent signaling events in LNCaP cells, including phosphorylation of JAK2 tyrosine kinase, of GHR itself and of STAT5A (JAK2-STAT5A pathway), of p42/p44 MAPK and of Akt/PKB.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2004 May 31 220(1-2) 109-23",
                "id": "15196705"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e224"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "protein phosphatase (PP) 2A dephosphorylates primarily Thr308, whereas the phosphatase PHLPP dephosphorylates Ser473 (Bayascas and Alessi, 2005; Gao et al., 2005). On the other hand, a pseudokinase, namely Tribbles homolog 3, binds to and inhibits AKT, which leads to insulin resistance (Du et al., 2003).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Sep 18 27(41) 5527-41",
                "id": "18794886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Here, we demonstrate that Akt phosphorylates the cell cycle inhibitory protein p21(Cip1) at Thr 145 in vitro and in intact cells as shown by in vitro kinase assays, site-directed mutagenesis, and phospho-peptide analysis.  Akt-dependent phosphorylation of p21(Cip1) at Thr 145 prevents the complex formation of p21(Cip1) with PCNA, which inhibits DNA replication",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Aug 21(16) 5644-57",
                "id": "11463845"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": ".Transgenic mice that express a mutant, constitutively active form of Akt1 in cardiac muscle have hypertrophic hearts [25]. Expression of an activated form of Akt1 in skeletal muscle cells is sufficient to induce hypertrophy [6,17,26].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2003 Aug 9(8) 344-50",
                "id": "12928036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "from full text - Phosphorylation of these two residues confers full activity upon Akt (29). Treatment with EGF or thrombin for 30 min stimulated both T308 and S473 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2005 Nov 8 44(44) 14595-605",
                "id": "16262259"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We demonstrate that Gab1 is essential for FGF1 stimulation of both PI 3-kinase and the antiapoptotic protein kinase Akt, while FGF1-induced mitogen-activated protein kinase (MAPK) stimulation is not affected by Gab1 deficiency",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jul 24(13) 5657-66",
                "id": "15199124"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1c0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Likewise, transfection of mutated-PTEN cells with a dominant negative Akt vector, resulted in COX-2 down-regulation and activation of apoptosis, as demonstrated by Hoechst nuclear staining. On the opposite, activation of Akt using a constitutively active expression vector, resulted in the up-regulation of COX-2 protein expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2004 May 24(5) 1311-24",
                "id": "15067356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of endometrium",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Initially, the activation of both PI3K and ERK signaling pathways by insulin were confirmed by the detection of phosphorylation of Akt and ERK by Western blotting (Fig. 2B). Activation was efficiently inhibited by wortmannin or PD098059, respectively (Fig. 2C).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2011 Jul 1 187(1) 510-9",
                "id": "21646299"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e179"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The forkhead transcription factor FoxO1 has been identified as a negative regulator of insulin/IGF-1 signaling. Expression of a 3A/LXXAA mutant, in which 3 Akt phosphorylation sites (T24, S253, and S316) and 2 leucine residues in the LXXLL motif (L462 and L463) were replaced by alanine, decreased both Igfbp-1 and G6Pase promoter activity and endogenous Igfbp-1 and G6Pase gene expression in simian virus 40-transformed (SV40-transformed) hepatocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2006 Sep 116(9) 2473-83",
                "id": "16917544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e174"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "ZIP kinase was cloned, purified, and the enzyme was able to phosphorylate MDM2 at Ser166, a site previously reported to be modified by Akt kinase, thus demonstrating that ZIP kinase is a bona fide MDM2-binding protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2004 Mar 12 337(1) 115-28",
                "id": "15001356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e16b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "SREBP-2 processing increased in response to various cholesterol depletion approaches (including statin treatment) and this increase was blunted by treatment with a potent and specific inhibitor of PI3K, LY 294002, or when a plasmid encoding a dominant-negative form of Akt (DN-Akt) was expressed.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2006 Jun 17(6) 2735-45",
                "id": "16571675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e157"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Biochemical and functional analyses showed that Akt interacts with RARalpha and phosphorylates the Ser96 residue of its DNA-binding domain.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 May 1 395(3) 653-62",
                "id": "16417524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e156"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The mechanism involves the ability of this integrin to stimulate the phosphorylation and inactivation of 4E-binding protein (4E-BP1), a translational repressor that inhibits the function of eukaryotic translation initiation factor 4E (eIF-4E). The regulation of 4E-BP1 phosphorylation by alpha 6 beta 4 derives from the ability of this integrin to activate the PI-3K-Akt pathway and, consequently, the rapamycin-sensitive kinase mTOR that can phosphorylate 4E-BP1.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jul 8 158(1) 165-74",
                "id": "12105188"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e154"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PI3K inhibitors or the proteasome inhibitor lactacystin interfere with this process. These data suggest that phosphorylation-dependent degradation of FoxO1 by means of proteasomes plays a role in oncogenic transformation by P3k and Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Sep 14 101(37) 13613-7",
                "id": "15342912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e14c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The Akt1 lipid-binding site PtdIns(3,4,5)P3 is dephosphorylated by two lipid phosphatases, SHIP (SH2- domain-containing inositol phosphatase) (which has two forms, SHIP1 and SHIP2) [35] and PTEN (phosphatase and tensin homologous on chromosome 10) [36] (Fig. 1).",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2003 Aug 9(8) 344-50",
                "id": "12928036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e14a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Indeed, in the most definitive study of VEC PDE2 expression published so far, capillary and venous VEC in human tissue sections were shown to express significant PDE2, whereas arterial VEC in these sections were uniformly negative for PDE2 expression (Sadhu et al., 1999). PDE3A and PDE3B are activated by PKA or PKB phosphorylation and consensus sites of phosphorylation for each kinase are located between NHR1 and NHR2 in both PDE3A and PDE3B (Manganiello and Degerman, 1999).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2003 Sep 64(3) 533-46",
                "id": "12920188"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e138"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Trends Biochem Sci 2001 Nov 26(11) 657-64",
                "id": "11701324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e137"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Phosphorylation of glycogen synthase kinase-3 (GSK-3) by Akt has also been reported to contribute to cell survival (36),",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Aug 19(8) 5308-15",
                "id": "10409722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e135"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Here, we show that exposure to 100 ng/ml EGF for 15 min, 1 U/ml GO for 30 min, or smoke from one cigarette for 45 min activates downstream ERK1/2 and Akt signaling (Fig. 7A) ",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2008 Mar 22(3) 910-7",
                "id": "17971399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e133"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The consequent autocrine TGF-beta signaling in response to glucose led to Akt-TOR pathway activation.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2009 Jul 17(1) 35-48",
                "id": "19619490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e130"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Remarkably, A-CREB severely disrupted expression of IRS2, an insulin signaling pathway component that is shown here to be a direct target for CREB action in vivo As induction of IRS2 by cAMP enhanced activation of the survival kinase Akt in response to insulin and IGF-1, our results demonstrate a novel mechanism by which opposing pathways cooperate in promoting cell survival.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jul 1 17(13) 1575-80",
                "id": "12842910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e128"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "By combining pharmacological and genetic approaches, we show here that the Ras/ERK pathway and phosphatidylinositol 3-kinase (PI3K) are both required for cortical neuron migration. By dissecting the downstream signals necessary for this event, we found that Rac1/p38 and Akt are required, whereas the c-Jun N-terminal kinase (JNK) and mTOR/p70(s6k) pathways are dispensable.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 24 281(8) 4771-8",
                "id": "16361255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e125"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Upstream regulators of S6K, such as PDK1 and protein kinase B (PKB/Akt), are recruited to the membrane via their pleckstrin homology (PH) or protein-protein interaction domains.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS J 2006 May 273(9) 2023-36",
                "id": "16640565"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e115"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The PI3-kinase/AKT signaling pathway is identified as a mediator of Epo-induced phosphorylation of GATA-1. AKT serine threonine kinase phosphorylates GATA-1S310 in vitro and in erythroid cells and enhances GATA-1 transcriptional activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2006 Feb 1 107(3) 907-15",
                "id": "16204311"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e104"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "erythroid progenitor",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "peroxynitrite inhibited Akt signalling in PC12 cells (45), endothelial cells (4649), and Raw 264.7 macrophages (50).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0fd"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We observed that LPS exposure results in phosphorylation of Akt (serine 473).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Apr 1 166(7) 4713-20",
                "id": "11254732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Sep 25(17) 7412-22",
                "id": "16107690"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Fig. 5C demonstrates that Akt could directly phosphorylate Bax in vitro. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 14 279(20) 21085-95",
                "id": "14766748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "expression of active AKT in T-cells alters T-cell homeostasis, promoting inflammation in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt then phosphorylates several substrates, one of which is the tuberous sclerosis complex (TSC1/2), a GTPase activating protein complex that suppresses Rheb, a GTPase that contributes directly to the activation of mTOR",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Jan 1 67(1) 1-4",
                "id": "17210675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "H2O2-induced activation of mitogen-activated protein kinases (MAPKs) and phosphatidylinositol- 3 kinase (PI3-K)/protein kinase B (PKB/Akt) pathways that play key role in mediating growth promotion and proliferative, migratory, survival, and death responses have been investigated in some detail in several cell types (17?21).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Biochem Biophys 2007 47(1) 1-10",
                "id": "17406055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "CCM1 strongly induces DLL4-NOTCH signaling, which promotes AKT phosphorylation but reduces phosphorylation of the mitogen-activated protein kinase ERK",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2010 Jul 13 107(28) 12640-5",
                "id": "20616044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In addition, Akt interacts with the coactivator and the activity of Akt is required to maintain the steady-state level of p300.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Jul 61(13) 1675-83",
                "id": "15224190"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "protein kinase B (PKB) plays a key role in mediating EGF-induced inhibition of GSK3alpha and that the classical MAP kinase (MAPK) cascade has two functions in this process. Firstly, it makes a transient contribution to EGF-induced inhibition of GSK3alpha",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1999 Nov 12 461(1-2) 120-4",
                "id": "10561508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The pro-survival effects detected in serum starved GD25beta1A cells were due to direct, PI3K-mediated stimulation of PKB/Akt activity by beta1-integrins and induced p130Cas and paxillin phosphorylation. Phosphorylated p130Cas and paxillin subsequently prevented activation of cell death-regulating JNK.",
              "citation": {
                "type": "PubMed",
                "name": "Radiother Oncol 2005 Aug 76(2) 129-34",
                "id": "16024122"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "This survival signal appears to be mediated by activation of the AKT, as detected by its phosphorylation in Ser473 upon CD53 ligation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Feb 27 22(8) 1219-24",
                "id": "12606948"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "B cell lymphoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "activation of beta-catenin-mediated transcription required ERK, PI3K, and Akt signaling.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 16 280(50) 41342-51",
                "id": "16251184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2002 Jun 4 12(11) 919-24",
                "id": "12062056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Dec 15 65(24) 11282-6",
                "id": "16357133"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Here we show that tumstatin functions as an endothelial cell-specific inhibitor of protein synthesis. Through a requisite interaction with alphaVbeta3 integrin, tumstatin inhibits activation of focal adhesion kinase (FAK), phosphatidylinositol 3-kinase (PI3-kinase), protein kinase B (PKB/Akt), and mammalian target of rapamycin (mTOR), and it prevents the dissociation of eukaryotic initiation factor 4E protein (eIF4E) from 4E-binding protein 1.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2002 Jan 4 295(5552) 140-3",
                "id": "11778052"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e089"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "in glioblastomas FOXO factors are repressed by an overactive phosphoinositide 3-kinase (PI3K)Akt pathway as well as by association with the oncogene FOXG, anotherFOX family member, to prevent FOXO from binding to the p21Cip1 promoter, thereby promoting cancer cell proliferation (Seoane et al., 2004).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2312-9",
                "id": "18391973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e084"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "glioblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "significant increase in Akt activation in rat CA1 hippocampal region extracts Active recombinant Akt phosphorylated recombinant VCP in vitro. Site-directed mutagenesis studies identified Ser352, Ser746, and Ser748 as Akt phosphorylation sites on VCP.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Sep 9 280(36) 31870-81",
                "id": "16027165"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e080"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We show that Crry increases early TCR-dependent activation signals, including p56lck-, zeta-associated protein-70 (ZAP-70), Vav-1, Akt, and extracellular signal-regulated kinase (ERK) phosphorylation but also costimulation-dependent mitogen-activated protein kinases (MAPK), such as the stress-activated c-Jun N-terminal kinase (JNK). It is intriguing that Crry costimulus enhanced p38 MAPK activation in T helper cell type 1 (Th1) but not in Th2 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2005 Dec 78(6) 1386-96",
                "id": "16301324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e071"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Ser(136) is thought to be phosphorylated by protein kinase B (PKB, also called Akt), which is activated when cells are exposed to agonists that stimulate phosphatidylinositol 3-kinase (PI3K)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2000 Jul 15 349(Pt 2) 547-57",
                "id": "10880354"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e056"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "ANGPTL3 bound to alpha(v)beta(3) and induced integrin alpha(v)beta(3)-dependent haptotactic endothelial cell adhesion and migration and stimulated signal transduction pathways characteristic for integrin activation, including phosphorylation of Akt, mitogen-activated protein kinase, and focal adhesion kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17281-90",
                "id": "11877390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e050"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Under stress, Akt underwent disulfide bond formation between Cys-297 and Cys-311 and dephosphorylation in accordance with an increased association with protein phosphatase 2A. Overexpression of GRX protected Akt from H2O2-induced oxidation and suppressed recruitment of protein phosphatase 2A to Akt, resulting in a sustained phosphorylation of Akt and inhibition of apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 12 278(50) 50226-33",
                "id": "14522978"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e049"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "the Jab1 binding site on S100A7 is necessary for the effect of S100A7 on NFKB, phospho-AKT and promotion of tumorigenesis in vivo the mechanism that results in activation of Akt is unknown but currently under investigation",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2004 6(4) 153-9",
                "id": "15217486"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e041"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "It has been shown that shear stress activates many Thr/Ser and Tyr kinases located in the cell membrane, focal adhesions, and cytoplasm. These kinases include focal adhesion kinase (FAK), c-Src, phosphatidylinositol 3-kinase (PI3K), myosin light chain kinase, Akt kinase, IB kinases, and receptor tyrosine kinase Flk-1.1925",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2002 Nov 1 91(9) 769-75",
                "id": "12411390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e00a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Mammalian expression vectors for the myc-tagged wild-type CHFR and the double mutant T39A and S205A (CHFR-TASA) were transiently transfected into HEK293 cells. Both proteins were efficiently detected with an antibody against myc epitope. The phosphospecific antibody recognized only the wild-type protein, indicating that it is phosphorylated on Thr 39 in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 Nov 1(13) 959-69",
                "id": "14638868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e007"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Finally, we demonstrated that CXCL5 mediates pancreatic cancer-derived angiogenesis through activation of several signaling pathways, including protein kinase B (Akt), extracellular signal-regulated kinase (ERK), and signal transducer and activator of transcription (STAT) in human endothelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2011 Mar 178(3) 1340-9",
                "id": "21356384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dff4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The inflammatory processes in CS-exposed lungs may be fueled through the potential cell survival activities provided by galectin-3 (lgals3) and osteopontin (opn/spp1) (Figs. 1 and 3, Table S8), which both function through activation of the antiapoptotic phosphatidyl inositol 3-kinase/protein kinase B (Akt) pathway (Lin and Yang-Yen, 2001Go; Oka et al., 2005Go; Zhu et al., 2005Go). ",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2006 Oct 93(2) 422-31",
                "id": "16870687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfd8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "observations that inhibition of PI3K or EGF-R is sufficient to prevent terminal differentiation in keratinocytes in suspension (Rodeck et al., 1997; Nikolopoulos et al., 2005), and that function disrupting antibodies to E-cadherin abrogate Akt phosphorylation inducing growth arrest and terminal differentiation in conventional submerged mouse keratinocyte cultures at confluency (Calautti et al., 2005).",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfd4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "cells expressing myrAkt maintained higher levels of transferrin receptor on the cell surface in the absence of IL3 than control cells these results indicate that transferrin receptor surface expression is regulated by IL3 and that myrAkt can support growth factor-independent transferrin receptor expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2002 Jul 13(7) 2276-88",
                "id": "12134068"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Although the precise mechanism of Cot regulation is not fully understood, a recent report by Kane et al. indicates that Akt (protein kinase B) up-regulates Cot activity by the phosphorylation of serine 400 at the carboxyl terminus (21).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 47089-97",
                "id": "12975377"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df9e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Jubilant: Expression of PTEN in both U87 MG and U373 MG resulted in the %reduction of BAD phosphorylation. expression of wild-type or substrate-trapping forms of PTEN in HEK293 cells altered the levels of the phospholipid products of phosphatidylinositol 3-kinase and ectopic expression of the phosphatase in PTEN-deficient tumor cell lines resulted in the inhibition of protein kinase (PK) B/Akt and regulation of cell survival.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Nov 10 95(23) 13513-8",
                "id": "9811831"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Coimmunoprecipitation analysis revealed that leptin promoted immune complex formation between Akt and the IkappaB kinase subunits as well as STAT-1alpha. Blocking the activity of Akt demonstrated a crucial role for Akt in translocation of STAT-1alpha and NF-kappaB to the nucleus and activation of the CD40 promoter. [CD40 mRNA and protein]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Sep 21 282(38) 27587-97",
                "id": "17660512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df79"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Inhibition of mTOR/S6K1 by rapamycin blunted insulin-induced Ser636/Ser639 phosphorylation of IRS-1, leading to a rapid (approximately 5 min) and persistent increase in IRS-1-associated phosphatidylinositol 3-kinase activity and Akt phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2005 Mar 146(3) 1473-81",
                "id": "15604215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df78"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "However, cells expressing the eNOS-S1179A mutant (disrupted Akt phosphorylation site) did not produce detectable NO in response to insulin, whereas the response to LPA was similar to that observed in cells expressing wild-type eNOS.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 10 276(32) 30392-8",
                "id": "11402048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df63"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Because ceramide up-regulated Txnip expression and reduced thioredoxin activity, we therefore investigated the effect of ceramide on ASK1 activity. The inhibitory residue serine 83 (Ser83) of ASK1 was dephosphorylated after ceramide treatment in both Jurkat T cells (Figure 5A) and 10I cells (Figure S2). This is consistent with the previous findings that Akt/PKB phosphorylates ASK1 Ser83,47 whereas ceramide inhibits Akt/PKB.4,6,48,49",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Apr 15 111(8) 4365-74",
                "id": "18270325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In all three groups of rats, insulin significantly increased ERK2, RSK2, Akt, and p70S6k activities",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1999 Jan 140(1) 106-11",
                "id": "9886813"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df58"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "IL-26 activates extracellular signal-related kinase (ERK)-1/2 and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) mitogen-activated protein (MAP) kinases, Akt and signal transducers and activators of transcription (STAT) 1/3.",
              "citation": {
                "type": "PubMed",
                "name": "Gut 2009 Sep 58(9) 1207-17",
                "id": "18483078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Consistent with the known role of the phosphoinositide 3-kinase (PI3K)/Akt/mTOR pathway in regulation of 4E-BP1, PKC signaling transiently inhibited PI3K activity and Akt phosphorylation in IEC-18 cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 May 11 282(19) 14213-25",
                "id": "17360714"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df55"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Reporter assays demonstrate that insulin suppresses the basal PGC-1 promoter activity and that coexpression of protein kinase (PK)-B mimics the effect of insulin in HepG2 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Mar 52(3) 642-9",
                "id": "12606503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df47"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In addition, anti-beta(3) integrin antibodies attenuated the activation of both the p42/44 MAPK and protein kinase B and the increase in fibronectin levels. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 15 277(46) 44187-94",
                "id": "12218048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df46"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Inhibition of PC activity and consequently alpha(v) cleavage inhibited the adhesion-dependent focal adhesion kinase(Y397)-autophosphorylation and subsequent Akt activation, whereas phosphorylation of extracellular signal-regulated kinase 1/2 was not affected.",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2004 Feb 17 109(6) 770-6",
                "id": "14970114"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df3d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PHA-665752 inhibited phosphorylation of several tyrosine residues in c-Met (Tyr(1003), Tyr(1230/1234/1235), and Tyr(1349)), blocked HGF-mediated activation of Akt and p44/42 mitogen-activated protein kinase, and prevented the adaptor molecule Gab1 from complexing with c-Met. ",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2004 Oct 1 10(19) 6686-94",
                "id": "15475459"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myeloid Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Indeed, activation of PKB in the absence of cytokines was sufficient to rescue cytokine-starved myrPKB:ER* cells from apoptosis, as measured by annexin V-FITC staining.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Feb 4 156(3) 531-42",
                "id": "11815629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df37"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In contrast, HepG2-CA-Akt/PKB cells showed an upregulation in the basal level of phosphorylated mTOR (Ser 2448) (ca. 40%)",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2007 Aug 23",
                "id": "17721885"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df36"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Protein kinase B phosphorylated recombinant bacterially expressed AMP-activated protein kinase heterotrimers at Ser(485) of the alpha1-subunits.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 3 281(9) 5335-40",
                "id": "16340011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "At the gene transcriptional level, both IL-6 and Stat3 mRNA levelswere up-regulated in response to MMP12 overexpression (Fig. 4C). Other intracellular oncogenic moleculeswere also analyzed (Supplementary Fig. S2). NFnB, extracellular signal-regulated kinase (ERK), p38, and AKT were all significantly activated in doxycycline-treated bitransgenic mice compared with untreated bitransgenic mice.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Sep 15 69(18) 7252-61",
                "id": "19706765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df2b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "activation of PI3K/AKT that directly phosphorylates and inactivates the proapoptotic function of Bax [86,87].  ",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "hese data indicate that Evi1 functions as a survival gene in intestinal epithelial cells and colon cancer cells, activating PI3K/AKT and conveying resistance to both physiological and therapeutic apoptotic stimuli.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Jun 15 25(25) 3565-75",
                "id": "16462766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df27"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "LOX metabolites 5-HETE and 12-HETE stimulate cancer growth through activation of p44/42 mitogen-activated protein kinase and PI3/Akt kinase pathways",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2002 Sep 1(11) 929-35",
                "id": "12481414"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df26"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Similarly, LAR+/+ neurons treated with LAR siRNA demonstrated decreased activation of Trk and AKT. ",
              "citation": {
                "type": "PubMed",
                "name": "J Neurobiol 2006 Nov 66(13) 1420-36",
                "id": "17013927"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "phosphorylation of AKT/mTOR kinases also results in increased translation of cyclin D1, D3, and E transcripts",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Nov 14 24(50) 7455-64",
                "id": "16288292"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df1e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Stimulation of cells using NGF or BDNF activates the anti-apoptotic protein Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2007 Jan 295(1-2) 19-26",
                "id": "16862449"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df13"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "HYAL2 becomes functionally active and consequently activates the Akt and mitogen-activated protein kinase pathways",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Apr 15 100(8) 4580-5",
                "id": "12676986"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Preclinical studies have shown that physiologically relevant concentrations of nicotine and its metabolite, the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), rapidly stimulate activation of Akt and mTOR in primary human bronchial and small airway epithelial cells, thereby promoting a partially transformed phenotype",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2007 Apr 1 13(7) 2281-9",
                "id": "17404113"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "IL-10 may potentiate GM-CSF-induced CCR1 protein expression in U937 cells via activation of PKB/Akt and p70(S6k).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 May 2 304(2) 417-24",
                "id": "12711332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407defc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Thus, in cardiomyocytes, as in skeletal muscle, FOXO3a activates an atrogene transcriptional program, which retards or prevents hypertrophy and is down-regulated by multiple physiological and pathological stimuli of myocyte growth.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 27 280(21) 20814-23",
                "id": "15781459"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407def4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Activation of C-MET enhances XIAP through the Akt pathway. XIAP up-regulation was shown to be correlated to colorectal cancer tumor progression. The Akt-XIAP pathway may be a potential molecular target for regulating colorectal cancer progression.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2005 Nov 1 11(21) 7621-8",
                "id": "16278380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dedb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PDK1 then activates protein kinase B (PKB) which, in turn, inactivates glycogen synthase kinase-3 (GSK3), leading to the dephosphorylation and activation of glycogen synthase and hence to an acceleration of glycogen synthesis",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1997 Jun 23 410(1) 3-10",
                "id": "9247112"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ded7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "activation of endogenous cGKI in primary aortic SMCs resulted in cells with increased levels of proliferation; increased levels of vascular cell adhesion molecule-1, peroxisome proliferator-activated receptor gamma, and phosphatidylinositol 3-kinase/Akt signaling; and decreased plasminogen activator inhibitor 1 mRNA",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Nov 11 100(23) 13519-24",
                "id": "14597716"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ded6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "we stimulated murine satellite cells (the C2C12 cell line) with SDF-1 and demonstrated the phosphorylation of p42/44 MAPK and AKT serine-threonine kinase in these cells.",
              "citation": {
                "type": "PubMed",
                "name": "Folia Histochem Cytobiol 2003 41(1) 13-21",
                "id": "12705474"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ded2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Satellite Cells, Skeletal Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "A main finding was that dexamethasone decreased expression of PKB and insulin-stimulated Ser(473) and Thr(308) phosphorylation in both muscles and adipocytes. ",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2008 Jun 1 474(1) 91-101",
                "id": "18328801"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407decb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Adipose Tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The antiapoptotic effect was reversed by inhibition of the PI3K/Akt pathway. Forkhead transcription factors (FOXO1, FOXO3a, FOXO4) exert proapoptotic effects and are phosphorylated and, thereby, inactivated by Akt.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2005 Jun 19(8) 974-6",
                "id": "15824087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dec7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Thrombin induces the activation of platelet serine/threonine kinase Akt. Akt activation is dependent on its phosphorylation at threonine 308 and serine 473. ",
              "citation": {
                "type": "PubMed",
                "name": "J Thromb Haemost 2007 Sep 19",
                "id": "17883592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dec6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "we performed an immunohistochemical analysis of the PI3K/Akt pathway in lung tissues derived from A/J mice treated with NNK. Active Akt and downstream components were detected in the normal bronchial epithelium, hyperplastic lesions, adenomas, and adenocarcinomas, with the most intense staining observed in adenocarcinomas.",
              "citation": {
                "type": "PubMed",
                "name": "Chest 2004 May 125(5 Suppl) 101S-2S",
                "id": "15136436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dec2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Moreover, AR gene silencing by siRNA or inhibition of AR biological activity by neutralizing antibodies and heparin prevents GPCR-induced EGFR tyrosine phosphorylation, downstream mitogenic signalling events, cell proliferation, migration and activation of the survival mediator Akt/PKB.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 May 15 22(10) 2411-21",
                "id": "12743035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407debe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "FSH-stimulated HIF-1 activity is inhibited by the PI 3-kinase inhibitor LY294002, the Rheb inhibitor FTI-277 (farnesyltransferase inhibitor-277), and the mTOR inhibitor rapamycin. These results show that FSH enhances HIF-1 activity downstream of the PI 3-kinase/AKT/Rheb/mTOR pathway in GCs and that HIF-1 activity is necessary for FSH to induce multiple follicular differentiation markers.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 7 279(19) 19431-40",
                "id": "14982927"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deb6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We show that Crry increases early TCR-dependent activation signals, including p56lck-, zeta-associated protein-70 (ZAP-70), Vav-1, Akt, and extracellular signal-regulated kinase (ERK) phosphorylation but also costimulation-dependent mitogen-activated protein kinases (MAPK), such as the stress-activated c-Jun N-terminal kinase (JNK). It is intriguing that Crry costimulus enhanced p38 MAPK activation in T helper cell type 1 (Th1) but not in Th2 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2005 Dec 78(6) 1386-96",
                "id": "16301324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dea6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Increases in the steady state production of mitochondrial derived H2O2, as a result of manganese superoxide dismutase (Sod2) overexpression, led to PTEN oxidation that was reversed by the coexpression of the H2O2-detoxifying enzyme catalase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 29 280(17) 16916-24",
                "id": "15701646"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de9e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PTEN counteracts Akt activation by dephosphorylating phosphatidylinositol-3,4,5-triphosphate (PIP3), the product of class I phosphoinositide-3-kinases (7, 9).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Apr 15 69(8) 3256-61",
                "id": "19351834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de94"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "On Myr-Akt expression (constitutively activated Akt), we have noticed a significant reduction in Bim expression (Fig. S5), and induction of FoxO3a phosphorylation and nuclear exclusion (Fig. 3D).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2008 Dec 30 105(52) 20840-5",
                "id": "19088189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de93"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "from full text Results - Data in Figure 5E and F clearly demonstrate that the knockdown of Par-4 provokes enhanced serum-activated phospho-Akt-Ser473 levels in A549 and 293 human cells, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Jul 24",
                "id": "18650932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de89"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The consequent autocrine TGF-beta signaling in response to glucose led to Akt-TOR pathway activation.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2009 Jul 17(1) 35-48",
                "id": "19619490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de87"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Stable transfection of H1299 NSCLC cells with Akt(DD), another constitutively active form of Akt, stimulated Akt-dependent signalling, as shown by increased expression of P-GSK3 (phosphorylated GSK3) (Figure 1C), and suppressed RA-induced RARB expression (Figure 1D). Together, these findings indicate that activation of Akt inhibits ligand-dependent activation of retinoid receptors.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 May 1 395(3) 653-62",
                "id": "16417524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The expression of active mAKT1 blocked the down-regulation of CKS2, HEC, UBE2C, and ZWINT genes (cell cycle-related, Fig. 7B); of RFC4 and TYMS genes (DNA replication and repair-related, Fig. 7B); and of HMGB2 and HIST1H4C  genes (chromatin-related, Fig. 7, B and C) induced by the anti-HER2 antibody.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 21 280(3) 2092-104",
                "id": "15504738"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de62"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The activation of PI 3-kinase lipid kinase and the downstream serine/threonine kinase, PKB/Akt, by insulin is critical for the translocation of GLUT4 to the plasma membrane and the increased glucose transport",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36045-51",
                "id": "12138086"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In addition, overexpression of a constitutively active protein kinase B increased p85alphaPI 3-K mRNA levels. These results indicate that the phosphatidylinositol 3-kinase/PKB/p70S6 kinase pathway is required for the stimulation by insulin of p85alphaPI 3-K gene expression in human muscle cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 26 274(48) 34005-10",
                "id": "10567366"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de58"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Angiotensin II induced activation of AKT in vascular smooth muscle cell. This activation was inhibited by PYK2 antisense oligonucleotides. Suggest that antisense oligonucleotide brings down regulation of PYK2 which itself brings inactivation of AKT 80% inhibition was observed.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 21902-6",
                "id": "11262415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de55"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Transgenic mice overexpressing a constitutively active mutant form of Akt1 displayed decreased phosphorylation of cardiac alpha-AMPK. Isolated neonatal cardiac myocytes infected with an adenovirus expressing constitutively active mutant forms of either Akt1 or Akt2 also suppressed AMPK phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39422-7",
                "id": "12890675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de3d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "ILK depletion and overexpression respectively decreased and increased the activation of its downstream substrate, PKB/Akt. The pharmacologic inhibition of Akt activity also increased SRF binding to the promoters of smooth muscle specific genes and increased expression of smooth muscle proteins, suggesting that ILK may exert its effects by regulating the activity of Akt. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Sep 19",
                "id": "18805960"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The up-regulation of IL-1R1 was associated with the second activation of Akt, which accelerated the phosphorylation of NF-kappaB p65 subunit.",
              "citation": {
                "type": "PubMed",
                "name": "J Hepatol 2004 Apr 40(4) 616-23",
                "id": "15030977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de36"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Based on these results, we conclude that SHP-2 is required for mediating PI3K/Akt activation, and the N-terminal SH2 domain is critically important for a \\\"positive\\\" role of SHP-2 in regulating PI3K pathway activation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Sep 20 20(42) 6018-25",
                "id": "11593409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "EphB4 stimulation by clustered EphrinB2/Fc, but not Fc alone, resulted in a significant increase in phosphorylated Akt levels at 20 minutes, with a further increase noted after stimulation of EphB4 for 60 minutes",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2006 Jul 169(1) 279-93",
                "id": "16816380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de27"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "TGFbeta-mediated phosphorylation of Akt at Ser-473 was inhibited by dominant-negative ILK and PI3K inhibitors, LY294002 and wortmannin. Treatment with TGFbeta stimulated induction of Akt and ILK kinase activity in HaCat control cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Apr 16 316(4) 997-1001",
                "id": "15044083"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The sentence (Jubilant) IL6 induced Akt activation was inhibited by bispecific EGFR/ERBB2 inhibitor.  is translated to Activation of ERBB2 (Homo sapiens) Protein by IL6 (Homo sapiens) Protein  The following edits have been made already none  Links Doc Sourcerer for 11196191 IL6 (Homo sapiens) Protein ERBB2",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Mar 1 61(5) 1862-8",
                "id": "11280739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de23"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "This pathway involves stimulation of phosphatidylinositol 3-kinase (PI3K) binding to insulin receptor substrate-1 and insulin receptor substrate-2, activation of PI3K and protein kinase B (AKT), and PI3K-dependent activation of cyclic nucleotide phosphodiesterase 3B, a cAMP-degrading enzyme.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 14 275(15) 11348-54",
                "id": "10753948"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de21"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In cells stably transfected with empty vector, AVP rapidly stimulated ERK, JNK, and p38 activity (Fig. 7A), similar to what we have previously reported (11). However, in both clones stably expressing myr-Akt, AVP-induced activation of JNK was completely blocked, and activation of p38 MAP kinases was significantly reduced (Fig. 7A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39830-8",
                "id": "12882977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddfc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Blocking ILK activity with a kinase-deficient mutant ILK (ILK-KD) inhibits NF-kappaB activation and sensitizes HER2/neu-transformed cells to TNF-alpha-induced apoptosis. Stable expression of ILK-KD in HER2/neu-transformed cells suppressed Akt phosphorylation and the expression of IkappaB kinase alpha and beta (IKKalpha and beta) at both the protein and mRNA levels upregulation of IKKalpha and IKKbeta by the ILK/Akt pathway",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 May 6 23(21) 3883-7",
                "id": "15021910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddf7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "These changes in the biology of PC-3 cells are associated with a decrease in the expression and activities of both matrix metalloproteinase (MMP)-2 and MMP-9 as well as decreases in AKT activation, cytosolic beta-catenin levels, T-cell factor transcription activity, and expression of Slug and Twist.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Nov 1 65(21) 9762-70",
                "id": "16266997"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dde5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We found that Akt phosphorylates Girdin in response to growth factors such as epidermal growth factor (EGF) in fibroblasts. Furthermore, phosphorylated Girdin accumulates at the leading edge of migrating cells, suggesting its role in Akt-dependent cell migration or tumor invasion.",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2006 Nov 1086 169-84",
                "id": "17185515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddd6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "down-regulation of GAK by small hairpin RNA has two pronounced effects on EGF receptor signaling: (i) the levels of receptor expression and tyrosine kinase activity go up by >50-fold; and (ii) the spectrum of downstream signaling is significantly changed. One very obvious result is a large increase in the levels of activated extracellular signal-regulated kinase 5 and Akt. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Jul 13 101(28) 10296-301",
                "id": "15240878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddd1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Our cellular and molecular dissection showed that the PDGF-BB/PDGFRbeta kinase axis promoted MM tumor growth and vessel sprouting by activating ERK1/2, AKT, and the transcription of MMEC-released proangiogenic factors, such as vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8)",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Aug 15 112(4) 1346-56",
                "id": "18524994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddb2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We have shown recently that DNA damage effector kinase Chk1 is phosphorylated in vitro by protein kinase B/Akt (PKB/Akt) on serine 280. Activation of Chk1 by DNA damage in vivo is suppressed in presence of activated PKB. In this study we show that Chk1 is phosphorylated by PKB in vivo, and that increased phosphorylation by PKB on serine 280 correlates with impairment of Chk1 activation by DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 May 3(5) 634-7",
                "id": "15107605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddaa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Serine-642 was identified as an Akt-dependent phosphorylation site. WEE1Hu kinase activity was not affected by serine-642 phosphorylation. We revealed that serine-642 phosphorylation promoted cytoplasmic localization of WEE1Hu. The nuclear-to-cytoplasmic translocation was mediated by phosphorylation-dependent WEE1Hu binding to 14-3-3theta but not 14-3-3beta or -sigma preventing Y15 phosphorylation of Cdc2 by WEE1. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jul 25(13) 5725-37",
                "id": "15964826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Mouse embryonic stem (ES) cells in which both copies of the PDK1 gene were disrupted were viable. In PDK1(-/-) ES cells, PKB, p70 S6 kinase and p90 Rsk were not activated by stimuli that induced strong activation in PDK1(+/+) cells.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2000 Apr 20 10(8) 439-48",
                "id": "10801415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd82"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Hence, we conclude that the induction of PAI-1 gene expression is cell adhesion dependent and is through PI-3 kinase and Akt activation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Commun Adhes 9(5-6) 239-47",
                "id": "12745435"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": " We show here that neither BAFF nor APRIL was able to induce STAT3 phosphorylation but did activate ERK1/2 and PI3K/Akt pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Apr 15 103(8) 3148-57",
                "id": "15070697"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd78"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "TGF-beta treatment significantly increased levels of p-Akt (activation) and p-FoxO3a (inactivation) in cultured MC.",
              "citation": {
                "type": "PubMed",
                "name": "J Am Soc Nephrol 2006 Dec 17(12) 3325-35",
                "id": "17082237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Under stress, Akt underwent disulfide bond formation between Cys-297 and Cys-311 and dephosphorylation in accordance with an increased association with protein phosphatase 2A. Overexpression of GRX protected Akt from H2O2-induced oxidation and suppressed recruitment of protein phosphatase 2A to Akt, resulting in a sustained phosphorylation of Akt and inhibition of apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 12 278(50) 50226-33",
                "id": "14522978"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd75"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Tryptic mass fingerprinting and phospho-specific antibodies showed that Ser466 and Ser483 of 14-3-3-affinity-purified PFK-2 were phosphorylated. 14-3-3 binding was abolished by selectively dephosphorylating Ser483, and 14-3-3 binding was restored when both Ser466 and Ser483 were phosphorylated with PKB, but not when Ser466 alone was phosphorylated by AMPK.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Jul 15 22(14) 3514-23",
                "id": "12853467"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "# Ariadne: In contrast, in Panc-1 cells  overexpressing RhoB-F, RhoB-GG, and RhoB-WT, the ability of IGF-1 to stimulate  AKT phosphorylation/activation was inhibited by 50% (.. 16%), 50% (.. 18%), and  65% (.. 15%), respectively. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 16 275(24) 17974-8",
                "id": "10770919"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We have recently identified anaplastic lymphoma kinase (ALK) as a tyrosine kinase receptor for pleiotrophin We reduced the endogenous ALK in glioblastoma cells by ribozyme targeting and demonstrated that this prevents pleiotrophin-stimulated phosphorylation of the anti-apoptotic protein Akt.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 19 277(16) 14153-8",
                "id": "11809760"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Time-dependent expression of PTPL1/FAP-1 in MCF7 cells completely abolished the survival action of insulin-like growth factor-I. This effect occurred through a highly significant reduction in phosphatidylinositol 3-kinase/Akt pathway activation (80% reduction in phosphatidylinositol 3-kinase activity, 55% inhibition of Akt activation) ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47861-9",
                "id": "12354757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd49"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In about 30% of the patients with acute myeloid leukemia, activating FLT3 receptor mutations have been identified, often as in-frame internal tandem duplications (ITD) at the juxtamembrane domain of the receptor. FLT3-ITD expression in Ba/F3 cells results in activation of Akt and concomitant phosphorylation of the Forkhead family member Foxo3a.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Apr 22 23(19) 3338-49",
                "id": "14981546"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd3e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Kinase activity was assessed in a kinetic study over 24 h, and actin was also immunoblotted as an internal loading control (Fig. 5A). Densitometry analysis was performed, and activities were presented as a fold increase above baseline (Fig. 5B). LPS rapidly induced activation of Akt and Erk1/2 within 15 min,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 8 277(45) 42808-14",
                "id": "12208854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd07"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Shear stress, via G proteins (Gs), can activate several signal transduction pathways, including the phosphoinoside 3-kinase (PI3K) and adenylate cyclase (AC) pathways, leading to eNOS activation via phosphorylation of serine residues (S617 and S1179 for Akt, and S635 and S1179 for PKA), which promote eNOS activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 May 15 117(Pt 12) 2427-9",
                "id": "15159447"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcf2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Recombinant active PKB/Akt phosphorylated recombinant 14-3-3zeta in an in vitro kinase assay. Transfection of active PKB/Akt into HEK293 cells resulted in phosphorylation of 14-3-3zeta. Based on a motif search of 14-3-3zeta, a potential PKB/Akt phosphorylation site, Ser-58, was mutated to alanine. PKB/Akt was unable to phosphorylate this mutant protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 14 277(24) 21639-42",
                "id": "11956222"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcf1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In vivo 32P labeling and mutagenesis demonstrated that m/p-PKBalpha activity was due to phosphorylation on Thr308 and Ser473, that are normally induced on PKB following stimulation of the cells with insulin or insulin-like growth factor-1 (IGF-1).... Following activation the kinase detached from the membrane and translocated to the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Dec 12 272(50) 31515-24",
                "id": "9395488"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt-dependent phosphorylation of Bad on Ser112 and Ser136 allows it to associate with 14-3-3 proteins and thereby suppresses its pro-apoptotic activity. Apoptotic kinases including JNK directly activate the cell death machinery by phosphorylating Bad at Serine 128 (Donovan et al., 2002Go). The phosphorylation of Bad at this residue disrupts the interaction of Bad with 14-3-3 proteins, thus allowing Bad to induce apoptosis (Konishi et al., 2002Go).",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 Dec 10 23(36) 11373-81",
                "id": "14673001"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dccb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Constitutively active Akt abolished UV-induced cytochrome c release and activation of caspases-9, -8, and -3. In cells infected with empty adenovirus, pretreatment with LY294002 substantially stimulated UV-induced cleavage of procaspase-8.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45737-45",
                "id": "12952968"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcbb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "we demonstrate that expression of CCR2 was functional in astrocytes and that signaling via this receptor lead to activation of NF-kB and Akt and was associated with increased astrocyte survival. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Neurosci 2008 Jan 37(1) 96-109",
                "id": "17949991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcb6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "These data demonstrate that Gi, but not Gq or G12/13, signaling pathways are required for activation of Akt in platelets, and Gi signaling pathways, stimulated by secreted ADP, play an essential role in the activation of Akt in platelets. his phosphorylation and activation of Akt were dramatically inhibited in the presence of AR-C69931MX, a P2Y12 receptor-selective antagonist,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 6 279(6) 4186-95",
                "id": "14623889"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Long term incubation with IL-6 has been shown to increase basal glucose transport in 3T3-L1 adipocytes, whereas acute stimulation had no effect IL-6 transiently (30-90 min) increased SOCS-3 expression in HepG2 cells and rat liver cells and that this was associated with an impaired effect of insulin to increase IRS-1 tyrosine phosphorylation, p85 binding, and downstream PKB/Akt phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45777-84",
                "id": "12952969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Intracellular Akt is associated with Hsp90 and Cdc37 in a complex in which Akt kinase is active and regulated by phosphatidylinositol 3-kinase. Antibodies-- Antibodies used were: Akt, P-Akt (Ser-473) Akt1 (D-17), Akt2 (D-17) Akt Activity Assay-- Kinase activity was assayed using a Cell Signaling Akt kinase kit",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39858-66",
                "id": "12176997"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc25"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Resveratrol effectively inhibits insulin-induced Akt and MAPK (mitogen-activated protein kinase) activation mainly through disruption of the interactions between insulin receptor substrates and its downstream binding proteins including p85 regulatory subunit of phosphoinositide 3-kinase and Grb2 (growth factor receptor-bound protein 2).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Aug 1 397(3) 519-27",
                "id": "16626303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc12"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The Akt activities were reduced by siRNA-mediated beta-catenin reduction, but the Wnt3a-induced immediate Akt activation was remained in cells reduced beta-catenin (Fig. 3B, right panel shows the quantification data) [19], indicating that Akt activation by Wnt3a-induced direct signaling occurs independently of beta-catenin as does the Wnt3a-induced ERK activation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Mar 19(3) 511-8",
                "id": "17011750"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbf9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "These results implicate galectin-8 as a modulator of cellular growth through up-regulation of p21. This process involves activation of JNK, which enhances the synthesis of p21, combined with the activation of PKB, which inhibits p21 degradation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 13 280(19) 19105-14",
                "id": "15753078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbf7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PKC mediates VEGF-induced Akt activation.  VEGF induced phosphorylation of PKC delta at Thr 505 in the activation loop, and this phosphorylation was inhibited by LY294002, suggesting that modulation of PKC delta activation by VEGF occurs distal to phosphatidylinositol 3'-kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Biol Int 2002 26(9) 751-9",
                "id": "12377207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "It activates phosphorylation of Shc, and p44/42 MAPK (mitogen activated protein kinase) in the ERK (extracellular regulated kinase) signaling pathway; PI3K (phosophatidyl inositol-3-kinase), AKT/protein kinase B, and p70S6kinase in the phosophatidyl inositol-3-kinase pathway; and focal adhesion kinase in the adhesion/motility pathway",
              "citation": {
                "type": "PubMed",
                "name": "Histol Histopathol 2003 Oct 18(4) 1275-88",
                "id": "12973694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dba5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Once activated by nicotine, Akt increased phosphorylation of multiple downstream components that control cellular cell cycle and protein translation, such as glycogen synthase kinase-3 (GSK- 3), binding protein for eukaryotic translation initiation factor 4E (4EBP-1), and ribosomal kinase p70S6K (Fig. 4) [50].",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Moreover, the combined treatment of C75 and Taxol inactivated the anti-apoptotic AKT (protein kinase B) kinase more than either agent alone, as evidenced by a synergistic down-regulation of AKT phosphorylation at its activating site Ser(473) without affecting AKT protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2005 May 20 115(1) 19-35",
                "id": "15657900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Further transfection experiments including expression of constitutively active and dominant-negative Akt and rapamycin treatment suggest that suppression of TGF-beta signaling/Smad3 activation by IGF-I occurs downstream of Akt and through mammalian target of rapamycin activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3 278(40) 38342-51",
                "id": "12876289"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e422"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Here, knockdown of endogenous BRCA1 caused about a 4-fold increase in c-Akt activity that was blocked by Wortmannin, suggesting that this increase in activity requires PI3K (Fig. 4DGo).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2007 Aug 21(8) 1905-23",
                "id": "17505062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e421"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2000 Dec 141(12) 4503-11",
                "id": "11108261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e419"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 1 277(44) 42344-51",
                "id": "12171920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e418"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The IRS family of substrates can interact with a number of SH2 domain proteins. Notable among these is the regulatory subunit of PI 3-kinase, which leads to the activation of PIP3-dependent protein kinases such as Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2001 Feb 23 104(4) 517-29",
                "id": "11239409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e416"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Overexpression of AND-34 in MCF-7 cells increased PI3K activity and augmented Akt Ser(473) phosphorylation and kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2005 Jan 3(1) 32-41",
                "id": "15671247"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e40a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We found that inhibition of PI3K activity by LY294002 decreased VEGF transcriptional activation and that forced expression of AKT completely reversed the inhibitory effect.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 29 279(44) 45643-51",
                "id": "15337760"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e401"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "RTK signaling potentiates GLI activity through PI3K-AKT-mediated GSK3 inactivation or RAS-STIL1-mediated SUFU inactivation, while GPCR signaling to Gs represses GLI activity through adenylate cyclase-mediated PKA activation",
              "citation": {
                "type": "PubMed",
                "name": "Curr Mol Med 2009 Sep 9(7) 873-86",
                "id": "19860666"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e400"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "AKT promotes the nuclear translocation of MDM2, thereby negatively regulating p53-mediated apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "However, the tyrosine phosphorylation of both the insulin receptor and IRS was enhanced (effect of pioglitazone).  Also, the downstream activation and serine phosphorylation of Akt/PKB were increased",
              "citation": {
                "type": "PubMed",
                "name": "Prostaglandins Leukot Essent Fatty Acids 2005 Jul 73(1) 65-75",
                "id": "15936183"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Investigation of multiple signaling pathways revealed that mitogen-induced phosphorylation and activation of AKT are inhibited in HIN-1-expressing cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Nov 1 65(21) 9659-69",
                "id": "16266985"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "One site, Ser(364), is conserved with c-Raf but two additional sites, Ser(428) and Thr(439), are unique to B-Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 1 275(35) 27354-9",
                "id": "10869359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3eb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Both Akt expression and serum treatment induced phosphorylation of Mdm2 at Ser186 ...Moreover, when Ser186 was replaced by Ala, Mdm2 became resistant to Akt enhancement of p53 ubiquitination and degradation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 14 277(24) 21843-50",
                "id": "11923280"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "acinus, a nuclear factor required for apoptotic chromatin condensation, is a direct target of Akt Akt phosphorylation of acinus on serine 422 and 573",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Oct 19 24(20) 3543-54",
                "id": "16177823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Overexpression of DN Akt blocked or reduced HGF-induced increase in Bcl-2, Egr-1, c-fos, ornithine decarboxylase, and COX-2 expression detected by the microarray (data not shown).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Apr 294(4) L778-86",
                "id": "18245266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Gene 33 inhibits EGFR autophosphorylation and specifically blunts epidermal growth factor (EGF)-induced activation and/or phosphorylation of Ras, ERK, JNK, Akt/PKB, and retinoblastoma protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2924-33",
                "id": "15556944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3db"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Tyrosine phosphorylation-dependent PI 3 kinase/Akt signal transduction regulates TGFbeta-induced fibronectin expression in mesangial cells. Inhibition of TGFbeta-induced Akt activity by adenovirus-mediated expression of a dominant-negative mutant of Akt abolished expression of fibronectin. Dominant-negative PI 3 kinase or dominant-negative Akt inhibited TGFbeta-induced fibronectin transcription.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Jan 16(1) 31-41",
                "id": "14607273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3da"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "RIP1 has been reported to activate NF-kB, which can activate Akt, and both of these can induce the pro-survival Mcl-1 gene (Meng et al., 2002; Schulze-Bergkamen et al., 2004; Francois et al., 2005; Kobayashi et al., 2005; Meylan and Tschopp, 2005; Festjens et al., 2007).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Oct 27 27(50) 6462-72",
                "id": "18955973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3d8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2000 Oct 15 96(8) 2856-61",
                "id": "11023522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Transfection with PTEN overexpressing vector significantly decreased activation of Akt (Fig. 1A) induced by TNF-alpha",
              "citation": {
                "type": "PubMed",
                "name": "Atherosclerosis 2010 Nov 213(1) 115-21",
                "id": "20864106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Moreover, the activity of Akt, a negative regulator of B-Raf, was decreased by calcium restriction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 24 279(39) 40419-30",
                "id": "15263001"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Under these circumstances, ceramide activated PKCzeta, leading to phosphorylation of the PKB-PH domain on Thr(34). This phosphorylation inhibited phosphatidylinositol 3,4,5-trisphosphate (PIP(3)) binding to PKB, thereby preventing activation of the kinase by insulin.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Nov 23(21) 7794-808",
                "id": "14560023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The association of ataxin-1 with 14-3-3 is regulated by Akt phosphorylation,",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2003 May 16 113(4) 457-68",
                "id": "12757707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Finally, it was shown that the tuberin/14-3-3zeta interaction is regulated by Akt-mediated phosphorylation of tuberin,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39417-24",
                "id": "12176984"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We provide evidence that Akt directly binds Grb10 and is able to phosphorylate Grb10 in an in vitro kinase assay",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 29 280(17) 16987-93",
                "id": "15722337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "here we show that PGC-1alpha binds and co-activates FOXO1 in a manner inhibited by Akt-mediated phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 May 29 423(6939) 550-5",
                "id": "12754525"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "SOCS1 augmented MEK phosphorylation and reduced Akt phosphorylation induced by IGF-I.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Mar 25 328(4) 953-61",
                "id": "15707970"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3b2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Sep 19(9) 6286-96",
                "id": "10454575"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3a6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The underlying mechanisms by which AdPTEN ameliorated arthritic symptoms involved at least antiangiogenic, antiproliferative, and antiinflammatory effects of PTEN via inhibition of the PI 3-kinase/Akt signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2008 Jun 58(6) 1650-6",
                "id": "18512785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3a2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We also show that Akt leads to the accumulation of nuclear SREBP-1 but not SREBP-2, and that activation of SREBP is required for Akt-induced activation of the FAS promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Sep 29 24(43) 6465-81",
                "id": "16007182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e39c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We propose that Akt phosphorylates beta-catenin, which results in 14-3-3zeta binding and stabilization of beta-catenin, and these interactions may be involved in stem cell development.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Oct 26 101(43) 15370-5",
                "id": "15492215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e396"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "CD2AP was required for early activation of anti-apoptotic phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular signal-regulated kinase 1/2 by TGF-beta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem. 2004 Aug 27;279(35):37004-12",
                "id": "15213232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e38f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "These data suggest that stimulation of glycogen synthase by insulin in HepG2 cells is mediated through the PI-3 kinase pathway by activating PKB and PP-1G and inactivating GSK-3beta.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2000 Aug 211(1-2) 123-36",
                "id": "11055555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e38c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PIP3 has been described as a downstream component of a wide range of receptors, including the c-Met receptor [5], the epidermal growth factor receptor family [6], fibroblast growth factor receptor [7], insulin growth factor receptor [8] and platelet-derived growth factor receptor",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2005 7(4) R394-401",
                "id": "15987444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e38a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The phosphoinositide 3-kinase (PI3K)/Akt pathway has been implicated previously in Bad phosphorylation. In response to IL-7, the PI3K/Akt pathway induced phosphorylation at Ser-136 and -155,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 9 279(28) 29160-6",
                "id": "15123689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e389"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Wild type as well as substrate-trapping DA forms of PTPepsilonM suppressed phosphorylation of IR downstream enzymes such as Akt, extracellular regulated kinase (ERK) and glycogen synthase kinase 3 (GSK3).",
              "citation": {
                "type": "PubMed",
                "name": "Zoolog Sci 2005 Feb 22(2) 169-75",
                "id": "15738637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e388"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Here, we show that Akt activation is diminished when p53 and 14-3-3 sigma is up-regulated in response to DNA damage. Evidence is provided that 14-3-3 sigma binds and inhibits Akt. In keeping with this concept, Akt-mediated cell survival is inhibited by 14-3-3 sigma.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Mar 15 66(6) 3096-105",
                "id": "16540659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e381"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "This reflects the ability of AMD 3100 to reduce the activation of extracellular signal-regulated kinases 1 and 2 and Akt, all of which are pathways downstream of CXCR4 that promote survival, proliferation, and migration.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Nov 11 100(23) 13513-8",
                "id": "14595012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e37f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Phosphorylation of FOXO4 (residues 11-213) by protein kinase B at Thr-28 and Ser-193 creates two 14-3-3 binding motifs.",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2003 Dec 30 42(51) 15264-72",
                "id": "14690436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e37d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Recent studies have identified a direct interaction of Akt with Smad3 that prevents Smad3 phosphorylation and Smad3 nuclear translocation, and inhibits both Smad3- mediated transcriptional events and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Mar 20 23(9) 2078-93",
                "id": "15774796"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e376"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Sep 25 98(20) 11598-603",
                "id": "11504915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e375"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PP1 treatment blocks EGF-induced activation of the anti-apoptotic protein kinase Akt suggesting that Src may regulate activation of Akt, perhaps by a Src --> c-Cbl --> phosphatidylinositol 3'-kinase --> Akt pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jul 12 277(28) 24967-75",
                "id": "11994282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e374"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "luteolin has beneficial effects against LPS-induced ALI in mice, and the attenuation of neutrophil chemotaxis and respiratory burst by luteolin involves the blockade of MEK-, ERK-, and Akt-related signaling cascades",
              "citation": {
                "type": "PubMed",
                "name": "Acta Pharmacol Sin 2010 Jul 31(7) 831-8",
                "id": "20562902"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e373"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Furthermore, mutation of S741 and S746, the two serine sites involved in negative regulation by PKC, led to increased mitogenic response and increased activation of PI3-kinase, as well as enhanced Akt activation, Bad phosphorylation and survival",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Oct 61(19-20) 2535-48",
                "id": "15526160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e370"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "platelet-derived growth factor-beta (PDGFbeta)-regulated genes; only T-cell death-associated gene 51 (TDAG51) was induced in both cases.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Genomics 2001 Dec 21 7(2) 105-14",
                "id": "11773597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e35a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Grx2 significantly activated the Ras/phosphoinositide 3-kinase/Akt/NF-kappaB cascade in parallel to the Jun N-terminal kinase (JNK)/AP1 cascade.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 21618-26",
                "id": "11290748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e354"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "phosphorylation of GSK3beta  at Ser9, which results in its inactivation (10), was higher in [wnt3a overexpressing] than in control cells (Fig. 1, A and B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 18 276(20) 17479-83",
                "id": "11278246"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e34d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2005 Nov 9(5) 663-73",
                "id": "16256741"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e343"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Together, this shows that Akt phosphorylates Miz1 at Ser 428 in vitro and that phosphorylation of Miz1 at Ser 428 is required for interaction with 14-3-3?.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2005 Jan 7(1) 30-41",
                "id": "15580267"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e33f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "This survival signal appears to be mediated by activation of the AKT, as detected by its phosphorylation in Ser473 upon CD53 ligation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Feb 27 22(8) 1219-24",
                "id": "12606948"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e33e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Site-specific phosphorylation of Akt declined and the levels of Gadd45, a DNA damage response protein, increased significantly as a consequence of elevated GPx-1 expression",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2004 Jul 15 37(2) 187-95",
                "id": "15203190"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e33c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Phosphorylation of Rac1 by Akt kinase was assayed with recombinant Rac1 protein and the fluorescein-labeled Rac1 peptide. It was shown that the Rac1 peptide and the recombinant protein were phosphorylated by the activated recombinant Akt kinase and the lysate of SK-MEL28 cells, a human melanoma cell line.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 7 275(1) 423-8",
                "id": "10617634"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e324"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Expression of wild-type (wt) Cbp remarkably suppressed EGF-induced activation of Src, ERK1/2, and Akt-1 enzymes, and NIH3T3 cell transformation, as well as colony formation of a breast cancer cell line (MDA-MB-468) in soft agar.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Sep 7 25(40) 5495-506",
                "id": "16636672"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e322"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Insulin stimulates Akt/PKB-mediated phosphorylation of PRAS40, which prevents its inhibition of mTORC1 in cells and in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2007 Mar 23 25(6) 903-15",
                "id": "17386266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e31f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We show that phosphorylation of B-Raf by Akt occurs at multiple residues within its amino-terminal regulatory domain, at both the conserved and unique phosphorylation sites. The alteration of the serine residues within the Akt consensus sites to alanines results in a progressive increase in enzymatic activity in vitro and in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 1 275(35) 27354-9",
                "id": "10869359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e31e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Activation of the PI3KAkt signalling pathway by TLRs4850 promotes cell survival, and TLR signalling has also been associated with the increased expression of the anti-apoptotic proteins Bcl-2-related protein A1 (BCL2A1), inhibitor of apoptosis 1 (cIAP1), cIAP2, XIAP and Bcl-2 family members51.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2009 Jan 9(1) 57-63",
                "id": "19052556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e31d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Lyn inhibited Akt/PKB",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1999 Jun 8 96(12) 6890-5",
                "id": "10359809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e30e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The protein product of the T-cell leukemia/lymphoma 1 (TCL1) oncogene was recently identified as a novel Akt kinase activator. Its crystal structure predicts regions most likely involved in protein-protein interactions, and complex formation is required for TCL1 to activate Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Biochem Cell Biol 2003 Dec 35(12) 1614-8",
                "id": "12962701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e30b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "activation of the PI3'K/Akt signaling pathway culminates in the phosphorylation of the BCL-2 family member BAD",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1997 Oct 17 91(2) 231-41",
                "id": "9346240"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e30a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The present study indicated that exposure of mouse epidermal Cl41 cells to either Ni(3)S(2) or NiCl(2) resulted in activation of phosphatidylinositol 3-kinase (PI-3K), Akt, and p70 S6 kinase (p70(S6k))",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Jan 1 64(1) 94-101",
                "id": "14729612"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e307"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 15 275(50) 39223-30",
                "id": "11010972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e305"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "we demonstrate that the E3 ligase activity of Mdm2 and phosphorylation of Mdm2 by Akt are essential for Mdm2 to affect AR ubiquitylation and degradation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Aug 1 21(15) 4037-48",
                "id": "12145204"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e304"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 28 276(52) 48997-9002",
                "id": "11585835"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e303"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In various cell types, AKT phosphorylates and inhibits glycogen synthase kinase-3 (GSK-3). Upon serum stimulation of EC, GSK-3beta was phosphorylated at Ser-9.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 22 277(12) 9684-9",
                "id": "11779850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We observed that LPS exposure results in phosphorylation of Akt (serine 473).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Apr 1 166(7) 4713-20",
                "id": "11254732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 24 278(4) 2228-35",
                "id": "12424252"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2f9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We also demonstrate that the PI3K effector Akt is required for Met-triggered Mdm2 upregulation, in addition to being necessary for the nuclear translocation of Mdm2.",
              "citation": {
                "type": "PubMed",
                "name": "Development 2007 Apr 134(7) 1443-51",
                "id": "17329361"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Second, mutation of threonine 509 in BRCA1, the site of Akt phosphorylation, to an alanine, attenuates the ability of heregulin to induce BRCA1 nuclear accumulation. ",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 May 15 313(9) 1735-44",
                "id": "17428466"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 2001 Mar 12(3) 129-35",
                "id": "11306513"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2001 Nov 142(11) 4852-60",
                "id": "11606453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2dd"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Addition of CHA, CGS 21680, and Compound 24 induced a concentration-dependent increase of pERK1/2, pp38, and pAkt, whereas Cl-IB-MECA was involved only in ERK1/2 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2010 Jan 30(1) 90-7",
                "id": "19834107"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Foam Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt phosphorylates MstI on the Thr(387) residue and protects MstI from apoptotic cleavage in vitro and in apoptotic cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Oct 19 282(42) 30836-44",
                "id": "17726016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "from full text - Figure 1 ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jul 35(1) 3-9",
                "id": "16484682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 5 278(36) 33753-62",
                "id": "12824193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2003 Jun 8(6) 515-23",
                "id": "12786942"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2bc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Moreover, stimulation of malignant cells with Epo-induced PI-4-phosphatase II transcription pointing this gene as an Epo-responsive gene. This study provides first insight for a physiological role of PI-4-phosphatase II in the proerythroblast by controlling Epo responsiveness through a negative regulation of the PI3K/Akt pathway.  PI-4-phosphatase II = INPP4B",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Mar 2 25(9) 1420-3",
                "id": "16247441"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2aa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PTEN expression rapidly reduced the activity of Akt, which was followed by a G(1) arrest and eventually apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jun 21(12) 3947-58",
                "id": "11359902"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Exposure of human bronchial epithelial cells (BEAS-2B) to nickel compounds induced the generation of ROS and activation of Akt that is associated with the activation of ASK1 and p38 mitogen-activated protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Chem Res Toxicol 2010 Mar 15 23(3) 568-77",
                "id": "20112989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e29c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "A/J mice treated with NNK showed phosphorylated Akt in airway epithelial cells, as well as in NNK-induced tumors (Figure 6b).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2003 Jan 111(1) 81-90",
                "id": "12511591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e299"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Recognition of tuberin by an alpha-14-3-3 binding site-specific antibody correlated with mitogen-induced phosphorylation of tuberin and recognition of tuberin by an alpha-Akt phosphorylation substrate antibody.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Nov 15 62(22) 6475-80",
                "id": "12438239"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e295"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2002 Mar 1 291(3) 628-34",
                "id": "11855836"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e294"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Here, we describe a protein partner for PKBalpha termed CTMP, or carboxyl-terminal modulator protein, that binds specifically to the carboxyl-terminal regulatory domain of PKBalpha at the plasma membrane. Binding of CTMP reduces the activity of PKBalpha by inhibiting phosphorylation on serine 473 and threonine 308.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2001 Oct 12 294(5541) 374-80",
                "id": "11598301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e28d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "APPL1 and TrkA co-immunoprecipitated in sympathetic neurons. Reduction of APPL1 or GIPC1 protein levels suppressed nerve growth factor (NGF)-dependent MEK, extracellular signal-regulated kinase, and Akt activation and neurite outgrowth in PC12 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Dec 26(23) 8928-41",
                "id": "17000777"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e287"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2002 Mar 43(3) 463-76",
                "id": "11893783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e285"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "n the presence of survival factors, Akt phosphorylates FKHRL1, leading to FKHRL1's association with 14-3-3 proteins and FKHRL1's retention in the cytoplasm.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1999 Mar 19 96(6) 857-68",
                "id": "10102273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e27e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "cbl-b overexpression markedly decreased the amplitude and duration of AKT activation upon EGF stimulation",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Mar 11 18(10) 1855-66",
                "id": "10086340"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e27d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "FOXN1 promoted early stages of terminal differentiation whereas Akt activation was sufficient to induce late stages",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Aug 15 117(Pt 18) 4157-68",
                "id": "15316080"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e274"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "TSC2 is also phosphorylated by Akt leading to its inactivation and consequently to increased mTOR activity.",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2006 Jan 30 94(2) 195-9",
                "id": "16404421"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e271"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "whereas Dexamethasone did not activate PI3K or AKT in the absence of GR, it readily induced AKT kinase activation after transfection with GR this suggests a DNA binding independent mechanism of activation",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Med 2003 Mar 81(3) 168-74",
                "id": "12682725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e24d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Matrigel invasion assays demonstrated that both overexpressed and endogenous ARK5 showed strong activity dependent on Akt. In addition, ARK5 expression induced activation of matrix metalloproteinase 2 (MMP-2) and MMP-9 following new expression of membrane type 1 MMP (MT1-MMP)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Apr 24(8) 3526-35",
                "id": "15060171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e22a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "peroxynitrite inhibited Akt signalling in PC12 cells (45), endothelial cells (4649), and Raw 264.7 macrophages (50).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e220"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "At a functional level, GATA3 knockdown inhibited angiopoietin (Ang)-1-mediated but not vascular endothelial cell growth factor (VEGF)-mediated AKT signaling, cell migration, survival, and tube formation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Oct 16 284(42) 29109-24",
                "id": "19674970"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e21e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Phosphatidylinositol 3,4,5-triphosphate is involved in the activation of the anti-apoptotic effector target, Akt.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 29 277(13) 11116-25",
                "id": "11799112"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e21d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 16 276(11) 8516-23",
                "id": "11116148"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e219"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "it was found that activation of the PI-3 kinase/ Akt pathway through enhanced growth factor signaling or inactivation of negative regulators including PTEN or TSC2 also increased HIF activity (Figure 2).5356",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2008 Apr 15(4) 678-85",
                "id": "18259193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e213"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We show that the type I neurotensin receptor-3 (also called sortilin) is the only known neurotensin receptor expressed in a murine microglial cell line and that its activation leads to phosphorylation of both extracellular signaling-regulated (Erk1/2) and Akt kinases.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci Res 2004 Oct 1 78(1) 92-9",
                "id": "15372498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e208"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Activation of the protein kinase B (Akt1) pathway is a necessary requirement for nicotinamide protection,",
              "citation": {
                "type": "PubMed",
                "name": "J Cereb Blood Flow Metab 2004 Jul 24(7) 728-43",
                "id": "15241181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e204"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2004 Jul 28 24(30) 6799-809",
                "id": "15282285"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1ff"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "we show that the Gas6-induced expression of SRA was mediated by the phosphatidylinositol 3-OH kinase (PI3-kinase)-serine/threonine kinase (Akt/protein kinase B [PKB]) pathway involving Akt phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2001 Oct 21(10) 1592-7",
                "id": "11597931"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "9381178;10949026",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1f7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "TSC2 is negatively regulated by Akt phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 22 277(47) 44593-6",
                "id": "12364343"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The oxidant response was also abrogated by specific inhibition of Akt/protein kinase B.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jan 6 281(1) 324-33",
                "id": "16230352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1ef"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Fluid shear stress elicited the phosphorylation and activation of Akt and eNOS as well as the tyrosine phosphorylation of Gab1 and its association with the p85 subunit of phosphatidylinositol 3-kinase and SHP2. ",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2005 Dec 9 97(12) 1236-44",
                "id": "16284184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Taken together, the translocation of PDK-1 from cytosol to the plasma membrane is critical for Akt and GSK-3 activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38863-9",
                "id": "12147684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1e6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "GSK-3 is also inhibited when it is phosphorylated by Akt, a downstream target of phosphatidylinositol 3-kinase (PI3K)",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Jul 15 169(2) 758-69",
                "id": "12097378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "MTOR complex 1 (mTORC1) phosphorylates S6K1, while mTOR complex 2 (mTORC2) phosphorylates Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Apr 14",
                "id": "18411301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Upon treating with group IIA PLA(2), Akt is phosphorylated in a PI3K-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Feb 15 170(4) 2093-9",
                "id": "12574380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "activated Akt was sufficient to maintain glucose uptake and surface Glut1",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2007 Apr 18(4) 1437-46",
                "id": "17301289"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1df"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The Ras effector Akt is known to regulate p27 mRNA abundance by phosphorylating and inactivating the FOXO transcription factors. Phosphorylated Akt and FOXO proteins were both increased in lung tumors, correlating with a reduction in p27 mRNA transcript. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2009 Oct 15 28(41) 3652-62",
                "id": "19648963"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1d6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "stimulation with FGF-2 also caused activation of Akt",
              "citation": {
                "type": "PubMed",
                "name": "Invest Ophthalmol Vis Sci 2003 Apr 44(4) 1521-8",
                "id": "12657588"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": " These data are consistent with PHLPP terminating Akt signaling by directly dephosphorylating and inactivating Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Apr 1 18(1) 13-24",
                "id": "15808505"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Thus, cardiac PI3Kgamma participates in two distinct signaling pathways: a kinase-dependent activity that controls PKB/Akt as well as MAPK phosphorylation and contributes to TAC-induced cardiac remodeling, and a kinase-independent activity that relies on protein interactions to regulate PDE3B activity and negatively modulates cardiac contractility.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Aug 6 118(3) 375-87",
                "id": "15294162"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1b9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Telmisartan induces adiponectin expression via PPARG activation [112], and adiponectin has been reported to induce angiogenesis [113]. Telmisartan-induced proliferation of human EPCs via PPARG-dependent PI3K/Akt signaling pathway [114]",
              "citation": {
                "type": "PubMed",
                "name": "PPAR Res 2010 2010",
                "id": "20814542"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "neutrophils predominantly migrated toward end target chemoattractants via p38 MAPK, whereas intermediary chemoattractant-induced migration was phosphoinositide 3-kinase (PI3K)/Akt dependent. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Oct 14 159(1) 91-102",
                "id": "12370241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Our study extend recent findings which implicate PDK1 in the activation of protein kinases B and C and p70(S6K)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 17 274(38) 27168-76",
                "id": "10480933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The Akt pathway, downstream of EGFR, is activated early in lung carcinogenesis [56].",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Agents Med Chem 2009 Sep 1",
                "id": "19663788"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Apr 15 164(8) 4286-91",
                "id": "10754327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "More importantly, PI3K-Akt signaling enhances AR activity and is involved in the induction of AR target genes, such as p21(WAF/CIP)",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2006 Jan 28(1) 245-51",
                "id": "16328002"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In vitro, DNA-PK phosphorylated PKB on Ser-473, resulting in a approximately 10-fold enhancement of PKB activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 24 279(39) 41189-96",
                "id": "15262962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Binding of IL-8 to CXCR1 (IL8RA) and -2 (IL8RB) activates protein kinase B (Akt)",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2004 Dec 56(4) 515-48",
                "id": "15602009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e198"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2003 Apr 9(4) 1274-83",
                "id": "12684395"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e197"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We found that KGF induced rapid activation of Akt, p70 S6K, JNK, and extracellular signal-regulated (ERK) ",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2005 Dec 46(12) 2624-35",
                "id": "16162944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e18d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Aug 22(16) 5962-74",
                "id": "12138205"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e18a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The treatment of NCI-N87 cells with EGF resulted in increases in phosphorylation of Erk1/2, Akt, and P38. Blockade of the Erk, phosphatidylinositol-3 kinase/Akt, or P38 pathways in this cell line",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2003 Mar 10 88(5) 796-802",
                "id": "12618892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e177"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jun 3 23(26) 4505-15",
                "id": "15048073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e16e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Jul 10(1) 151-62",
                "id": "12150915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e166"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "from Figure 2 caption",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2000 May 49(5) 677-83",
                "id": "10905472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e145"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "the src inhibitor PP1 abolished MAPK and Akt phosphorylation in all three clones",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2006 May 18(5) 729-39",
                "id": "16098714"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e11d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt physically associates with MDM2 and phosphorylates it at Ser166 and Ser186.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Nov 3(11) 973-82",
                "id": "11715018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e116"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PRMT1 methylated FOXO1 at conserved Arg248 and Arg250 within a consensus motif for Akt phosphorylation; this methylation directly blocked Akt-mediated phosphorylation of FOXO1 at Ser253 in vitro and in vivo. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2008 Oct 24 32(2) 221-31",
                "id": "18951090"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e108"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Furthermore, insulin-stimulated activation of Akt, but not mitogen-activated protein kinase, was diminished.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 3 274(49) 34795-802",
                "id": "10574950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0c9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 7 278(6) 3897-902",
                "id": "12458207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "NRG-1beta induced activation of both ERK and AKT in the hearts of control mice but not in those of DKO mice. ",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2007 Jul 2 117(7) 1771-1781",
                "id": "17571162"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0a3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Expression of dominant negative form of Rac1 in 293-TLR2 cells blocked Akt activation induced by Heat killed S.aureus (HKSA).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2000 Dec 1(6) 533-40",
                "id": "11101877"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In cardiac myocyte cultures, transduction with constitutively active Akt or treatment with IGF suppressed atrogin-1 mRNA expression, whereas transduction with FOXO3a stimulated its expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 27 280(21) 20814-23",
                "id": "15781459"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e094"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "To determine whether Akt phosphorylation of huntingtin at S421 occurs in cells, we cotransfected 293T cells with 480-17 or 480-68 with Akt c.a. or k.n.  We found that Akt c.a. induces a phosphorylation of huntingtin at S421 (Figure 2D), indicating that active Akt alone is sufficient to induce the phosphorylation of huntingtin at S421.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2002 Jun 2(6) 831-7",
                "id": "12062094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e091"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Bone morphogenetic protein-9 (BMP-9) gave a positive response in two independent assays: reducing phosphoenolpyruvate carboxykinase (PEPCK) expression in hepatocytes and activating Akt kinase in differentiated myotubes",
              "citation": {
                "type": "PubMed",
                "name": "Nat Biotechnol 2003 Mar 21(3) 294-301",
                "id": "12598908"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e090"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "HMGA1 silencing resulted in reduction in Akt kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "J Gastrointest Surg 2006 Nov 10(9) 1254-62; discussion 1263",
                "id": "17114012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e08d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Induction of SNT-1 PTB resulted in a significant decrease of FGF-1-dependent tyrosine phosphorylation of endogenous SNT-1, strong inhibition of complex formation between SNT-1, Gab-1 and Sos-1, and reduced activation of Ras, mitogen-activated protein kinase (MAP kinase), and Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Sep 28 25(44) 6003-14",
                "id": "16682955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e08b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Moreover, we find that activation of the PI3K/Akt pathway by insulin-like growth factor-1 alters Mdm2-mediated GRK2 degradation, leading to enhanced GRK2 stability and increased kinase levels.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Oct 18 25(20) 4752-4762",
                "id": "17006543"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e077"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e073"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Variant PKBCaaX has constitutive PKB activity and induces GCK and SREBP1 mRNAs",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Dec 15 376(Pt 3) 697-705",
                "id": "14505487"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e072"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "These results provide in vivo evidence supporting the hypothesis that loss of Pten and subsequent Akt activation result in the activation of several",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2006 Aug 208(2) 255-66",
                "id": "16688764"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e070"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "endometrium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "overexpression of S100A7 in MDA-MB-231 cell lines promotes survival under conditions of anchorage-independent growth. This effect is paralleled by increased activity of nuclear factor-kappaB (3-fold) and phospho-Akt (4-fold)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jul 1 65(13) 5696-702",
                "id": "15994944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e06e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Furthermore, the binding affinity of HNF-4 with phosphorylated FKHR significantly decreased in comparison to that with unphosphorylated FKHR.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 11 278(15) 13056-60",
                "id": "12519792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e06c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Oxidized low-density lipoprotein has been reported to inactivate telomerase by inhibiting the phosphoinositol 3-kinase/Akt pathway in vascular endothelial cells (31), thus inducing premature senescence (32).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2008 13 2971-9",
                "id": "17981770"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e061"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Nuclear exclusion of the forkhead transcription factor FOXO3a by protein kinase Akt contributes to cell survival.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Apr 16 117(2) 225-37",
                "id": "15084260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e060"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In previous work, PI3K and Akt activities were found to be elevated in the epidermis of BK5.IGF-1 transgenic mice compared to nontransgenic littermates.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2005 Oct 44(2) 137-45",
                "id": "16086373"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e052"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The phosphorylation of Rac1 inhibited its GTP-binding activity without any significant change in GTPase activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 7 275(1) 423-8",
                "id": "10617634"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e051"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2002 Dec 31 41(52) 15845-53",
                "id": "12501214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e04c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We found that KGF induces a dose- and time-dependent increase in Akt kinase activity and that, as expected, activation of Akt via KGF is PI3K dependent.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2005 Jan 288(1) L36-42",
                "id": "15347568"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e044"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Recently we identified a novel 250 kDa protein in adipocytes that is a substrate for the insulin-activated protein kinase Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2006 Oct 18(10) 1626-32",
                "id": "16490346"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e040"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Pubmed:gene: Receptor protein tyrosine phosphatase sigma inhibits axon regrowth in the adult injured CNS. paof(Ptprd)-|tissue repair; occursInTissue; neuron Finally, we show constitutively elevated activity of mitogen-activated protein kinase (MAPK) and Akt kinase in adult RPTPsigma (-/-) mice retinas,",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Neurosci 2005 Apr 28(4) 625-35",
                "id": "15797710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e03f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "from full text Results - From the data of Figure 5G, it is apparent that the lack of Par-4 leads to increased levels of phospho- Akt-Thr308, phospho-GSK3b and phospho-FOXO3",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Jul 24",
                "id": "18650932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e039"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "West et al. showed that activation of nAChR resulted in downstream activation of the Akt pathway (1), protein kinase C pathway, and the mitogen-activated protein kinase (MAPK) pathways, leading to inhibition of apoptosis and promotion of growth and proliferation in human bronchial epithelial cells (HBEC; refs. 1, 25).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 May 15 67(10) 4638-47",
                "id": "17510389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e030"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We have demonstrated that AKT, which is activated downstream from epidermal growth factor receptor signaling, phosphorylates beta-catenin at Ser552 in vitro and in vivo. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Apr 13 282(15) 11221-9",
                "id": "17287208"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e02e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2003 Mar 63(3) 690-8",
                "id": "12606779"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e02a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Fetuin knockout (KO) mice demonstrate increased basal and insulin-stimulated phosphorylation of IR and the downstream signaling molecules mitogen-activated protein kinase (MAPK) and Akt in liver and skeletal muscle.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2002 Aug 51(8) 2450-8",
                "id": "12145157"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e026"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13756-61",
                "id": "11278812"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e023"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Here we show that Akt/protein kinase B (PKB) interacts with and directly phosphorylates Skp2. We find that Skp2 phosphorylation by Akt triggers SCF complex formation and E3 ligase activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2009 Mar 8",
                "id": "19270694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e022"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "focal adhesion kinase/phosphatidylinositol 3-kinase/Akt/mTOR/4E-BP1 pathway",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Apr 15 100(8) 4766-71",
                "id": "12682293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e021"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Science 1998 Nov 13 282(5392) 1318-21",
                "id": "9812896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e01f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt phosphorylates caspase 9 at Ser-196 (Cardone et al. 1998). This phosphorylation event has functional consequences, as extracts from cell lines overexpressing Akt block cytochrome C-mediated caspase 9 activation in vitro (Cardone et al. 1998). In 293 cells Akt can suppress caspase 9-induced cell death in a manner that is partially dependent on the phopshorylation of Ser-196.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Nov 15 13(22) 2905-27",
                "id": "10579998"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e019"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The identification of p21Waf1/Cip1 and p27Kip1 as novel substrates of PKB provided new insights into mechanisms whereby hyperactivation of this lipid signaling pathway may lead to cell cycle deregulation in human cancers",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2(4) 339-45",
                "id": "12851486"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e018"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "we demonstrate that Akt phosphorylates the androgen receptor (AR) at Ser-210 and Ser-790.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Jun 19 98(13) 7200-5",
                "id": "11404460"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e017"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "beta1 integrins play an important role in cell proliferation and in some cancers and we report here that CD98hc enhances beta1 activation of signaling pathways such as FAK, Rac and Akt",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Jan 11 102(2) 355-60",
                "id": "15625115"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e009"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We now show that the regulation of E2F1 by TopBP1 involves the phosphoinositide 3-kinase (PI3K)-Akt signaling pathway, and is independent of pocket proteins. Akt phosphorylates TopBP1 in vitro and in vivo.... The Akt-dependent oligomerization is crucial for TopBP1 to interact with and repress E2F1.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Oct 18 25(20) 4795-807",
                "id": "17006541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e008"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Aug 15 366(Pt 1) 289-97",
                "id": "12027802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e004"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "a-ATX, an a3/a4 agonist (27), increased Akt activation in H157 and H1703 cells within minutes.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2005 Jul 26(7) 1182-95",
                "id": "15790591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Oct 12(4) 889-901",
                "id": "14580340"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dffc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Reexpression of PTEN or treatment with the PI3K inhibitor LY294002 abolished the levels of both PtdIns(3, 4)P2 and PtdIns(3,4,5)P3, reduced phosphorylation of PKB on Thr308 and Ser473, and inhibited PKB activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Sep 20(18) 6860-71",
                "id": "10958682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dff9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Importantly, MAGI3 and PTEN/MMAC cooperate to modulate the kinase activity of AKT/PKB.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jul 14 275(28) 21477-85",
                "id": "10748157"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dff7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Phosphatidylinositol-3,4,5-triphosphate recruits proteins containing pleckstrin homology domains, such as phosphatidylinositol-dependent protein kinase and Akt/ protein kinase B (PKB), to the plasma membrane where they are activated.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 351-6",
                "id": "15294054"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dff6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Consistent with this, the ability of infused insulin to cause IRS-1 tyrosine phosphorylation was reduced by approx50% in MKO animals (P = 0.005), and Akt activation (as measured by phosphorylation of Akt serine 473) was similarly reduced (P = 0.0006).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2003 Dec 9(12) 1491-7",
                "id": "14625542"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfee"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 16 276(7) 5116-22",
                "id": "11084019"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfed"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Gas6, through its receptors, activates PI3K and Akt and stimulates tyrosine phosphorylation of the beta3 integrin, thereby amplifying outside-in signaling via alphaIIbbeta3.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2005 Feb 115(2) 237-46",
                "id": "15650770"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfe9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 4 278(14) 12361-6",
                "id": "12517744"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfe5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Overexpression of Gab2 enhanced the phosphorylation state of Akt, but not of ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 May 1 103(9) 3305-12",
                "id": "14656892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfe0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1999 Sep 2 401(6748) 82-5",
                "id": "10485710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfc6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "inhibition of LPAAT-beta inhibits signaling in both the Ras/Raf/Erk and PI3K/Akt pathway",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2003 Oct 2(10) 1067-78",
                "id": "14578472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfc5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2001 Mar 1 21(5) 1464-72",
                "id": "11222636"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfbc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Oct 12(4) 889-901",
                "id": "14580340"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfb9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "GSK-3 is also inhibited when it is phosphorylated by Akt, a downstream target of phosphatidylinositol 3-kinase (PI3K)",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Jul 15 169(2) 758-69",
                "id": "12097378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfb6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Rosso et al190 demonstrated that EPCs from diabetic donors undergo premature senescence and that activation of the Akt signaling pathway is essential for such senescence to occur.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Jan 5 100(1) 15-26",
                "id": "17204661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "endothelial progenitor cell"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt negatively regulates translation of the Elk-1 mRNA",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Aug 28 22(36) 5554-61",
                "id": "12944902"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfa4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Exposure of HBE1 cells to DETA NONOate also inhibited Akt phosphorylation after 24h. {But not at earlier timepoints]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jun 27 283(26) 17919-28",
                "id": "18424783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfa3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Fetuin knockout (KO) mice demonstrate increased basal and insulin-stimulated phosphorylation of IR and the downstream signaling molecules mitogen-activated protein kinase (MAPK) and Akt in liver and skeletal muscle.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2002 Aug 51(8) 2450-8",
                "id": "12145157"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df9c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Using both adenoviral vectors and a cell line permanently expressing constitutively active myristoylated Akt (myrAkt), we show that activation of Akt, which is downstream of PI3K, increases VEGF expression in vitro and increases angiogenesis in a Matrigel plug assay",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2004 Nov 15(11) 4841-53",
                "id": "15342781"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "p21WAF1 expression was markedly increased in K179M-10 cells after NGF treatment compared to that in parental PC12 cells, while barely detectable levels of protein were expessed in Akt-116 cells. These results suggested that Akt blocked the NGF-induced increase of p21WAF1 protein expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2001 Jan 114(Pt 1) 81-88",
                "id": "11112692"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df96"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "This reflects the ability of AMD 3100 to reduce the activation of extracellular signal-regulated kinases 1 and 2 and Akt, all of which are pathways downstream of CXCR4 that promote survival, proliferation, and migration.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Nov 11 100(23) 13513-8",
                "id": "14595012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df94"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2002 Oct 8(10) 1145-52",
                "id": "12244301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "EGF stimulation of Akt kinase activity blocked Fas-induced apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 18 274(25) 17612-8",
                "id": "10364198"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df8a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "SU11274 also inhibited reactive oxygen species formation and phosphorylation of c-Met receptor, AKT and S-6 kinase by the hepatocyte growth factor.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2007 Apr 1 13(7) 2246-53",
                "id": "17404109"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In vivo inhibition of Akt blocked insulin stimulation of phospho-Akt translocation and blunted insulin-mediated activation of complex V.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2009 Jun 46(6) 919-26",
                "id": "19249309"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df7d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 15 277(46) 43623-30",
                "id": "12218049"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df7c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "This effect of Skp2 requires Akt-specific phosphorylation of FOXO1 at Ser-256.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Feb 1 102(5) 1649-54",
                "id": "15668399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PKB phosphorylated GSK3a at Ser-21",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Soc Trans 2001 May 29(Pt 2) 1-14",
                "id": "11356119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df43"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Upstream proteins known to phosphorylate BAD include Akt, extracellular signal-regulated kinase/mitogen-activated protein kinase (Erk/ MAPK), Pim-1 and Pim-2.",
              "citation": {
                "type": "PubMed",
                "name": "Br J Haematol 2006 Sep 134(5) 500-9",
                "id": "16869825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df42"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "At the molecular level, fenofibrate markedly decreased basic fibroblast growth factor-induced Akt activation and cyclooxygenase 2 gene expression",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2003 Apr 60(4) 810-9",
                "id": "12785728"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df16"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Feb 21(3) 893-901",
                "id": "11154276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df14"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 15 277(7) 4932-44",
                "id": "11733515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407def5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In addition, Fhit inhibited activity of Akt, a key effector in the phosphatidylinositol 3-OH kinase (PI3K) pathway",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 May 11 25(20) 2860-72",
                "id": "16407838"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dee1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Upon its activation downstream of PI(3)K, Akt phosphorylates and inactivates GSK-3, decreasing the rate of phosphorylation of glycogen synthase, thus increasing its activity state59.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407debb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "AKT is tyrosine phosphorylated in cells stimulated with TPO.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Jun 1 105(11) 4258-63",
                "id": "15705785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deb9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hematopoietic",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Under normal growth conditions, blocking PI3K/Akt signals by LY294002 causes LNCaP cell arrest in G1 phase rather than apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Sep 30 280(39) 33558-65",
                "id": "16061480"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deb5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt/PKB activation requires the phosphorylation of Thr308",
              "citation": {
                "type": "PubMed",
                "name": "Science 2005 Feb 18 307(5712) 1098-101",
                "id": "15718470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PKC controls BAFF-mediated activation of Akt. In addition to PKC translocation to the plasma membrane, BAFF promotes the association of PKC with Akt (Fig. 6 B). This association does not depend on PI3K activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2006 Oct 30 203(11) 2551-62",
                "id": "17060474"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de84"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Phosphoinositide-dependent protein kinase-1 (PDK-1), also downstream of PI3K, mediates activation of atypical PKC isoforms and Akt",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Aug 52(8) 1935-42",
                "id": "12882908"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 32274-8",
                "id": "10542266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de80"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 May 1 21(9) 2263-71",
                "id": "11980723"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "the activation of ARK5 is triggered by Akt",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Sep 18 22(40) 6177-82",
                "id": "13679856"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "rHDL administration decreased hepatic TNFalpha, LBP, iNOS, and caveolin-1 expression, restored hepatic eNOS and Akt activity",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2007 Dec 46(6) 1893-906",
                "id": "17918268"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de77"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Suppression of Akt signaling increased the activity of c-Jun N-terminal kinase, and transduction of dominant-negative c-Jun inhibited FasL induction under these conditions.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jan 22(2) 680-91",
                "id": "11756562"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "This study shows that Akt binds to and increases the activity of IKKalpha and thereby increases p52 production in cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jun 16 281(24) 16473-81",
                "id": "16613850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de69"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Pretreatment of cells with LY294002, a pharmacologic inhibitor of PI3K or transfection with the kinase-dead mutant Akt abrogated the SIN-1-induced Nrf2 activation",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2006 Oct 1 41(7) 1079-91",
                "id": "16962933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de5d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt1 is bound, phosphorylated, and activated by PDK1",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2004 Aug 3 2004(244) re11",
                "id": "15292521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Hypoxia results in energy starvation and activation of the AMPK/TSC2/Rheb/mTOR pathway",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Feb 17 21(4) 521-31",
                "id": "16483933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de5a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "importantly, PKCalpha-dependent suppression of apoptosis correlated with its ability of activating endogenous AKT",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Another PI3K effector, the cell survival protein Akt, displayed increased activity in T19N cells, which did not express active RhoA, compared with TRAMP and Q63L cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 May 1 62(9) 2630-6",
                "id": "11980660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de4a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PEA-15 is a phosphoprotein containing a serine 104 residue phosphorylated by PKC and a serine 116 residue phosphorylated by Cam Kinase II or AKT.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 May 26",
                "id": "15916534"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de46"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Tese results indicate that HIMF enhances angiogenesis by promoting proliferation and migration of endothelial cells via activation of the PI-3K/Akt pathways",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2006 Nov 1 312(18) 3559-69",
                "id": "16982054"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de41"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "FOXN1 promoted early stages of terminal differentiation whereas Akt activation was sufficient to induce late stages",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Aug 15 117(Pt 18) 4157-68",
                "id": "15316080"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Silencing Spry2 in this context resulted in increased apoptosis, associated with decreased Akt activation and decreased phosphorylation of HDM2 at Ser-166, which has been shown to stabilize HDM2. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jan 9 284(2) 848-54",
                "id": "19008219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Similarly, Akt can block p53 activation by potentiating Mdm2, whereas activated p53 can tune down Akt in several different ways.",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2002 Nov 973 374-83",
                "id": "12485897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Results show that active AKT directly phosphorylates Bax in vitro (Fig. 3C). Furthermore, active AKT can also directly phosphorylate recombinant Bax protein (Fig. 3D).  ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 18 280(11) 10781-9",
                "id": "15642728"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de1a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Incubation of cells with 100 nM of insulin increased the Akt activity by 4-fold and when preincubated with 50 mM of glucosamine for 3 and 6 hour decreased the insulin stimulated Akt activity by 15 and 50%, indicating that activation of alpha-p85 PI3K by insulin increased the activation of Akt which showed a correlation with the glucose uptake.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Nov 25 100(24) 14297-302",
                "id": "14610276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de16"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "the phosphorylation of Raf-1 on Ser-259 induced by paclitaxel he region surrounding Ser-259 in Raf-1 conforms to a consensus sequence for phosphorylation by Akt",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 6 277(36) 33490-500",
                "id": "12087097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de13"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 28 275(17) 12889-95",
                "id": "10777587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de10"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "activation of protein kinase B (PKB; also known as Akt) in heart was found to cause decreased Thr172 phosphorylation of AMPK",
              "citation": {
                "type": "PubMed",
                "name": "Trends Biochem Sci 2004 Jan 29(1) 18-24",
                "id": "14729328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de08"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "cardiac muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Constitutive activation of Akt in human vascular endothelial cells not only leads to cellular senescence but also to vascular dysfunction, such as impairment of angiogenesis and an increase of inflammation. 186",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Jan 5 100(1) 15-26",
                "id": "17204661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt regulates intracellular ATP level and demonstrate that Akt is a negative regulator of the AMP-activated protein kinase (AMPK), which is an activator of TSC2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Sep 16 280(37) 32081-9",
                "id": "16027121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de01"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Thus, p38alpha-induced re-localization of PP2A to caveolae can lead to dephosphorylation and inhibition of Akt, which in turn would contribute to the decreased survival observed in wild type cells",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Jan 19(1) 62-74",
                "id": "16844343"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddff"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "fibers and lamellipodia. Akt phosphorylates serine at position 1416 in Girdin, and phosphorylated Girdin accumulates at the leading edge of migrating cells.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2005 Sep 9(3) 389-402",
                "id": "16139227"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddfb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "APPL-mediated suppression of AR transactivation is dependent on the PI3K/Akt pathway. We also observed that APPL could further enhance the Akt-mediated suppression of AR transactivation and AR target gene using the reporter gene and Northern blot assay.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 9 278(19) 16820-7",
                "id": "12621049"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddfa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In pVHL-deficient renal cell carcinoma cells, PI3K inhibition by LY294002 and wortmannin or transfection of either a dominant negative PI3K or a kinase-dead Akt mutant substantially lowered constitutively expressed HIF-1alpha without altering HIF-1alpha mRNA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 2 279(14) 13506-13",
                "id": "14726529"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddf6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PMID: 14769947",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2004 Sep 5(9) 901-5",
                "id": "15309026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddf5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Plasminogen, fibrinogen, and P2-C suppressed apoptosis via activation of Akt and ERK1/2 kinases, while angiostatin and P1 failed to activate these prosurvival pathways and did not prevent neutrophil apoptosis. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2008 Sep 1 181(5) 3609-19",
                "id": "18714035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddf3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PED/PEA-15 was phosphorylated by Akt Akt phosphorylation of PED/PEA-15 occurred mainly at Ser(116). PED/PEA-15 specifically bound Akt, independently of Akt activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jul 23(13) 4511-21",
                "id": "12808093"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddf2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 25 277(4) 2573-8",
                "id": "11707464"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Differential inhibition of signaling pathways suggested that FGF-1 stimulates apoE synthesis via the phosphoinositide 3-OH kinase for PI3K/Akt pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2005 Apr 46(4) 679-86",
                "id": "15627653"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dded"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Amphiregulin treatment enhanced the activation of Akt and Erk in lung epithelial cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2010 Feb 298(2) L131-8",
                "id": "19915156"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddeb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Interestingly, insulin injection of wild-type mice, which activates PKB (protein kinase B) and inhibits GSK3 to a greater degree than feeding (50% versus 25%), does not repress these genes.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Dec 15 392(Pt 3) 633-9",
                "id": "16176184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddea"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jul 1 62(13) 3729-35",
                "id": "12097282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dde7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "9829964;7958915;11969286;8887554;15733869;12356771;9687510;9528766",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dddf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Inhibition of Akt by dominant-negative Akt suppressed atorvastatin-induced nNOS {protein} expression as well as Akt and NF-kappaB activation {RelA nuclear localization}.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2007 Jan 27(1) 92-8",
                "id": "17082483"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddd7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Phosphorylation of Akt is regulated positively by Btk and Syk and negatively by Lyn. Akt in turn can regulate positively the transcriptional activity of interleukin (IL)-2 and tumor necrosis factor (TNF)-alpha promoters.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2000 Sep 4 192(5) 729-40",
                "id": "10974038"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddd3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "It was found that the inhibition of Akt, mediated by K10 expression, leads to impaired NF-kappa B activity. This appears to occur through the decreased expression of IKK beta and IKK gamma. Remarkably, increased production of tumor necrosis factor alpha and concomitant JNK activation was observed in the epidermis of these transgenic mice.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 11 278(15) 13422-30",
                "id": "12566451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddcb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 7 278(6) 3897-902",
                "id": "12458207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddc9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Upon polyubiquitination, FOXO proteins are degraded by proteolysis through the proteasome pathway (Vogt et al., 2005). Phosphorylation by Akt at serine 256 in FOXO1 creates a binding site forSkp2 , the substrate-binding component of the Skp1/culin 1/F-box protein (SCFSkp2) E3 ligase complex (Matsuzaki et al., 2003; Huang et al., 2005).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2312-9",
                "id": "18391973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddc2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In contrast, phosphorylation of AKT substrate 160kDa (AS160) at T642, which is essential for 14-3-3 recruitment and GLUT4 translocation, was reduced by 50% in basal and insulin-stimulated cells and this was mirrored by decreased 14-3-3 association. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2009 Apr 10 302(1) 33-40",
                "id": "19013499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddc1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Loss of DEPTOR activates S6K1, Akt, and SGK1, promotes cell growth and survival, and activates mTORC1 and mTORC2 kinase activities. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2009 May 29 137(5) 873-86",
                "id": "19446321"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddbc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "from full text - The EGFR (HER1) is part of a bigger family of transmembrane receptors, including HER2, HER3, and HER4. They activate the MAPK and the PI3K/PKB signaling pathways (17)",
              "citation": {
                "type": "PubMed",
                "name": "Ann Thorac Cardiovasc Surg 2009 Aug 15(4) 213-20",
                "id": "19763051"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddaf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "cells expressing constitutively active Akt exhibited reduced cell-cell adhesion, increased motility on fibronectin-coated surfaces, and increased invasiveness in animals",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 May 1 63(9) 2172-8",
                "id": "12727836"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dda6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Mar 15 60(6) 1541-5",
                "id": "10749120"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Oct 15 16(20) 6151-61",
                "id": "9321394"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd92"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We also found that IRS-1 protein levels and IRS-1 phosphorylation states were decreased in fat and muscle from hyper-resistinemic animals and that IRS-2 protein levels and IRS-2 phosphorylation states as well as Akt activity were markedly decreased in all three tissues.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2004 Jul 114(2) 224-31",
                "id": "15254589"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd8e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": ".Transgenic mice that express a mutant, constitutively active form of Akt1 in cardiac muscle have hypertrophic hearts [25]. Expression of an activated form of Akt1 in skeletal muscle cells is sufficient to induce hypertrophy [6,17,26].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2003 Aug 9(8) 344-50",
                "id": "12928036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd55"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "It has a putative Akt phosphorylation motif at amino acids 595-600, and Ser(600) was found to be phosphorylated by active Akt resulting in the activation of kinase activity toward the SAMS peptide, a consensus AMPK substrate.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 3 278(1) 48-53",
                "id": "12409306"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd51"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Here we show that TRB3, a mammalian homolog of Drosophila tribbles, functions as a negative modulator of Akt. TRB3 expression is induced in liver under fasting conditions, and TRB3 disrupts insulin signaling by binding directly to Akt and blocking activation of the kinase. ",
              "citation": {
                "type": "PubMed",
                "name": "Science 2003 Jun 6 300(5625) 1574-7",
                "id": "12791994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd4b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Mar 27 98(7) 3690-4",
                "id": "11274386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd4a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "the activation of extracellular signal-regulated kinase was inhibited by Y356F and was significantly reduced by Y327F. Both mutations significantly impaired Akt phosphorylation. Interestingly, both mutations did not affect the kinase activity of NOK.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Dec 1 65(23) 10838-46",
                "id": "16322230"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd34"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Dec 1 117(Pt 25) 5985-93",
                "id": "15546921"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd2a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Fig. 7. Akt is activated by IL-6, and active Akt directly phosphorylates Bax in vitro. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2009 Jul 297(1) L6-16",
                "id": "19376889"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd25"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "higher activities of PDK1 and Akt but not PI3-K in cav-1-stimulated cells compared to control cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Dec 23(24) 9389-404",
                "id": "14645548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We upregulated Akt activity using two experimental models: treatment with a protein phosphatase inhibitor, okadaic acid",
              "citation": {
                "type": "PubMed",
                "name": "Neuroscience 2004 127(3) 649-58",
                "id": "15283964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The growth factor-activated AGC protein kinases RSK, S6K, PKB, MSK and SGK are activated by serine/threonine phosphorylation in the activation loop and in the hydrophobic motif, C-terminal to the kinase domain. In some of these kinases, phosphorylation of the hydrophobic motif creates a specific docking site that recruits and activates PDK1, which then phosphorylates the activation loop.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Oct 15 21(20) 5396-407",
                "id": "12374740"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd17"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We also found that HER2/neu engages Akt to regulate WT1 levels since inhibition of Akt reduced WT1 levels.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Feb 24 24(9) 1648-52",
                "id": "15674342"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd15"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "IL-18 induced CXCL16 expression via a MyD88 --> IRAK1-IRAK4-TRAF6 (tumor necrosis factor receptor-associated factor 6) --> c-Src--> PI3K --> Akt --> JNK --> AP-1 pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 11",
                "id": "15890643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd14"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "suppresses its methyltransferase activity",
              "citation": {
                "type": "PubMed",
                "name": "Science 2005 Oct 14 310(5746) 306-10",
                "id": "16224021"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Treatment of Balb 3T3 cells with IL-1beta activated two signaling pathways, Erk and Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2003 Dec 23(6) 1727-31",
                "id": "14612947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcfa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "the outcome of RAGE stimulation by S100B or by S100A6 differs: while S100B activates PI3/AKT kinase and NF-?B, S100A6 selectively activates JNK pathway, despite the fact both ligands are structurally identical and belong to the same calciumbinding polypeptide superfamily (52)",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 1403-13",
                "id": "19273137"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dceb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2004 Jun 145(6) 2845-57",
                "id": "15001544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcea"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Additionally, rosiglitazone increased IRS-1 and IRS-2 levels, thereby enhancing insulin effects on IRS-1- and IRS-2-dependent PI3K and downstream signaling factors PKC-lambda and protein kinase B",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2002 May 143(5) 1705-16",
                "id": "11956152"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dce9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Moreover, LY294002, but not PD98059, inhibited the PSA and AR suppression effect by EGF in concurrence with the suppression of phosphorylation levels of Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Mar 31 342(1) 92-100",
                "id": "16472761"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dce8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Transfection of the dominant negative Akt-K178A vector led to a 75% reduction in VEGF promoter activity in Hct116 cells and 60% in LoVo cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Aug 15 61(16) 6050-4",
                "id": "11507052"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dce6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 May 21(10) 3534-46",
                "id": "11313479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dce4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Using newly developed phosphospecific antibodies to p300 (pSer(1834)), and site-directed mutant proteins, we find that suberoylanilide hydroxamic acid stimulates Akt activity, which is required to phosphorylate p300 at Ser(1834).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 20 281(42) 31359-68",
                "id": "16926151"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dce1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Nov 15 63(22) 7708-16",
                "id": "14633695"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcd3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Cells expressing SPARC display increased AKT activation with decreased caspase 3/7 activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 10 279(50) 52200-9",
                "id": "15469933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcd2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Phosphorylated Akt and Akt-mediated phosphorylation of FOXO3A also decreased in responsive breast cancer cell lines exposed to lapatinib",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2007 May 6(5) 1629-40",
                "id": "17513611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcd1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "This is also reflected by a rapid increase in the phosphorylation of ERK and Akt, elicited by SDF-1? in Jurkat T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Med 2003 Jan 81(1) 4-19",
                "id": "12545245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcc9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The apoptotic activity of nicotine is mediated by a3- and a4-containing nAChRs in NHBE cells and involves activation of the Akt pathway [21].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Pharmacol Sci 2008 Mar 29(3) 151-8",
                "id": "18262664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcc6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jul 29 23(34) 5834-42",
                "id": "15208677"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcc1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "These effects appear to be protein kinase A-dependent.  Furthermore inhibition of protein kinase C restored the beta(3)-receptor-mediated reductions in insulin-induced IRS-1 tyrosine phosphorylation and IRS-1-associated PI3-kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 3 274(49) 34795-802",
                "id": "10574950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcbf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "brown adipose"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Mar 27 98(7) 3690-4",
                "id": "11274386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcbd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "These data provide the first evidence of the involvement of both SHIP-1 and Lyn in the negative regulation of M-CSF-R-induced Akt activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3 278(40) 38628-36",
                "id": "12882960"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "the transcription factor cyclic AMP-responsive element binding protein (CREB1) has been shown to be a regulatory target for AKT in non-haematopoietic cells and PKCtheta in T-cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcb9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "confluent mouse and human keratinocytes subjected to Akt activation exhibit phosphorylated GSK3a and GSK3b (Calautti et al., 2005; Thrash et al., 2006)  ",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcb5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Dec 8 23(24) 4760-9",
                "id": "15538381"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Stable transfection of MCF-7 cells with a constitutively active Akt mimicked the effect of estradiol.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Sep 11 22(39) 7998-8011",
                "id": "12970748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dca8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "These findings demonstrate that c-met receptor activation by SF/HGF protects certain glioblastoma cells from DNA-damaging agents by activating phosphoinositol 3-kinase-dependent and Akt-dependent antiapoptotic pathways",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Aug 1 60(15) 4277-83",
                "id": "10945642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dca5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "glioblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "IGF1 may also improve muscle regeneration via promoting cell survival IGF1 promotes myogenic cell survival in vitro, primarily through the PI3K pathway and Akt activation",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2004 Jan 84(1) 209-38",
                "id": "14715915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc9e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "squamous cell carcinoma lines engineered to express constitutively active Akt underwent EMT, characterized by down-regulation of the epithelial markers desmoplakin, E-cadherin, and beta-catenin and up-regulation of the mesenchymal marker vimentin.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 May 1 63(9) 2172-8",
                "id": "12727836"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Anti-CD3 antibody activated the PI3K/Akt",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2005 7(1) R139-48",
                "id": "15642134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc93"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "peripheral blood mononuclear cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Another insulin-stimulated protein kinase inactivates GSK3 under these conditions, and we demonstrate that it is the product of the proto-oncogene protein kinase B (PKB, also known as Akt/RAC). AKT-|catof(GSK3B)",
              "citation": {
                "type": "PubMed",
                "name": "Nature 378(6559) 785-9",
                "id": "8524413"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt is a serine/threonine kinase that is activated by phosphatidylinositol 3-kinase (PI3K) signaling and phosphorylates GSK3 on Ser9, thereby inactivating it",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 18 278(16) 13995-4001",
                "id": "12584189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc8a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "activation of the AKT signalling pathway alone is sufficient to induce hypertrophy",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2002 Sep 1 543(Pt 2) 399-411",
                "id": "12205177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Thus, Akt/PKB activity is involved in K-Ras-induced expression of COX-2 and stabilization of COX-2 mRNA largely depends on the activation of Akt/PKB.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Mar 15 61(6) 2670-5",
                "id": "11289146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc87"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We found that Akt physically interacts with G-protein-coupled receptor kinase-2 (GRK2), and that this interaction inhibits Akt activity",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2005 Sep 11(9) 952-8",
                "id": "16142243"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc86"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "While both kinases can phosphorylate Thr-32, SGK displays a marked preference for Ser-315 whereas Akt favors Ser-253.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Feb 21(3) 952-65",
                "id": "11154281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We demonstrate that HGF/SF can induce angiogenesis independently of VEGF, possibly through the direct activation of the Akt and ERKs",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2003 Jan 1 23(1) 69-75",
                "id": "12524227"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc75"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "IL-4, IL-3, and GM-CSF activated mitogen-activated protein (MAP) kinase and protein kinase B",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Apr 15 162(8) 4864-75",
                "id": "10202031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc70"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myeloid Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The protein TRB3 (tribbles 3), also called NIPK (neuronal cell death-inducible protein kinase), was recently identified as a protein-protein interaction partner and an inhibitor of PKB (protein kinase B).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Feb 15 386(Pt 1) 113-8",
                "id": "15469416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc6f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PTEN and a catalytically inactive AKT decreased PI 3-kinase-induced [Estrogen-independent ESR1] activity, suggesting that PI 3-kinase utilizes AKT-dependent and AKT-independent pathways in activating ERalpha . The consensus AKT phosphorylation site Ser-167 of ERalpha is required for phosphorylation and activation by AKT.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 30 276(13) 9817-24",
                "id": "11139588"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Exposure to NMDA or QUIN for 24 h resulted in concentration-dependent cell death (p < 0.001) that was completely attenuated (p < 0.001) by pre-treatment of cells with SF/HGF (50 ng/mL) or FGF-1 (40 ng/mL). SF/ HGF and FGF-1 activated both Akt and MAP-kinase > threefold (p < 0.001)",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2002 Apr 81(2) 365-78",
                "id": "12064484"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc69"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt-mediated inhibition of the FoxO family of transcription factors Akt-mediated inhibition of MuRF1 and MAFbx upregulatio",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2004 May 7 14(3) 395-403",
                "id": "15125842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc66"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "EGFR is required for Akt activation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jun 30 24(28) 4580-7",
                "id": "15856020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The serine/threonine kinase Akt/PKB was recently reported to promote FLIP expression in endothelial and tumor cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 9 279(2) 1513-25",
                "id": "14551207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc62"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Pharmacological or genetic inhibition of the PI3K/Akt pathway, whose activity is inversely correlated with that of GSK3, increased ERalpha-mediated transcription, and this effect was blocked by GSK3 inhibitors.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2006 Jun 147(6) 3027-39",
                "id": "16497810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc4f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of neuron",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jan 22(2) 680-91",
                "id": "11756562"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Song et al. (46). These authors showed that exposure of cultured human umbilical vein endothelial cells (HUVECs) to peroxynitrite or high glucose significantly inhibited both basal and insulin-stimulated serine phosphorylation of PKB/Akt and its activation.",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc4b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "At least two Akt substrates, Bad  and the translation inhibitor 4E-BP1, are also phosphorylated by Pim-2",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Aug 1 17(15) 1813-6",
                "id": "12897050"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc46"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 13 279(7) 5405-12",
                "id": "14645242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc34"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "peroxynitrite inhibited Akt signalling in PC12 cells (45), endothelial cells (4649), and Raw 264.7 macrophages (50).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc32"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Because insulin is able to activate Akt and inactivate AMP-activated protein kinase (AMPK) in the heart, we hypothesized that Akt can regulate the activity of AMPK. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39422-7",
                "id": "12890675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc2f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Other pathways underlying nAChR-induced cell proliferation include activation of NF-kB, Src, the 5-lipooxygenase pathway [36], Akt, HIF-1a [37,38] and COX-2 [19,26,33].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Pharmacol Sci 2008 Mar 29(3) 151-8",
                "id": "18262664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc29"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Surprisingly, DEPTOR is highly overexpressed in a subset of multiple myelomas harboring cyclin D1/D3 or c-MAF/MAFB translocations. In these cells, high DEPTOR expression is necessary to maintain PI3K and Akt activation and a reduction in DEPTOR levels leads to apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2009 May 29 137(5) 873-86",
                "id": "19446321"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc1f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 9 278(19) 16667-74",
                "id": "12609989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc1c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The dn-AKT used in this study was also able to inhibit the phosphorylation of GSK-3beta by endogenous AKT after stimulation with TNF-alpha",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Nov 16(13) 1732-7",
                "id": "12409315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc1a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Correspondingly, overexpression of a constitutively active form of the GSK-3 inhibitor, protein kinase B/Akt, increases GR transcriptional enhancement.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jun 5 273(23) 14315-21",
                "id": "9603939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc11"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "insulin gene transcription is promoted by signaling through insulin receptor type A, PI3K class Ia and p70s6k insulin stimulates the betaGK gene via insulin receptor B type, PI3K class II-like activity and PKB (Akt)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Mar 7(3) 559-70",
                "id": "11463381"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc0f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "and phosphorylation by protein kinases A (PKA) and B (PKB/Akt),",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc0a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Expression of ERb in ERa-positive T47-D and MCF-7 human breast cancer cells resulted in a decrease in Akt signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2011 Apr 14 13(2) R43",
                "id": "21492444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc09"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "No RPTC necrosis was observed during Akt activation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2007 Jan 292(1) F292-303",
                "id": "16940564"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Renal Epithelial Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The APS adapter protein is recruited to the autophosphorylated kinase domain of the insulin receptor and initiates the phosphatidylinositol 3-kinase (PI3K)-independent pathway of insulin-stimulated glucose transport by recruiting CAP and c-Cbl. In this study, we have identified APS",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 11 280(45) 37827-32",
                "id": "16141217"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbf3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Prok-1 was able to activate both Akt and MAPK (ERK) pathways and induce the proliferation  of NCCs via PK-R1 Prok1-induced activation of  erk and akt were inhibited by pd98059 and ly294002. 24 hrs prok1 overexpression. Sirna to prk1 inhibited proliferation induction. and PROK1 increased expression of NOS1 NEFL and VIP",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2007 Apr 1773(4) 536-45",
                "id": "17324478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbf0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "constitutively activated myristylated Akt reduced ERalpha expression, whereas agents that negatively affect the PI3K/Akt pathway, i.e., wortmannin, celecoxib, and the green tea polyphenol epigallocatechin-3 gallate, induced ERalpha.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Oct 24(19) 8681-90",
                "id": "15367686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbe7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The myrAkt-expressing cells continued to proliferate, even in the absence of hormones, and they were resistant to programmed cell death induced by starvation. These effects were paralleled by the induction of the G1 cyclins D3 and E and by the inhibition of induction of the proapoptotic Fas, Fas ligand, and BAD genes in starved cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jul 15 60(14) 3916-20",
                "id": "10919669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbe2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Treating human Panc-48 adenocarcinoma cells with EGF activated Akt and Erk but not P-38.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer 2003 Aug 15 98(4) 720-9",
                "id": "12910515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbde"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In a human colorectal carcinoma cell line, b-arrestin1-mediated Src activation was necessary for transactivation of the EGFR and downstream Akt activation and also for the migration of the cells in vitro (Buchanan et al., 2006).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Dec 8 24(5) 643-52",
                "id": "17157248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbdc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Using pharmacological inhibitors, we further show that p38 MAPK and Akt signaling pathways are crucial for the ErbB2-induced MMP-9 up-regulation, invasion and migration of MCF10A cells",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2009 Mar 18 275(2) 227-33",
                "id": "19022565"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbdb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The phosphorylation of FoxO by Akt and SGK at the first and second phosphorylation sites (T32 and S253 in FoxO3) creates binding sites for the chaperone protein 14-3-3 (Brunet et al., 1999; Obsilova et al., 2005; Rinner et al., 2007; Li et al., 2007a).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2276-88",
                "id": "18391970"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 9 277(32) 28706-13",
                "id": "12042314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbd9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 Feb 15 378(Pt 1) 257-68",
                "id": "14611643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbd8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "RNF11 localization was altered from the cytoplasm to the nucleus by activated AKT.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2005 Aug 3(8) 453-61",
                "id": "16123141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbd5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "In MEFs, stimulation of the IGF1 receptor exerts antiapoptotic actions via activation of PI-3 kinase and Akt by a mechanism that is independent of the intrinsic tyrosine kinase activity of the receptor (Povsic et al., 2003).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Dec 8 24(5) 643-52",
                "id": "17157248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbd1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": "embryo"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Mar 19 99(6) 4061-6",
                "id": "11904450"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbcf"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Sep 8(3) 693-704",
                "id": "11583630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbcd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Ndrg2 contains several potential phosphorylation sites, including three Akt consensus sequences. Thr-348 is the major phosphorylation site detected by the antibody and that Akt stimulates phosphorylation of this site",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 30 279(18) 18623-32",
                "id": "14985363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbcc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 31 276(35) 32799-805",
                "id": "11438550"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbc7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "We propose that Foxo1 turns on a feed-forward loop, relayed by p38 and acting to amplify both PKB activation and Foxo1 inhibition",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2007 Feb 15",
                "id": "17303659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbc6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jul 5 277(27) 24169-79",
                "id": "11976320"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbc2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 May 7 274(19) 13085-90",
                "id": "10224060"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbb5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "growth factors, cytokines and other signalling molecules stimulate HIF-1a synthesis via activation of the phosphatidylinositol 3-kinase (PI3K) or mitogen- activated protein kinase (MAPK) pathways (FIG. 1).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Oct 3(10) 721-32",
                "id": "13130303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbb3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Figure 2. PD98059, SB203580, and Akt-deficient mice reduced high-tidal-volume-induced lung fibrosis. ",
              "citation": {
                "type": "PubMed",
                "name": "Crit Care 2008 12(4) R103",
                "id": "18691424"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbb2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Jan 11(1) 11-23",
                "id": "12535517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dba1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Both authentic peroxynitrite and the peroxynitrite donor SIN-1 triggered PKB/Akt phosphorylation and activation, as reflected by increased phosphorylation of the PKB/Akt substrate GSK3 in human skin fibroblasts (24).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "The results of the present study clearly show that insulin activates Rac1 via PI3K/Akt ",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2010 Jun 30(6) 1237-45",
                "id": "20339116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db8e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jul 1 62(13) 3729-35",
                "id": "12097282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db8a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "To further investigate this link, we determined that IGFBP-2 expression is negatively regulated by PTEN and positively regulated by phosphatidylinositol 3-kinase (PI3K) and Akt activation. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2007 Mar 27 104(13) 5563-8",
                "id": "17372210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db74"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "Akt then phosphorylates tuberin on three residues (S939, S1130 and T1462 of full length human tuberin), and this inhibits the tuberin-hamartin complex through an as-yet-undefined mechanism (reviewed in [8]).",
              "citation": {
                "type": "PubMed",
                "name": "Trends Biochem Sci 2003 Nov 28(11) 573-6",
                "id": "14607085"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "activation of PI3K and Akt, necessary for insulin stimulation of glucose transport, is impaired in insulin resistance",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Apr 52(4) 935-41",
                "id": "12663464"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"AKT Family\") actsIn kin(p(SFAM:\"AKT Family\"))",
              "summary_text": "IL-1beta also increased tyrosine phosphorylation of PLC-gamma in Src kinase-dependent manner. Pharmacological inhibition of the PLC-PKC cascade by using specific inhibitor for PLC-gamma (U73122) and PKC (GFX) strongly inhibited IL-1beta-induced Erk and Akt activation.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2003 Dec 23(6) 1727-31",
                "id": "14612947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db5f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAC1)",
        "relation": "actsIn",
        "target": "gtp(p(HGNC:RAC1))",
        "directed": false,
        "label": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053292",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Ox-LDL induced rapid RhoA and Rac1 activation as well as MT1-MMP activity in cultured human aortic ECs.....the present study provides evidence that the LOX-1-MT1-MMP axis plays a crucial role in RhoA and Rac1 activation signalling pathways in ox-LDL stimulation......Fluorescent immunostaining revealed the colocalization of LOX-1 and MT1-MMP, and the formation of a complex of LOX-1 with MT1-MMP was detected by immunoprecipitation. ",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2009 Oct 1 84(1) 127-36",
                "id": "19487339"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "ARAP3 is a GTPase activating protein (GAP) for Rho and Arf GTPases that is implicated in phosphoinositide 3-kinase (PI 3-kinase) signalling pathways controlling lamellipodia formation and actin stress fibre assembly. Rho-family GTPases including Rac1, Cdc42 and RhoA play central roles in controlling actin cytoskeletal dynamics (Hall, 1998Go). The activities of these proteins are tightly controlled during cell adhesion to the ECM (Hynes, 2002Go; Etienne-Manneville and Hall, 2002Go). For example, Rac1 and Cdc42 are activated by integrin-mediated cell adhesion and, via specific effectors, stimulate the actin-nucleating activity of the Arp2/3 complex leading to actin polymerisation and lamellipodia and filopodia formation at the leading edge of cells",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Dec 1 117(Pt 25) 6071-84",
                "id": "15546919"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Neutrophils contain a soluble guanine-nucleotidebinding protein, made up of two components with molecular masses of 23 and 26 kDa, that mediates stimulation of phospholipase C-beta2 (PLCbeta2). We have identified the two components of the stimulatory heterodimer by amino acid sequencing as a Rho GTPase and the Rho guanine nucleotide dissociation inhibitor LyGDI. Using recombinant Rho GTPases and LyGDI, we demonstrate that PLCbeta2 is stimulated by guanosine 5'-O-(3-thiotriphosphate) (GTP[S])-activated Cdc42HsxLyGDI, but not by RhoAxLyGDI. Stimulation of PLCbeta2, which was also observed for GTP[S]-activated recombinant Rac1, was independent of LyGDI, but required C-terminal processing of Cdc42Hs/Rac1. Cdc42Hs/Rac1 also stimulated PLCbeta2 in a system made up of purified recombinant proteins, suggesting that this function is mediated by direct protein-protein interaction.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Nov 2 17(21) 6241-9",
                "id": "9799233"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Comparative microarray analysis of a human colorectal carcinoma cell line genetically engineered to display different levels of Rac1 identified novel target genes for this GTPase. The colorectal adenocarcinoma cell line SW620 was modified stably to express differentlevels of Rac1 protein. First, a vector encoding the wild-type form of Rac1 protein was transfected in SW620 cell line, generating the stable clones Rac1 wt. Also, shRNA specific for Rac1 was introduced to reduce Rac1 levels in SW620 cells. The Tables contain genes with a p-parametric value less than 0.0015. Table 2 - Significant down-regulated genes by Rac1",
              "citation": {
                "type": "PubMed",
                "name": "Int J Biochem Cell Biol 2007 39(12) 2289-302",
                "id": "17766170"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e29b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Scar/WAVE proteins do not interact with Rac1 directly, but instead assemble into multiprotein complexes, which was shown to regulate their activity in vitro. However, little information is available on how these complexes function in vivo. Here we show that the specifically Rac1-associated protein-1 (Sra-1) and Nck-associated protein 1 (Nap1) interact with WAVE2 and Abi-1 (e3B1) in resting cells or upon Rac activation. Consistently, Sra-1, Nap1, WAVE2 and Abi-1 translocated to the tips of membrane protrusions after microinjection of constitutively active Rac. Moreover, removal of Sra-1 or Nap1 by RNA interference abrogated the formation of Rac-dependent lamellipodia induced by growth factor stimulation or aluminium fluoride treatment. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Feb 25 23(4) 749-59",
                "id": "14765121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "CAPRI-knockout mouse. Cells from this animal have the predicted hyperactivation of Ras signalling, which is consistent with the loss of an important Ras-GAP. Interestingly, Zhang et al. [40] also noted a decrease in the activation of the small GTPases Rac and Cdc42. This effect appeared not to arise through the hyperactivation of Ras, nor was it a consequence of CAPRI functioning as a Cdc42/Rac GEF, rather the authors show that CAPRI, via its Ras-GAP domain, can bind Rac and Cdc42 directly and act as a scaffold for presenting these GTPases to an unidentified GEF. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Soc Trans 2006 Nov 34(Pt 5) 846-50",
                "id": "17052212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e175"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "To determine the role of Vav1 and Rac on CXCL12-triggered T-cell migration involving ?4?1 activity, we subjected wt and DN Vav1, Rac, and Cdc42 Peer cell transfectants to migration assays across confluent layers of TNF-?-activated HUVEC (to induce VCAM-1 expression; unpublished data). The results revealed that CXCL12-promoted migration of DN Rac or Vav1 SH3-SH2-SH3 transfectants was substantially lower than that displayed by transfectants expressing wt Rac, Vav1, or Cdc42, or DN Cdc42 (Figure 8Figure 8.). This migration was inhibited by anti-CXCR4 mAb (unpublished data), and by anti-?4 (Figure 8Figure 8.), indicating that was mediated by ?4?1. Together, these data indicate that activation of Rac and Vav1 by CXCL12 is a key signaling event that leads to efficient up-regulation of ?4?1-dependent T-cell adhesion and transendothelial migration.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Jul 16(7) 3223-35",
                "id": "15872091"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e151"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "    The relative contributions of the EC MLCK and Rho pathways in regulating EC permeability are not well understood: inhibition of either MLCK activity (50) or Rho activation (16, 18) attenuates thrombin-induced EC barrier dysfunction. A recent report suggests that Rho/Rho kinase and MLCK may differentially regulate MLC phosphorylation according to spatial localization within cultured cells (144). Additional complexity in the system is provided by the contribution of the p21-activated kinase (PAK) family, downstream effectors of the small GTPases Rac and Cdc42. Isoforms PAK1 and PAK2 have both been shown to phosphorylate smooth muscle MLCK and decrease MLCK activity in cultured cells (61, 123), but whether PAK regulates the high-molecular-mass MLCK present in endothelium in this fashion is not clear. Conversely, PAK2 can directly phosphorylate MLC to produce EC contraction (163).",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2001 Oct 91(4) 1487-500",
                "id": "11568129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e113"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "TLR4 and Syk were required for mmLDL activation of guanine nucleotide exchanging factor Vav1, small GTPase Ras, kinases Raf, MEK1 and ERK1/2; in turn, ERK1/2 phosphorylated paxillin at Ser126 and activated small GTPases Cdc42, Rac and Rho (Figure 3 and Online Figure III). These signaling events lead to actin polymerization, a necessary step in membrane ruffling. Our results agree with the reports of Syk-dependent ERK1/2 activation in phagocytosis45, ERK1/2 activation in TLR4-dependent antigen uptake by dendritic cells46, and the role of paxillin and small GTPases in actin reorganization and pinocytic vesicle formation9,26,27,47. ",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2009 Jun 19 104(12) 1355-63",
                "id": "19461045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e109"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Active Rac-1 enhanced PAI-1 mRNA and protein levels, since we have previously shown that thrombin increases HIF-1a at the transcriptional level (28) we determined whether Rac-1 acts via this mechanism. In the presence of RacG12V, HIF-1a mRNA levels in PASMC as well as HIF-1a promoter ac tivity in rSMC were enhanced, whereas RacT17N prevented induction of HIF-1a mRNA and promoter activity by thrombin",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2008 Dec 100(6) 1021-8",
                "id": "19132225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Recently, it has been shown that KDR is responsible for VPF/VEGF-stimulated endothelial cell (EC) proliferation and migration, whereas Flt-1 activation down-modulates KDR-mediated EC proliferation. Although KDR-mediated EC proliferation and migration have been extensively studied, much less is known about Flt-1-mediated antiproliferation. Here, we demonstrate that Flt-1-mediated antiproliferative activity can be blocked completely by the dominant negative mutant of CDC42 (CDC42-17N) and partially by a Rac1 dominant negative mutant (Rac1-17N) but is not affected by a RhoA dominant negative mutant (RhoA-19N).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 8 277(6) 4003-9",
                "id": "11726672"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfb1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "RhoA and Rac1 proteins were efficiently expressed in a cell line of human bronchial epithelial cells (16HBE) by adenovirus-based gene transfer. We found that both constitutively active RhoA and dominant negative RhoA inhibited wound healing, suggesting that both activation and inhibition of RhoA interfere with normal wound healing. Overexpression of wild-type Rac1 induced upregulation of RhoA, disrupted intercellular junctions, and inhibited wound closure. Dominant negative Rac1 also inhibited wound closure. Inhibition of the downstream effector of RhoA, Rho-kinase, with Y-27632 suppressed actin stress fibers and focal adhesion formation, increased Rac1 activity, and stimulated wound closure.RhoA and Rac1 are both required for efficient wound closure of airway epithelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2004 Dec 287(6) L1134-44",
                "id": "15298851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "we monitored Rac1 translocation in dominant negative PI3K-infected cells that were subjected to ischemia (Fig. 5A). Rac1 translocation also was evaluated after treatment of cells with 24 mM KCl (high K+) as a membrane depolarizing agent (Fig. 5B). Based on the yellow colocalization signal, wild type cells and AdlacZ (adenovirus control) infected cells showed Rac1 translocation with both ischemia (Fig. 5A) and high K+ (Fig. 5B). On the other hand, Rac1 translocation with these agonists was significantly suppressed by dominant negative PI3K infection of PMVEC. Thus, PI3K activity is required for Rac1 translocation ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2011 Oct 14",
                "id": "22003059"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df6c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We first determined whether Rac-1 is activated in NIH-3T3 cells allowed to adhere after presuspension. In agreement with previous reports (del Pozo et al., 2000), we observed an early accumulation of GTP-bound (i.e., active) Rac-1 upon cell plating on fibronectin with a kinetic comparable with the generation of oxygen species (Fig. 3 A). A causal link between Rac activation and adhesion-induced ROS was further demonstrated by overexpressing constitutively active Rac-1 mutant (RacQL) or the corresponding dominant-negative form (RacN17) of the GTPase (Fig. 3 B). As shown in Fig. 3 C, Rac-1?overexpressing cells plated on fibronectin produce significantly more hydrogen peroxide than cells in suspension. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2003 Jun 9 161(5) 933-44",
                "id": "12796479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deec"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "A G protein-coupled chemoattractant receptor (R) activates PI3K isoforms, which converts PtdIns(4,5)P2 to PtdIns(3,4,5)P3. PI3K activation itself would lead only to a transient increase in PtdIns(3,4,5)P3 followed by a decrease in this lipid product as a result of depletion of the upstream phosphoinositide substrates, such as PtdIns(4,5)P2. Hence, PtdIns(3,4,5)P3 at the leading edge or front of the cell stimulates its own accumulation through the activation of one or more Rho GTPases (Rac, cdc42 and/or Rho), which in turn activate PI3K and increase PtdIns(3,4,5)P3 formation. ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2004 Feb 25(2) 67-74",
                "id": "15102365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407decd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "CHF1/Hey2-deficient VSMCs proliferate slowly compared with WT VSMCs and also show decreased migration in response to platelet-derived growth factor (PDGF) (62.6+/-10.3 CPF versus 37.2+/-13.5 CPF; P epidermal growth factor-like growth factor (HB-EGF) (27.4+/-7.7 CPF versus 6.4+/-3.7 CPF, P ruffling induced by these chemoattractants are diminished in KO VSMCs, which is correlated with decreased activation of the small GTPase Rac1.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2004 Nov 24(11) 2069-74",
                "id": "15345511"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de32"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Both RhoGDI and D4GDI (hereafter referred to collectively as GDIs) are cytosolic and form 1:1 complexes with Rho family GTPases, although several Rho family members have been reported to not effectively bind to GDIs (Table 1). First, they inhibit the dissociation of GDP from Rho proteins, maintaining the GTPase in an inactive form and preventing GTPase activation by GEFs (Box 1). Second, they are able to interact with the GTP-bound form of the Rho GTPase to inhibit GTP hydrolysis, blocking both intrinsic and GAP-catalyzed GTPase activity and preventing interactions with effector targets.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cell Biol 2005 Jul 15(7) 356-63",
                "id": "15921909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddcc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "The Rho family of small GTPases, consisting of Rho, Rac, and cyclin-dependent kinase (Cdc) 42, regulate cytoskeletal organization during the cell cycle and also mediate Ras-induced activation of Raf, especially C-Raf.134-136 These GTPases do not directly bind to Raf but, instead, signal by activating downstream kinases. Rho signals by activating the serine/threonine protein kinases N1 and N2 and Rho-associated kinase 1, whereas Rac and Cdc42 signal through p21-activated kinase (PAK).134-136",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd36"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "These results link signaling pathways previously shown to be associated with cell proliferation (18) and cytoskeletal organization (29, 30) to growth factor gene activation and identify a cis element in FGF1 promoter 1D that can be defined as an SRE. This SRE is comprised of Ets and CArG sites. These sites are targets of regulation by divergent signaling pathways; Ets site target of Ras, Rac1, and Cdc42 regulation; and the CArG site target of de novo protein synthesis-independent cascade.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 29 275(39) 30432-8",
                "id": "10849427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcfc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "One critical event after stimulation of the TCR that is essential for activation of the MAPK signal cascade is the recruitment of linker for activation of T cells (LAT) and the activation of guanine nucleotide exchange factors (GEFs). GEFs activate small GTP-binding proteins such as Ras, Rac-1, and Cdc42 by promoting the conversion of the GDPbound inactive state to the GTP-bound active state, leading to the activation of the MAPK signaling cascade. Activation of the p38 MAPK cascade in Jurkat T cells has been shown to require phosphorylation of the GEF Vav by Zap-70 and subsequent activation of Rac-1. CD28 co-stimulation augments the recruitment of Vav to LAT and Zap-70 and increases Zap-70 mediated Vav phosphorylation [23]. Rac-1 elicits the p38 MAPK cascade through the p21-activated kinase 1 (Pak1),",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2006 8(2) 205",
                "id": "16542479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dca4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "As discussed above, the EC intracellular vacuole formation process (Davis and Camarillo, 1996) is reminiscent of other pinocytic events, such as macropinocytosis and phagocytosis. Like vacuole formation, both of these latter processes are dependent on actin and microtubules (Greenberg, 1995; Davis and Camarillo, 1996; Cardelli, 2001). In addition, the inner surfaces of the pinocytosed membranes contain F-actin (Greenberg, 1995; Davis and Camarillo, 1996; Cardelli, 2001) (Fig. 11). Recent work has elucidated some of the molecular components involved in the cytoskeletal signaling pathways regulating macropinocytosis and phagocytosis. In both cases, Rho GTPases regulate these events. Rac and Cdc42 GTPases have been found to be required for macropinocytosis (Cardelli, 2001; Ridley, 2001a) and Fc receptor-mediated phagocytosis (Caron and Hall, 1998). Dominant negative Rac1 and Cdc42 markedly blocked EC vacuole and lumen formation in collagen and fibrin matrices, while dominant negative RhoA had no effect.",
              "citation": {
                "type": "PubMed",
                "name": "Anat Rec 2002 Nov 1 268(3) 252-75",
                "id": "12382323"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "TNF alpha stimulation of EC increased the membrane association of Rac1, an event that is essential for Rac1 activity. ICMT inhibitor N-acetyl-S-farnesyl-L-cysteine (AFC) blocked the accumulation of Rac1 into the membrane both in resting and TNF alpha-stimulated conditions. Similarly, the membrane-associated Rac1 was lower in Icmt-deficient versus wild-type mouse embryonic fibroblasts (MEFs).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 13 280(19) 18790-6",
                "id": "15647276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db9f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We show that functional RhoA is required for LPA-, serum-, and AIF4--induced transcriptional activation by SRF and that tw~ other Rho family GTPases, Racl and CDC42Hs, can also potentiate SRF activity.......NIH 3T3 cells were transfected with CAT reporter genes controlled by either two copies of the wild-type c-los SRE, or its derivative SRE.L, which cannot bind TCF, together with expression plasmids producing the activated small GTPases Ras.R12, RhoA.V14, Rac1.V12, or CDC42Hs.......The serum response element (SRE) is a regulatory sequence found in many growth factor-regulated promoters (reviewed by Treisman, 1990). The SRE binds the ubiquitous transcription factor SRF (serum response factor; Norman et al., 1988), which is required for its activity. V12. Coexpression of each of the proteins activated the wild-type SRE in the absence of growth factor stimulation, with an efficiency approaching that of serum stimulation in the case of CDC42Hs (Figure 3A, left).",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1995 Jun 30 81(7) 1159-70",
                "id": "7600583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db69"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Here, we demonstrate an activation of the small G-proteins Rac 1 and Rac 2 after Fas receptor triggering. Expression of a transdominant inhibitory Ras mutant (N17Ras) prevents Rac 1 and Rac 2 stimulation, suggesting a signaling cascade from the Fas receptor via Ras to Rac 1 and Rac 2. Genetic and pharmacological inhibition of Ras or Rac 1 and Rac 2 stimulation blocks Fas-induced apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Oct 18 271(42) 26389-94",
                "id": "8824295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e407"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "In this study, we showed that c-Abl-PKCdelta-Rac1-p38 MAPK signaling is required for the conformational changes of Bak and Bax during ionizing radiation-induced apoptotic cell death in human non-small cell lung cancer cells. Ionizing radiation induced conformational changes and subsequent oligomerizations of Bak and Bax, dissipation of mitochondrial membrane potential, and cytochrome c release from mitochondria.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 17 281(11) 7049-59",
                "id": "16410245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Here, we report that Rac1, a member of the Rho family of GTPases, is a critical regulator of both mTORC1 and mTORC2 in response to growth-factor stimulation. Deletion of Rac1 in primary cells using an inducible-Cre/Lox approach inhibits basal and growth-factor activation of both mTORC1 and mTORC2.Rac1 appears to bind directly to mTOR and to mediate mTORC1 and mTORC2 localization at specific membranes.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2011 Apr 8 42(1) 50-61",
                "id": "21474067"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Phosphatidylinositol 3-kinase (PI3K) is recruited to the membrane by intact E-cadherin adhesion junctions, where it generates phosphatidylinositol-(3,4,5)- triphosphate (PIP3), resulting in the activation of the RHO-GEF TIAM1 and subsequently of RAC1 and CDC42.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Feb 4(2) 118-32",
                "id": "14964308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e382"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "TNF alpha stimulation of EC increased the membrane association of Rac1, an event that is essential for Rac1 activity. ICMT inhibitor N-acetyl-S-farnesyl-L-cysteine (AFC) blocked the accumulation of Rac1 into the membrane both in resting and TNF alpha-stimulated conditions. Similarly, the membrane-associated Rac1 was lower in Icmt-deficient versus wild-type mouse embryonic fibroblasts (MEFs).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 13 280(19) 18790-6",
                "id": "15647276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2db"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "More importantly, palladin knockdown results in decreased ruffle formation and decreased Rac activation following PDGF treatment. In addition, we describe a novel interaction between palladin and Eps8, a receptor tyrosine kinase (RTK) substrate that participates in the activation of the Rac-specific guanine nucleotide-exchange function of Sos-1",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2006 Aug 15 119(Pt 16) 3316-24",
                "id": "16868024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We observed in primary mouse embryonic fibroblasts that deletion of rac1 by gene targeting, as well as expression of the constitutively active Rac1 mutant L61Rac1, led to decreased cell growth that was associated with altered cell cycle progression at both G(1)/S and G(2)/M phases, increased apoptosis, and premature senescence.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Dec 15 281(50) 38519-28",
                "id": "17032649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2cf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Molecular dissection of signaling down-stream of PKCiota demonstrates that Rac1 is a critical molecular target for PKCiota-dependent transformation, whereas PKCiota is not necessary for NFkappaB activation in vitro or in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Sep 2 280(35) 31109-15",
                "id": "15994303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "However, the molecular mechanism by which KDR mediates EC migration is not clear yet. Here we show for the first time that activation of RhoA and Rac1 is fully and partially required for KDR-mediated human umbilical vein endothelial cell (HUVEC) migration, respectively, and that CDC42, however, is not involved.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 46791-8",
                "id": "12244099"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Furthermore, Iba1 colocalized with a small GTPase Rac in the membrane ruffles and the phagocytic cups.   The Iba1 mutants also suppressed membrane ruffling induced by dominant active Rac1V12",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2000 Sep 113 ( Pt 17) 3073-84",
                "id": "10934045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Bam32 variants also affected downstream signaling to JNK in a manner similar to that of Rac1, suggesting that the effect of Bam32 on JNK activation may be at least partially mediated through Rac1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 17 279(38) 39775-82",
                "id": "15247305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e281"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "B cell lymphoma",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Using the chimeric-receptor EGLT in which the extracellular domain of epidermal growth factor receptor was fused to the transmembrane and intracellular domains of Flt-1, we also demonstrate that CDC42 and Rac1 are activated by EGLT. Previously, we showed that phosphatidylinositol 3-kinase is required for Flt-1-mediated antiproliferative activity, but phospholipase C is not required.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 8 277(6) 4003-9",
                "id": "11726672"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e27c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Induction of STAT3 Tyr705 and Ser727 phosphorylations by Galpha(s)QL was suppressed by inhibition of protein kinase A, Janus kinase 2/3, Rac1, c-Jun N-terminal kinase (JNK), or phosphatidylinositol 3-kinase, and a similar profile was observed in response to beta2-adrenergic receptor stimulation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 24 281(47) 35812-25",
                "id": "17008315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e27a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Upon stimulation, a functional NADPH oxidase is assembled when the cytosolic proteins, Rac, p67phox, p47phox, and possibly p40phox, associate with the gp91phox and p22phox transmembrane proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1999 Sep 16 263(1) 118-22",
                "id": "10486263"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e26d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We show that EGF stimulation activates the catalytic activity of Brk, which in turn phosphorylates paxillin at Y31 and Y118. These phosphorylation events promote the activation of small GTPase Rac1 via the function of CrkII",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10558-72",
                "id": "15572663"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e250"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e24f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Here we show that TLR2 stimulation by Staphylococcus aureus induces a fast and transient activation of the Rho GTPases Rac1 and Cdc42 in the human monocytic cell line THP-1 and in 293 cells expressing TLR2.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2000 Dec 1(6) 533-40",
                "id": "11101877"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e218"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Rather, laminin-1 induced persistent activation of the GTPase Rac. Thus, these studies identify activation of Src and Rho as key mechanisms by which collagen I provokes capillary morphogenesis of microvascular endothelial cells, and they define marked differences between the functions of collagen I and laminin-1 in regulating endothelial cell morphogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Mar 18(3) 457-68",
                "id": "15003991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e209"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Herein, we demonstrate that RhoA, Rac1, and Cdc42 promote the expression of cyclooxygenase-2 (COX-2) at the transcriptional level. Rho GTPases induce the expression of COX-2 in NIH3T3, HT29, DLD-1, and MDCK cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Jul 14(7) 3041-54",
                "id": "12857884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e16c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "however, simvastatin was able to decrease Rac1 translocation by 63 0.37% in control cells, by 690.76% in nLDL-exposed VSMC and by 340.32% in agLDL-exposed VSMC (Fig. 2B).",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2007 Jan 1 73(1) 208-16",
                "id": "17141748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e169"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Inhibition of PRL-1 decreased c-Src and p130Cas (BCAR1) expression and Rac1 and Cdc42 activation without any apparent modification of focal adhesion kinase (FAK) expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Jan 15 67(2) 643-50",
                "id": "17234774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e148"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "In accordance with PG-induced Rac activation, PGE2 and beraprost caused timedependent phosphorylation of Rac effector PAK1 at Thr423 detected by western blot (Figure 2D). PAK autophosphosphorylation at this site results from PAK activation induced by Rac and Cdc42 GTPases [45].",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e13d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Mig6 functions in cells of hepatic origin and in neurons, which suggests a role for Mig6 in different cell lineages. Mechanistically, Mig6 requires an intact Cdc42/Rac interactive binding site to exert its inhibitory action, which suggests that Mig6 acts, at least in part, distally from Met, possibly by inhibiting Rho-like GTPases.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2005 Oct 24 171(2) 337-48",
                "id": "16247031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e12b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We show here the transient activation of the small GTPase Rac, followed by a rise in reactive oxygen species (ROS), as necessary early steps in a signal transduction cascade that lead to NFkappaB activation and collagenase-1 (CL-1)/matrix metalloproteinase-1 production after integrin-mediated cell shape changes.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jul 22 158(2) 357-68",
                "id": "12119354"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Activated, GTP-bound Cdc42, Rac1, and Rac2 bind to the p21-binding domain (PBD) of PAK1",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2004 Aug 15(8) 3509-19",
                "id": "15169870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Inactivation of Rac1 by N17Rac1 significantly inhibited IGF-I-induced ROS production (Figure 3D). ",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2008 Nov 1 80(2) 299-308",
                "id": "18567639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0dd"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "in Fig. 7A, STAT3 KO cells were unresponsive to the active RhoA-, Rac1-, or Cdc42-stimulated cyclin D1 transcription in a luciferase-based reporter assay, whereas in WT- or STAT3-reconstituted cells, the cyclin D1 luciferase activity was significantly up-regulated by all three GTPases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 29 280(17) 17275-85",
                "id": "15705584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0d9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "VEGF rapidly activates Rac1 and promotes translocation of Rac1 from the cytosol to the membrane, thereby activating NADPH oxidase in ECs (100).",
              "citation": {
                "type": "PubMed",
                "name": "Antioxid Redox Signal 2007 Jun 9(6) 731-9",
                "id": "17511588"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "FGF2 [50] and FGF8b [17] can enhance endothelial cell reorganization onMatrigel.The process requires the activation of the proteolytic machinery, including type IV collagenase(s) and TIMPs production [51] as well as uPA and PAI-1 upregulation [52], a6b1 integrin receptor engagement [53], PECAM-1 [54], and activation of the small GTPase Rac [55].",
              "citation": {
                "type": "PubMed",
                "name": "Cytokine Growth Factor Rev 2005 Apr 16(2) 159-78",
                "id": "15863032"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "the chemokine Mig, a ligand for CXCR3, activates the small GTPases RhoA and Rac1, induces a reorganization of the actin cytoskeleton, and triggers cell chemotaxis and modulation of integrin VLA-5- and VLA-4-dependent cell adhesion to fibronectin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 30 276(48) 45098-105",
                "id": "11571298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Furthermore, Iba1 colocalized with a small GTPase Rac in the membrane ruffles and the phagocytic cups.   The Iba1 mutants also suppressed membrane ruffling induced by dominant active Rac1V12",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2000 Sep 113 ( Pt 17) 3073-84",
                "id": "10934045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "FA-CRKL induced cotranslocation of a Rac1 activator, Dock1, to focal adhesions. These results therefore indicate a role for CrkL in mediating Src signaling by activating small G proteins at focal adhesions. Furthermore, MEFs lacking CrkL show impaired integrin-induced migration despite expression of a closely related protein, Crk-II, in these cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Apr 23(8) 2883-92",
                "id": "12665586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e092"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "we found that siRNA-mediated knockdown of AMPKalpha1 abrogates agonist-mediated activation of the small GTPase Rac1. Conversely, siRNA-mediated knockdown of Rac1 decreased the agonist-mediated phosphorylation of AMPK substrates without affecting that of AMPK, implicating Rac1 as a molecular link between AMPK and Akt in agonist-mediated eNOS activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jul 13 282(28) 20351-64",
                "id": "17519230"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e07d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We found that IgE-induced cysLT synthesis is completely abolished in RBL-2H3(Rac-N17) cells, a stable cell line expressing Rac(N17), a dominant negative Rac1 mutant; conversely, synthesis was enhanced in cells expressing Rac(V12), a constitutively active Rac1 mutant, suggesting that Rac1 is a key mediator of IgE signaling to cysLT synthesis. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Jul 1 173(1) 624-31",
                "id": "15210825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e01a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Deletion of Y687 enhances RET induction of lamellipodia formation, suggesting that Y687 recruits protein/s that negatively modulate activation of the Rac small GTPase.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Dec 61(23) 2954-64",
                "id": "15583857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "T cells deficient for the RAC1 GEF TIAM1 (T cell lymphoma invasion and metastasis 1) show reduced polarization and chemotaxis in response to CXCL12. In addition to activating RAC1, TIAM1 may function as a scaffold protein by associating with active RAP1, which activates the PAR (partitioning defective) polarity complex through CDC42 (Ref. 114). ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2009 Sep 9(9) 630-44",
                "id": "19696767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df65"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "increases protein - ligands of other receptors (thrombin, angiotensin), RAS expression, small G-protein RAC1, PTEN inhibition, diacyl glycerol kinase",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Jan 2(1) 38-47",
                "id": "11902584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Rac1 inhibitor completely inhibited the stimulation of OKL38 by OxPAPC (Fig. 2B).",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2007 Mar 48(3) 709-15",
                "id": "17192422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df32"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "This indicated that DEF6 acts upstream of the Rho GTPases resulting in the activation of the Cdc42, Rac1, and RhoA signaling pathways. In vitro, DEF6 specifically interacted with Rac1, Rac2, Cdc42, and RhoA, suggesting a direct role for DEF6 in the activation of Rho GTPases",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2004 Apr 1 294(2) 335-44",
                "id": "15023524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df29"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "inhibition of Rac1, PI3-kinase, or JNK blocked the fibroblast migration significantly",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(8) e12228",
                "id": "20808927"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df25"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "This increase in staining was confirmed by activity assays showing an increase in Rho activity with decreased LOX activity. Additionally, Rac and Cdc42 activity decreased with the reduction in LOX activity. Taken together, these data demonstrate a loss of a motogenic phenotype with decreased LOX activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2006 Jul 1 98(4) 827-37",
                "id": "16440329"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df23"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Furthermore, expression of the activated Rac1(V12) in NIH 3T3 cells leads to an increased A6/twinfilin localization to nucleus and cell cortex, whereas a dominant negative form of Rac1(V12,N17) induces A6/twinfilin localization to cytoplasm.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Mar 20(5) 1772-83",
                "id": "10669753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df1f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "FceRI stimulation resulted in the activation of Syk, which targeted numerous substrates in mast cells (33). Tyrosine phosphorylation of Vav (a Sykdependent event) was sufficient for the activation of Rac1, but not of Ras. Vav-mediated activation of Rac1 resulted in the induction of JNK1 activity and increased levels of IL-2 and IL-6 mRNAs. Inhibition of Rac1 or JNK1 activity resulted in inhibition of the studied IL-6 response.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Jul 15 163(2) 802-10",
                "id": "10395673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df05"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We found that both Rac1 and ERK activation in HCs are downstream of active Src and protein kinase C (PKC). Treatment with specific small interfering RNA for various PKC isoforms, or with PKC isoform-specific inhibitors, demonstrated a central role for PKCepsilon in the constitutive activation of Rac1 and ERK in HCs.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2007 Feb 170(2) 745-54",
                "id": "17255340"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407def8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "leukemia",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "When Rac1QL was introduced into cultured human keratinocytes, phosphorylation of PAK2 increased (fig. S6G). ",
              "citation": {
                "type": "PubMed",
                "name": "Science 2005 Aug 5 309(5736) 933-5",
                "id": "16081735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ded3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Furthermore, the association of DOCK2 and Vav, the guanine-nucleotide exchanging factor (GEF) for Rac1, was demonstrated in Jurkat cells. Finally, the stable expression of DOCK2-dCS mutant in Jurkat cells was shown to reduce cell attachment. These data suggest the presence of a novel protein complex of CrkL, DOCK2, and Vav to regulate Rac1 in leukemia cell lines.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2002 Dec 1 100(12) 3968-74",
                "id": "12393632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dec9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Expression of a dominant active Rac1 or a dominant active Rac3 resulted in a more invasive and motile phenotype. Moreover, expression of either dominant negative Rac1 or dominant negative Rac3 into the most metastatic cell variant resulted in decreased invasive and motile properties",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2005 7(6) R965-74",
                "id": "16280046"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Ligation of the chemokine receptor CCR2 on monocytes and macrophages with its ligand CCL2 results in activation of the cascade consisting of phosphatidylinositol-3-OH kinase (PI(3)K), the small G protein Rac and lamellipodium protrusion.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2005 Aug 6(8) 827-35",
                "id": "15995708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de7a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Endothelin 1 and phenylephrine (both hypertrophic agonists) induced rapid activation of endogenous Rac1, and endothelin 1 also promoted significant activation of RhoA.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Feb 21(4) 1173-84",
                "id": "11158304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de79"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "By combining pharmacological and genetic approaches, we show here that the Ras/ERK pathway and phosphatidylinositol 3-kinase (PI3K) are both required for cortical neuron migration. By dissecting the downstream signals necessary for this event, we found that Rac1/p38 and Akt are required, whereas the c-Jun N-terminal kinase (JNK) and mTOR/p70(s6k) pathways are dispensable.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 24 281(8) 4771-8",
                "id": "16361255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de78"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We show that initially exposure of fibroblasts to Cr (III) induced membrane-dependent signaling including activation of Rac1 GTPase, Src and apoptosis signal-regulating kinase 1 (ASK-1) kinases leading to increased activities of p38 and particularly Jun N-terminal kinase (JNK) and subsequent activation of caspase-3. ",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Lett 2009 Aug 10 188(3) 236-42",
                "id": "19406221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Chemokine receptors signal through Galphai2 proteins to activate DOCK2 (dedicator of cytokinesis 2) and other guanine nucleotide exchange factors (GEFs), leading to the activation of RAC1 and RHOA. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2009 Sep 9(9) 630-44",
                "id": "19696767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "WAVE1 exists in a heterotetrameric complex that includes orthologues of human PIR121 (p53-inducible messenger RNA with a relative molecular mass (M(r)) of 140,000), Nap125 (NCK-associated protein with an M(r) of 125,000) and HSPC300. Whereas recombinant WAVE1 is constitutively active, the WAVE1 complex is inactive. We therefore propose that Rac1 and Nck cause dissociation of the WAVE1 complex, which releases active WAVE1-HSPC300 and leads to actin nucleation.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 Aug 15 418(6899) 790-3",
                "id": "12181570"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de34"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Ligation of the chemokine receptor CCR2 on monocytes and macrophages with its ligand CCL2 results in activation of the cascade consisting of phosphatidylinositol-3-OH kinase (PI(3)K), the small G protein Rac and lamellipodium protrusion.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2005 Aug 6(8) 827-35",
                "id": "15995708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de2c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "When applied locally to a passive cell edge, HA promoted the formation of lamellipodial protrusions in the direction of the stimulus. This process was inhibited by the prior injection of cells with dominant-negative N17Rac recombinant protein or by pretreatment of cells with monoclonal anti-CD44 antibodies, interfering with HA binding, implying the direct involvement of CD44 in signaling to Rac1.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Mar 20 148(6) 1159-64",
                "id": "10725329"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "S1P inhibition of PDGF-induced cell migration and Rac activation in VSMCs was abolished by the selective S1P(2) receptor antagonist JTE-013. # From Materials PDGF-B chain were purchased from BIOMOL.., Pull-down assays to determine GTP-bound active forms of RhoA and Rac1 were performed as described in detail previously.8,9,13 \\\"#",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2008 Sep 1 79(4) 689-97",
                "id": "18480127"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "These effects were markedly attenuated in Rat2-Rac(N17) cells expressing a dominant negative Rac1 mutant. Pretreatment with SB203580, a specific inhibitor of p38 MAP kinase",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2001 Jun 1 284(1) 126-32",
                "id": "11374881"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd7c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "endogenous P-Rex1 was involved in cell migration of PC12 cells and primary cultured neurons from the embryonic day 14 cerebral cortices, induced by extracellular stimuli (NGF, BDNF, and epidermal growth factor).",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2005 Apr 27 25(17) 4406-19",
                "id": "15858067"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd7a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "RICS is mainly expressed in the brain and functions as a RhoGAP protein for Cdc42 and Rac1 in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2006 Jun 11(6) 607-14",
                "id": "16716191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd73"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We performed Rac1 pull-down assays and found an increase of active Rac1 by ANP with a maximum at 2 to 5 minutes (Figure 4A).",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2005 Jan 7 96(1) 43-53",
                "id": "15569826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Vav2 phosphorylation observed in these experiments reflects the activation of Rac-specific Vav2 nucleotide exchange activity (Aghazadeh et al., 2000).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Inhibition of lamellipodia formation by mutation of either serine 696 or tyrosine 1062 was associated with decrease of the Rac1-guanine nucleotide exchange factor (GEF) activity, suggesting that this activity is regulated by two different signaling pathways via serine 696 and tyrosine 1062 in RET. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 24 277(21) 19114-21",
                "id": "11886862"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "LipoxinA4 rapidly stimulates macrophages to phagocytose apoptotic neutrophils, induces RhoA- and Rac-dependent cytoskeleton re-organization of macrophages and inhibits macrophage CXCL8 release, supporting macrophage-mediated resolution of inflammation. In turn,as a result of engulfment of apoptotic neutrophils, macrophages themselves become a primary source of lipoxins  ",
              "citation": {
                "type": "PubMed",
                "name": "Front Immunol 2011 2 65",
                "id": "22566854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd30"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Constitutive activation of the small GTPase rac-1 results in mitochondrial oxidative stress via the generation of ceramide and thus induces premature endothelial cell senescence.24",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Jan 5 100(1) 15-26",
                "id": "17204661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd03"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Silencing (small interfering RNA) Akt expression blocked OxPAPC-mediated S1P(1) activation (threonine phosphorylation), whereas silencing S1P(1) receptor expression blocked OxPAPC-mediated Tiam1 recruitment to CEMs, Rac1 activation, and EC barrier enhancement.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2009 Apr 24 104(8) 978-86",
                "id": "19286607"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "APC induces rapid phosphorylation of S1P1 on threonine residue 236 via an EPCR and PI3-kinase/AKT-dependent pathway and mediates Rac1-dependent cytoskeleton reorganization. Silencing of S1P1 expression using siRNA significantly reduces APC-mediated barrier protection against thrombin (Finigan et al., 2005).",
              "citation": {
                "type": "PubMed",
                "name": "Microvasc Res 2009 Jan 77(1) 39-45",
                "id": "18973762"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We conclude that IGF-I induces rat aortic SMC motility by increasing phosphotyrosine levels of p130(cas) and activating Rac1 and that NO decreases motility by activating PTP-PEST, inducing dephosphorylating p130(cas), and decreasing Rac1 activity.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Apr 290(4) C1263-70",
                "id": "16354758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Constitutive activation of Rac1, a protein that belongs to the Rho family of small guanosine triphosphatases and is a regulatory component of the plasma membrane reduced form of nicotinamide-adenine dinucleotide phosphate oxidase, enhances mitochondrial oxidative stress and induces premature senescence in endothelial cells.75",
              "citation": {
                "type": "PubMed",
                "name": "Am J Kidney Dis 2008 Jan 51(1) 131-44",
                "id": "18155543"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbdf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "TNF alpha stimulation of EC increased the membrane association of Rac1, an event that is essential for Rac1 activity. ICMT inhibitor N-acetyl-S-farnesyl-L-cysteine (AFC) blocked the accumulation of Rac1 into the membrane both in resting and TNF alpha-stimulated conditions. Similarly, the membrane-associated Rac1 was lower in Icmt-deficient versus wild-type mouse embryonic fibroblasts (MEFs).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 13 280(19) 18790-6",
                "id": "15647276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbcb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Structure function analysis revealed that Nogo-A protein contains at least two active domains, NiG and Nogo-66, with diverse effects on neurite outgrowth and cell spreading. We now provide evidence that these inhibitory domains mediate their effects via an antagonistic regulation of the small GTPases RhoA and Rac1, resulting in activation of RhoA and suppression of Rac1.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2002 Dec 1 22(23) 10368-76",
                "id": "12451136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db8b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Taken together, our results suggest that Rac1 and the Rac1-specific activator Tiam1 are components of transcriptionally active beta-catenin/TCF complexes at Wnt-responsive promoters, and the presence of Rac1 and Tiam1 within these complexes serves to enhance target gene transcription. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2008 7 73",
                "id": "18826597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of large intestine",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "This activation could be restored after transfection of Gsn-/- cells with gelsolin-expressing constructs and with calcium ionophores [56]. Based on these results, the authors proposed a mechanism starting from a gelsolin-mediated remodeling of actin cytoskeleton necessary for a subsequent calcium influx and Rac activation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Oct 61(19-20) 2614-23",
                "id": "15526166"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "p21-activated kinase (PAK), an effector molecule of the Rho GTPases Rac and Cdc42",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2004 Jun 15(6) 2965-77",
                "id": "15047871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e423"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2000 Dec 1(6) 533-40",
                "id": "11101877"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e415"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "First, we determined that RhoG was regulated by guanine nucleotide exchange factors that also activate Rac and/or Cdc42. Vav2 (which activates RhoA, Rac1, and Cdc42) and to a lesser degree Dbs (which activates RhoA and Cdc42) activated RhoG in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47810-7",
                "id": "12376551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e409"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Dominant-negative forms of Ras and/or Rac-1 significantly suppressed HIF-1 activation by muscarinic signaling. Signaling via M1- and M3- but not M2- or M4-AchRs promote accumulation and transcriptional activation of HIF-1alpha.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 1 279(40) 41521-8",
                "id": "15280370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Ras-GRF1 acts as a GEF for Rac when tyrosine-phosphorylated following G protein-coupled receptor stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 22 275(38) 29788-93",
                "id": "10882715"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "RNAi depletion of beta2-chimaerin significantly extended the duration of Rac activation by EGF, suggesting that beta2-chimaerin serves as a mechanism that self-limits Rac activity in response to EGFR activation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 May 17 25(10) 2062-74",
                "id": "16628218"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Using a constitutively active form for Mer (CDMer) or Gas6 as a ligand to stimulate Mer, we found that Mer activation induced a post-receptor signaling cascade involving Src-mediated tyrosine phosphorylation of FAK on Tyr(861), the recruitment of FAK(Tyr861) to the alphavbeta5 integrin, and increased formation of p130(CAS)/CrkII/Dock180 complex to activate Rac1.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2005 Feb 1 118(Pt 3) 539-53",
                "id": "15673687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Dominant negative Rac1, dominant negative MKK3, and knockdown of MKK3 by RNA interference inhibited the kinase activity of co-expressed Mirk.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 23 280(51) 42097-105",
                "id": "16257974"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Phosphorylation of cortactin tyrosine 421 and 466 was elevated in response to Src, epidermal growth factor receptor and Rac1 activation, and tyrosine 421 phosphorylated cortactin localized with F-actin in lamellipodia and podosomes.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Aug 14(8) 3216-29",
                "id": "12925758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "KCl also activated Rac1, but not RhoA, in PC12 cells, and KCl-induced moesin phosphorylation was suppressed in dominant negative Rac1 (N17 Rac1)-expressed cells. The inhibition of protein kinase A (PKA), known as an upstream kinase of Rac1, abolished Rac1 activation and moesin phosphorylation by KCl.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 1 280(13) 12181-9",
                "id": "15634677"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3a1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Pitx2a expression resulted in activation of the Rho GTPases Rac1 and RhoA",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2002 Feb 13(2) 683-97",
                "id": "11854422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e394"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Fgr increased Rac GTP loading, and phosphorylation of the Rac GEF Vav2, and bound to a protein complex formed by the Rho inhibitor p190RhoGAP and FAK, increasing p190RhoGAP phosphorylation, in a manner absolutely dependent on membrane localization. ",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2005 Jan 15 302(2) 253-69",
                "id": "15561106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e377"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Taken together, these results indicate that IQGAP3 can link the activation of Rac1 and Cdc42 with the cytoskeletal architectures during neuronal morphogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2007 Feb 15 120(Pt 4) 567-77",
                "id": "17244649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e360"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "After 1 min exposure to thrombin RhoA activity was enhanced 3.760.3-fold (P,0.0001, n = 7), while Rac1 activity was reduced to 76610% of control (P = 0.0256, n = 5).",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(8) e23448",
                "id": "21858121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e35b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "In DOCK2-deficient neutrophils, chemoattractant-induced activation of both Rac1 and Rac2 were severely impaired, resulting in the loss of polarized accumulation of F-actin and phosphatidylinositol 3,4,5-triphosphate (PIP3) at the leading edge.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2006 Aug 28 174(5) 647-52",
                "id": "16943182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e34e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "These results indicate that Rac1 promotes intestinal epithelial cell migration after wounding by increasing Ca(2+) influx as a result of its interaction with PLC-gamma1.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2008 Dec 295(6) C1499-509",
                "id": "18923057"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e34c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Activation of protein kinase A inhibits cell migration and angiogenesis by inhibiting the small GTPase Rac.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2002 Sep 8(9) 995-1003",
                "id": "12185361"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e323"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "dominant negative Rho-family GTPase (RhoA, Rac1, and Cdc42) and an expression vector encoding a mutated c-jun (TAM67) partially blocked the LPA-induced uPAR expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2008 Feb 4",
                "id": "18247343"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e31c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "ARF6-mediated recruitment of Nm-23-H1 to cell junctions is accompanied by a decrease in the cellular levels of Rac1-GTP, consistent with previous findings that Nm23-H1 down-regulates activation of Rac1.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Dec 4(12) 929-36",
                "id": "12447393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e31a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "AIF-1 is an actin-polymerizing and Rac1-activating protein that promotes vascular smooth muscle cell migration",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2003 May 30 92(10) 1107-14",
                "id": "12714565"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e314"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Tiam1 and Ras-GRF1 are guanine nucleotide exchange factors (GEFs) that activate the Rac GTPase.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(12) 4073-85",
                "id": "12024021"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e308"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "The results of the present study clearly show that insulin activates Rac1 via PI3K/Akt ",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2010 Jun 30(6) 1237-45",
                "id": "20339116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2fe"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "These results suggest that ROS production in growth factor-stimulated cells is mediated by the sequential activation of PI3K, beta Pix, and Rac1, which then binds to Nox1 to stimulate its NADPH oxidase activity. # beta-PIX = ARHGEF7",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 May 24(10) 4384-94",
                "id": "15121857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Finally, we determined that STAT3 expression is required for PDGF-mediated regulation of cell cycle targets cyclin D3 and p27. These data define a novel mitogenic signaling pathway in airway smooth muscle cells leading from PDGF to Rac1 and STAT3 and subsequent cell cycle gene regulation",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Apr 294(4) L698-704",
                "id": "18310224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "all the four are required for the NADPH oxidase activation Thus the TPR motifs of p67(phox) are packed to function as a Rac target, thereby playing a crucial role in the active oxidase complex formation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Aug 27 274(35) 25051-60",
                "id": "10455184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Rac2, but not Rac1, regulates superoxide production and directed migration in neutrophils, and in each cell type, the two GTPases play distinct roles in actin organization, cell survival, and proliferation",
              "citation": {
                "type": "PubMed",
                "name": "Science 2003 Oct 17 302(5644) 445-9",
                "id": "14564009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2cc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "The subsequent activation of Rac and Rho leads to the formation of focal complexes and focal adhesions, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 27 276(30) 28300-8",
                "id": "11382766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "IGF1 incudes keratinocyte migration via RAC1",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2003 Aug 1 116(Pt 15) 3227-38",
                "id": "12829742"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "The phosphorylation of Rac1 inhibited its GTP-binding activity without any significant change in GTPase activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 7 275(1) 423-8",
                "id": "10617634"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e29f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We report here that B(a)P promoted Cdc42/Rac1, p21-activated kinase 1 (PAK1), and JNK1 activities in 293T and HeLa cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Oct 21(20) 6796-807",
                "id": "11564864"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e290"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "cell invasion and Rac activity were induced by H-RasV12 and inhibited by the CD44 blocking antibody",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jan 13 24(3) 489-501",
                "id": "15516973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e27b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Tiam1 effects on cellular migration are mediated through its downstream substrate, Rac.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Metastasis 2006 23(5-6) 301-13",
                "id": "17086355"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e270"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Asef2-DeltaABR/SH3, induced increases in the levels of the active forms of Rac1 and Cdc42. Full-length Asef2 also showed this activity when co-transfected with truncated mutant APC expressed in colorectal tumor cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Dec 6 26(55) 7620-267",
                "id": "17599059"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e22f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Functional studies with the human D4 protein demonstrate that D4 has GDI activity against the CDC42Hs and rac I proteins,",
              "citation": {
                "type": "PubMed",
                "name": "Genes Chromosomes Cancer 1993 Dec 8(4) 253-61",
                "id": "7512369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e226"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jul 15 23(32) 5513-22",
                "id": "15077174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e210"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Rac promotes cell cycle progression, an effect that correlates with its ability to organize the cytoskeleton and promote spreading, rather than with its ability to activate MAP kinases (63).",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Aug 13 285(5430) 1028-32",
                "id": "10446041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e203"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "overexpression of dominant negative Rac1 potentiated LPS-induced permeability change",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2011 Aug 45(2) 426-35",
                "id": "21148740"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Apr 1 62(7) 2131-40",
                "id": "11929835"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Activated Rac1 and Cdc42 form a tripartite complex with IQGAP1 and APC (Watanabe et al., 2004). The depletion of IQGAP1 or APC by RNAi inhibits formation of an actin meshwork at the leading edge, as well as cell migration, immobilization of the plus-ends of microtubules and polarization of the MTOC.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2005 May 15 118(Pt 10) 2085-92",
                "id": "15890984"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We show here that upon detachment from the extracellular matrix, fibroblasts undergo rapid apoptosis that can be rescued by constitutive activation of Rac1 and Cdc42Hs GTPases.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 May 11 19(20) 2377-85",
                "id": "10828879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1b1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Indeed, mouse Dishevelled-2 (Dvl2) activates RhoA and Rac but not Cdc42 (Figure 1A).",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2001 Dec 28 107(7) 843-54",
                "id": "11779461"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1ac"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Overexpression of dominant negative Rac1 (T17N) led to a striking (>80%) inhibition of LPA-induced ERK2 activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2003 Sep 15 116(Pt 18) 3835-46",
                "id": "12902401"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Constitutively active Rac1 enhanced OCL survival, which was completely suppressed by phosphatidylinositol 3'-kinase (PI3K) inhibitors, Rac1 is critically involved in M-CSF receptor signaling and mediates survival signaling of osteoclasts primarily by modulating PI3K/Akt pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Bone Miner Res 2005 Dec 20(12) 2245-53",
                "id": "16294277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e19a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Guanosine 5'-(3-O-thio)triphosphate (GTPgammaS).glutathione S-transferase (GST)-Cdc42 and GTPgammaS. GST-Rac1 inhibited the binding of IQGAP1 to beta-catenin in a dose-dependent manner in vitro",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 10 274(37) 26044-50",
                "id": "10473551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e18e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Tiam1 is a ubiquitous guanine nucleotide exchange factor (GEF) that activates the Rac GTPase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 18833-41",
                "id": "12531897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e165"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Reduced SCF-induced activation of Rac1 and Rac2 GTPases, p38 mitogen-activated protein kinase, and filamentous actin polymerization was observed in fyn(-/-) mast cells compared to wild-type mast cells.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 May 1 109(9) 3679-86",
                "id": "17213284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e152"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We show that p66shc, an adaptor protein that promotes oxidative stress, increases the rac1-specific GEF activity of sos1, resulting in rac1 activation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2006 Mar 13 172(6) 817-22",
                "id": "16520382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e14d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Of the 17 tested members of the Rho family, only the active isoforms of Rac (Rac1, Rac2, and Rac3) both stimulate PLC-beta activity in vivo and bind PLC-beta2 and PLC-beta3, but not PLC-beta1, in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 6 278(23) 21099-104",
                "id": "12657629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Although expression of constitutively active Rac1 does not increase apoptosis in the basal condition, inhibition of Rac1 either by NSC-23766 (Rac1 inhibitor) or expression of dominant negative Rac1 protects cells from TNF-alpha-induced apoptosis by inhibiting caspase-3, -8, and -9 activities",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2006 Dec 291(6) G1137-47",
                "id": "16798728"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Rac1 can also activate JNK, resulting in the NFAT pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "J Angiogenes Res 2010 2 1",
                "id": "20150991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "nm23H1 negatively regulates Tiam1 and inhibits Rac1 activation in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Apr 10 98(8) 4385-90",
                "id": "11274357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "activation of PKC can bypass the functional defects in T-cells deficient for Vav-1, RAC-1 and also WASP (WAS) function indicating that, in T-cells, PKCtheta might function downstream of those proteins",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2002 Jun 38(15) 1087-99",
                "id": "12044776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 5 278(36) 34339-46",
                "id": "12810717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e078"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Taken together, our data demonstrate a novel mechanism of Wnt pathway regulation whereby activation of Rac1 amplifies the signaling activity of stabilized/mutated beta-catenin by promoting its accumulation in the nucleus, and synergizing with beta-catenin to augment TCF/LEF-dependent gene transcription.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Sep 20",
                "id": "15377999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e06b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "overexpression of integrin alpha5 increases Rac activity",
              "citation": {
                "type": "PubMed",
                "name": "Cell Metab 2005 Sep 2(3) 165-77",
                "id": "16154099"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e03e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Syk then phosphorylates and activates Btk and Vav, which activate PLC?2 and Rac, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2012 7(2) e31829",
                "id": "22363743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e034"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Fz2 was internalized through a clathrin-mediated route in response to Wnt5a, and inhibition of clathrin-dependent internalization suppressed the ability of Wnt5a to activate Rac.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2010 Jan 6 29(1) 41-54",
                "id": "19910923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e01d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "In vitro the GAP domain activates RhoA, Rac1, and Cdc42 GTPases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 24 275(47) 36885-91",
                "id": "10967100"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dffb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Lis1 haploinsufficiency is shown here to also result in reduced filamentous actin at the leading edge of migrating neurons, associated with upregulation of RhoA and downregulation of Rac1 and Cdc42 activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 Sep 24 23(25) 8673-81",
                "id": "14507966"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "FIGURE 6. Activated Rac induces phosphorylation of JNK1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Feb 12 285(7) 4511-9",
                "id": "20018857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfe7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "dominant negative forms of Rac1 and Cdc42Hs inhibit the expression of the muscle-specific genes myogenin, troponin T, and myosin heavy chain in L6 and C2 myoblasts",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2000 Aug 11(8) 2513-28",
                "id": "10930450"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfe3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "from full text:Our data showed that phosphorylation of Pak1 Ser-199/204 was enhanced by DSCAM (Fig. 5B), whereas Pak1 phosphorylation induced by RacL61 was observed as a positive control.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 30 279(31) 32824-31",
                "id": "15169762"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfdb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Table 2 Summary of genes regulated by H-Ras V12, RhoA QL, Rac1 QL and Cdc42 QL [activated forms]",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 May 1 22(17) 2689-97",
                "id": "12730683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfcf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Together, our findings indicate that NT-stimulated IL-8 expression is mediated via a Rho-dependent NF-kappaB-mediated pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Jun 284(6) C1397-404",
                "id": "12584113"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfc4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Herein, we demonstrate that RhoA, Rac1, and Cdc42 promote the expression of cyclooxygenase-2 (COX-2) at the transcriptional level. Rho GTPases induce the expression of COX-2 in NIH3T3, HT29, DLD-1, and MDCK cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Jul 14(7) 3041-54",
                "id": "12857884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfc0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Ephrin-A stimulation of EphA receptors modulates the activity of ephexin leading to RhoA activation, Cdc42 and Rac1 inhibition, and cell morphology changes.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2001 Apr 20 105(2) 233-44",
                "id": "11336673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfbd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "in NIH 3T3 cells transient expression of constitutively activated forms of the small GTP-binding proteins Ras or Rac1 leads to a significant increase in intracellular ROS",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1996 Sep 1 318 ( Pt 2) 379-82",
                "id": "8809022"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfb2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Recently, an NADPH oxidase complex, regulated by Rac1, has been characterized in nonphagocytic cells, such as vascular smooth muscle, cardiac myocytes, and endothelial cells (for review, see Ref. 32)..In contrast to phagocytes, nonphagocytic cells exhibit low-intensity basal production of superoxide, tightly controlled by Rac1, as well as small bursts of NADPH oxidase activity upon Rac1 stimulation. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Oct 285(4) C723-34",
                "id": "12958025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "from full text - The molecular mechanisms for the effects of azathioprine have now been identified and include blockade of STAT-3 and NF-kB activation. T-cell death is induced by Rac1 suppression. 64,65",
              "citation": {
                "type": "PubMed",
                "name": "Inflamm Bowel Dis 2006 Nov 12(11) 1068-83",
                "id": "17075348"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfa8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Transient transfection assays demonstrated that constitutively activated PI3K and Rac1 enhanced the activation of the MDR1 promoter by 2-AAF.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Mar 27 21(13) 1945-54",
                "id": "11960367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df89"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "In neuroblastoma cells, GEFT promotes the active GTP-bound state of Rac1, Cdc42, and RhoA and increases neurite outgrowth primarily via Rac1. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 29 279(44) 45824-32",
                "id": "15322108"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "we show that platelet-derived growth factor activates Rac1 in vivo by increasing PtdIns(3,4,5)P(3) concentrations, rather than the closely related lipid, PtdIns(3,4)P(2). ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 Sep 15 382(Pt 3) 857-65",
                "id": "15242348"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Rac-dependent protein kinase PAK phosphorylates MEK and thereby stabilizes its association with Raf.",
              "citation": {
                "type": "PubMed",
                "name": "Hematol Oncol Clin North Am 2000 Jun 14(3) 517-35",
                "id": "10909038"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "The down-regulation of TSC1 with TSC1 siRNA in TSC2-/- cells activated Rac1 and induced loss of stress fibers.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2004 Dec 20 167(6) 1171-82",
                "id": "15611338"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407def9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Interleukin-3 (IL-3)-induced activation of endogenous Rac-1, Rac-2, and Cdc42",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2002 Nov 1 100(9) 3183-92",
                "id": "12384416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407def6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Cdc42/Rac1 signaling pathway activates proteasomal degradation of p21(CIP1).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jul 22(13) 4587-97",
                "id": "12052868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deeb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "GFRalpha1a but not GFRalpha1b promoted neurite outgrowth in neuroblastoma cells through the activations of ERK1/2, Rac1 and Cdc42. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Neurosci 2009 Aug 41(4) 464-73",
                "id": "19463953"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dee5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 22 274(43) 30957-62",
                "id": "10521491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dee0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Eps8 has been shown to form a Rac-specific guanine nucleotide exchange factor complex with Abi-1 and Sos-1, which seems essential for ruffling formation induced by oncogenic Ras.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Aug 1 64(15) 5237-44",
                "id": "15289329"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deb7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Neurotrophin-3 (NT3) acting through the TrkC receptor tyrosine kinase stimulates Schwann cell migration via the Rho GTPases Rac1 and Cdc42.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Oct 11 102(41) 14889-94",
                "id": "16203995"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "In contrast to wild-type p120ctn, the microtubule-associated p120ctn mutant did not activate Rac1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 20 279(8) 6588-94",
                "id": "14660598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "The constitutively active Rho GTPases, V12Cdc42 and V12Rac1, both stimulate actin nucleation in permeabilized neutrophils.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Aug 21 150(4) 785-96",
                "id": "10953003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "DOCK180, via its DHR-1 and DHR-2 domains, couples PtdIns(3,4,5)P(3) signalling to Rac GTP-loading, which is essential for directional cell movement.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2005 Aug 7(8) 797-807",
                "id": "16025104"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de1f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "WAVE proteins are members of the Wiskott-Aldrich syndrome protein (WASP) family of scaffolding proteins that coordinate actin reorganization by coupling Rho-related small molecular weight GTPases to the mobilization of the Arp2/3 complex.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2000 Sep 1 19(17) 4589-600",
                "id": "10970852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de1d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "HeLa cells expressing ArhGAP15 were also resistant to phorbol myristatate acetate treatment, suggesting that ArhGAP15 is a potential regulator of Rac1.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Mar 27 539(1-3) 131-7",
                "id": "12650940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de1b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "activated Rac1-induced Bad phosphorylation by a cell-permeable competitive peptide inhibitor representing this Bad phosphorylation site sensitizes lymphoma cells to drug-induced apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jul 24(14) 6205-14",
                "id": "15226424"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de15"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "B cell lymphoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "The interaction is regulated, requiring phosphatidylinositol-4,5-bisphosphate and Rac1 activation,",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Dec 9 159(5) 881-91",
                "id": "12473693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de06"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Cotransfection of SGK1 with activated small GTP-binding proteins revealed that Rac1, but not Rho or Rap1, induces activation of SGK1.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2002 May 1 115(Pt 9) 1985-93",
                "id": "11956329"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dddb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "On the other hand, Vav induced the activation of Rac1 or Cdc42 and c-Jun N-terminal kinase (JNK), enhanced the transcriptional and DNA-binding activities of AP-1, and induced increased phosphorylation of c-Jun.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 May 21(9) 3126-36",
                "id": "11287617"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddd4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Expression of GC-GAP in 293T cells led to a reduction in active Rac1 and Cdc42 levels but not RhoA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 5 278(36) 34641-53",
                "id": "12819203"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddc0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Lastly, RAC itself is also an obligate subunit of the cellular NADPH oxidase. The expression of active Rac1 in many cell types causes increased superoxide production, while expression of a dominant-negative Rac1 block superoxide production.",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2004 Jul 7 336(1) 1-13",
                "id": "15225871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddb5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "In human neutrophils, beta2 integrin engagement mediated a decrease in GTP-bound Rac1 and Rac2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 27 278(26) 24181-8",
                "id": "12676940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "enhancement is mediated through a phosphatidylinositol 3-kinase (PI3K)-independent signaling pathway These results indicate the existence of a novel signaling pathway where PLC-gamma activates Rac1 in a manner dependent on Iba1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 31 277(22) 20026-32",
                "id": "11916959"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddab"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "These results document a specific PI3K-->Rac1-->PAK1-->MEK-->ERK pathway in NK cells that effects lysis.  ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2000 Nov 1(5) 419-25",
                "id": "11062502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "natural killer cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Rac1 was activated in four out of five pancreatic cancer cell lines, and was activated by signaling from oncogenic K-ras. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Aug 1 67(15) 7247-55",
                "id": "17671193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of pancreas",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "In human neutrophils, beta2 integrin engagement mediated a decrease in GTP-bound Rac1 and Rac2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 27 278(26) 24181-8",
                "id": "12676940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd53"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "it has been reported that Rac1 inhibits RhoA activity in a number of cell systems (Rottner et al., 1999; Sander et al., 1999)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2009 Mar 20(6) 1715-27",
                "id": "19158396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd46"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "The Dbl-homology domains of Bcr and Abr were active in stimulating GTP binding to CDC42Hs, RhoA, Rac1, and Rac2",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1995 Oct 24 92(22) 10282-6",
                "id": "7479768"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd3d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Figure 2 | Regulation of cyclin-dependent kinase inhibitors and cyclins by the Rho pathway. Rho-family GTPases regulate mitogenic signalling in the G1 phase of the cell cycle. Rac-CDC42 and extracellular signal-regulated kinase (ERK) function in parallel pathways to stimulate cyclin D1 (encoded by CCND1) expression.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Dec 4(12) 948-55",
                "id": "15573116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd27"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "In the present study we report that, compared with wild type cells, fibronectin-adherent syndecan-4-null fibroblasts showed enhanced lamellipodia and increased Rac1 activity that could be down-regulated by re-expression of syndecan-4 in the mutant cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 5 279(45) 47172-6",
                "id": "15371457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "THP-1 cells exposed to LXA4 (10?9 mol/L) showed a twofold increase in the membrane-associated Rac, whereas the levels of membrane-associated Cdc42 were unaffected by LXA4 (Figure 8)",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2002 Jun 160(6) 2275-83",
                "id": "12057930"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd1b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "The neurotrophin receptor p75 can induce apoptosis both in vitro and in vivo p75 activates Rac GTPase, which in turn activates c-jun N-terminal kinase (JNK), including an injury-specific JNK3, in an NGF-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2002 Jan 1 22(1) 156-66",
                "id": "11756498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd16"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "In the present study, we found that alphav integrin ligation activated small GTPase Rac1 preferentially",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 13 277(50) 48379-85",
                "id": "12377770"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd13"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": " we examined the effect of Ad-mycV12Rac1 on SHP2-pY542 in MECs cultured on collagen with no BM overlay. Strikingly, V12Rac1 inhibited the phosphorylation of this residue (Fig. 8 C) and prevented phospho-SHP2 from complexing with Jak2 (Fig. 8 D). ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2006 Jun 5 173(5) 781-93",
                "id": "16754961"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd12"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "The amount of the GTP form of Rac1 is up-regulated by enforced overexpression of alsinLF.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 11 280(6) 4532-43",
                "id": "15579468"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcf9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "S. pneumoniae induced release of interleukin-8 (IL-8) by human bronchial epithelial cell line BEAS-2B.Specific inhibition of Rac1 by Nsc23766 or a dominant-negative mutant of Rac1 strongly reduced cytokine release. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2006 Apr 290(4) L730-L737",
                "id": "16299055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcf5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Specific inhibition of geranylgeranyltransferase-I and Rac/Cdc42 by GGTI-286 and Clostridium sordellii lethal toxin, respectively, enhanced TM expression.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2003 Mar 1 23(3) 512-7",
                "id": "12615662"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcf0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We demonstrate that BDNF, acting through TrkB, directly binds and specifically activates Tiam1 by phosphorylating Tyr-829, leading to Rac1 activation and lamellipodia formation in Cos-7 cells and increased neurite outgrowth from cortical neurons.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Jul 5 103(27) 10444-9",
                "id": "16801538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcdb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "P-Rex1 is a guanine-nucleotide exchange factor (GEF) for the small GTPase Rac.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 11 280(6) 4166-73",
                "id": "15545267"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcc8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Cyclic strain activated Rac1 and induced Rac1 translocation to cell membranes. Mechanical strain also induced rapid sustained phosphorylation of c-Src at Tyr(418), Rac1 at Ser(71), FAK at Tyr(397) and Tyr(576), and ERK1/2 at Thr(202)/Tyr(204).  ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jan 5 282(1) 14-28",
                "id": "17088251"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Pak3 phosphorylates Raf-1 on serine 338 in vitro and in vivo. The p21-activated protein kinases are regulated by the Rho-family GTPases Rac and Cdc42.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1998 Nov 12 396(6707) 180-3",
                "id": "9823899"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Figure 4. Actin polymerization is necessary for Rac-dependent PI(3,4,5)P3 accumulation. # treated with latrunculin B",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2003 Feb 3 160(3) 375-85",
                "id": "12551955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We show that in Jurkat cells, activated forms of Rac1 or Cdc42, but not Rho, stimulate an increase in Akt/PKB activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Aug 20(15) 5469-78",
                "id": "10891487"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "activation of Jnk was inhibited by dominant-negative Ras and Rac1 and by the phosphoinositide 3-kinase inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 May 1 16(9) 2365-75",
                "id": "9171350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc7d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Kalirin5-induced Rac1 activation is increased by the expression of wild type Arf6 and decreased by Arf6T27N.",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cell Biol 2007 8 29",
                "id": "17640372"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "These results indicate that extracellular cues can affect actin in the growth cone via microtubules, as well as affect microtubules via actin. They also point to the mediation of microtubule-dependent accumulation of F-actin at the front of the growth cone as a role of Rac 1 in neurite growth.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2003 Sep 15 116(Pt 18) 3739-48",
                "id": "12890754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Here we show that overexpression of IQGAP1 in mammalian cells enhances cell migration in a Cdc42- and Rac1-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 17 278(42) 41237-45",
                "id": "12900413"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Coexpression of activated alleles of Cdc42 or Rac1 also caused complete redistribution of TRE17 to the plasma membrane, where it partially colocalized with the GTPases in filopodia and ruffles, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Mar 23(6) 2151-61",
                "id": "12612085"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We show that RN-tre is a Rab5 GTPase-activating protein, whose activity is regulated by the EGFR. By entering in a complex with Eps8, RN-tre acts on Rab5 and inhibits internalization of the EGFR. Furthermore, RN-tre diverts Eps8 from its Rac-activating function, resulting in the attenuation of Rac signalling.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2000 Nov 16 408(6810) 374-7",
                "id": "11099046"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc4a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "A Mirk promoter construct was activated when C2C12 myoblasts were switched from growth to differentiation medium and was also activated by the Rho family members RhoA, Cdc42, and to a lesser degree Rac1, but not by MyoD or Myf5",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 17 278(42) 41347-54",
                "id": "12902328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "In the present study, we show that Fas receptor ligation or cellular treatment with synthetic C6-ceramide results in activation or phosphorylation, respectively, of the small G-protein Rac1, Jun N-terminal kinase (JNK)/p38 kinases (p38-K), and the transcription factor GADD153",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Aug 29 272(35) 22173-81",
                "id": "9268362"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbe8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "endogenous P-Rex1 was involved in cell migration of PC12 cells and primary cultured neurons from the embryonic day 14 cerebral cortices, induced by extracellular stimuli (NGF, BDNF, and epidermal growth factor).",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2005 Apr 27 25(17) 4406-19",
                "id": "15858067"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbe3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Rac1 stimulates serine 152 phosphorylation in a PAK1-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 1 280(13) 12152-61",
                "id": "15684429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbe0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbd6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Using M14 melanoma cells stably transfected with a constitutively active form of Rac1, we show that activated Rac inhibits tumor cell response to apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Sep 27 20(43) 6263-8",
                "id": "11593437"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Rac V12 expression results in the induction of the IL-6 and IL-6 receptor genes and neutralizing antibodies directed against the IL-6 receptor block Rac1-induced STAT3 activation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Jul 31 98(16) 9014-9",
                "id": "11470914"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbc4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "Surprisingly, Wnt-1, which has been studied primarily in ?-catenin signaling, activates RhoA and Rac, but not Cdc42 (Figure 1B).",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2001 Dec 28 107(7) 843-54",
                "id": "11779461"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbaf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "The phosphorylation of Rac1 inhibited its GTP-binding activity without any significant change in GTPase activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 7 275(1) 423-8",
                "id": "10617634"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "gether, these data demonstrate that Rho GTPases regulate lymphocyte polarization and chemokine-induced migration, and underscore the key role of Cdc42 in lymphocyte directional migration.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 1999 Nov 29(11) 3609-20",
                "id": "10556816"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dba3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAC1) actsIn gtp(p(HGNC:RAC1))",
              "summary_text": "We also show that the Smad site in the CTGF/CCN2 promoter is responsive to both Rac1 inhibition and cytochalasin D treatment, suggesting a role of TGFbeta/Smad signaling in mediating the effects of actin dynamics and Rac1.",
              "citation": {
                "type": "PubMed",
                "name": "Osteoarthritis Cartilage 2008 Aug 28",
                "id": "18760941"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"RAS Family\")",
        "relation": "actsIn",
        "target": "gtp(p(SFAM:\"RAS Family\"))",
        "directed": false,
        "label": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405327a",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway  for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-DCdk4 from phosphorylating Rb  unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 46,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Sep 2(9) 647-56",
                "id": "12209154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e424"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Figure 8. Model for the role of HBP1/p16INK4A  in Ras-induced premature senescence. The results of this article are summarized in this schematic diagram. Activated Ras in primary cells initiates a premature senescence program that is orchestrated by MEK/MKK3/6-p38 MAPK/HBP1/p16INK4A pathway activation. Our study data indicate that p16INK4A is a novel target of the transcription factor HBP1. HBP1 is involved in Ras-induced premature senescence by mediating p16INK4A expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2010 Sep 9 29(36) 5083-94",
                "id": "20581871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e41d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "NF-IL6, a member of the basic leucine zipper (bZIP) family transcription factors, is involved in expression of inducible genes involved in immune and inflammatory responses. We observed that coexpression of oncogenic p21ras stimulated the transactivating activity of NF-IL6 and induced phosphorylation of Thr-235 located just N-terminal to the DNA binding domain of NF-IL6. Recently, mitogen-activated protein (MAP) kinases have been shown to be implicated in the cellular response to activated ras. Purified MAP kinases specifically phosphorylated Thr-235 of NF-IL6 in vitro. Mutation of Thr-235 abolished the ras-dependent activation of NF-IL6. From these results, we conclude that NF-IL6 is regulated through phosphorylation by MAP kinases in response to activated ras.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1993 Mar 15 90(6) 2207-11",
                "id": "8384717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3c8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "A role for PLD in cell proliferation is indicated from reports showing that PLD activity is elevated in response to platelet-derived growth factor (PDGF; 6), fibroblast growth factor (7, 8), epidermal growth factor (EGF; 9), insulin (10), insulin-like growth factor 1 (11), growth hormone (12), and sphingosine 1-phosphate (13). PLD activity is also elevated in cells transformed by a variety of transforming oncogenes including v-Src (14), v-Ras (15, 16), v-Fps (17), and v-Raf (18).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 Sep 1(11) 789-800",
                "id": "14517341"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Two classes of differentiation factors, the neurotrophins and fibroblast growth factors, induce rapid tyrosine phosphorylation of SNT1(FRS2alpha), which in turn enables SNT1 to recruit Shp2 tyrosine phosphatase and Grb2 adaptor protein in complex with the Ras GDP/GTP exchange factor Sos. Mutagenesis of SNT1(IRS)CX identified three classes of effector motifs within SNT critical for both sustained ERK activation and neuronal differentiation: 1) four phosphotyrosine motifs that mediate recruitment of Grb2, 2) two phosphotyrosine motifs that mediate recruitment of Shp2, and 3) a C-terminal motif that functions by helping to recruit Sos.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 20 276(16) 13049-56",
                "id": "11278583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e34b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "However, it is p27 that seems to be the primary target of SKP2, given that Skp2 ko mice show a marked accumulation of p27 (REF. 24), and that prominent cellular phenotypes apparent in Skp2 00 mice (see Supplementary information S1 (table)) including nuclear enlargement, polyploidy and an increased number of centrosomes that are probably caused by overreplication of chromosomes and centrosomes disappear in Skp2 ko p27 ko double mutant mice. The oncogenic potential of SKP2 has also been shown in transgenic mouse models 35,36. Furthermore, Ras signalling induces SKP2 expression through the binding of GA-binding protein, an Ets-family transcription factor, to the SKP2 promoter37. Such evidence supports the notion that SKP2 is a growth promoter and an oncoprotein.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2006 May 6(5) 369-81",
                "id": "16633365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e32b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Mitogen-activated protein (MAP) kinases comprise a family of ubiquitous proline-directed, protein-serine/threonine kinases, which participate in signal transduction pathways that control intracellular events including acute responses to hormones and major developmental changes in organisms. MAP kinases lie in protein kinase cascades. This review discusses the regulation and functions of mammalian MAP kinases. Nonenzymatic mechanisms that impact MAP kinase functions and findings from gene disruption studies are highlighted. Particular emphasis is on ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2001 Apr 22(2) 153-83",
                "id": "11294822"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e223"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Also, antioxidants decrease the mRNA abundance of MSR-1 by suppressing NF-kB and decreasing MSR-1 mRNA stability rather than through direct effects on transcription [102]. A summary of redox effects on various transcription factors as well as on some elements of signal transduction pathways is presented in Table 1. Although Table 1 presents an overview of the effects as well as the differences that may occur between different cell models, a comprehensive presentation of all redox effects on these factors and their interactions is far beyond the scope of the present discussion. For more detailed discussions of some of the effects listed in Table 1, the reader is referred to several excellent reviews [14-17,93,103-105]. Also, we have primarily focused on oxygen-centered species rather than on reactive nitrogen species; for a review of nitrogen intermediates in signal transduction, the reader is referred to the article by Lander [90]. SIGNAL TRANSDUCTION PATHWAYS Although many pathways are known to be redoxsensitive, none have been more thoroughly examined than the MAP kinase and NF-kB signal transduction pathways. Many of the redox effects on cells are mediated either directly or indirectly through these pathways, which contain multiple steps sensitive to ROS. Because of the large number of studies of oxidants on the various components of the MAP kinase and NF-kB signal transduction pathways, we provide a brief overview of both these pathways. MAP kinases Extracellular signaling molecules such as growth factors and cytokines induce changes in cell behavior via complex mechanisms that involve transmission of the signal from the plasma membrane to the nucleus, where gene expression is altered [303,304]. The first step of a signaling cascade usually involves the activation of receptors that either have protein kinase activity or activate protein kinases in the cytoplasm. The signal is eventually transmitted to the nucleus, where it activates the transcription factors that regulate gene expression. One of the most studied families of signal transduction pathways is the (MAP) kinase family (Fig. 1). Four MAP kinase subfamilies have been identified to date: (i) ERK [305- 309], (ii) JNK/SAP kinase [310-314], (iii) p38 kinases, [315-318], and (iv) big MAP kinase (BMK/ERK5) [319, 320]. All these pathways contain redox-sensitive sites (Table 1). In the ERK and JNK pathways, a guanine nucleotide exchange factor such as the mammalian homologue of Sos [321] activates Ras by conversion of Ras-GDP to Ras-GTP [322-324]. Sos must usually complex with other proteins to perform this function. It contains SH2 domains, which are a conserved sequence of 100 amino acids that bind to tyrosine phosphorylated motifs in other proteins [17]. In the cytoplasm, Sos is constitutively bound to another SH2 domain-containing protein, Grb-2 [325-327]. Activation of growth factor receptors results in tyrosine autophosphorylation and recruitment of SH2 domain-containing affectors, including Grb-2 [325,328-330]. The result is plasma membrane targeting of Sos [331], where it is tyrosinephosphorylated [332] (Fig. 1). The phosphorylated Grb-2/Sos complex binds to an adapter protein, the SH-containing (SHC) protein [330, 333-336], and the multiprotein complex activates Ras-GDP by converting it to its GTP-bound form [337]. Interestingly, treatment of cells with oxidants such as H2O2 stimulates formation of the SHC-Grb2-Sos complex [99].",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Figure 5. This is a figure in the review representing the cross talk between FGFR3 and IL6 signaling in multiple myeloma cell line KH11; the legend is as follows: Fig. 5. Enhanced proliferation of myeloma cells by interleu- kin- 6 cooperatingwith FGFR3-mediated signals. IL- 6 and FGF induce the distinct intracellular signaling pathways in myeloma cells carryingt(4 ;14)(p16. 3 ;q32) that ectopically express FGFR3. FGF and IL- 6 activate ERK1/ 2, PI- 3 kinase and STAT3, respectively. The serine phosphorylation of STAT3 via the FGF- induced ERK1/ 2 activation contributes to the full activation of STAT3, leadingto the expression of c-myc and bcl- 2 genes and cell proliferation 91 .FRS:FGF receptor substrate.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Exp Hematop 2006 Nov 46(2) 55-66",
                "id": "17142955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e16a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Extensive data indicate that oncoproteins, such as oncogenic H-Ras, initiate signal transduction cascades that ultimately lead to the activation of specific transcription factors. We and others have previously demonstrated that Ras activates the inherent transcriptional activation function of the transcription factor nuclear factor kappaB (NF-kappaB). Supportive of the importance of NF-kappaB in transformation, Ras-induced cellular transformation can be suppressed by expression of IkappaBalpha, an inhibitor of NF-kappaB, or by dominant-negative forms of the upstream activator IkappaB kinase (IKK). However, conclusive evidence for a requirement for NF-kappaB subunits in oncogenic transformation has not been reported. Furthermore, there is little understanding of the gene targets controlled by NF-kappaB that might support oncogenic conversion. The data presented here demonstrate that, although both p65 and c-Rel enhance the frequency of Ras-induced cellular transformation, these NF-kappaB subunits are not essential for Ras to transform spontaneously immortalized murine fibroblasts. Microarray analysis identified a set of genes induced by Ras that is dependent on NF-kappaB for their expression and that likely play contributory roles in promoting Ras-induced oncogenic transformation.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Oct 15 64(20) 7248-55",
                "id": "15492243"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e161"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We chose to analyze pancreatic cancer cells since this tumor type displays the highest frequency of somatic mutations of RAS genes of all human malignancies (5, 22). Hs766T cells express activated KRAS and display elevated levels of pERK1/2 and pAKT (Fig. 4C). Treatment of Hs766T cells with the PI3'-kinase inhibitor LY294002 led to a selective decrease in pAKT with little or no effect on pERK1/2. By contrast, treatment of the cells with the MEK inhibitor U0126 or CI-1040 led to a selective decrease in pERK1/2 with little or no effect on pAKT. Strikingly, both the PI3'-kinase and the MEK inhibitors led to accumulation of p27Kip1 expression. These data are consistent with the observation that both MEK and PI3'-kinase inhibitors elicited a G0/G1 cell cycle arrest in Hs766T cells (data not shown). Further consistent with these observations, treatment of a panel of pancreatic cancer cells (eight cell lines) (57) with a MEK inhibitor (U0126 or CI-1040) led to a consistent G0/G1 cell cycle arrest accompanied by induced expression of p27Kip1 in all eight cell lines tested (S. Gysin and M. McMahon, sub- mitted for publication). For the most part, treatment of cells with MEK inhibitors led to a cytostatic rather than a cytotoxic effect, although cell death was often observed after prolonged treatment (+6 days). Treatment of pancreatic cancer cells with LY294002 led in some cases to a cytostatic effect and in others to a more rapid cytotoxic effect. Consistent with the observations in Fig. 4C, inhibition of PI3'-kinase by LY294002 led to elevated p27Kip1 expression in five of eight pancreas cancer cell lines tested. These data are fully consistent with the hypothesis that the RAS-activated RAF-MEK-ERK and PI3'-kinase- PDK-AKT pathways play a role in the regulation of p27Kip1 expression in bona fide human cancer cell lines.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10868-81",
                "id": "15572689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e10e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Another major signaling pathway is the Ras/MAP kinase cascade [33] (fig. 1). The activated Kit recruits SH-2-containing proteins such as Grb2, Shc and SHP2. Grb2 may bind Kit either directly or indirectly through interaction with Shc or SHP2. Since Grb2 is constitutively associated with Sos, a guanine nucleotide exchange factor, the recruitment of Grb2 to the activated Kit resultes in the colocalization of Sos and Ras and the subsequent activation of Ras. This promotes the interaction of Ras with Raf serinethreonine kinase and then the activation of MEK (a MAP kinase kinase). MEK phosphorylates ERK (a MAP kinase), and ERK phosphorylates a number of substrates, including pp90rsk [33]. Imatinib mesylate also inhibits the phosphorylation of ERK [34]. This process is considered to be due to blocking of the Kit signaling by this drug. Thus, both major signaling pathways of Kit, the PI3K/Akt system and the Ras/MAP kinase cascade, are inhibited by imatinib mesylate.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Dec 61(23) 2924-31",
                "id": "15583854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Although the growth-inhibitory effect of TGF-B is believed to be mediated by the Smad dependent TGF-B signaling pathway, there have been reports of TGF-B mediated inhibition of proliferation in Smad4 null cells.22 Proposed alternative mechanisms for resistance to TGF-B include decreased expression of TBRI,34 TBRII,35 or TBRIII36 on the cell surface; increased expression of the inhibitory Smad, Smad7; repression of TGF-B signaling by a variety of oncoproteins including p53,38 Myc,39 E1A,40 Ras,41 Ski/ SnoN,42,43 and Evi-1 44; reduced expression or inactivation of tumor suppressors that directly regulate the TGF-B signaling pathway including Menin,45 Disabled-2 ,46 and RUNX3; and activation of other signaling pathways includings protein kinase C (PKC). TGF-B is able to increase the production of mitogenic growth factors, including platelet-derived growth factor,51 fibroblast growth factor,52 TGF-B,53 and connective tissue growth factor,54 and to increase expression of the platelet derived growth factor receptor,55 and the epithelial growth factor receptor.56 In addition, TGF-B can activate Smad independent pathways, including the Ras/Raf/MAPK pathway,20-22,57,58 which often mediates the proliferative signal of growth factors. Indeed, it is in conjunction with oncogenic forms of Ras (Ha-Ras or Ki-Ras), that TGF-B drives Smad-independent proliferation of human colon and prostate cancer cells.3,49",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Mar 20 23(9) 2078-93",
                "id": "15774796"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "A specific subset of integrins (including {alpha}1{beta}1, {alpha}5{beta}1, and {alpha}v{beta}3) can induce or enhance cell proliferation through interaction of the integrin  {alpha}-subunit cytoplasmic domain with caveolin-1, a membrane protein that plays a role in organizing membrane microdomains. In this pathway, caveolin-1 recruits the src family kinases, yes or fyn, which recruit the adaptor protein shc that in turn leads to recruitment and activation of the well-characterized Ras pathway (122).",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2003 Jul 83(3) 673-86",
                "id": "12843406"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e07a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "mice lacking a functional gene for IL-5 or IL-5 receptor alpha chain (IL-5Ralpha) display a number of developmental and functional impairments in B cells and eosinophils. IL-5 receptor (IL-5R) comprises alpha and betac chains. IL-5 specifically binds to IL-5Ralpha and induces the recruitment of betac to IL-5R. Although precise mechanisms on cell-lineage-specific IL-5Ralpha expression remain elusive, several transcription factors including Sp1, E12/E47, Oct-2, and c/EBPbeta have been shown to regulate its expression in B cells and eosinophils. JAK2 and JAK1 tyrosine kinase are constitutively associated with IL-5Ralpha and betac, respectively, and are activated by IL-5 stimulation. IL-5 activates at least three different signaling pathways including JAK2/STAT5 pathway, Btk pathway, and Ras/ERK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Adv Immunol 2009 101 191-236",
                "id": "19231596"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e042"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "These results link signaling pathways previously shown to be associated with cell proliferation (18) and cytoskeletal organization (29, 30) to growth factor gene activation and identify a cis element in FGF1 promoter 1D that can be defined as an SRE. This SRE is comprised of Ets and CArG sites. These sites are targets of regulation by divergent signaling pathways; Ets site target of Ras, Rac1, and Cdc42 regulation; and the CArG site target of de novo protein synthesis-independent cascade.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 29 275(39) 30432-8",
                "id": "10849427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The life history of cancer cells encompasses a series of genetic missteps in which normal cells are progressively transformed into tumor cells that invade surrounding tissues and become malignant. Most prominent among the regulators disrupted in cancer cells are two tumor suppressors, the retinoblastoma protein (RB) and the p53 transcription factor. Here, we discuss interconnecting signaling pathways controlled by RB and p53, attempting to explain their potentially universal involvement in the etiology of cancer. Pinpointing the various ways by which the functions of RB and p53 are subverted in individual tumors should provide a rational basis for developing more refined tumor-specific therapies.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2002 Aug 2(2) 103-12",
                "id": "12204530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df2a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Immortalized rat colon epithelial cell lines expressed only ACBP and SCP-2 at levels of 0.75 +/- 0.13 and 0.42 +/- 0.02 ng/microgram protein. Ras and src transformation increased colon cell density and differentially altered ACBP and SCP-2 expression without affecting I-FABP or L-FABP levels. ACBP levels were 1.8-fold and 1.5-fold increased in ras- and src-transformed cells, respectively. In contrast, SCP-2 expression was significantly decreased 55 and 67% in ras- and src-transformed cells, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "Lipids 1997 Jun 32(6) 577-85",
                "id": "9208385"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dee3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The human AF-6, a scaffold protein between cell membrane-associated proteins and the actin cytoskeleton, plays an important role in special cell-cell junctions and signal transduction. It can be phosphorylated by the protein kinase Bcr, which allows efficient binding of the C terminus of Bcr to the PDZ domain of AF-6 and consequently enhances the binding affinity of AF-6 to Ras. Formation of the AF-6, Bcr, and Ras ternary complex results in down-regulation of the Ras-mediated signal transduction pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Protein Sci 2007 Jun 16(6) 1053-62",
                "id": "17473018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Tyrosine phosphorylation led to the association of BCR with the RAS guanine nucleotide exchange complex GRB2-SOS in vivo via the GRB2 SH2 domain, linking BCR to RAS signaling (Maru, Y., Peters, K. L., Afar, D. E. H., Shibuya, M., Witte, O. N., and Smithgall, T. E. (1995) Mol. Cell. Biol. 15, 835-842). In the present study, we demonstrate that BCR Tyr-246 and at least one of the closely spaced tyrosine residues, Tyr-279, Tyr-283, and Tyr-289 (3Y cluster), are phosphorylated by FES both in vitro and in 32Pi-labeled cells. Mutagenesis of BCR Tyr-177 to Phe completely abolished FES-induced BCR binding to the GRB2 SH2 domain, identifying Tyr-177 as an additional phosphorylation site for FES.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Dec 20 271(51) 32930-6",
                "id": "8955135"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Oncogenic Ras induces the transcription activity of NF-kappaB that confers cell survival. Oncogenic Ras also down-modulates the expression of Par-4, a transcriptional repressor protein, that is essential but not sufficient on its own to induce apoptosis. Here we show that reintroduction of Par-4 by transient transfection leads to apoptosis in cells expressing oncogenic Ras but not in those that lack oncogenic Ras expression. Par-4 abrogates oncogenic Ras-inducible NF-kappaB transcription activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 29976-83",
                "id": "10514481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc38"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "After activating Ras using EGF, the GTP-bound form of Ras was precipitated with GST-RBD (GST-Raf containing Ras binding domain). Precipitated Ras was detected using the HA-antibody. As shown in Fig. 5D, in the presence of EGF, the amount of GTP-bound Ras increased over that of the control. Levels of the GTP-bound Ras significantly decreased in cells expressing DIP1/2; however, DIP1/2m failed to stimulate Ras GTPase in cells treated with EGF.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 12 277(15) 12622-31",
                "id": "11812785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc13"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The human interstitial collagenase (MMP-1) promoter has been also shown to be a Ras-responsive promoter by virtue of the presence of ETS and AP-1 cis-elements, which act synergistically to activate Ras-dependent transcription of the gene (15, 16). Similarly to what was observed previously with the synthetic ORE reporter, ESE-3 was able to repress the -1200 to +63 collagenase promoter response to Ras (Fig. 6B). In both cases, expression of ETS-2 resulted in enhanced expression of the reporter in these cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 8 276(23) 20397-406",
                "id": "11259407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The treatment of rat lung epithelial cells with nicotine for various periods differentially mobilizes multiple intracellular pathways [64]. Protein kinase C and PI3-OH-kinase are transiently activated after the treatment. Also, Ras and its downstream effector ERK1/2 are activated after long-term exposure to nicotine. The activation of Ras by nicotine treatment is responsible for the subsequent perturbation of the methotrexate (MTX)-mediated G1 cell cycle restriction, as well as an increase in production of reactive oxygen species [64].",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbfc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Raf may also be activated by Ras-independent elements and, in turn, propagates signals through diverse effectors that mediate proliferation, angiogenesis, metastases, and survival.5 Raf may be activated by signaling upstream or constitutively. Constitutive activation of Raf and Ras are indistinguishable in their potential to induce malignant transformation.6-8 Activating raf mutations have been identified in melanoma, thyroid, colon, and other cancers (Table 1).9-43 Furthermore, the disappointing clinical results of farnesyltransferase (FTase) inhibitors (FTIs) that were developed based on a flawed premise that they would effectively target malignancies with a high incidence of Ras mutation has led to scrutiny of signaling elements downstream of Ras, such as Raf, as therapeutic targets.44 This review highlights relevant information about the biology of Raf and novel strategies directed at exploiting this knowledge to more effectively treat malignant diseases. SIGNALING THROUGH THE MAPK PATHWAY The molecular mechanisms and signaling pathways that regulate cell proliferation and survival are receiving considerable attention as potential targets for anticancer strategies. 45,46 Recently, there has been a notable increase in efforts directed at targeting the MAPK pathway, which integrates a wide array of proliferative signals initiated by receptor tyrosine kinases (RTKs) and G protein- coupled receptors.47,48 The network of signals emanating from the MAPK pathway are transmitted by proteins that serve as chemical switches, cycling between phosphorylated (activated) and dephosphorylated (inactivated) states.49 These on and off switches are regulated by kinases and phosphatases, respectively. Activated signaling elements, in turn, phosphorylate amino acid residues on downstream signaling proteins in a cascade-like and expansive manner.50 Not only does the centrality of the MAPK pathway render its components important targets for therapeutic development, but many genes that encode for its critical signaling elements undergo mutations, constitutively activating downstream signaling elements and conferring the potential for transformation and autonomous growth.50-52 In addition to efforts directed at Ras, therapeutic strategies directed at the MAPK pathway are targeting the cascade of downstream effector proteins including Raf, MAPK kinase (MAPKK; also called MEK or extracellular signal-regulated kinase [ERK] kinase), and ERK. The Raf/MEK/ERK module (Fig 1) of the MAPK pathway, which is immediately downstream of Ras, may be less redundant and innately resistant to therapeutic manipulations compared with Ras (as discussed in the next section). The Unfilled Promise of Targeting Ras The Raf/MEK/ERK module of the MAPK pathway has been the focus of considerable attention because therapeutic efforts directed at Ras, which is situated at the apex of the MAPK pathway, have been disappointing.44 Ras belongs to a superfamily of guanine nucleotide triphosphatases (GTPases) that transmit proliferative and survival signals to the MAPK, phosphatidylinositol 3-kinase (PI3K), and other pathways (Figs 1 and 2). Three ras proto-oncogenes encode four 21-kd proteins, called p21ras or Ras (H-Ras, N-Ras, K-Ras4A, and K-Ras4B, resulting from two alternatively spliced K-Ras gene products), that are localized to the inner surface of the cell membrane.44 Of the three ras genes, K-ras mutations are most commonly found in solid malignancies, whereas N-ras mutations are encountered less often, and H-ras mutations are rarely encountered.53,54 Ras isoforms impart distinct biologic effects as a result of the potential of these proteins to differentially activitate critical effectors.55 After synthesis as inactive cytosolic propeptides, Ras undergoes a series of post-translational modifications at its carboxyl terminus that increase its hydrophobicity.56,57 These modifications render Ras functional and capable of lo...",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbb0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Shc and FRS2 mediates recruitment of Grb2-SOS complexes leading to Ras/ERK stimulation, and of Grb2-GAB1/2 complexes leading to stimulation of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway. ShcC and IRS are required to trigger PI3K/AKT activation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Dec 61(23) 2954-64",
                "id": "15583857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e351"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We analyzed jacalin-induced intracellular signaling events in CD4(+) T cells and have shown that cell activation resulted in tyrosine phosphorylation of intracellular substrates p56(lck), p59(fyn), ZAP-70, p95 (vav), phospholipase C-gamma1, and ras activation, as assessed by conversion of ras guanosine 5'-diphosphate to ras guanosine 5'-triphosphate. ",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2003 May 73(5) 682-8",
                "id": "12714584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e32a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "It is also found that overexpression of the GLRX1 gene leads to deglutathionylation of Ras protein, thus inhibiting its activation [291].",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry (Mosc) 2008 Dec 73(13) 1493-510",
                "id": "19216714"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e327"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We demonstrated that silencing of gelsolin expression by small interfering RNA sensitized cells to butyrate-induced apoptosis through amplification of the activation of caspase-9 and caspase-7. These data therefore demonstrate that gelsolin protects cells from butyrate-induced apoptosis and suggest that Ras promotes apoptosis, at least in part, through its ability to down-regulate the expression of gelsolin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 27 279(35) 36680-8",
                "id": "15213223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We demonstrate that co-expression of DIP1/2 and the N-terminal domain of DOC-2/DAB2 (i.e. Delta B) has an additive effect on suppressing either TPA-induced SRE or TRE reporter gene activity (Fig. 6B and Table I). Therefore, we believe that the in vivo interaction of DIP1/2 with the N-terminal domain of DOC-2/DAB2 acts as a feedback mechanism to modulate PKC-induced gene activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31981-6",
                "id": "10542228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "COX-2 is inducible by oncogenes ras and scr, interleukin-1, hypoxia, benzo[a]pyrene, ultraviolet light, epidermal growth factor, transforming growth factor beta, and tumor necrosis factor alpha.",
              "citation": {
                "type": "PubMed",
                "name": "Ann Clin Lab Sci 2000 Jan 30(1) 3-21",
                "id": "10678579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Each of these stimuli triggers a cell cycle arrest and the expression of a battery of senescence associated markers (e.g., SA-associated b-galactosidase). Other markers include the p16 and p21 CDK inhibitors, of which the latter is a new p38 MAPK target.",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2004 Jul 7 336(1) 1-13",
                "id": "15225871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2b2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Full text: SHB binds the activated FGFR-1 at tyrosine 766, which causes SRC-dependent tyrosine phosphorylation of SHB. SHB also associates constitutively to SHP-2, and upon FGF-2 stimulation, SHB/SHP-2 bridging promotes FRS-2 phosphorylation and activation. Thus, SHB is required for an adequate activation of the RAS/ERK pathway and endothelial cell cell mitogenesis [13].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Mol Med 2003 Jun 3(4) 313-24",
                "id": "12776987"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Inhibition of Ras has been reported to prevent intimal formation after vascular injury, suggesting a critical role of Ras activation inVSMC proliferation [82].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Feb 36(2) 175-83",
                "id": "14871544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e266"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Rap-1 antagonizes Ras in T cells42 but activates the Raf-ERK cascade, as does Ras, in PC12 cells43 and contributes to the integrin-mediated adhesion of T lymphocytes and embryonic fibroblasts.44,45",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2002 Nov 1 91(9) 769-75",
                "id": "12411390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e25f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Incubation of neutrophils in the presence of 25 nM IL-8 for 2 minutes resulted in the stimulation of Ras/GTP exchange followed by the rapid hydrolysis of GTP to GDP by Ras, identified by the Ras-bound GDP.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Feb 2 271(5) 2832-8",
                "id": "8576262"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e255"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The LHR-mediated phosphorylation of the EGFR and Shc, the activation of Ras, and the phosphorylation of ERK1/2 are inhibited by expression of a dominant-negative mutant of Fyn, a member of the Src family kinases (SFKs) expressed in MA-10 cells and by PP2, a pharmacological inhibitor of the SFKs. ",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2006 Jul 147(7) 3419-27",
                "id": "16614081"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e232"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In addition, the Y716(P) peptide significantly decreased the amount of GTP bound to Ras [Ras activation] in response to PDGF",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Oct 14(10) 6715-26",
                "id": "7935391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e22c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Expression of activated MEK completely blocked apoptosis induced by serum withdrawal (Fig. 5). In addition, the expression of active Ras and Raf-1, which also activate MEK, similarly inhibited cell death induced by growth factor deprivation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Aug 19(8) 5308-15",
                "id": "10409722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1e1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We found that activation of the Met receptor for hepatocyte growth factor results in the tyrosine phosphorylation of beta4, which is instrumental for integrin-mediated recruitment of the tyrosine phosphatase Shp2. Shp2 binding to beta4 enhances the activation of Src, which, in turn, phosphorylates the multiadaptor Gab1 predominantly on consensus sites for Grb2 association, leading to privileged stimulation of the Ras-extracellular signal-regulated kinase (ERK) cascade.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2006 Dec 18 175(6) 993-1003",
                "id": "17158954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Transcriptional up-regulation of uridine phosphorylase is shown to be mediated in a DNA binding-dependent manner, and reporter gene assays demonstrated that EWS/FLI1 and RAS mediate activation through a single activator protein 1/ETS site located in the uridine phosphorylase promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jul 15 63(14) 4268-74",
                "id": "12874036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1bf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Cofilin has been identified as a key mediator of actin reorganization. Its activity is regulated via reversible phosphorylation of ser-3......Thus, stimulation of Ras through platelet-derived growth factor (PDGF) or transient expression of activated Ras-proteins induces the dephosphorylation of cofilin",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Feb 16(2) 235-43",
                "id": "14636893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Induction of SNT-1 PTB resulted in a significant decrease of FGF-1-dependent tyrosine phosphorylation of endogenous SNT-1, strong inhibition of complex formation between SNT-1, Gab-1 and Sos-1, and reduced activation of Ras, mitogen-activated protein kinase (MAP kinase), and Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Sep 28 25(44) 6003-14",
                "id": "16682955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e158"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "RAF pull-down assays showed elevated levels of activated Ras-GTP in Lkb1 mutant SCC relative to papillomas and normal skin despite the absence of H-ras mutations in these tumors (Fig. 4A).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Jan 1 68(1) 55-63",
                "id": "18172296"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e132"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Carcinoma, Squamous Cell",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "TNF- induced binding of Ras to beads conjugated to the Ras binding domain (RBD) of Raf, indicative of Ras activation (Figure 2A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Jun 28(6) 762-9",
                "id": "12600818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e12f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Genetic and biochemical analyses in Caenorhabditis elegans, Drosophila, Xenopus, and mammals support the notion that Shp2 promotes Ras activation by growth factors and cytokines......most functional analyses suggest that the catalytic activity of Shp2 is required for promotion of signaling through the Ras-Erk pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Feb 1 109(3) 862-7",
                "id": "17053061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e107"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We conclude (i) that PP2A negatively regulates the Ras/MAP kinase pathway by binding to Shc, inhibiting tyrosine phosphorylation;",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Apr 22(7) 2375-87",
                "id": "11884620"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e102"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "high levels of Bcr-Abl activate a signaling cascade involving the sequential activation of Ras, phosphatidylinositol-3 kinase, atypical protein kinase C, Raf-1, and mitogen-activated protein kinase kinase, leading to the ultimate expression of OPN.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2005 Jul 78(1) 289-300",
                "id": "15857938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "GRB7 also maps to 17q12 and has been shown to be overexpressed in some TGCTs [21,22]. GRB7 is an adapter molecule that can bind directly to KIT and ERBB2 through its SH2 domain [23] and is also proposed to bind directly to RAS through its RAS association domain. In this way, GRB7 may have an important role in the regulation of the downstream signaling of these kinases. Furthermore, GRB7 is also known to play a role in cell migration",
              "citation": {
                "type": "PubMed",
                "name": "Neoplasia 2005 Dec 7(12) 1047-52",
                "id": "16354586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "PDGF-AA-induced activation of Ras, initiation of DNA synthesis, or growth of cells alphaPDGFR to activate Ras or initiate a proliferative response",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Dec 16(12) 6926-36",
                "id": "8943348"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Here we found that DOC-2/DAB2, a signaling molecule inhibiting the Ras cascade, binds to myosin VI at the globular tail domain.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2002 Mar 29 292(2) 300-7",
                "id": "11906161"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The activation and targeting of both RhoA and Ras to the ER further confirmed the action of Nox4 on the ER, as these GTPases function upstream and downstream of Nox4, respectively.Thus, RhoA, Nox4, and Ras appear to signal on the ER surface to mediate the Tat-dependent ER stress response.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2010 Jul 30(14) 3553-68",
                "id": "20457808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "At the same time, the ROS dependent activation of Ras is found to be one of the causes of development of atherosclerosis and restenosis [292]",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry (Mosc) 2008 Dec 73(13) 1493-510",
                "id": "19216714"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0c7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Knockout mouse studies have established that the transformation-selective death program triggered by farnesyltransferase inhibitor (FTI) requires a gain-of-function in the stress-regulated small GTPase RhoB. In support of the concept of RhoB as a negative regulator of Ras signaling pathways, the most strongly downregulated gene scored was farnesyl pyrophosphate synthetase, the enzyme that produces the substrate used by FT to farnesylate Ras proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 2(3) 273-80",
                "id": "12878865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0c0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "By combining pharmacological and genetic approaches, we show here that the Ras/ERK pathway and phosphatidylinositol 3-kinase (PI3K) are both required for cortical neuron migration. By dissecting the downstream signals necessary for this event, we found that Rac1/p38 and Akt are required, whereas the c-Jun N-terminal kinase (JNK) and mTOR/p70(s6k) pathways are dispensable.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 24 281(8) 4771-8",
                "id": "16361255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "FAK also combines with, and may activate, phosphoinositide 3-OH kinase (PI 3-kinase), either directly or through the Src kinase (13). Finally, there is evidence that Src phosphorylates FAK at Tyr925, creating a binding site for the complex of the adapter Grb2 and Ras guanosine 5'-triphosphate exchange factor mSOS (10). These interactions link FAK to signaling pathways that modify the cytoskeleton and activate mitogen-activated protein kinase (MAPK) cascades (Fig. 3A).",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Aug 13 285(5430) 1028-32",
                "id": "10446041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e04a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We previously reported that Ras activation induced vascular cell senescence and inflammation, and we suggested that vascular cell senescence might contribute to human atherogenesis.19",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2006 Aug 29 114(9) 953-60",
                "id": "16908765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e048"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We found that Pak directly associates with Raf-1 under both physiological and overexpressed conditions. The association is greatly stimulated by 4beta-12-O-tetradecanoylphorbol-13-acetate and nocodazole and by expression of the active mutants of Rac and Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 8 277(6) 4395-405",
                "id": "11733498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e046"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Of potential functional relevance, the expression of Par-4 allows TNFalpha to induce apoptosis in NIH-3T3 cells. In addition, the down-regulation of Par-4 levels by oncogenic Ras sensitizes cells to TNFalpha-induced NF-kappaB activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 9 274(28) 19606-12",
                "id": "10391896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df9d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Similarly, somatostatin receptor (Lahlou et al., 2003), as well as insulin and low doses of EGF (Wennstrom and Downward, 1999) can drive Ras activation through PI3K",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Sep 18 27(41) 5527-41",
                "id": "18794886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The EGFR and ErbB2 suppression of RhoB promoter activity is mediated by Ras. Furthermore, Ras suppresses basal as well as 5-fluorouracil (5-FU)-induced RhoB promoter activity and RhoB protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Feb 5 23(5) 1136-45",
                "id": "14647415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df75"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Hematopoietic progenitors isolated from CML patients in the chronic phase contain a constitutively tyrosine-phosphorylated protein that migrates at 62 kDa by SDS-PAGE and associates with the p120 ras GTPase-activating protein (GAP). ",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1997 Jan 24 88(2) 197-204",
                "id": "9008160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "U-87 MG cells treated with FTI-277 (farnesyltransferase inhibitor), which block the Ras activity, decreased VEGF mRNA expression to approximately 30% of baseline. Also, cells transfected with dominant negative form of Ras, showed a decreased VEGF promoter activity in U-87 and U87/T691cells MG cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Oct 15 60(20) 5879-86",
                "id": "11059786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Importantly, other molecules such as p16INK4 are probably also involved in the induction of permanent cell-cycle arrest. Because disruption of p16INK4 enables escape from RAS-induced senescence [60],",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2007 Jan 13(1) 4-11",
                "id": "17118707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "hDAB2IP (human DAB2 (also known as DOC-2) interactive protein) is a novel GTPase-activating protein for modulating the Ras-mediated signal pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 31 278(5) 3121-30",
                "id": "12446720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df4b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df44"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "however, phosphorylation of Raf-1 was significantly lower in Hpca(-/-) slices. These results suggest that Hpca plays an important role in the activation of Raf conducted by Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci Res 2007 Mar 85(4) 837-44",
                "id": "17279541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df3c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Thus far, only a single Shc phosphorylation site, the tyrosine at position 317 (Y317) has been identified. Phosphorylation of Y317 has been implicated in Grb2 binding and activation of the Ras pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1996 Nov 1 6(11) 1435-44",
                "id": "8939605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Through its phosphorylated tyrosine residues, the activated VEGFR-2 associates with the adapter molecules Shc, Grb2 and Nck, to Ras GTPase activating protein, p59fyn, pp62yes and phospholipase Cg, and to the tyrosine phosphatases SHP-1 and SHP-2",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Feb 15 18(4) 882-92",
                "id": "10022831"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "(Figure 6B). The average of three experiments showed that 55.8+6.9% of ERK phosphorylation and 43.0+7.9% of IkBa degradation were reverted by the Ras inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2008 Aug 1 79(3) 537-44",
                "id": "18411230"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df1b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "These findings suggest that inhibition of ICMT causes endothelial cell apoptosis by attenuation of Ras GTPase methylation and activation and its downstream antiapoptotic signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Mar 14(3) 848-57",
                "id": "12631708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df17"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Our results indicate that autocrine secretion of PRL stimulates tyrosine phosphorylation of ErbB-2 by Jak2, provides docking sites for Grb2 and stimulates Ras-MAP kinase cascade, thereby causing unrestricted cellular proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 27 275(43) 33937-44",
                "id": "10938266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df11"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We previously showed that TESK1 interacts with Sprouty-4 (referred to as Spry4), an inhibitor of growth factor-induced Ras/MAP (mitogen-activated protein) kinase signalling, but the functional role of this interaction has remained unknown.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 May 1 387(Pt 3) 627-37",
                "id": "15584898"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df09"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In turn, Grb2 stimulates a guanine nucleotide exchange protein, SOS, to convert Ras from the inactive GDP-bound state to the active GTP-bound form. ",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2000 2(3) 211-6",
                "id": "11250712"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df08"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Levels of AFP mRNA but not albumin mRNA were elevated by simvastatin in a dose-dependent manner (1-10 micromol/l).",
              "citation": {
                "type": "PubMed",
                "name": "J Hepatol 1999 May 30(5) 904-10",
                "id": "10365819"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407defe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Reconstitution of PKCbetaI expression in these cells by retroviral transfection increased Ras/ERK activation by 3050%, indicating full restoration of Ras/ERK activation (Fig. 2 D and E). ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Aug 5 100(16) 9470-5",
                "id": "12881490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407def1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "consistent with its role in tumor angiogenesis, expression of VEGF is upregulated by the common genetic events leading to malignant transformation, including loss of tumor suppressor genes, such as p53, and activation of oncogenes, such as ras, v-src and HER2",
              "citation": {
                "type": "PubMed",
                "name": "Oncologist 2004 9 Suppl 1 2-10",
                "id": "15178810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dede"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "\\\"Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Aug 17(8) 4509-16",
                "id": "9234708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ded4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "EphrinB2 not only increased the phosphorylation of EphB2 and EphB4 in a time-dependent manner but also increased recruitment of p120-Ras-GTPase-activating protein (p120-RasGAP) to EphB2 and EphB4. Accordingly, ephrinB2 inhibited VEGF- and Ang1-induced Ras-MAPK activities, whereas ephrinB2 did not alter VEGF-induced Flk phosphorylation or Ang1-induced Tie2 phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Jul 16(9) 1126-8",
                "id": "12039842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407debd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In addition to its role in cell proliferation, we have found that constitutive activation of Ras induces vascular cell senescence that is associated with vascular inflammation [20].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Feb 36(2) 175-83",
                "id": "14871544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dea7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "This stimulation matched or exceeded phospholipase activation promoted by co-expression of PLC-epsilon with the known regulators Ras, Galpha12/13, or Gbeta1gamma2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 17 278(42) 41253-8",
                "id": "12900402"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de92"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The ectodomain of SHPS-1 has now been shown to be shed from cells in a reaction likely mediated by a metalloproteinase. This process was promoted by activation of protein kinase C or of Ras, and the released ectodomain exhibited minimal CD47-binding activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 27878-87",
                "id": "15123722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de8e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "we demonstrate that Ras activity can be increased by tyrosine phosphorylated Vav upon cellular stimulation via the IL-2 receptor or the TCR/CD3-complex.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1995 Dec 26 217(3) 876-85",
                "id": "8554611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "H2O2-dependent stimulation of HDC promoter activity was completely inhibited by kinase-deficient ERKs, dominant-negative (N17 and N15) Ras, and dominant-negative Raf, and partially blocked by a dominant-negative EGFR mutant.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Sep 4 273(36) 23046-54",
                "id": "9722530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de03"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": " The small guanine nucleotide (GTP)-binding protein Rac regulates mitogen-induced cytoskeletal changes and c-Jun amino-terminal kinase (JNK), and its activity is required for Ras-mediated cell transformation. Epistatic analysis placed Rac as a key downstream target in Ras signalling; however, the biochemical mechanism regulating the cross-talk among these small GTP-binding proteins remains to be elucidated.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1999 Sep 16 401(6750) 290-3",
                "id": "10499589"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ang II is an important molecule that activates the Ras signaling pathway. Consistent with the influence of Ang II on senescence, constitutive activation of Ras has been found to induce vascular cell senescence and is associated with vascular inflammation.60",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Jan 5 100(1) 15-26",
                "id": "17204661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddc7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Helicobacter pylori infection, one of the risk factors for gastric cancer, can activate Ras through EGFR transactivation [13].",
              "citation": {
                "type": "PubMed",
                "name": "Am J Transl Res 2011 Feb 3(2) 209-18",
                "id": "21416062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd8b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "we found that PGE2 stimulated the activation of Ras and ERK, but not Akt, and reduced matrix deprivation-induced apoptosis, in untransformed epithelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2007 Dec 46(12) 958-70",
                "id": "17477350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Cortical OP (oligodendrocyte precursor) cells treated with 10 ng/ml of pDGF and 10 ng/ml of bFGF for 5 minutes showed significant increase in GTP-bound, active Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 1997 Feb 15 17(4) 1291-301",
                "id": "9006973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd6b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Gel electrophoretic analysis demonstrated that 1,10-phenanthroline almost totally abolished the labeling of methylated proteins in kidney intracellular membranes. Immunoblotting analysis showed that one of the two major peaks of (3)H-methylated proteins in intracellular membranes comigrated with the small G proteins Ras, Cdc42, RhoA, and Rab1.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1999 Aug 11 261(3) 790-7",
                "id": "10441503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd47"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We have previously shown in NIH 3T3 fibroblasts that treatment with 12-O-tetradecanoylphorbol 13-acetate (TPA) or fibroblast growth factor-2 (FGF-2) activates the Ras/Erk signaling pathway in NIH 3T3 fibroblasts, leading to the induction of the urokinase-type plasminogen activator (uPA) gene.",
              "citation": {
                "type": "PubMed",
                "name": "Gene 1997 Nov 12 201(1-2) 179-87",
                "id": "9409785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd3a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Co-transfection of the MAO B promoter with dominant negative forms of Ras, Raf-1, MEKK1, MEK1, MEK3, MEK7, ERK2, JNK1, and p38/RK inhibit the PMA-dependent activation of the MAO B promoter",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22222-30",
                "id": "11956220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd37"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "wild-type AMs exposed to CSE had increased levels of active Ras, a small GTPase that perpetuates proinflammatory signaling. Conversely, RAGE KO AMs had less Ras activation compared with wild-type AMs after exposure to CSE.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2012 Jun 1 302(11) L1192-9",
                "id": "22505673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dca2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages, Alveolar",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "By directly targeting ezrin expression, miR-204 functions as a new miRNA regulator of Ras activation, and its downregulation represents a novel mechanism for aberrant Ras activation in cancer development.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Transl Res 2011 Feb 3(2) 209-18",
                "id": "21416062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc23"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "",
                "tissue": "gastric epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Overexpression of N17Ras completely eliminated ERK phosphorylation at 5 minutes and 24 hours following NGF treatment indicating that Ras plays a critical role in the apoptotic pathways that are induced by NGF-mediated activation of TrkA receptors in the cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 7 275(1) 565-70",
                "id": "10617652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbfa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Here, we demonstrate an activation of the small G-proteins Rac 1 and Rac 2 after Fas receptor triggering. Expression of a transdominant inhibitory Ras mutant (N17Ras) prevents Rac 1 and Rac 2 stimulation, suggesting a signaling cascade from the Fas receptor via Ras to Rac 1 and Rac 2. Genetic and pharmacological inhibition of Ras or Rac 1 and Rac 2 stimulation blocks Fas-induced apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Oct 18 271(42) 26389-94",
                "id": "8824295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbf6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "To examine the mechanism of Unc51.1 regulation of axon extension, we have identified two direct binding partners. The first, SynGAP, a negative regulator of Ras, is expressed within axons and growth cones of developing granule cells.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2004 Mar 1 18(5) 541-58",
                "id": "15014045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbbf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Moreover, Erbin inhibits the Erk activation by active Ras, while it fails to do so in the presence of active Raf-1. Erbin associates with active Ras, but not inactive Ras nor Raf. Consistently, Erbin interferes with the interaction between Ras and Raf both in vivo and in vitro. Erbin associates with active Ras, but not inactive Ras nor Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 10 278(2) 1108-14",
                "id": "12379659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Mutation of tyrosine 766 to phenylalanine prevented PLC-gamma activation and resulted in a reduced phosphorylation of FRS2 and reduced activation of the Ras/MEK/MAPK pathway relative to the wild-type chimeric receptor.  -- ([bcd]  looked at full text and they bloted with anti-phosphotyrosine)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2002 Aug 13(8) 2881-93",
                "id": "12181353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db5c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e404"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "From CST pathway map for GPCR Signaling to ERK. ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Endocrinol Metab 2006 Sep 17(7) 276-83",
                "id": "16890451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Lysophosphatidic acid (LPA) is the prototypic G-protein-coupled receptor agonist that activates the Ras-mitogen-activated protein (MAP) kinase cascade",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1999 Apr 1 339 ( Pt 1) 11-4",
                "id": "10085221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3d4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "three members of the Raf family of protein-serine/threonine kinases have been identified (Raf-1, A-Raf, and B-Raf), whose activation is linked to receptor protein-tyrosine kinases by Ras (24).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Aug 19(8) 5308-15",
                "id": "10409722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3c9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "TNFalpha-induced Ras activation is important in hepatic proliferation in response to ethanol-induced liver injury.",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2004 Mar 39(3) 721-31",
                "id": "14999690"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3bb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "RTK signaling potentiates GLI activity through PI3K-AKT-mediated GSK3 inactivation or RAS-STIL1-mediated SUFU inactivation, while GPCR signaling to Gs represses GLI activity through adenylate cyclase-mediated PKA activation",
              "citation": {
                "type": "PubMed",
                "name": "Curr Mol Med 2009 Sep 9(7) 873-86",
                "id": "19860666"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e372"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Active Ras was reduced in Sirtinol-treated senescent cells",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Jan 12 25(2) 176-85",
                "id": "16170353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e36f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Although ligation of both receptors induces Ras and Raf-1 activation,",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Feb 15 162(4) 2087-94",
                "id": "9973482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e367"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Growth factor and other survival signals are transduced through receptor tyrosine kinases via adaptor proteins (such as GRB2 and the guanine-nucleotide exchange factor SOS) and activate Ras and its downstream targets, Raf and MEK1/2, which results in the activation of ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2008 Sep 118(9) 3003-6",
                "id": "18725993"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e350"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The dimerization of two EGFR family molecules leads to .... exchange of a GTP from the receptor complex for a GDP from the RAS protein to form activated RAS",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e347"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In response to stimulation with epidermal growth factor (EGF), the guanine nucleotide exchange factor human SOS1 (hSOS1) promotes the activation of Ras by forming a complex with Grb2 and the human EGF receptor (hEGFR)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Mar 8 271(10) 5871-7",
                "id": "8621459"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e339"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Epo has also been shown to stimulate activation of Ras and Raf-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Nov 25 269(47) 29962-9",
                "id": "7961995"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e333"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The sentence from ResnetDB These data suggest that Src, Raf, and H-Ras oncoproteins stimulate elevated ARF6 expression is translated to the assertions Activation of ARF6 (Homo sapiens) Gene Expression by Oncogene Activation of ARF6 (Homo sapiens) Gene Expression by RAF1 (Homo sapiens) Protein",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jan 23(2) 645-54",
                "id": "12509462"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e332"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras-GTP levels were elevated 2 days after infection and were suppressed to levels significantlylower than cycling vector-infected cells several days later (Figure 3B).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Dec 10(6) 459-72",
                "id": "17157787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e313"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ligation of this receptor by EGF activates Erk1 and Erk2, members of the mitogen-activated protein (MAP) kinase family, through a Ras-dependent signal transduction pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1998 Oct 15 395(6703) 713-6",
                "id": "9790194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e312"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "jubilant",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1999 Feb 15 93(4) 1338-45",
                "id": "9949177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e30c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Although both Rac and CDC42 are clearly activated by RAS",
              "citation": {
                "type": "PubMed",
                "name": "Prog Cell Cycle Res 2003 5 203-10",
                "id": "14593714"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e301"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 1997 Jan 6 185(1) 43-53",
                "id": "8996240"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2fc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "senescence was induced by replicative exhaustion, oncogenic RAS, p14(ARF), or hydrogen peroxide",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Oct 9 98(21) 12072-7",
                "id": "11593017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We also found that NCK binds directly to the guanine nucleotide exchange factor SOS. This interaction is mediated by the SH3 domains of NCK. These findings suggest that NCK can regulate p21ras-dependent gene transcription through interaction with SOS protein.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 Mar 15(3) 1169-74",
                "id": "7862111"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2ed"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We found that oncogenic ras promotes an increase in the intracellular level of ceramides together with an increase in the PPP1CA protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2008 Mar 29(3) 491-9",
                "id": "18204081"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Precancerous hyperproliferation and sustained activation of the Ras-MAPK cascade was recently found in skin with tissue-specific ablation of a-catenin [8].",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2001 3(5) 289-93",
                "id": "11597316"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Consistent with our findings, functional inhibition of Ras has been demonstrated to suppress pro-inflammatory molecules, thereby reducing lesion formation in ApoE-deficient mice [83].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Feb 36(2) 175-83",
                "id": "14871544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2b8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Atherosclerosis",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras activation was decreased in RAGE null mouse lung exposed to chronic cigarette smoke.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2011 Aug 45(2) 411-8",
                "id": "21131443"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2a9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "calcimycin, a calcium mobilizer, activates the RAF/MEK/ERK pathway through RAS,",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Sep 16(9) 4437-53",
                "id": "16000378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e291"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We showed that the expression of Gro-1 is activated by RAS and is vital for cell survival and the malignant transformation of ovarian epithelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Oct 31 103(44) 16472-7",
                "id": "17060621"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e288"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Gene 33 inhibits EGFR autophosphorylation and specifically blunts epidermal growth factor (EGF)-induced activation and/or phosphorylation of Ras, ERK, JNK, Akt/PKB, and retinoblastoma protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2924-33",
                "id": "15556944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e283"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The constitutive activation of Ras provokes premature senescence in vascular cells, which is associated with accumulation of the proteins p53 as well as p16 [20].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Feb 36(2) 175-83",
                "id": "14871544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e275"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "from full text - Figure 1 ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jul 35(1) 3-9",
                "id": "16484682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e24a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 21039-45",
                "id": "11274196"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e23f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Thus, in addition to negatively regulating Src family kinases by recruiting Csk, PAG also negatively regulates Ras by recruiting RasGAP to the membrane. ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Jul 15 110(2) 596-625",
                "id": "17389760"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e207"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Feb 28 302(1) 46-55",
                "id": "12593846"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e201"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "overexpression of either dominant negative Rac2 or the N-terminal regulatory domain of PAK1 inhibits Ras-mediated activation of ERK2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Jul 16(7) 3707-13",
                "id": "8668187"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 8 277(10) 8076-82",
                "id": "11779872"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We show that p52Shc is phosphorylated on both YY239/240 and Y317 following TCR engagement. Mutation of either YY239/240 or Y317 results in impaired interaction with Grb2 and inhibition of Ras/MAP kinase activation and CD69 induction, supporting a role for both Grb2 binding sites in this function.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Mar 24 24(13) 2218-28",
                "id": "15688026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e195"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "These findings suggest that inhibition of ICMT causes endothelial cell apoptosis by attenuation of Ras GTPase methylation and activation and its downstream antiapoptotic signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Mar 14(3) 848-57",
                "id": "12631708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e18f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Tumour incidence in the Rasexpressing Par-4 KO lungs was significantly higher as compared with the Ras-expressing WT controls (Figure 2B).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Jul 24",
                "id": "18650932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e18b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Dominant-negative forms of Ras and/or Rac-1 significantly suppressed HIF-1 activation by muscarinic signaling. Signaling via M1- and M3- but not M2- or M4-AchRs promote accumulation and transcriptional activation of HIF-1alpha.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 1 279(40) 41521-8",
                "id": "15280370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e188"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Apr 21(8) 2659-70",
                "id": "11283246"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e17d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "C2-ceramide-induced membrane association of p21Ras was reduced by 30-50% in PPT1-overexpressing cells compared with control.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2000 Apr 74(4) 1478-88",
                "id": "10737604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e10f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Protein kinase A-dependent phosphorylation of serine 43 within the regulatory domain of Raf-1 reciprocally potentiates its interaction with Rheb and decreases its interaction with H-Ras.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Feb 17(2) 921-33",
                "id": "9001246"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e10a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Jul 20(13) 4494-504",
                "id": "10848576"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e106"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Expression of oncogenic Ras in thyroid cells results in loss of expression of several thyroid-specific genes and inactivation of TTF-1,",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Apr 20(8) 2783-93",
                "id": "10733581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Thus, while p120 and NF1 (neurofibromatosis-related protein 1) are clearly Ras-specific and do not enhance the catalytic activity of Rap, RASA1 (p120-RASGAP)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Soc Trans 2006 Nov 34(Pt 5) 846-50",
                "id": "17052212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras is required to recruit Raf-1 to the plasma membrane, which is where S338 phosphorylation occurs. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Apr 21(7) 2423-34",
                "id": "11259591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras activates several proteins to initiate human tumour growth, only PI3K, through activation of protein kinase B (PKB; also known as AKT), must remain activated by oncogenic Ras to maintain this growth",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2008 Apr 3 452(7187) 646-9",
                "id": "18344980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e09c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Together, the results show that K/E-FR3 is transforming and that the Ras-ERK and the PI3K-Akt signaling pathways, which are positively regulated by SHP2, are important for K/E-FR3-induced transformation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Oct 9 22(44) 6909-18",
                "id": "14534538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e08c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We tested the hypothesis that up-regulation of DNA methyltransferase 1 (DNMT1) will lead to methylation and silencing of uPA and inhibition of the invasiveness of metastatic breast cancer cells. Since RAS was previously shown to up-regulate DNA methylation, we examined the effects of ectopic expression of constitutively active RAS on methylation and expression of uPA.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2005 Mar 26(3) 557-64",
                "id": "15618232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e087"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We also provide evidence for the importance of the downregulation of RhoB in oncogenesis by demonstrating that RhoB antagonizes Ras/PI3K/Akt malignancy.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jun 24(12) 5565-76",
                "id": "15169915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e083"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras GTPase was activated by EGF, NGF, insulin and phorbolester in PC12 cells",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2000 May 16(5) 1043-8",
                "id": "10762643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e07f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "TNF? initiates the activation of ERK/mitogen-activated protein kinase through the adaptor protein, Grb2, binding to the TNF? receptor 1, leading to activation of the ras/mitogen-activated kinase kinase (MEK)/ERK signalling cascade",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2009 11(1) R8",
                "id": "19144181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e07e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1999 Oct 15 94(8) 2754-66",
                "id": "10515879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e07c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The Dok-1 mutants having tyrosine-to-phenylalanine (YF) substitution(s) at Tyr-336 and/or Tyr-340 lost their inhibitory effect on Ras and Erk downstream of Src-like PTK, Lyn or Fyn, whereas the rasGAP-binding of each mutant remained intact. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2004 Jun 9(6) 601-7",
                "id": "15189452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e07b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We previously showed that the cytoplasmic adapter 3BP2 (also known as SH3BP2) promotes NFAT/AP-1 transcriptional activities in T cells through the activation of Ras- and calcineurin-dependent pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 28 278(9) 7146-53",
                "id": "12501243"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e074"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Reactive oxygen species (ROS) activate Ras",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 23 274(30) 21003-10",
                "id": "10409649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e06a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "inhibition of LPAAT-beta inhibits signaling in both the Ras/Raf/Erk and PI3K/Akt pathway",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2003 Oct 2(10) 1067-78",
                "id": "14578472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e054"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Taken together, these findings suggest that IL-6 might activate the Ras signaling pathway via tyrosine phosphorylation of Shc and subsequent recruitment of Grb2.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 1996 Feb 26(2) 379-84",
                "id": "8617307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e045"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "These observations suggest that SR gene expression is regulated via a signal transduction pathway involving ras, AP-1, and ets domain proteins",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Mar 14(3) 2129-39",
                "id": "8114743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e002"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Using a physiological model of beta-cell expansion, we show that HNF-4alpha is required for beta-cell replication and the activation of the Ras/ERK signaling cascade in islets",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2007 Apr 1 21(7) 756-69",
                "id": "17403778"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dff3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We also examined the interaction between Oog1 and Ras by GST pull-down assay and revealed that Oog1 interacts with Ras in a GTP-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 May 19 343(4) 1105-12",
                "id": "16580637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfea"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In addition, DN Ras, DN focal adhesion kinase (FAK), but not Stat3beta, restored intercellular adhesion, which indicates that Ras and FAK may be downstream effectors of Src-mediated homotypic adhesion.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 May 1 62(9) 2669-74",
                "id": "11980666"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfe2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Shc tyrosine phosphorylation and Ras activation by H(2)O(2) were also significantly reduced in Fyn-/- cells, but not altered in Src-/- cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 23 274(30) 21003-10",
                "id": "10409649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfdc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In the second case, Fyn or Yes, activated by some b1 and aV integrins, recruit Shc through their SH3 domain and phosphorylates it, thus promoting Shc association with the Grb2-Sos complex [62,63].",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Mar 4 1654(1) 51-67",
                "id": "14984767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfd9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Thus HGF stimulation can trigger the Ras pathway by recruiting Grb2 both directly through the receptor, and indirectly, through Shc.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1995 Apr 20 10(8) 1631-8",
                "id": "7731718"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfd1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "This antiapoptotic effect is not mediated by an increase in H(+)-ATPase activity but through activation of the Ras-mitogen-activated protein kinase (MAPK)-signaling pathway that results in the serine phosphorylation of Bad at residues 112 and 155.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2006 Dec 13(12) 2109-17",
                "id": "16710359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfcd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Moreover, the aFGF-induced Ras signaling pathway, which is essential for PC12 cell differentiation, is not affected by elimination of PI hydrolysis",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 May 20 269(20) 14419-23",
                "id": "7514169"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfcb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1986 Jan 24 14(2) 843-52",
                "id": "3945555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df8b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 34679-91",
                "id": "12105209"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "On the other hand, prostate cancer cells LNCaP or normal prostatic epithelial cells that were resistant to apoptosis by Par-4 did not show Fas or FasL trafficking. Par-4 is down-regulated by oncogenic-Ras, -Raf, or -Src.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Oct 1 61(19) 7255-63",
                "id": "11585763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In Fyn-/- fibroblasts, activation of Ras by H(2)O(2) was significantly attenuated.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 21 275(3) 1739-48",
                "id": "10636870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df66"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "cyclic stretch causes AEC DNA damage and that FGF-10 attenuates these effects by mechanisms involving MAPK activation via the Grb2-SOS/Ras/RAF-1/ERK1/2 pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2003 Feb 284(2) L350-9",
                "id": "12533312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "from full text - bombesin treatment significantly increased Ras activation (Fig. 2 C). The expression of KUZ, but not K MP, further elevated the increase of activated Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jul 22 158(2) 221-6",
                "id": "12119356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dee8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dee7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Here we report that oncogenic Ras inhibits TGFbeta signaling in mammary and lung epithelial cells by negatively regulating the TGFbeta mediators Smad2 and Smad3.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Apr 1 13(7) 804-16",
                "id": "10197981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407debc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Oncogenes which activate ras signal transduction pathways stimulate expression of the K18 gene through transcription factors including members of the AP-1 (jun and fos) and ETS families.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Metastasis Rev 1996 Dec 15(4) 445-71",
                "id": "9034603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dea2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Under these circumstances activated RhoA is reported to prevent the expression of the CKI p21Cip1, a major mediator of RAS- or RAF-induced cell cycle arrest in mouse fibroblasts (43).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10868-81",
                "id": "15572689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de74"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "activation of Jnk was inhibited by dominant-negative Ras and Rac1 and by the phosphoinositide 3-kinase inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 May 1 16(9) 2365-75",
                "id": "9171350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Interestingly, VSMC lines stably expressing dominant negative Ras (Ras N17) or Rac (Rac N17) exhibited a marked decrease in MKP-1 expression; the inhibition of ERK kinases (MEK1/2) by PD 98059 or of p38 MAPKs by SB 202190 resulted in a down-regulation of MKP-1 induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 3 274(36) 25273-80",
                "id": "10464250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de50"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Thus, in addition to negatively regulating Src family kinases by recruiting Csk, PAG also negatively regulates Ras by recruiting RasGAP to the membrane. ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Jul 15 110(2) 596-625",
                "id": "17389760"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de4f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "oncogenic mutations or amplification of ras leads to VEGF up-regulation",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2004 Aug 25(4) 581-611",
                "id": "15294883"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de47"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "BMP-2 and TGF-beta stimulated Ras, MAPK, and AP-1 activities (note: Ras is upstream of the otehr two)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15514-22",
                "id": "11854297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de1c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Src inhibition leads to activation of the Ras pathway upon PDGF stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Nov 16(11) 5418-32",
                "id": "16135530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "These events have been detected in primary scleroderma fibroblasts, which generate reactive oxygen species-Ras-ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2009 May 7 360(19) 1989-2003",
                "id": "19420368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddde"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Sprouty (Spry) proteins were found to be endogenous inhibitors of the Ras/mitogen-activated protein kinase pathway that play an important role in the remodeling of branching tissues.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Sep 1 64(17) 6127-36",
                "id": "15342396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddd2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We show that wild-type B-RAF forms a complex with C-RAF in a RAS-dependent manner, whereas the mutants bind independently of RAS. Importantly, we show that wild-type B-RAF can also activate C-RAF.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Dec 22 20(6) 963-9",
                "id": "16364920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dda8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The phorbol ester PMA is a Ras agonist and, similar to Ras, inhibits Dicer protein expression in IMR-90 human fibroblasts (data not shown) and in JAR (Fig. 4).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2009 Mar 46(6) 1222-8",
                "id": "19118902"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd9d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Protein phosphatase 1alpha is a Ras-activated Bad phosphatase",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2000 May 15 19(10) 2237-46",
                "id": "10811615"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The RasRafMek pathway is involved in signaling downstream from EGFR and in other pathways leading to the growth of cancer cells and tumor progression (Fig. 2).",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2008 Sep 25 359(13) 1367-80",
                "id": "18815398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd50"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In the presence of an inhibitor of farnesly transferase (Ftase-1), which prevent the maturation of Ras, both Estradiol and TGF alpha induced ERK activation was significantly inhibited.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15514-22",
                "id": "11854297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Src inhibition leads to activation of the Ras pathway upon PDGF stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Nov 16(11) 5418-32",
                "id": "16135530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd44"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The activation of Ras by the guanine nucleotide-exchange factor Son of sevenless (Sos) constitutes the rate-limiting step in the transduction process that links receptor tyrosine kinases to Ras-triggered intracellular signalling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2007 Jun 9(6) 706-12",
                "id": "17486115"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "growth factors, cytokines and other signalling molecules stimulate HIF-1a synthesis via activation of the phosphatidylinositol 3-kinase (PI3K) or mitogen- activated protein kinase (MAPK) pathways (FIG. 1).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Oct 3(10) 721-32",
                "id": "13130303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd32"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Expression of Cdo and Boc in myoblast cell lines is downregulated by the ras oncogene,",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2003 May 37(1) 1-4",
                "id": "12720294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Consistent with these findings, inhibition of Ras activity has been demonstrated to suppress the release of proinflammatory molecules, thereby reducing lesion formation in apoE-deficient mice.125",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Jan 5 100(1) 15-26",
                "id": "17204661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd2e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Atherosclerosis",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "This results in sustained activation of Met Y1003F and downstream signals involving the Ras-mitogen-activated protein kinase pathway, cell transformation, and tumorigenesis.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Nov 25(21) 9632-45",
                "id": "16227611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "STAT3 inhibited myogenic differentiation induced by low serum or MyoD as efficiently as the Ras/mitogen-activated protein kinase cascade",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2003 Dec 24(12) 659-66",
                "id": "14644140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd0a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras acting via Erk MAP kinases causes phosphorylation of Smad2 and Smad3 at specific sites in the region linking the DNA-binding domain and the transcriptional activation domain.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Apr 1 13(7) 804-16",
                "id": "10197981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcfd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Hyaluronan-CD44 binding  stimulated Ras-Mek1-Mapk pathway, which inturn stimulated MMP-2 secretion in a time and dose dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jul 15 62(14) 3962-5",
                "id": "12124327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dce3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We show that JNK- but not p38-activating pathways regulate the DSE activity. Furthermore, the JNK/SAPK signaling pathway cooperates with the Raf-MEK-ERK cascade in TPA/ionomycin-induced DSE activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Apr 24 273(17) 10112-9",
                "id": "9553058"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcd9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The interaction of Ras with p110alpha is thus required in vivo for certain normal growth factor signaling and for Ras-driven tumor formation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Jun 1 129(5) 957-68",
                "id": "17540175"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcd8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1991 Aug 6(8) 1353-62",
                "id": "1679529"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcd0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36216-22",
                "id": "12147692"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcc4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In the case of the Ras proteins, carboxyl methylation is important for targeting of the proteins to the plasma membrane.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2004 Feb 113(4) 539-50",
                "id": "14966563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcb8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "A significant increase of alpha-D-mannosidase (up to 16-fold increase) activity, and a parallel increase of alpha-D-mannosidase transcript in fibroblasts overexpressing Ras with respect to those infected with the empty vector was observed.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3 278(40) 38453-60",
                "id": "12878600"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcaf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "NF1, a tumor suppressor and negative regulator of Ras",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2010 Jun 29",
                "id": "20587590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "5PC-12 cells stimulated with 100 ng per ml NGF showed increase in Ras activation after 5 minutes, which was maintained after 45 minutes of NGF stimulation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Mar 20(6) 1931-46",
                "id": "10688641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc5d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The mechanism of action of farnesyltransferase inhibitors (FTIs) has not been fully clarified. We investigated the cytotoxic effects of various FTIs in chronic myeloid leukemia (CML)",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2003 Aug 15 102(4) 1490-8",
                "id": "12714496"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22558-65",
                "id": "11960991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbe6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras is involved in CpG ODN signaling as an early event by associating with TLR9 and promoting IRAK1/TRAF6 complex formation, and MAPK and NF-kappaB activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 19 278(38) 36334-40",
                "id": "12867418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbe5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In Fyn-/- fibroblasts, activation of Ras by H(2)O(2) was significantly attenuated.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 21 275(3) 1739-48",
                "id": "10636870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbce"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Necl-5, known as a poliovirus receptor and up-regulated in many cancer cells, enhances platelet-derived growth factor (PDGF)-induced activation of Ras-Raf-MEK-ERK signaling, but not PDGF-induced tyrosine phosphorylation of PDGF receptor, resulting in facilitation of cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2007 Mar 12(3) 345-57",
                "id": "17352739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbc5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Moreover, mutation of Thr-133 in RasGRP3 alone severely impaired its ability to activate Ras in B cell receptor signaling. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Nov 23 101(47) 16612-7",
                "id": "15545601"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Lysyl oxidase (LOX) down-regulation induced an oncogenic phenotype in NRK-49F. This event was accompanied by a constitutive activation of ras oncogene and down-regulation of PDGF beta receptor, among other important phenotypic and molecular modifications.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2003 Apr 11 1647(1-2) 239-44",
                "id": "12686140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbaa"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Following platelet-derived growth factor treatment, this receptor induces persistent activation of ectopically expressed PLC epsilon through activation of Ras and Rap1.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Nov 21 21(53) 8105-13",
                "id": "12444546"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db9e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The angiogenic switch can be induced at a predictable time and usually more rapidly, by introduction of oncogenes into the tumors. When the human non-angiogenic osteosarcoma was transfected with the ras oncogene, neovascularized tumors appeared within 2 weeks [7].",
              "citation": {
                "type": "PubMed",
                "name": "Semin Cancer Biol 2003 Apr 13(2) 159-67",
                "id": "12654259"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The Son of Sevenless 1 protein (sos1) is a guanine nucleotide exchange factor (GEF) for either the ras or rac1 GTPase. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2006 Mar 13 172(6) 817-22",
                "id": "16520382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db83"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras activation of Rac",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Aug 4(8) 621-5",
                "id": "12134164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"PRKA Family\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"PRKA Family\"))",
        "directed": false,
        "label": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053278",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Forskolin did not promote the binding of 14-3-3 proteins to PDE3A (Figures 2A and 5A). However, using the pSer312-PDE3A antibodies, we found that forskolin stimulated the phosphorylation of PDE3A at Ser312 (Figures 5A and 5C). This residue lies within a sequence SHRRTS312LPCIP that conforms to a consensus site for PKA. The forskolin-stimulated phosphorylation of Ser312 was inhibited by the PKA inhibitor H-89 (Figure 5C), and by mimosine and aphidicolin (Figure 5A), but not by inhibitors of PI3K (LY 294002), mTOR (mammalian target of rapamycin) (rapamycin) or the MAPK cascade (U0126) (Figure 5C; see [35] for inhibitor specificities), nor by H-7 (results not shown).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Nov 15 392(Pt 1) 163-72",
                "id": "16153182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e425"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Transcription of the ornithine decarboxylase (ODC) gene is rapidly elevated by activation of protein kinase A (PKA). The additive influence of three cis-acting elements is responsible for this regulation in an adrenal carcinoma cell line. Two sites, CRE2 at -48 base pairs (bp) relative to the start of transcription and CRE3 at +95 bp, are identical to the core motif of the cAMP-responsive element (CRE) of the somatostatin gene and are conserved in the mouse, rat, and human ODC genes. Mutation of CRE2 resulted in a substantial decrease in basal promoter activity, as well as a 5-fold decrease in inducibility of the ODC promoter by PKA. CRE3 did not contribute to the basal activity of the ODC promoter, but mutation of this site resulted in a 2-fold decrease in inducibility by PKA. Deletion of a 45-bp sequence (GC-box) located 5' of CRE2, also resulted in a 2-fold decrease in inducibility of the ODC promoter. DNase I protection revealed the presence of protein binding at CRE2, the TATA box, and the GC-box of the ODC promoter. Mutation of CRE2 resulted in loss of protection of this sequence, as well as the 3' extension of the footprint over the TATA box, without affecting interactions at the GC box. Antibodies to the well characterized CRE-binding protein CREB recognized proteins binding to CRE2, suggesting that binding of CREB, or an antigenically related protein, is important for the activity of CRE2. Additionally, recombinant CREB bound to a DNA probe containing the CRE2 sequence.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1992 Sep 15 267(26) 18866-73",
                "id": "1356108"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e369"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Here, we report that the catalytic subunit of cAMP-dependent protein kinase (PKA) but not casein kinase II or protein kinase C phosphorylates recombinant human acetylcholinesterase (AChE) in vitro. This enhances acetylthiocholine hydrolysis up to 10-fold as compared to untreated AChE, while leaving unaffected the enzyme's affinity for this substrate and for various active and peripheral site inhibitors. Phosphorylation of AChE may possibly offer a rapid feedback mechanism that can compensate for impairments in cholinergic neurotransmission, modulating the hydrolytic activity of this enzyme and enabling acetylcholine hydrolysis to proceed under such challenges.",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res Mol Brain Res 1997 Nov 51(1-2) 179-87",
                "id": "9427520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e359"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "phosphorylation by PKA strongly repressed the binding affinity of the wild-type factor but not that of HNF4 mutants. Accordingly, in transfection assays, expression vectors for the mutated HNF4 proteins activated transcription more efficiently than that for the wild-type protein-when cotransfected with the PKA catalytic subunit expression vector. Therefore, HNF4 is a direct target of PKA which might be involved in the transcriptional inhibition of liver genes by cAMP inducers.from full text (mutated HNF4 proteins at positions 133 and 134 Serine.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Aug 17(8) 4208-19",
                "id": "9234678"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2e5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The Raf kinases serve as central intermediates to relay signals from Ras to ERK. Cell-specific effects of these signals on growth, differentiation and survival can be observed due to the recruitment of different isoenzymes of the Raf family. The in vitro phosphorylation of a site unique to B-Raf (Ser429) has been proposed to be responsible for the negative regulation of the isoenzyme by Akt. Using phosphopetide mapping and site-directed mutagenesis we showed that Ser429 is phosphorylated upon cAMP elevation in PC12 cells and proposed that PKA is a major kinase phosphorylating the B-Raf-specific site in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "C R Acad Sci III 2001 Aug 324(8) 673-81",
                "id": "11510412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e280"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The importance of the nitric oxide inhibitory pathway in vivo is shown by two brothers with a defect in the bioavailability of nitric oxide, heightened platelet reactivity to agonists, and a history of cerebrovascular events.100 One common substrate of PKA and PKG is VASP, a 50-kD protein that localizes to focal adhesions and regulates actin dynamics.101 The phosphorylation of VASP on specific serine residues by agents that activate PKA or PKG correlates with inhibition of platelet aggregation.102",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1998 Apr 15 91(8) 2645-57",
                "id": "9531572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e24c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "FIG. 6. Transcriptional regulation of the PGC-1 promoter by FKHR and CREB. A schematic model for PGC-1 gene transcription mediated by FKHR and CREB through each responsive element via different hormone signals. Left: insulin activates PI3 kinase signaling pathway, which stimulates phosphorylation of FKHR by PKB, followed by nuclear exclusion and repression of PGC-1 gene transcription. Right: Glucagon activates cAMP signaling pathway, which stimulates phosphorylation of CREB by PKA, and thereby induces the expression of PGC-1.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Mar 52(3) 642-9",
                "id": "12606503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e21b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Addition of forskolin or prostaglandin E1, agents known to elevate platelet cAMP and calcium efflux, to platelets pre-labeled with [32P]PO4 resulted in the direct phosphorylation of platelet PMCA. Similarly, addition of the catalytic subunit of protein kinase A to platelet plasma membranes resulted in a 1.4-fold stimulation of activity. Thus, the previously reported inhibition of platelet activation by elevated intracellular cAMP may be accomplished in part by stimulation of PMCA, likely resulting in a decrease in intracellular calcium. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Jun 13 272(24) 15113-9",
                "id": "9182531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Cyclindependent kinases (CDKs), mainly CDK1 associated with cyclin B, have been identified as the kinase system that phosphorylates Ser-25 and Ser-38, but the protein kinase involved in phosphorylation of Ser-16 and Ser-63 during mitosis remains to be identified (5, 21). Besides cell cycle-regulated phosphorylation, Op18 is phosphorylated by members of the mitogen-activated protein kinase family on Ser-25 (22-24), by the Ca21/calmodulin-dependent kinase IV/Gr (CaMK IV/Gr) on Ser-16 (25), and by the cyclic AMP-dependent protein kinase (PKA) on Ser-16 and Ser-63 (4).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Sep 17(9) 5530-9",
                "id": "9271428"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e189"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Several factors can influence the activation of f-channels. ?-Adrenergic receptor activation stimulates (21) while muscarinic agonists inhibit If (129). This regulation is mediated by direct activation of f-channels by cAMP (50, 128), which facilitates channel opening (126). DiFrancesco and Tortora (128) failed to observe a direct regulation of SAN f-channels by purified protein kinase A (PKA) (128). In SAN cells, direct regulation of voltage dependence by cAMP can quantitatively account for If regulation by autonomic agonists (126). The existence of a PKA-mediated regulation of If has been suggested by Chang et al. (80) in canine Purkinje cells and in murine stem cells derived from cardiomyocytes (1). Intracellular Ca2+ have been reported to positively regulate If by either increasing current conductance (171) or by positively shifting the current voltage dependence (416). The mechanisms by which Ca2+ regulate If has not been elucidated. Inside-out patch-clamp experiments seem to exclude a direct Ca2+ effect on f-channels (540).",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2008 Jul 88(3) 919-82",
                "id": "18626064"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e176"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Insulin Stimulated phosphorylation cascade This pathway involves the tyrosine phosphorylation of IRS proteins and/or Shc, which in turn interact with the adapter protein Grb2, recruiting the Son-of-sevenless (SOS) exchange protein to the plasma membrane for activation of Ras. The activation of Ras also requires stimulation of the tyrosine phosphatase SHP2, through its interaction with receptor substrates such as Gab-1 or IRS1/2. Activated ERK can translocate into the nucleus, where it catalyses the phosphorylation of transcription factors such as p62TCF, Blockade of the pathway with dominant negative mutants or pharmacological inhibitors prevents the stimulation of cell growth by insulin, but has no effect on the metabolic actions of the hormone54. Insulin increases synthesis and blocks the degradation of proteins through activation of mTOR. The stimulation of this protein kinase involves PI(3)K activation, although another signal may also be required56. mTOR can control the mammalian translation machinery by direct phosphorylation and activation of p70 ribosomal S6 kinase (p70rsk)57, as well as phosphorylation of the initiation factor 4E for eukaryotic translation (eIF-4E) inhibitor, PHAS1 or 4E-binding protein 1 (ref. 58). P70rsk activates ribosome biosynthesis by phosphorylating the ribosomal S6 protein, producing increased translation of mRNAs with a 58-terminal oligopyrimidine tract. P70rsk also requires a second PtdIns(3,4,5)P3-dependent phosphorylation, presumably catalysed by PDK1. Phosphorylation of PHAS-1 by mTOR results in its dissociation from eIF-2, allowing capdependent translation of mRNAs with a highly structured 58-untranslated region. Although the mechanism of activation of mTOR remains unclear, it seems to require the presence of amino acids in the media for full activation by growth factors, and thus may also represent a nutrient sensor55. Glucose and lipid regulation Regulation of glycogen synthesis Insulin stimulates glycogen accumulation through a coordinated increase in glucose transport and glycogen synthesis. The hormone activates glycogen synthase by promoting its dephosphorylation, through the inhibition of kinases such as PKA or GSK-3 (ref. 59), and activation of protein phosphatase 1 (PP1)60.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e15d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In human osteoblast-like Saos2 cells, PTH (human 1-34 PTH, 10 nM) increased BSP mRNA and protein levels at 3 h. From transient transfection assays, 2- to 2.5-fold increase in transcription by PTH was observed at 3 and 6 h in -184, -211, -428, -868, and -927 luciferase constructs that included the human BSP gene promoter. Effect of PTH was abrogated by 2 bp mutations in either the CRE1 (-79 to -72) or CRE2 (-674 to -667). Luciferase activities induced by PTH were blocked by protein kinase A inhibitor H89 and tyrosine kinase inhibitor herbimycin. The CRE1-protein and CRE2-protein complexes were disrupted by CRE binding protein 1 (CREB1) antibodies and supershifted by phospho-CREB1 antibody. ChIP assays detected binding of CREB1 and phospho-CREB1 to a chromatin fragment containing CRE1 and CRE2, and increased binding of phospho-CREB1 to the both sites.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2009 Mar 1 106(4) 618-25",
                "id": "19127545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e15c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Vinogradova et al. (508) have reported that basal PKA activity is higher in rabbit SAN cells than in working myocytes. High phosphorylation of PLB and RyRs generates periodical LCICR causing INCX-mediated membrane voltage oscillations, which contribute to the control of the chronotropic state of the cell (43, 508). .....Figure 23. In pacemaker cells, high basal cAMP-mediated PKA-dependent phosphorylation stimulates a perpetual \\\"free running\\\" Ca2+ cycling by pumping Ca2+ into the SR via SERCA2 and LCICR via RyRs. PKA also stimulates Ca2+ entry through Cav1.3-mediated ICa,L. The thick red line indicates the persistent spontaneous Ca2+ cycling. The possibility that Cav3.1-mediated ICa,T can contribute to replenishment of SR Ca2+ stores is suggested. Spontaneous LCICR from SR is linked to the diastolic depolarization via Ca2+ activation of inward INCX current. Direct cAMP-dependent activation of HCN channels or cAMP-mediated, PKA-dependent phosphorylation of Cav1.3 channels and Ist (dashed lines) strongly stimulates the pacemaker cycle driven by the \\\"membrane ion channels clock\\\" (MCC). It is conceivable that the MCC can entrain the intracellular Ca2+ clock because of the dependency of SR Ca2+ content from VDCCs. (see Fig 23 for detail)",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2008 Jul 88(3) 919-82",
                "id": "18626064"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e131"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In the present study, we have shown that (i) beta-catenin can be phosphorylated by protein kinase A (PKA) in vitro and in intact cells at two novel sites, Ser-552 and Ser-675; (ii) phosphorylation by PKA promotes the transcriptional activity (TCF/LEF transactivation) ofbeta-catenin; (iii) mutation of Ser-675 attenuates the promoting effect of PKA; (iv) phosphorylation by PKA does not affect the GSK3-dependent phosphorylation ofbeta-catenin, its stability, or intracellular localization; and (v) phosphorylation at the Ser-675 site promotes the binding of beta-catenin to its transcriptional coactivator, CREB-binding protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 14 281(15) 9971-6",
                "id": "16476742"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e05a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Treatment with PTH or forskolin, an activator of adenylate cyclase, facilitated T-cell factor (TCF)-dependent transactivation in a dose-dependent manner, which was abolished by pre-treatment with a PKA inhibitor, H89. Wnt3a and forskolin synergistically increased the TCF-dependent transactivation. Interestingly, intermittent treatment with PTH enhanced the TCF-dependent transactivation more profoundly than continuous treatment. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2008 May 1 104(1) 304-17",
                "id": "17990294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfdd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Insulin is the most-potent physiological anabolic agent known, promoting the synthesis and storage of carbohydrates and lipids and inhibiting their degradation and release into the circulation. This action of the hormone is due in part to the acute regulation of metabolic enzymes through changes in their phosphorylation state. In fat, liver, and muscle, insulin stimulates the dephosphorylation of a number of enzymes involved in glycogen and lipid metabolism via activation of protein phosphatases. Numerous studies have indicated that protein phosphatase-1 (PP1) is the primary phosphatase involved in insulin action. Although PP1 is a cytosolic protein, the phosphatase is compartmentalized in cells by discrete targeting subunits. These proteins confer substrate specificity to PP1 and mediate the specific regulation of intracellular pools of PP1 by a variety of extracellular signals. Four proteins have been described that target the phosphatase to the glycogen particle. G(M) and GL are expressed exclusively in striated muscle and liver, while protein targeting to glycogen (PTG) and R6 are more widely expressed. Despite a common targeting function, these four proteins are not highly conserved, suggesting profound differences in the mechanisms by which they contribute to the hormonal regulation of PP1 activity. Overexpression studies in cell lines or animals have revealed major differences among these proteins regarding basal glycogen levels and hormonal responsiveness. Furthermore, alterations in the expression or function of PP1 glycogen-targeting subunits may contribute to the onset of insulin resistance and type 2 diabetes.",
              "citation": {
                "type": "PubMed",
                "name": "Recent Prog Horm Res 2001 56 157-73",
                "id": "11237211"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfd2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Insulin also profoundly inhibits lipolysis in adipocytes, primarily through inhibition of the enzyme hormone sensitive lipase71. This enzyme is acutely regulated by control of its phosphorylation state, which is activated by PKA-dependent phosphorylation, and inhibited as a result of a combination of kinase inhibition and phosphatase activation. Insulin inhibits the activity of the lipase primarily through reductions in cAMP levels, owing to the activation of a cAMP-specific phosphodiesterase in fat cells72.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Adipose Tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In contrast, in mesangial cells, enzyme assay and Western blots showed that MAO activity and protein increased by approximately 80% after 48-h incubation with the D(2)-like receptor agonist bromocriptine and quinpirole but not with the D(1)-like receptor agonist SKF-38393. This effect was prevented by the D(2)-receptor antagonist sulpiride and domperidone. The increase in MAO-A protein was preceded by an augmentation of MAO-A mRNA that was prevented by the transcriptional inhibitor actinomycin D. Bromocriptine effect was mimicked by the PKA inhibitor H89 and inhibited by the PKA activator 8-bromo-cAMP. These results show for the first time the existence of a dopamine-dependent MAO-A regulation involving D(2)-like receptors, inhibition of the cAMP-PKA pathway, and an ex novo enzyme synthesis.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2003 Jan 284(1) F167-74",
                "id": "12388421"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407defb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Activation is abolished when either CRE or SRE are removed/mutated. Furthermore, mutation of CRE abolishes SREBP-dependent activation after overexpression of SREBP-1a and CRE binding protein (CREB). This shows that CRE is essential, and that under ex vivo conditions CREB and SREBP cooperate in transactivating CYP51. Interestingly, protein kinase A shows a marked stimulation of the CYP51 promoter activity when overexpressed together with SREBP-1a but not when overexpressed with CREB, suggesting phosphorylation of SREBP-1a. Using a DNA probe containing all three regulatory elements, it is found that SREBP-1a, a CREB-like factor, and specificity protein (Sp1) all probably bind the CYP51 promoter. While SREBP-1a and the CRE-bound proteins are essential for the SREBP-dependent response, Sp1 apparently functions only to maximize sterol regulation of CYP51.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2002 Aug 16(8) 1853-63",
                "id": "12145339"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The effect of OPC3911 on cAMP-PK activity ratios at different levels of lipolysis achieved by noradrenaline stimulation revealed that the reduction of cAMP-PK caused by 1 nM insulin was completely blocked by 3 microM OPC3911. The effect of OPC3911 was not due to an excessive increase in cellular cAMP resulting in 'supramaximal' lipolysis unresponsive to insulin. These data demonstrate that reduction in cAMP levels by the activation of cGI-PDE may be sufficient to account for the antilipolytic action of insulin.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 1995 Apr 6 1266(1) 101-7",
                "id": "7718614"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd9f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In human thyroid tissue, the ligand-independent activation of the adenylyl cyclase may be caused by mutations affecting two elements of the cAMP pathway, the TSH receptor, or the Gs protein itself ...gain of function mutations of TSH receptors or Gs. Moreover, we provide biochemical and molecular evidence for the induction of specific PDE isoforms in the presence of constitutive activation of the cAMP cascade induced by these oncogenes. ...the ATAs bearing constitutively active mutant TSH receptors",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2000 Aug 85(8) 2872-8",
                "id": "10946896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcf8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "cAMP and cGMP reduce [Ca2]i and relax smooth muscle through their cAMP- (PKA) and cGMP-activated (PKG) kinases (50, 410, 418). Several effects of cAMP are mediated by cross activation of PKG (50, 104), and significant components of the relaxant effects of cGMP are mediated through Ca2 desensitization (188) (Fig. 6). Inhibition of cAMP-induced Ca2 desensitization by a relatively selective PKG inhibitor also suggests that major effects of both cAMP and cGMP on the Ca2 sensitivity of myosin II are mediated by PKG, rather than PKA, whereas the nitric oxide (NO)-induced decrease in [Ca2]i is independent of PKG (418), and perhaps mediated by PKA cross-activated by cGMP.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2003 Oct 83(4) 1325-58",
                "id": "14506307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dca6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Second, agents that increase intracytoplasmic [cAMP], which activates PKA, induce LPL phosphorylation. Finally, two pharmacologic PKA inhibitors block IC-induced LPL phosphorylation in PMN. While the data in whole cells demonstrate only that PKA activation can lead to LPL phosphorylation, together with the demonstration of direct phosphorylation in vitro, these data support the hypothesis that PKA can directly phosphorylate LPL in cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Aug 20 274(34) 24349-56",
                "id": "10446213"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Insulin also profoundly inhibits lipolysis in adipocytes, primarily through inhibition of the enzyme hormone sensitive lipase71. This enzyme is acutely regulated by control of its phosphorylation state, which is activated by PKA-dependent phosphorylation, and inhibited as a result of a combination of kinase inhibition and phosphatase activation. Insulin inhibits the activity of the lipase primarily through reductions in cAMP levels, owing to the activation of a cAMP-specific phosphodiesterase in fat cells72.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Phosphorylation of cholesterol ester hydrolase by cyclic AMP-dependent protein kinase results in activation of both cholesterol ester and triacylglycerol hydrolase activities. Activation against both substrates correlates closely with phosphorylation in time course experiments Phosphoserine is the only phosphoamino acid detected following partial acid hydrolysis of the phosphorylated enzyme.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1986 Jun 9 201(2) 257-61",
                "id": "3011511"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbd7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Thus, although beta-adrenergic agonists, such as isoproterenol, increase cardiomyocyte membrane- associated cAMP and PKA activity and have positive inotropic effects, other activators of cardiomyocyte adenylyl cyclase activity, such as prostaglandin E1, fail to increase membrane-associated cAMP levels and have only weak inotropic effects (Buxton and Brunton, 1985; Movsesian, 2000).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2003 Sep 64(3) 533-46",
                "id": "12920188"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbbb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Exendin-4 and forskolin have previously been reported to improve ?-cell survival following ER stress induced by the synthetic stressors thapsigargin or tunicamycin (29). This cAMP-protein kinase A (PKA)-dependent protection was apparently mediated through enhanced ATF4-CHOP-GADD34 signaling, resulting in eIF2? dephosphorylation and translational recovery (29). ",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2009 Dec 58(12) 2851-62",
                "id": "19720788"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db92"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "To determine which cAMP effector-PKA or Epac-is capable of inhibiting collagen expression and proliferation, fibroblasts were treated with varying concentrations of the selective PKA agonist 6-bnz-cAMP or the selective Epac agonist 8-pCPT-29-O-Me-cAMP.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 Oct 39(4) 482-9",
                "id": "18421013"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e40f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Here, we show that serine 21 in GSK-3 alpha and serine 9 in GSK-3 beta are also physiological substrates of cAMP-dependent protein kinase A. Protein kinase A physically associates with, phosphorylates, and inactivates both isoforms of GSK-3",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 24 97(22) 11960-5",
                "id": "11035810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e40d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PDE3s are activated when phosphorylated either by cAMP-dependent protein kinase (PKA) or by phosphatidyl inositol-3-phosphate-dependent protein kinase (Manganiello and Degerman, 1999). In addition, cAMP-elevating agents increase PDE3 activities and levels in several cell types (Degerman et al., 1997), including cultured rat and human aortic vascular smooth muscle cells (Rose et al., 1997; Liu and Maurice, 1998; Palmer and Maurice, 2000).",
              "citation": {
                "type": "PubMed",
                "name": "J Smooth Muscle Res 2003 Aug 39(4) 67-86",
                "id": "14692693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3ec"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The recently described cAMP-dependent guanine nucleotide exchange factor (GEF) Epac activates small GTPase Rap1, which results in activation of small GTPase Rac-specific GEFs Tiam1 and Vav2 and Rac-mediated EC barrier protective responses. Our results show that ANP stimulated protein kinase A and the Epac/Rap1/Tiam/Vav/Rac cascade",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e363"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Hypothalamic cells transfected with rat TRH promoter (-776/+85) linked to the luciferase reporter showed increased transcription by protein kinase (PK) A and PKC activators, or by dexamethasone (dex), but co-incubation with dex and 8Br-cAMP decreased their stimulatory effect (as observed for proTRH mRNA levels).",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Endocrinol 2005 Feb 34(1) 177-97",
                "id": "15691887"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e32d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In skeletal muscle, voltage-dependent potentiation of L-type Ca(2+) channel (Ca(V)1.1) activity requires phosphorylation by cyclic AMP-dependent protein kinase (PKA) anchored via an A kinase-anchoring protein (AKAP15).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 8 277(6) 4079-87",
                "id": "11733497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Thus, a local feedback regulation serves to control cAMP access to an anchored PKA (31, 32). An increase in cAMP causes activation of the PKA that in turn phosphorylates accessible substrates including the closely positioned PDE4D3. This phosphorylation causes PDE activation, a local decrease in cAMP, and a return of the PKA to a basal activity state.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 5493-6",
                "id": "12493749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In the TPC-1 cell line, stimulation by TSH and serum up-regulated Id-1 mRNA expression 1.5- and 4.0-fold, respectively. Activation of the mitogen intracellular protein kinase A and protein kinase C signaling pathways also up-regulated Id-1 mRNA expression",
              "citation": {
                "type": "PubMed",
                "name": "Surgery 2003 Aug 134(2) 235-41",
                "id": "12947323"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": "thyroid"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Results: (i) An inhibitor of PKA (H89) reduces tonicity-dependent increases in transactivation, ORE/TonE reporter activity, and induction of aldose reductase and betaine transporter mRNAs.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Dec 24 99(26) 16800-5",
                "id": "12482947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PP17b synthesis in HeLa cells, which was significantly inhibited by protein kinase C (PKC) inhibitor This data shows that PP17b is a neutral lipid droplet-associated protein, and its expression is regulated by PKC- and PKA-dependent pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2003 Mar 270(6) 1176-88",
                "id": "12631276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e273"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Here, we show that serine 21 in GSK-3 alpha and serine 9 in GSK-3 beta are also physiological substrates of cAMP-dependent protein kinase A. Protein kinase A physically associates with, phosphorylates, and inactivates both isoforms of GSK-3",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 24 97(22) 11960-5",
                "id": "11035810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e272"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "EDNRB reduces cyclic AMP (cAMP) production via Gai, thus leading to protein kinase A (PKA) inhibition. Since chemical PKA blockade mimics the effects exerted by ET-3 on ENS progenitors, it is likely that the RET-EDNRB interaction is mediated by PKA (fig. 1) [19]. This is supported by the finding that serine 686 in the juxtamembrane domain of RET is phosphorylated by PKA, thereby enhancing RET-mediated lamellipodia formation [20].",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Dec 61(23) 2954-64",
                "id": "15583857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e26a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "This indicates that ERK1/2, reported to be located downstream of PKA, participates in the PKA-mediated CREB phosphorylation elicited by glucose. In ERK1/2-downregulated MIN6 cells by siRNA, glucose-stimulated CREB phosphorylation was highly reduced and CREB protein content was decreased by 60%.% blockade of ERK1/2 activity with PD98059 caused a significant decrease in CREB protein level",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Aug 55(8) 2220-30",
                "id": "16873684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e261"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PKA activated Src both in vitro and in vivo by phosphorylating Src on serine 17 within its amino terminus. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Jan 9(1) 85-94",
                "id": "11804588"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e260"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Cotransfection assays employing CRE-reporter gene showed that SIK1 could repress the PKA-dependent activation of CRE by acting on the bZIP domain of the CRE-binding protein (CREB), though the target site of SIK1-mediated phosphorylation has yet to be determined.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2004 Mar 31 217(1-2) 109-12",
                "id": "15134808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e25e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "We have also established that EGF receptor activation, which is known to function upstream of HD disassembly, results in the phosphorylation of only one or more of these three residues and the partial disassembly of HDs in keratinocytes. Additionally, we show that S1360 and S1364 of beta4 are the only residues phosphorylated by PKC and PKA in cells, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2007 Jul 5",
                "id": "17615294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e25d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The NE stimulation of R2 expression in preadipocytes was mimicked by forskolin and abolished by H89, demonstrating mediation via cAMP and protein kinase A (PKA). Also, inhibitors of Src and of Erk1/2 kinases markedly reduced NE-stimulated R2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2002 Apr 1 274(2) 207-15",
                "id": "11900481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e247"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "brown adipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In particular, the protein kinase  A-induced phosphorylation of nuclear proteins, such as CREB or CREM, could be  responsible for transcriptional effects via CREs present in gene promoters",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Dec 26 272(52) 32919-24",
                "id": "9407070"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e246"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Correlation of the extent of phosphorylation with activity showed that a 50% decrease in the ratio of kinase activity to bisphosphate activity occurred when only 0.25 mol of phosphate was incorporated per mol of enzyme subunit",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1984 Jun 25 259(12) 7673-81",
                "id": "6330071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e237"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Furthermore, stimulation of C5aR mediates the inhibition of cAMP production and protein kinase A activity and is involved in activation of PI3K/AKT and NF-kappaB signaling in DCs. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2009 Nov 15 183(10) 6058-68",
                "id": "19864610"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e231"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Phosphorylation and 14-3-3 proteins play important roles in the regulation of TPH activity. We have found that phosphorylation of TPH by cAMP-dependent protein kinase increased the activity of the hydroxylase by 25-30% and that 14-3-3 proteins increased the hydroxylase activity of phosphorylated TPH by approximately 45%. Under these conditions, the 14-3-3 proteins were not phosphorylated, and unphosphorylated TPH was not activated by 14-3-3 proteins.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Oct 17 272(42) 26219-25",
                "id": "9334190"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e222"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Phosphorylation of PLB by cAMP- or cGMP-dependent protein kinase has been shown to increase Ca2+ uptake in SR vesicles prepared from bovine pulmonary artery (26, 27) and in cultured smooth muscle cells from rat aorta (2).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol 1999 Sep 277(3 Pt 2) H963-70",
                "id": "10484417"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e221"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Dephosphorylated PLN inhibits the SR Ca(2+) pump, whereas phosphorylation of PLN, at either Ser(16) by PKA or Thr(17) by calmodulin-dependent protein kinase II (CaMKII), reverses this inhibition, thus increasing SERCA2a activity and the rate of Ca(2+) uptake by the SR. ",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2005 Dec 1 68(3) 366-75",
                "id": "16226237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e21f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In many cells PKA inhibits the extracellular receptor kinase (ERK1/2) cascade of the mitogen-activated protein kinase (MAPK) pathway leading to inhibition of cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2003 Jul 1 12(13) 1475-84",
                "id": "12812976"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e21c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Protein kinase A-dependent phosphorylation of serine 43 within the regulatory domain of Raf-1 reciprocally potentiates its interaction with Rheb and decreases its interaction with H-Ras.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Feb 17(2) 921-33",
                "id": "9001246"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e217"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Rap1b has been implicated in the transduction of the cAMP mitogenic response. Agonists that increase intracellular cAMP rapidly activate (i.e. GTP binding) and phosphorylate Rap1b on Ser(179) at its C terminus.cAMP-dependent protein kinase (PKA)-mediated phosphorylation of Rap1b is required for cAMP-dependent mitogenesis, tumorigenesis, and inhibition of AKT activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Oct 2 284(40) 27480-6",
                "id": "19651783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Furthermore, we found that inhibition of dephosphorylation resulted in an increase in clustering, whereas inhibition of protein kinase A (PKA) markedly reduced WPB clustering",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2006 Jan 26(1) 49-55",
                "id": "16239597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The expression of PDE3A was increased in HPASMCs maintained under chronic hypoxic conditions for 14 days. This may be mediated via a protein kinase A-dependent mechanism, as treatment of cells with Br-cAMP (100 microM) mimicked chronic hypoxia in increasing PDE3A expression, while the PKA inhibitor, H8 peptide (50 microM) abolished the hypoxic-dependent increase in PDE3A transcript.",
              "citation": {
                "type": "PubMed",
                "name": "Br J Pharmacol 2002 Dec 137(8) 1187-94",
                "id": "12466227"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e19f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Shear stress, via G proteins (Gs), can activate several signal transduction pathways, including the phosphoinoside 3-kinase (PI3K) and adenylate cyclase (AC) pathways, leading to eNOS activation via phosphorylation of serine residues (S617 and S1179 for Akt, and S635 and S1179 for PKA), which promote eNOS activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 May 15 117(Pt 12) 2427-9",
                "id": "15159447"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e185"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Treatment of HL-60 cells with phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, or dibutyryl-cyclic AMP (dbcAMP), a protein kinase A (PKA) activator, resulted in a 90% decrease in the level of TfR mRNA",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1995 May 29 365(2-3) 137-40",
                "id": "7781766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e183"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "We report here that the human glutathione S-transferase P1 (GSTP1) protein, involved in phase II metabolism of many carcinogens and anticancer agents and in the regulation of c-Jun NH(2)-terminal kinase-mediated cell signaling, undergoes phosphorylation by the Ser/Thr protein kinases, cAMP-dependent protein kinase (PKA) and protein kinase C (PKC), resulting in a significant enhancement of its metabolic activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Dec 15 64(24) 9131-8",
                "id": "15604283"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e163"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of brain",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "This effect was completely abolished by H89, a specific inhibitor of cAMP-dependent protein kinase A (PKA)",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Endocrinol 2004 Jun 150(6) 851-61",
                "id": "15191357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e15f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Taken together, these findings indicate that cAMP and PKA signaling are involved in the stimulation of MUC5AC production by IL-1beta and PGE2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2004 Aug 66(2) 337-46",
                "id": "15266025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e14b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "These effects appear to be protein kinase A-dependent.  Furthermore inhibition of protein kinase C restored the beta(3)-receptor-mediated reductions in insulin-induced IRS-1 tyrosine phosphorylation and IRS-1-associated PI3-kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 3 274(49) 34795-802",
                "id": "10574950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e144"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "brown adipose"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 2 278(18) 15601-7",
                "id": "12571245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e13e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Adenylyl cyclase activation is thought to be responsible for most cellular responses to PTH and PTHrP, although many actions appear to be independent of adenylyl cyclase. PTH treatment of cells that express the NHERF2 PTH1R complex markedly activates phospholipase C beta and inhibits adenylyl cyclase through stimulation of inhibitory G proteins (G(i/o) proteins).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 Jun 20 417(6891) 858-61",
                "id": "12075354"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e139"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Northern blot analysis and runoff transcription assays demonstrated that the protein kinase A pathway not only stimulated the activity of the luciferase reporter construct but also the transcription of the endogenous LAP/C/EBP beta gene in different cell types.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Jul 17(7) 3600-13",
                "id": "9199295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e134"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Transcription of mitochondrial serine:pyruvate aminotransferase (SPT) mRNA (SPTm-mRNA) in rat liver is unique in that it occurs from the upstream site of the two transcription start sites within the first exon of the SPT gene and is selectively enhanced by cAMP via the protein kinase A (PKA) signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39082-92",
                "id": "12169688"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e12d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Ariadne: In vitro , OTR  expression is increased by activation of protein kinase A (PKA) or protein kinase C (PKC) (Bale and Dorsa, 1998 ).",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2001 Apr 1 21(7) 2546-52",
                "id": "11264328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e121"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Indeed, in the most definitive study of VEC PDE2 expression published so far, capillary and venous VEC in human tissue sections were shown to express significant PDE2, whereas arterial VEC in these sections were uniformly negative for PDE2 expression (Sadhu et al., 1999). PDE3A and PDE3B are activated by PKA or PKB phosphorylation and consensus sites of phosphorylation for each kinase are located between NHR1 and NHR2 in both PDE3A and PDE3B (Manganiello and Degerman, 1999).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2003 Sep 64(3) 533-46",
                "id": "12920188"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e120"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The results indicate that PKA regulates cAMP levels in smooth muscle via stimulatory phosphorylation of PDE3A and PDE4 and inhibitory phosphorylation of adenylyl cyclase type V/VI. Concurrent generation of cGMP inhibits PDE3 activity and augments cAMP levels.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Mar 282(3) C508-17",
                "id": "11832336"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e11c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "pretreatment of aortic rings from banded mice with H89 or KT5720 resulted in a significant inhibition of Ang II?induced increases in both p-eNOS-Ser633 and p-eNOS-Ser1177 (Figure 5).",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 2006 Nov 48(5) 958-64",
                "id": "17000928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e11b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Dibutyryl-cAMP was used to activate PKA in MEFs. Dibutyryl-cAMP enhanced the phosphorylation of Rb at Ser780 inMEFtg2+/+ cells, and this effect was attenuated by the PKA inhibitor (Fig. 6B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 22 282(25) 18108-15",
                "id": "17478427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e118"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Feb 3 270(5) 2158-62",
                "id": "7530719"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e105"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Coimmunoprecipitation experiments showed that PKA stimulation markedly attenuated the PMA-induced association of HDAC5 and 14-3-3 proteins (Fig. 3F).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2010 Aug 31 107(35) 15467-72",
                "id": "20716686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "but this interaction is blocked by phosphorylation of the RyRs by PKA (243).",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2004 Jan 84(1) 1-39",
                "id": "14715909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": ". TEF-1 is phosphorylated by PK-A at residue serine-102.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2000 Aug 15 28(16) 3168-77",
                "id": "10931933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "SM-alpha-actin and SM22, are extremely sensitive to regulation by PKA, and even transient PKA activation by ATP is sufficient for their downregulation",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2004 Aug 287(2) C449-56",
                "id": "15238360"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "MSK1 is localized in the nucleus of unstimulated or stimulated cells, and phosphorylates CREB at Ser133 with a Km value far lower than PKA, MAPKAP-K1(p90Rsk) and MAPKAP-K2.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Aug 3 17(15) 4426-41",
                "id": "9687510"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Maintenance of condensed chromatin requires PKA binding to chromatin-associated AKAP95 and cAMP signaling through PKA.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 1999 Dec 13 147(6) 1167-80",
                "id": "10601332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Elevation of the cellular concentration of cAMP activates the PKA holoenzyme anchored to AKAP-Lbc, which phosphorylates the anchoring protein on the serine 1565.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Jul 21 23(14) 2811-20",
                "id": "15229649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Jun 20(11) 4149-58",
                "id": "10805756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": ", cAMP-dependent protein kinase A (Immenschuh et al., 1998)",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2003 Sep 55(3) 551-71",
                "id": "12869663"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Ser(155) is phosphorylated preferentially by PKA in vitro and is the only residue in BAD that becomes phosphorylated when cells are exposed to cAMP-elevating agents.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2000 Jul 15 349(Pt 2) 547-57",
                "id": "10880354"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PKAc is required for RelA Ser(276) phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Jul 19(7) 1419-33",
                "id": "17317104"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Nov 25 269(47) 29351-4",
                "id": "7525582"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Changes in Cocaine- and Amphetamine-Regulated Transcript (CART) mRNA levels have been observed in brain as a result of various physiologic stimuli including feeding, drugs of abuse, stress and glucocorticoids, and activators of the cyclic AMP (cAMP) and protein kinase A (PKA) pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res Mol Brain Res 2004 Jul 5 126(1) 22-9",
                "id": "15207912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0af"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The affinity of PMCA1 for calmodulin was similar to that of PMCA4, the other ubiquitous PMCA isoform. The affinity of PMCA1 for ATP, evaluated by the formation of the phosphorylated intermediate, was higher than that of the PMCA4 pump. The recombinant PMCA1 pump was a much better substrate for the cAMP-dependent protein kinase than the PMCA2 and PMCA4 isoforms.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3 278(40) 38141-8",
                "id": "12851406"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e09e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Activation of the activity of FGF receptor tyrosine kinase in smooth muscle cells by ligand binding resulted in tyrosine phosphorylation of one of the FGF receptors and a 90-kDa-protein as well as increased tyrosine phosphorylation of phospholipase C-gamma. Parallel observations were made in that increased PKC and protein kinase A activities occurred with bFGF as compared with control cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Mar 25 269(12) 9213-20",
                "id": "7510705"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e04f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Elevated protein kinase A (PKA) activity noted in cancer cells activated the apoptotic function of ectopic Par-4 or its SAC (selective for apoptosis induction in cancer cells) domain, which induces apoptosis selectively in cancer cells and not in normal or immortalized cells. PKA preferentially phosphorylated Par-4 at the T155 residue within the SAC domain in cancer cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Feb 25(3) 1146-61",
                "id": "15657440"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e005"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PGE2-dependent activation of C/EBPbeta was blocked by expression of a mutated regulatory subunit of protein kinase A or by mutation of two previously identified cAMP-sensitive cis-acting regulatory elements within the promoter between bp -111 and -61. Nuclear protein binding to these elements was induced by PGE2, required new protein synthesis, and was sensitive to antibody to the transcription factor termed Fos-related antigen 2 (Fra-2).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 8 279(41) 42438-44",
                "id": "15299028"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfbe"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "These data suggest that H2O2 stimulates CFTR Cl(-) channel-mediated Cl(-) secretion through cyclooxygenase- and mPGES-1-dependent release of PGE2 and subsequent activation of PKA.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2007 Nov 293(5) F1571-6",
                "id": "17699556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df9f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "renal medulla"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Iloprost activated cAMP/protein kinase A (PKA) signaling in human VSMC, and the cell-permeable cAMP analog 8-bromo-cAMP mimicked the iloprost-induced differentiation. Both myristoylated PKA inhibitor amide-(14-22) (PKI, specific PKA inhibitor), as well as ablation of the catalytic subunits of PKA by small interfering RNA, opposed the upregulation of contractile markers induced by iloprost.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2006 Apr 290(4) H1337-46",
                "id": "16399867"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df74"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Mar 1 370(Pt 2) 429-38",
                "id": "12441002"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "NE activated a 1.3-kilobase I kappa B alpha promoter transfected into astrocytes or C6 glioma cells, and this activation was prevented by a beta-antagonist and by protein kinase A inhibitors but not by an NF kappa B inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 16 277(33) 29662-8",
                "id": "12050158"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df6a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "From these experiments, we concluded that PKA activity mediates basal and PGE2/8-brcAMP-stimulated alphaVbeta3-dependent HUVEC adhesion and Rac activation and that active Rac does not reconstitute cell adhesion in the absence of PKA activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 45838-46",
                "id": "12237321"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The EPAC-specific cAMP analog 8CPT-2Me-cAMP (8-(4-chloro-phenylthio)-2'-O-methyladenosine-3',5'-cAMP) activates Rap1 in B-CLL cells, but, unlike rolipram/forskolin or 8-Bromo-cAMP, it does not induce PKA activation, as judged by phosphorylation of the transcription factor cAMP-response element binding protein (CREB).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Apr 1 103(7) 2661-7",
                "id": "14615375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df51"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Pharmacologic inhibition of protein kinase C (PKC) and protein kinase A (PKA), which are involved in hexosamine-mediated matrix production, blocked the CREB phosphorylation and fibronectin synthesis seen in HG and GlcN conditions.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Oct 50(10) 2355-62",
                "id": "11574420"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df41"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The induction was mediated through the protein kinase A and mammalian target of rapamycin signaling pathways and required a cyclic AMP response element associated with the promoter region of the Adss1 gene.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 11 278(15) 13143-50",
                "id": "12522136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df30"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2001 Oct 15 62(8) 997-1012",
                "id": "11597569"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df2f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "promoter activity of cyclin D2 was shown to be induced by FSH and the catalytic alpha subunit of PKA (PRKACA)",
              "citation": {
                "type": "PubMed",
                "name": "Biol Reprod 2006 Aug 75(2) 279-88",
                "id": "16625003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df1d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "granulocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "KCl also activated Rac1, but not RhoA, in PC12 cells, and KCl-induced moesin phosphorylation was suppressed in dominant negative Rac1 (N17 Rac1)-expressed cells. The inhibition of protein kinase A (PKA), known as an upstream kinase of Rac1, abolished Rac1 activation and moesin phosphorylation by KCl.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 1 280(13) 12181-9",
                "id": "15634677"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df0a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Pharmacological inhibition of cAMP-dependent protein kinase (PKA) and siRNA-mediated depletion of PKA greatly reduced B-Raf activity, ERK1/2 activation, and cell proliferation in (WT)B-Raf cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 7 281(14) 9238-50",
                "id": "16452469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The predicted LKB1 protein sequence terminates with a conserved prenylation motif (Cys(433)-Lys-Gln-Gln(436)) directly downstream from a consensus cAMP-dependent protein kinase (PKA) phosphorylation site (Arg(428)-Arg-Leu-Ser(431)).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2000 Feb 1 345 Pt 3 673-80",
                "id": "10642527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407def2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "this can elicit the phosphorylation of the target serine residue in the UCR1 of PDE4 long isoforms, leading to the ablation of the inhibitory effect of ERK phosphorylation on long PDE4 isoforms",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Feb 15 370(Pt 1) 1-18",
                "id": "12444918"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dee2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Cyclooxygenase-2 (COX-2) antagonists, by blocking prostaglandin production, might inhibit this pathway 149.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Feb 2(2) 101-12",
                "id": "12635173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dedf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1995 Nov 1 233(3) 963-8",
                "id": "8521865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dedd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In vitro kinase assay analysis confirms that Akt and PKA both phosphorylate p21Cip1 at the same site (Thr 145) (Fig. 2B).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Aug 21(16) 5644-57",
                "id": "11463845"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ded9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Fig. 3. CREB phosphorylation is induced by OxPAPC via PKA, PKC, p38MAPK, and ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 19 278(51) 51006-14",
                "id": "14523007"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ded1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 29 278(35) 33029-38",
                "id": "12819195"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ded0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Here, we report that in primary mouse adipocytes, PKA associates with and phosphorylates AMPKalpha1 at Ser-173 to impede threonine (Thr-172) phosphorylation and thus activation of AMPKalpha1 by LKB1 in response to lipolytic signals.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2009 Nov 26",
                "id": "19942859"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407decc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2004 Sep 24 15(6) 889-99",
                "id": "15383279"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dec8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PGE(2) caused a rapid increase in StAR expression that involves activation of the EP2 receptor-coupled protein kinase A pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2003 Sep 144(9) 3934-42",
                "id": "12933667"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dec4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Experimental data indicate that exogenous IFN-gamma stimulated cAMP accumulation and PKA activation in time-dependent and dose-dependent manners in murine peritoneal macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "J Interferon Cytokine Res 2004 Jun 24(6) 334-42",
                "id": "15212707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dec1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "peritoneal macrophage",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In another paper (5) Uyeda's group reported that ChREBP contained three consensus sequences for protein kinase A phosphorylation sites and that phosphorylation of Ser-196 inhibited nuclear entry of ChREBP, whereas phosphorylation of Thr-666 inhibited its binding to the LPK promoter site. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 May 13 100(10) 5578-80",
                "id": "12721358"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 25 277(43) 40937-43",
                "id": "12185072"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deaf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Transforming growth factor beta-activated kinase 1 (TAK1), an important MAPK kinase kinase in several cytokine signals, possesses a PKA recognition site at amino acids 409-412. PKA directly phosphorylated TAK1 in RAW264.7 cells transfected with wild-type TAK1 but not with the Ser412 --> Ala mutant TAK1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 25 280(12) 11395-403",
                "id": "15647289"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deae"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "We now have evidence that phosphorylation of rap1b in platelets is also induced by nitric oxide generating compounds through stimulation of guanylate cyclase and activation of the cyclic GMP-dependent protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1996 Feb 6 219(1) 1-5",
                "id": "8619788"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dea8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PACAP induced expression of GLAST  via activation of PKA-dependent signaling pathways only, but it affected the  expression of GLT-1 via both PKA and PKC-dependent signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2000 May 15 20(10) 3596-605",
                "id": "10804201"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Here, we show that PGE(2) activated the cyclic AMP/protein kinase A pathway,",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Sep 1 63(17) 5218-23",
                "id": "14500348"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Forskolin (10 microM), db-cAMP (2 mM), LH-releasing hormone (LHRH; 1 microM) and PMA (200 nM) were also stimulatory (on 11betaHSD1 exp) activators of protein kinase A (PKA) (forskolin and dibutyryl (db) cAMP)",
              "citation": {
                "type": "PubMed",
                "name": "J Endocrinol 1999 Dec 163(3) 417-23",
                "id": "10588815"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de86"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "granulocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The increase in the activity of the NurRE reporter induced by TSH was completely inhibited by the PKA inhibitor, H89 (50 uM). However, CRIF1 expression decreased TSH-induced NurRE reporter activities (Fig. 7A) in a dose-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2005 Jan 19(1) 12-24",
                "id": "15459248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de75"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Because Rap1b is one of the proteins that become phosphorylated by PKA upon elevation of intracellular cAMP levels, we evaluated the effect of the absence of Rap1b in platelets on cAMP-induced inhibition of AYPGKF peptide-induced platelet aggregation (Figure ?(Figure4C).4C).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2005 Mar 115(3) 680-7",
                "id": "15696195"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de6e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Our recent studies have mapped the PKA-mediated phosphorylation site to Ser(66) and established its functional role in parietal cell activation [R. Zhou et al., Characterization of protein kinase A-mediated phosphorylation of ezrin in gastric parietal cell activation, J. Biol. Chem. 278 (2003) 35651-35659], but the underlying basis for this regulation is not known.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Mar 17 341(3) 784-91",
                "id": "16438931"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de49"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Geniposide protected PC12 cells from oxidative damage induced by 3-morpholinosydnonimine hydrochloride (SIN-1) by enhancing the expression of heme oxygenase 1 (HO-1) via the cAMP-PKA-CREB signal pathway. After transfecting PC12 cells with the AB1 enhancer from the HO-1 gene, luciferase activity induced by geniposide increased in a dose-dependent manner, but not in the PC12 cells whose Glp-1r gene was disrupted",
              "citation": {
                "type": "PubMed",
                "name": "Acta Pharmacol Sin 2010 Apr 5",
                "id": "20364157"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de3e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "when administered at these doses to 293 cells transfected with pEFNeo- wtDYRK3 (and pCRE-Luc), H-89 and (Rp)-cAMP-S each efficiently blocked the ability of DYRK3 to activate a CREB/CRE response (Fig. 8).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47052-60",
                "id": "12356771"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": " The findings of this study indicate that hydrophobic bile salts activate GPBAR1 on GBSM, and this leads to activation of the cyclic AMP-PKA pathway, and ultimately the opening of K(ATP) channels, thus hyperpolarizing the membrane and decreasing GBSM activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2010 Sep 1 588(Pt 17) 3295-305",
                "id": "20624794"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de20"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "This binding is regulated in vitro by phosphorylation of a single serine residue (Ser76) in the immediately adjacent amino-terminal domain Mp1. M-protein phosphorylation by cAMP-dependent kinase A inhibits binding to myosin LMM. Transient transfection studies of cultured cells revealed that the myosin-binding site seems involved in the targeting of M-protein to its location in the myofibril.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1998 Apr 9(4) 829-40",
                "id": "9529381"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de17"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "GST-fused PDE5 R domain was phosphorylated by PKA primarily at Ser102. Phosphorylation of the R domain increases affinity for cGMP approximately 10-fold (K(D) values 97.8 +/- 17 and 10.0 +/- 0.5 nm for unphospho- and phospho-R domains, respectively). Increased cGMP binding leads to increased hydrolysis by PDE.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47581-7",
                "id": "12359732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddf0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The cyclic AMP (cAMP)-dependent protein kinase (PKA) can inhibit Raf-1 by direct phosphorylation.  We have mapped all cAMP-induced phosphorylation sites in Raf-1, showing that serines 43, 259, and 621 are phosphorylated by PKA in vitro and induced by cAMP in vivo. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 May 22(10) 3237-46",
                "id": "11971957"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd95"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In vitro phosphorylation assays using glutathione S-transferase fusion constructs demonstrated that the C terminus of claudin-3 is an excellent substrate for cAMP-dependent protein kinase (PKA). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 15 280(28) 26233-40",
                "id": "15905176"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Apr 15 22(8) 1790-800",
                "id": "12682012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Apr 5 271(14) 8075-81",
                "id": "8626492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "This up-regulation of CNP1 expression (a) is due to an increase of transcription, (b) requires de novo protein synthesis, and (c) requires the activity of protein kinase A.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2000 Nov 75(5) 1940-50",
                "id": "11032883"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd68"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "oligodendrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Of the 1,680 genes that showed 1.5-fold change within 2 h, 111 of the up-regulated genes and 41 of the down-regulated genes contained at least one conserved CRE site (Table 4, which is published as supporting information on the PNAS web site), suggesting that these are likely primary targets of cAMP/PKA.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Jun 14 102(24) 8561-6",
                "id": "15939874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd41"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "lymphoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The PKA inhibitor H-89 (2.5, 5, and 10 umol/L) reduced the phosphorylation level of BAD at Ser112 ( Fig. 4B). To confirm that PKA mediated BAD phosphorylation in BaF3/FLT3/ITD cells, we showed that immunoprecipitated PKA from BaF3/FLT3/ITD cells had the ability to phosphorylate BAD at Ser112 with a BAD absent control, indicating that the phosphorylated BAD was not from immunoprecipitation ( Fig. 4C).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Aug 15 65(16) 7338-47",
                "id": "16103085"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd18"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PGE2 increased phosphorylation of Akt and endothelial nitric oxide synthase (eNOS), eNOS activity, and nitric oxide (NO) production by the activation of cAMP-dependent protein kinase (PKA) and phosphatidylinositol 3-kinase (PI3K). Dibutyryl cAMP (DB-cAMP) mimicked the role of PGE2 in angiogenesis and the signaling pathway, suggesting that cAMP is a down-stream mediator of PGE2",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2005 Dec 31 37(6) 588-600",
                "id": "16391520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Moreover, this LDL-increased AP-1 binding is suppressed by several protein kinase (PK) inhibitors: the PKC inhibitor calphostin C, the cAMP-dependent PK inhibitor H89, and the tyrosine PK inhibitors genistein and lavendustin A.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 1998 Mar 18(3) 473-80",
                "id": "9514417"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcb2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "We found that the purified catalytic domain of PKA phosphorylated an amino-terminal LPL peptide (containing LPL amino acids 219) but not the peptide in which Ser5 was mutated to Ala or a peptide in which LPL sequence 219 was scrambled (Fig. 2A). Mutation of Ser7 to Ala as a control did not block PKA phosphorylation (Fig. 2A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Aug 20 274(34) 24349-56",
                "id": "10446213"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc95"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "To investigate which regions of PPARs were phosphorylated by PKA, we constructed a set of different GST fusion proteins corresponding either to the AB, DBD, or LBD domains of the mPPARa and b... We observed a strong phosphorylation of the DBD and a weaker labeling of the LBD from PPARa and PPARb, suggesting that the DBD is the main phosphorylation target. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2000 Dec 14(12) 1962-75",
                "id": "11117527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc47"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Induction of STAT3 Tyr705 and Ser727 phosphorylations by Galpha(s)QL was suppressed by inhibition of protein kinase A, Janus kinase 2/3, Rac1, c-Jun N-terminal kinase (JNK), or phosphatidylinositol 3-kinase, and a similar profile was observed in response to beta2-adrenergic receptor stimulation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 24 281(47) 35812-25",
                "id": "17008315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "C-terminal domain harbors three known phosphorylation sites (S325, T366 and S428), the latter two of which are targeted by ATM (ataxia telangiectasia mutated), and protein kinase A (PKA), ribosomal protein S6 kinase 90 kDa or protein kinase C z, respectively (Collins et al., 2000; Xie et al., 2006; Sapkota et al. 2002a, b).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Nov 24 27(55) 6908-19",
                "id": "19029933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc2a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Our results show that, in addition to significant elevation of intracellular cGMP levels, ANP treatment of human pulmonary EC induced time-dependent increases in intracellular cAMP concentrations (Fig. 1A,B) and activation of cAMP-dependent protein kinase (PKA, Fig. 1C).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "We report here that adrenaline activates another NADPH-producing enzyme, NADP(+)-dependent 'malic' enzyme, while also inhibiting glucose-6-phosphate dehydrogenase, via cyclic AMP-dependent protein kinase (PKA) activation",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1995 Sep 1 310 ( Pt 2) 709-14",
                "id": "7654215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Hepatic gluconeogenesis is essential for maintenance of normal blood glucose concentrations and is regulated by opposing stimulatory (cyclic adenosine monophosphate, cAMP) and inhibitory (insulin) signaling pathways. The cAMP signaling pathway leads to phosphorylation of cAMP response element-binding (CREB) protein, resulting in recruitment of the coactivators CREB-binding protein (CBP) and p300 and subsequent activation of gluconeogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2004 Jun 10(6) 633-7",
                "id": "15146178"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbe4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "To explore IP3R3 phosphorylation further, immunopurified receptors were phosphorylated with the catalytic subunit of PKA in vitro (Figure 1C). Surprisingly, whereas mutation of Ser934 reduced PKA-mediated phosphorylation by approx. 80% (IP3R3SAS; lane 4), mutation of either Ser916 (IP3R3ASS; lane 3) or Ser1832 (IP3R3SSA; lane 5) had little or no effect on PKA mediated phosphorylation, indicating that Ser934 is the only site efficiently phosphorylated in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Dec 15 392(Pt 3) 493-7",
                "id": "16107208"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbc1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In platelets, PGI2 and prostaglandin E1 (PGE1) stimulate transmembrane adenylyl cyclase (AC) through receptors coupled to G?s leading to the formation cyclic adenosine 3?,5?monophosphate (cAMP). In turn, elevated cAMP concentrations activate protein kinase A (PKA), which is thought to blunt platelet activation through phosphorylation of various target proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2010 Nov 18 116(20) 4297-306",
                "id": "20664056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "GPR30 anti-sense oligonucleotide did, but anti-sense estrogen receptor beta did not suppress 17beta-estradiol-induced cAMP signal, cAMP response element-binding protein phosphorylation, Bcl-2 expression, and apoptosis resistance. These results suggest that 17beta-estradiol may enhance Bcl-2 expression and prevent H2O2-induced apoptosis by phosphorylating cAMP response element-binding protein via cAMP/protein kinase A pathway in keratinocytes.",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2003 Dec 121(6) 1500-9",
                "id": "14675202"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db87"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The increase of AChE expression was reciprocally regulated by a cAMP-dependent signaling pathway. The level of intracellular cAMP, the activity of cAMP-dependent protein kinase, the phosphorylation of cAMP-responsive element binding protein and the activity of cAMP- responsive element (CRE) were down-regulated during the myotube formation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36129-36",
                "id": "12140295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PKA activation by beta-adrenoreceptor (isoproterenol) stimulation results in stoichiometric phosphorylation of troponin I (TnI) and C-protein. PKC activation by either 12-O-tetradecanoylphorbol-13-acetate (TPA) or by alpha-adrenoreceptor (phenylephrine plus propranolol) stimulation results in phosphorylation of the same two proteins to similar extents",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1993 Feb 5 268(4) 2705-11",
                "id": "8381412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db75"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Treatment with FSH (presumptively PKA-mediated) markedly attenuated the ability of PMA or GnRH to upregulate the accumulation of the IGFBP-5 (but not IGFBP-4) protein. Taken together, our present findings indicate that the modulation of rat ovarian IGFBP-4 and -5 is PKC as well as PKA dependent and that these two signaling pathways interact in a diametrically opposed and antagonistic fashion.",
              "citation": {
                "type": "PubMed",
                "name": "Biol Reprod 2002 Sep 67(3) 1003-12",
                "id": "12193414"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db6c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In this study we show that merlin is also a target for PKA-induced phosphorylation. In vitro [gamma-(33)P]ATP labeling revealed that both the merlin N and C termini are phosphorylated by PKA. Furthermore, both in vitro and in vivo phosphorylation studies of the wild-type and mutated C termini demonstrated that PKA can phosphorylate merlin at serine 518, a site that is phosphorylated also by p21-activated kinases (PAKs).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 30 279(18) 18559-66",
                "id": "14981079"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db65"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jan 2 273(1) 215-21",
                "id": "9417067"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e41e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Treatments with hCG, forskolin, or phorbol 12 myristate 13-acetate stimulated Runx1 mRNA expression",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2006 Sep 20(9) 2156-72",
                "id": "16675540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3f6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PKIgamma is required for efficient termination of nuclear PKA activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2700-7",
                "id": "15557275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Nov 12 324(2) 801-9",
                "id": "15474498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "RTP was partially phosphorylated at seven or more sites. The phosphorylation was reversible, and was enhanced by an increased level of intracellular cAMP and inhibited by both a protein kinase A inhibitor and a calmodulin kinase inhibitor. Protein kinase A directly phosphorylated recombinant RTP in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2000 Jun 16 272(3) 641-7",
                "id": "10860807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "treatment with forskolin or the cAMP analog 8-Bromo-cAMP resulted in an up to 3.8-fold stimulation of biglycan promoter activity",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1997 Jun 18 235(2) 413-7",
                "id": "9199208"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In adipocytes, stimulation of beta-adrenergic receptors increases cyclic AMP levels and activates protein kinase A (PKA), which stimulates lipolysis by phosphorylating hormone-sensitive lipase and perilipin.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2005 Sep 22 437(7058) 569-73",
                "id": "16177793"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1989 May 86(9) 3174-8",
                "id": "2541433"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jan 1 274(1) 48-51",
                "id": "9867809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Rhes is constitutively bound to GTP and activates PI3K, and, on the other hand, interferes with cAMP/PKA pathway activation induced by G protein-coupled receptors",
              "citation": {
                "type": "PubMed",
                "name": "Methods Enzymol 2005 407 535-42",
                "id": "16757351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Protein kinase A phosphorylation of CREB at serine 133 facilitates transcription from cellular CREs by recruiting CBP/p300 via its KIX domain. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jun 29 282(26) 18750-7",
                "id": "17449469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Interestingly, activation of PKA abrogates the inhibitory effect of Rab13 on the recruitment of vasodilator-stimulated phosphoprotein, ZO-1, and claudin1 to cell-cell junctions. Rab13 is, therefore, the first GTPase that controls PKA activity and provides an unexpected link between PKA signaling and the dynamics of TJ assembly.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2004 Apr 26 165(2) 175-80",
                "id": "15096524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PGE2 stimulated the CD14 gene expression at the transcriptional level via protein kinase A.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 May 15 164(10) 5403-8",
                "id": "10799905"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3b9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "beta 2 receptors can also couple to Gi proteins, resulting in stimulation of of the ERK and p38 MAPK pathways.  Activation of this pathway by the beta 2 receptor requires that the receptor be phosphorylated by PKA",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy Clin Immunol 2006 Jan 117(1) 18-24; quiz 25",
                "id": "16387578"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Leptin impairs several metabolic actions of insulin, i.e. stimulation of glucose transport, glycogen synthase, lipogenesis, inhibition of isoproterenol-induced lipolysis, and protein kinase A activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Apr 18 272(16) 10585-93",
                "id": "9099705"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3b4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Activation of beta-adrenergic receptors and consequent phosphorylation by cAMP-dependent protein kinase A (PKA) greatly increases the L-type Ca2+ current through CaV1.2 channels in isolated cardiac myocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Oct 28 100(22) 13093-8",
                "id": "14569017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3ad"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PTH promoted the expression of Smad3 mRNA within 10 min and the protein level in a dose-dependent manner in MC3T3-E1 and rat osteoblastic UMR-106 cells. Protein kinase A (PKA) activator as well as protein kinase C (PKC) activators increased Smad3 protein level, and both PKA and PKC inhibitors antagonized PTH-induced Smad3, indicating that PTH promotes the production of Smad3 through both PKA and PKC pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 26 278(52) 52240-52",
                "id": "14517210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3aa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Apr 25 272(17) 11457-62",
                "id": "9111058"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Here we report that cAMP-dependent hormonal stimulation of DNA synthesis requires Rap1b in a manner dependent on its phosphorylation by protein kinase A.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Apr 16 99(8) 5418-23",
                "id": "11959997"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e3a0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "both casein kinase 2 (CK2) and protein kinase A (PKA), which promote and block APC nuclear import, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 29 280(17) 17221-6",
                "id": "15649893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e39e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Here, we show that elevation of cAMP levels causes the protein kinase A-dependent phosphorylation and nucleocytoplasmic translocation of PTB1, thereby preventing the rapid degradation of insulin mRNA and enhancing the expression of various granule proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Metab 2006 Feb 3(2) 123-34",
                "id": "16459313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e39a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Apr 15 21(8) 1889-98",
                "id": "11953308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e399"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Inhibition of PKA with H-89 prevents NMDA-induced phosphorylation and degradation of matrin 3 as well as neuronal death.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2005 Aug 94(3) 808-18",
                "id": "16000164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e393"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PKA phosphorylates HA95 but not LAP2beta in vitro and elicits a release of LAP2beta from HA95. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2003 Sep 9 42(35) 10456-61",
                "id": "12950172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e392"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 1997 May 68(5) 2220-3",
                "id": "9109552"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e390"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 25 277(4) 2381-4",
                "id": "11723108"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e38e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Figure 5B demonstrates that apoE induced activation of PKA comparable to that brought about by 8Br-cAMPa cell-permeable PKA activator.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2007 Jul 27(7) 1610-7",
                "id": "17510469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e38d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "RTK signaling potentiates GLI activity through PI3K-AKT-mediated GSK3 inactivation or RAS-STIL1-mediated SUFU inactivation, while GPCR signaling to Gs represses GLI activity through adenylate cyclase-mediated PKA activation",
              "citation": {
                "type": "PubMed",
                "name": "Curr Mol Med 2009 Sep 9(7) 873-86",
                "id": "19860666"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e378"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 11 277(2) 1002-12",
                "id": "11682477"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e368"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Parathyroid hormone-related peptide or a ten-amino-acid peptide from its N terminus inhibits endothelial cell migration in vitro and angiogenesis in vivo by activating endothelial cell protein kinase A.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2002 Sep 8(9) 995-1003",
                "id": "12185361"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e35d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "hnRNP A1 is directly phosphorylated in vitro by PKA, casein kinase II (CKII) and PKC",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Apr 17 149(2) 307-16",
                "id": "10769024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e358"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Zinc-mediated cGMP elevation led to cross activation of protein kinase A.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Sep 15 179(6) 4180-6",
                "id": "17785857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e355"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "# sentences for pubmedID=12857755: # GeneRif: apoE inhibits cell migration via cAMP-dependent protein kinase A activation as a consequence of its binding to LRP-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 19 278(38) 36257-63",
                "id": "12857755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e34a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Feb 19(2) 1002-15",
                "id": "9891036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e345"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PKA signaling pathway is involved in the xenobiotic responsive element (XRE)-mediated transactivation of the human CYP1B1 gene",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem (Tokyo) 2006 Mar 139(3) 527-34",
                "id": "16567417"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e33b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "T212 and S214, two sites previously shown to be phosphorylated by glycogen synthase kinase 3beta (GSK3beta) and protein kinase A (PKA)",
              "citation": {
                "type": "PubMed",
                "name": "Neuroscience 2004 127(3) 649-58",
                "id": "15283964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e336"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Feb 18 100(4) 2029-34",
                "id": "12578970"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e335"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "This effect of cAMP is mediated, in part, by protein kinase A phosphorylation of NFAT. The mechanism of regulation involves the creation of a phosphorylation-dependent binding site for 14-3-3.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Jan 20(2) 702-12",
                "id": "10611249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e330"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Phosphorylation of the lipid droplet-associated protein perilipin A (Peri A) mediates the actions of cyclic AMP-dependent protein kinase A (PKA) to stimulate triglyceride hydrolysis (lipolysis) in adipocytes. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jan 12 282(2) 996-1002",
                "id": "17114792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e325"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "TPA treatment results in phosphorylation of cAMP responsive element binding protein (CREB) and activation of cAMP-dependent protein kinase (PKA) in PC12",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2001 Mar 76(5) 1376-85",
                "id": "11238722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e318"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2003 Apr 144(4) 1301-14",
                "id": "12639913"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e300"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 29 279(44) 45423-32",
                "id": "15308669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1995 Dec 18 377(2) 131-4",
                "id": "8543035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "exposure of HUVEC to exogenous PAF stimulates adenylate cyclase and protein kinase A (PKA) activity",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Mar 18(3) 568-70",
                "id": "14715700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "# Pubmed:gene: AMY-1 interacts with S-AKAP84 and AKAP95 in the cytoplasm and the nucleus, respectively, and inhibits cAMP-dependent protein kinase activity by preventing binding of its catalytic subunit to A-kinase-anchoring protein (AKAP) complex.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 27 277(52) 50885-92",
                "id": "12414807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1984 Nov 10 259(21) 13504-10",
                "id": "6333425"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2001 Apr 20 105(2) 257-67",
                "id": "11336675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1992 Oct 12(10) 4634-42",
                "id": "1406653"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Simultaneous treatment with OA plus dibutyryl cAMP caused a synergistic up-regulation of steady-state levels of HO-1 mRNA, and the specific protein kinase A inhibitor KT5720 markedly reduced the OA-dependent HO-1 mRNA induction.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2000 Mar 57(3) 610-8",
                "id": "10692503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2c6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The antiapoptotic mechanism of epinephrine primarily involves phosphorylation and inactivation of the proapoptotic protein BAD by cAMP-dependent protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 May 11 282(19) 14094-100",
                "id": "17353197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e297"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Finally, PKA enhanced InsP3-induced Ca2+ mobilization in a range of permeabilized cell types, irrespective of whether the type I, II, or III receptor was predominant.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Mar 6 273(10) 5670-7",
                "id": "9488697"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e293"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Mutation of serine 104, the site of phosphorylation by protein kinase A in ARPP-19, to either alanine or aspartate abolished this regulation in PC12 cells",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Sep 17 99(19) 12427-31",
                "id": "12221279"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e292"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "An activator of the PKA pathway (8-bromo cyclic adenosine monophosphate [cAMP]) induced NTPPPH.",
              "citation": {
                "type": "PubMed",
                "name": "J Bone Miner Res 1996 Feb 11(2) 183-92",
                "id": "8822342"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e28f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Feb 21 272(8) 5183-6",
                "id": "9030586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e28e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 16 279(29) 29988-93",
                "id": "15133036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e28a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Cyclic AMP activates PKA, therefore we expect to see an increased difference between active and inactive PKA when cAMP levels are physiologically high. ",
              "citation": {
                "type": "PubMed",
                "name": "BMC Syst Biol 2009 3 70",
                "id": "19607691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e278"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Nov 28 272(48) 30356-61",
                "id": "9374525"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e25b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "This zinc-induced protein kinase A activation inhibited Raf-1 activity by phosphorylation at serine 259, preventing activation of Raf-1 by phosphorylation of serine 338. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Sep 15 179(6) 4180-6",
                "id": "17785857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e20b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "it has recently been demonstrated that increased cAMP-levels and in particular the cAMP-dependent protein kinase A (PKA) can modulate erythroid signal transduction pathways.... In other cases, such as the STAT5 pathway, PKA enhances Epo signaling by inducing recruitment of additional co-regulators of transcription. In addition to STAT5, PKA also activates other transcription factors that are required for erythroid gene expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Leuk Lymphoma 2003 Nov 44(11) 1893-901",
                "id": "14738140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e206"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "A mutant SIK whose Ser-577, the cAMP-dependent protein kinase (PKA)-dependent phosphorylation site, was replaced with Ala could not move out of the nucleus under stimulation by ACTH.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 1 277(44) 42334-43",
                "id": "12200423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1fa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "synthesis of HSP-72 and -90 was inhibited when cells were treated with the protein kinase A inhibitor, H89",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2000 Jan 204(1-2) 169-78",
                "id": "10718636"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Activation of protein kinase A inhibits cell migration and angiogenesis by inhibiting the small GTPase Rac.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2002 Sep 8(9) 995-1003",
                "id": "12185361"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1ec"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "This receptor has recently been shown to undergo activation in vitro through a protein kinase A-dependent mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Hematol 2004 Feb 75(2) 63-72",
                "id": "14755370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "erythrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Sp-5,6- DCl-cBIMPS treatment for 10 min resulted in decreased PKB/Akt phosphorylation similar to forskolin treatment (Fig. 1B).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Oct 20(10) 1715-24",
                "id": "18565730"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1993 Nov 25 268(33) 24808-12",
                "id": "8227042"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1d3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Pharmacologic inhibition of protein kinase C (PKC) and protein kinase A (PKA), which are involved in hexosamine-mediated matrix production, blocked the CREB phosphorylation and fibronectin synthesis seen in HG and GlcN conditions.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Oct 50(10) 2355-62",
                "id": "11574420"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1ce"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "and phosphorylation by protein kinases A (PKA) and B (PKB/Akt),",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 5 280(31) 28241-50",
                "id": "15946941"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2001 Dec 15 537(Pt 3) 659-65",
                "id": "11744745"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e1b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1991 Sep 15 266(26) 17124-30",
                "id": "1680128"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e19c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "phosphorylation of CREB at Ser-133 is induced 6-fold in vivo, following treatment of PC12 cells with forskolin.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1989 Nov 17 59(4) 675-80",
                "id": "2573431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e199"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Stimulation of VEGFR3 alone protected these cells from serum-deprivation-induced apoptosis and induced cell growth and migration.At least some of these signals were transduced via a protein- kinase-C-dependent activation of the p42/p44 mitogen-activated protein kinase (MAPK) signalling cascade and via AKT phosphorylation40.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Aug 2(8) 573-83",
                "id": "12154350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e192"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Nov 7 97(23) 12577-82",
                "id": "11050185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e190"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1993 Jul 5 268(19) 14294-300",
                "id": "8390988"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e184"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "This modification reduces binding of MAP kinases to the KIM, an effect that is prevented by mutation of serine 23 to alanine.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 1999 Sep 1(5) 305-11",
                "id": "10559944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e178"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Jul 21 270(29) 17407-13",
                "id": "7615546"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e173"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The differentiation was mediated though activation of the protein kinase A (PKA) and phosphatidylinositol-3 kinase (PI-3K) pathways",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci Res 2006 Jun 1 83(8) 1415-24",
                "id": "16547973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e171"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "indicate that the cAMP/PKA pathway mediates the PTHrP-mediated down-regulation of BSP mRNA expression in cementoblasts; and furthermore, this pathway may, through an intrinsic inhibition mechanism, regulate the basal level of BSP mRNA expression.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2000 Dec 141(12) 4671-80",
                "id": "11108282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e170"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PKC and PKA phosphorylate at Ser726 in the MARCKS domain (42).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 18 275(33) 25805-13",
                "id": "10823823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e159"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Aug 21(15) 5169-78",
                "id": "11438671"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e110"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The main PKA substrate following NMDA receptor activation was identified by MALDI-TOFF fingerprinting as the nuclear protein, matrin 3.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2005 Aug 94(3) 808-18",
                "id": "16000164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The activation of protein kinase A (PKA) is required for the albuterol-dependent inhibition of HASM cell migration.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2012 Jan 46(1) 48-54",
                "id": "22210825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Elevation of cAMP was associated with increased enzymatic activity of PKA (Figure 3B) in a time scale corresponding to dynamics of cAMP increase.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 28 275(4) 2513-9",
                "id": "10644707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e099"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Cdc2 dephosphorylation was accelerated in PKI [PKA inhibitor]-microinjected embryos.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Dyn 2005 Jan 232(1) 98-105",
                "id": "15580572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e095"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "We report in this study the acute functional regulation of RGS10 thru the specific and inducible phosphorylation of RGS10 protein at serine 168 by cAMP-dependent kinase A",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 31 276(35) 32828-34",
                "id": "11443111"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e093"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PKA activity of C2C12 cells was increased upon BMP-2 treatment",
              "citation": {
                "type": "PubMed",
                "name": "Int J Biochem Cell Biol 2006 38(12) 2064-73",
                "id": "16870489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e08e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e076"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Inhibitor experiments confirmed that the positive effect of isoproterenol on TIMP-1 is mediated via beta-adrenergic receptors and protein kinase A.",
              "citation": {
                "type": "PubMed",
                "name": "J Endocrinol 2006 Jun 189(3) 665-70",
                "id": "16731796"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e075"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2001 Mar 10 264(1) 74-99",
                "id": "11237525"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e069"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 23 276(12) 9406-12",
                "id": "11096081"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e067"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Feb 21(4) 1185-95",
                "id": "11158305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e066"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In rat C6 glioma cells, post-transcriptional gene regulation occurs through PKA-mediated stabilization of LDH-A mRNA and subsequent increase of intracellular LDH-A mRNA levels.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 1 280(26) 25170-7",
                "id": "15878851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e058"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Apr 22(8) 2716-27",
                "id": "11909964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e04b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "As shown in Figure 2A, protein kinase A (PKA) inhibitor, H89, and protein kinase C (PKC) inhibitor, GF109302X, significantly inhibited I-BOP-induced Nurr1 expression",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2009 Sep 30(9) 1606-13",
                "id": "19570744"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e03b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "FIG. 6. Rac1 stimulates PKA activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jul 24(14) 6205-14",
                "id": "15226424"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e03a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "B cell lymphoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "inhibition of protein kinase A (PKA) with KT5720 attenuated the upregulation of both renin and Ao mRNA",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2005 Dec 15 132(1-3) 1-8",
                "id": "16194576"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e037"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "12-O-tetradecanoylphorbol-13-acetate (TPA) could induce cell apoptosis via induction of TR3 and E2F1 expression in LNCaP prostate cancer cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 31 278(44) 42840-5",
                "id": "12947120"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e029"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Inhibition of PDE4 activity with rolipram enhances cAMP accumulation, yields maximal PKA phosphorylation of phospholamban and TnI, and myocyte contraction responses.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2008 Nov 74(5) 1453-62",
                "id": "18703669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e024"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 4 276(18) 15192-9",
                "id": "11278469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e01e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 10 278(2) 1186-94",
                "id": "12417592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e011"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Apr 18(4) 2164-72",
                "id": "9528788"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e006"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "In vitro phosphorylation of recombinant mouse LASP-1 by cAMP- and cGMP-dependent protein kinase (PKA and PKG, respectively) occurs at serine 61, serine 99, and threonine 156 whereas in intact cells mouse LASP-1 is phosphorylated only at threonine 156.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Nov 5 324(1) 308-16",
                "id": "15465019"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e001"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "extracellular signal-regulated kinase 5 (ERK5), but not ERK1/2, by growth factors is disrupted by cAMP through cAMP-dependent protein kinase (PKA).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Apr 26(8) 3039-47",
                "id": "16581779"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dffe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "# Pubmed:gene: A-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3beta (GSK-3beta ) and mediates protein kinase A-dependent inhibition of GSK-3beta. # Ariadne: Therefore, AKAP220 may associate with  PKA selectively among the GSK-3eta upstream molecules and enhance the signaling  between PKA and GSK-3eta. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 4 277(40) 36955-61",
                "id": "12147701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dff1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Neuron 1999 Oct 24(2) 377-87",
                "id": "10571231"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dff0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Our results support a simple model whereby PKA triggers a cascade of Gli3 phosphorylation by GSK3beta and CK1 that leads to direct betaTrCP binding and ubiquitination by SCFbetaTrCP.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Jun 26(11) 4316-26",
                "id": "16705181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfeb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Stabilization of -catenin by PKA. PKA-dependent phosphorylation of -catenin at Ser675 inhibits the ubiquitination of -catenin, although GSK-3 -dependent phosphorylation of -catenin is not affected. ",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2006 Feb 28 38(1) 1-10",
                "id": "16520547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfe8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Proteomics 2002 Jul 1(7) 517-27",
                "id": "12239280"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfe1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "This study provides evidence that cAMP and protein kinase A are important regulators of CD14 expression in macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2000 Jun 67(6) 894-901",
                "id": "10857864"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfd7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Thus, nuclear/cytoplasmic translocation of DNA-PK is under dual control by cAMP, with EPAC activation promoting nuclear exit while PKA promotes its nuclear entry (Fig. 1F).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2008 Sep 2 105(35) 12791-6",
                "id": "18728186"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfcc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PKA activity attenuates KV3.2 channel currents and A-type current and is involved in the inhibition of K+ conductances by prostaglandin E-2 . ",
              "citation": {
                "type": "PubMed",
                "name": "BMC Pharmacol 2004 Aug 4 4 14",
                "id": "15294026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfc7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Electrophoretic mobility shift assays revealed that treatment of hepatoma cells or cultured rat hepatocytes with 1 mM 8-Br-cAMP or glucagon reduced binding of FP330-3' by HNF4 by half. In vitro phosphorylation of HNF4 by PKA decreased binding to FP330-3'",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2002 Feb 1 398(1) 79-86",
                "id": "11811951"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfc1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "we compared the time-dependent changes in the PLB phosphorylation at Ser(16) (PKA site) and Thr(17) (CaMKII site) in perfused normoxic rat hearts with those in IHA hypoxic rat hearts",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2005 Jun 288(6) H2594-602",
                "id": "15637115"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfbf"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "cardiac muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "bacterially expressed PCTAIRE is completely inactive as a protein kinase, but is a very good substrate for protein kinase A (PKA), which phosphorylates a total of four sites in the N-terminus of PCTAIRE-1",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2002 Sep 1 115(Pt 17) 3479-90",
                "id": "12154078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfb5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "protein kinase A-dependent phosphorylation of cTnI",
              "citation": {
                "type": "PubMed",
                "name": "FEBS J 2005 Dec 272(23) 6087-97",
                "id": "16302972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfb4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 3 278(1) 124-30",
                "id": "12399457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39102-11",
                "id": "12167624"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfa7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Expression of PKIalpha inhibits  PKA activity in VSMC.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 1998 Sep 54(3) 514-24",
                "id": "9730910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df99"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "protein kinase C phosphorylation of cTnI plays a dominant role in depressing contractility and exerts an antithetic role on the ability of protein kinase A to increase relaxation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 7 280(1) 703-14",
                "id": "15507454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df92"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Although protein kinase A-dependent phosphorylation of one of the three phospho-acceptors in Kir1.1, Ser-44, also a canonical serum-glucocorticoid-regulated kinase (SGK-1) phosphorylation site, controls the number of active channels,it is unknown whether this involves activating dormant channels already residing on the plasma membrane or recruiting new channels to the cell surface.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 20 278(25) 23066-75",
                "id": "12684516"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df91"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 309-14",
                "id": "15294048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df8f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "rat liver cholesterol ester hydrolase is activated by cyclic AMP dependent protein kinase and protein kinase C. Deactivation is accomplished by dephosphorylation catalyzed by a phosphoprotein phosphatase, dependent on Mg2+.",
              "citation": {
                "type": "PubMed",
                "name": "Lipids 1989 Aug 24(8) 733-6",
                "id": "2555647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df84"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Serine 916 was a substrate for protein kinase A both in vivo and in vitro, suggesting a novel link between the cAMP and Ras signaling systems.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 24 274(52) 37379-84",
                "id": "10601308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df83"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "stimulation of ERalpha transcription by the PKA-dependent pathway",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2004 Jun 145(6) 2730-8",
                "id": "15033909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df6e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "aken together, these data provide strong evidence that PKA is the enzyme responsible for phosphorylating CREB at S133 in response to PTH and that PKA activity is required for PTH-induced c-fos expression.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1999 Mar 140(3) 1255-61",
                "id": "10067851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df69"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2000 Mar 278(3) F388-94",
                "id": "10710543"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "93388570",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df5e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cardiovasc Med 2002 May 12(4) 160-5",
                "id": "12069755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Whereas PKA phosphorylation is activated by cAMP, PDEs degrade cAMP and inactivate the cAMP signal",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 22 276(25) 21999-2002",
                "id": "11285255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deea"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "RasGRF1 has been shown to be phosphorylated by protein kinase A and more recently, by the non-receptor tyrosine kinases Ack1 and Src.",
              "citation": {
                "type": "PubMed",
                "name": "Neurosignals 15(4) 157-73",
                "id": "16921254"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dee9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "on ERK there is a serine residue which can be phosphorylated by PKA, whereupon docking to ERK is ablated",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Soc Trans 2003 Dec 31(Pt 6) 1186-90",
                "id": "14641023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dee6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "compounds that stimulate protein kinase A (PKA) activity inhibit the activation of the NKCC.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2004 Mar 286(3) C586-95",
                "id": "14592811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407deb4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PTH(1-34), forskolin (FSK), and 8-bromo-cAMP (8Br-cAMP) induced ICER expression, while phorbol myristate acetate (PMA), ionomycin, and PTH(3-34) did not.",
              "citation": {
                "type": "PubMed",
                "name": "Bone 2003 May 32(5) 483-90",
                "id": "12753864"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dea3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jan 24(2) 765-73",
                "id": "14701748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dea1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Site-directed mutagenesis and phosphorylation analyses revealed two sites in the SAF-1 protein, serine 187 and threonine 386, as the target of PKA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 20 278(25) 22586-95",
                "id": "12697757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de9d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "from full text - p27Kip1 mRNA levels were suppressed by bombesin/insulin, but elevated by activation of PKA signalling",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Apr 17 14(15) 1759-66",
                "id": "9150381"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de83"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PTH(1-34), forskolin (FSK), and 8-bromo-cAMP (8Br-cAMP) induced ICER expression, while phorbol myristate acetate (PMA), ionomycin, and PTH(3-34) did not.",
              "citation": {
                "type": "PubMed",
                "name": "Bone 2003 May 32(5) 483-90",
                "id": "12753864"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de66"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "These results are consistent with the hypothesis that CGRP produces hyperalgesia by a direct action on CGRP1 receptors in the spinal cord dorsal horn and suggest that the effects of CGRP are mediated by both PKA and PKC second-messenger pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurophysiol 2004 Nov 92(5) 2859-66",
                "id": "15486424"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de5b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Stimulation that induced LTP triggered cAMP-dependent phosphorylation of endogenous inhibitor-1 and a decrease in PP1 activity.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1998 Jun 19 280(5371) 1940-2",
                "id": "9632393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de4b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "inhibitors of protein kinase A and phospholipase C mediated signalling. Our results demonstrate that both pathways are involved in VIP induced per gene expression",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Neurosci 2002 Feb 15(3) 570-4",
                "id": "11876785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de44"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "the proliferation was mediated through the mitogen-activated protein kinase and PKA pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci Res 2006 Jun 1 83(8) 1415-24",
                "id": "16547973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de43"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Apr 9 274(15) 10086-93",
                "id": "10187789"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de2f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "By the incubation with H8, an inhibitor of PKA, the inhibitory effect of PGE1 on the expression of PAI-1 mRNA was abolished, suggesting that PGE1 inhibited the PAI-1 mRNA expression via the PKA pathway",
              "citation": {
                "type": "PubMed",
                "name": "Exp Clin Endocrinol Diabetes 2005 Jul 113(7) 365-71",
                "id": "16025396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Here we report that PKA phosphorylates HSPDE3B at several distinct sites (Ser-73, Ser-296, and Ser-318), and we show that phosphorylation of HSPDE3B at Ser-318 activates this PDE and stimulates its interaction with 14-3-3 proteins.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Mar 30 282(13) 9411-9",
                "id": "17255105"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "we have found that G alpha 13 induced release of the cPKA from the AKAP110-rPKA complex, resulting in a cAMP-independent PKA activation.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2001 Oct 30 11(21) 1686-90",
                "id": "11696326"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de11"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The primary site of phosphorylation by protein kinase C was also near the amino terminus at Ser-27. The major site of phosphorylation by adenosine cyclic 3',5'-phosphate dependent protein kinase was on the carboxy-terminal half of the molecule at Thr-216. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1988 May 17 27(10) 3682-90",
                "id": "2457390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "These results indicate that amylin is positively regulated by cAMP and PKA through the transcription factors HNF-1 and NFY.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2003 Nov 28 210(1-2) 63-75",
                "id": "14615061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Protein kinase A directly phosphorylates human caspase-9 at serines 99, 183, and 195.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 15 280(15) 15449-55",
                "id": "15703181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddcf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2002 Aug 1 64(3) 375-83",
                "id": "12147288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Furthermore, monophosphorothioate analogs of cAMP, which activate protein kinase A (PKA), also inhibited LT biosynthesis and 5-LO translocation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2002 Aug 62(2) 250-6",
                "id": "12130675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddc8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Expression and selectivity of OCT1 is regulated. For example, after expression in human embryonic kidney cells (HEK-293), transport by rOCT1 was stimulated by PKC, PKA and tyrosine kinase and inhibited by cGMP [31, 40], and stimulation by PKC was associated with altered substrate selectivity",
              "citation": {
                "type": "PubMed",
                "name": "Pflugers Arch 2003 Jul 19",
                "id": "12883891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddc5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "FIGURE 6. PKA is an AMPKK active on AMPK {alpha}1-Ser485.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Dec 1 281(48) 36662-72",
                "id": "17023420"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddbb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Phosphorylation of Ser188 by PKA inhibited the ability of FRAT1 to activate beta-catenin-dependent transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 17 281(46) 35021-9",
                "id": "16982607"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dda4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "9829964;7958915;11969286;8887554;15733869;12356771;9687510;9528766",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dda0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PDK1 has now been shown to play a central role in activating many of the AGC subfamily members (reviewed in [150,151]). Apart from phosphorylating PKB on Thr308, PDK1 phosphorylates the equivalent residues on PKC isoforms [48,152,153], p70-S6K [32,154], the three isoforms of SGK [27,28,155] and PKA [156] (Figure 6).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2000 Mar 15 346 Pt 3 561-76",
                "id": "10698680"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Ser155 is a major site of phosphorylation by PKA",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2000 Sep 21 10(18) 1151-4",
                "id": "10996800"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The present work provides evidence that cAMP, through PKA-mediated CREB phosphorylation, and phenobarbital induce ALA-S expression at the transcriptional level, while heme represses it.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 1999 Dec 15 372(2) 261-70",
                "id": "10600163"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd93"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 8 276(23) 20774-80",
                "id": "11279195"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "transcription of brain creatine kinase (CKB) mRNA in U87-MG glioblastoma cells is stimulated by a forskolin-mediated increase in cyclic AMP (cAMP) via a pathway involving protein kinase A (PKA)",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci Res 1999 May 15 56(4) 371-85",
                "id": "10340745"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd48"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 16 279(3) 1585-93",
                "id": "14576165"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd43"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PTH induces NR4A members through the cAMP-protein kinase A (PKA) pathway in vitro",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Jul 1 332(2) 494-503",
                "id": "15910753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 1 277(44) 42344-51",
                "id": "12171920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 1999 Jun 15 19(12) 4748-54",
                "id": "10366608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jul 22 100(15) 8776-81",
                "id": "12851456"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Expression of the wild-type PKA catalytic subunit markedly increased Nur77-mediated transactivation of the NurRE reporter and its effects were significantly blunted by coexpression of CRIF1 (Fig. 7B).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2005 Jan 19(1) 12-24",
                "id": "15459248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd09"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Gli2 degradation is dependent on the phosphorylation of a cluster of four PKA sites as well as the PKA-primed phosphorylation of multiple adjacent CK1 and GSK3 sites within the Gli2 C-terminal region. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 May 26(9) 3365-77",
                "id": "16611981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd08"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Here, we demonstrate that stimulation of Rat-2 or embryonic stem cells with activators of ERK1/2 or of cAMP-dependent protein kinase induced phosphorylation of endogenously expressed LKB1 at Ser(431).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 1 276(22) 19469-82",
                "id": "11297520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcfe"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Nov 12(5) 1225-37",
                "id": "14636580"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcf6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 8 277(10) 8267-72",
                "id": "11751901"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcf4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Phosphorylation of P-Rex1 with protein kinase A (PKA) inhibits the PIP(3)- and Gbetagamma-stimulated P-Rex1 guanine nucleotide exchange activity on Rac.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jan 27 281(4) 1921-8",
                "id": "16301320"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcf3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Ser-726 and Ser-713 in the C-terminal MARCKS-related domains of alpha- and beta-adducin, respectively, were identified as the major phosphorylation sites common for PKA and PKC. PKA, in addition, phosphorylated alpha-adducin at Ser-408, -436, and -481 in the neck domain. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Oct 11 271(41) 25157-66",
                "id": "8810272"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcdf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 19023-31",
                "id": "12654918"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Comp Physiol [B] 2001 Feb 171(1) 33-40",
                "id": "11263724"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcd4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "These results provide the first demonstration that Peri A regulates ATGL-dependent lipolysis and identify serine 517 as the Peri A PKA site essential for this regulation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jan 12 282(2) 996-1002",
                "id": "17114792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dcca"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "GABAB receptor-mediated inhibitory action on GABA release was mediated via decreases in PKA activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2003 Aug 15 551(Pt 1) 263-76",
                "id": "12815184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dca9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 24 275(47) 36514-22",
                "id": "10969067"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dca7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2000 Jul 279(1) C266-73",
                "id": "10898738"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dca1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Protein kinase A was able also to phosphorylate and activate histidine decarboxylase in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2005 Jan 67(1) 195-203",
                "id": "15465923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc9c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "the PKA responsive domain in CBP resides near its amino terminus..at this point PKA activation of p300/CBP remains egnimatic",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13505-8",
                "id": "11279224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1992 Jan 25 267(3) 1496-501",
                "id": "1370476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc92"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 2 276(44) 40903-9",
                "id": "11533025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "We now show that PKA directly phosphorylates RIM1alpha at two sites.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2003 Oct 3 115(1) 49-60",
                "id": "14532002"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1993 Feb 25 21(4) 949-55",
                "id": "8451194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "(i) EDF-1 is in vitro and in vivo phosphorylated by protein kinase A (PKA);",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 May 61(9) 1069-74",
                "id": "15112053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc80"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "From CST pathway map for GPCR Signaling to ERK. ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Endocrinol Metab 2006 Sep 17(7) 276-83",
                "id": "16890451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Following extracellular stimuli, stathmin is phosphorylated on four serines (Ser16, Ser25, Ser38, and Ser63) by several kinases, such as mitogen-activated protein (MAP), cdc2 kinase, protein kinase A, and Ca2+/calmodulin-dependent kinase-Gr.",
              "citation": {
                "type": "PubMed",
                "name": "Electrophoresis 1998 May 19(5) 867-76",
                "id": "9629929"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc73"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "97263637",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc72"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Beta2-adrenergic receptor stimulation increased CREB phosphorylation, OCA-B expression, and OCA-B binding to the 3'-IgH enhancer in a protein kinase A-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 28 279(22) 23394-404",
                "id": "15024018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1994 Sep 9(9) 2733-6",
                "id": "8058338"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc58"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Activation of D1-like dopamine (DA) receptors reduces peak Na(+) current in acutely isolated hippocampal neurons via a modulatory mechanism involving phosphorylation of the Na(+) channel alpha subunit by cAMP-dependent protein kinase (PKA).",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 1999 Sep 1 19(17) RC21",
                "id": "10460275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc50"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PKA directly phosphorylates Tyk2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2000 Sep 212(1-2) 99-109",
                "id": "11108141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc43"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Jan 15 16(2) 211-20",
                "id": "9029142"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc40"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Muscle Res Cell Motil 2001 22(5) 425-37",
                "id": "11964068"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc3d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 2002 Jan 21(1) 41-6",
                "id": "11879579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc24"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1999 Aug 10 38(32) 10361-70",
                "id": "10441130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras Our results suggest that cAKI may act as a mediator of ras and erbB-2 oncogene action in human breast cells and that interference with cAKI action provides a potential tool for inhibiting the growth-promoting effects of these oncogenes.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 1993 Feb 1 53(3) 438-43",
                "id": "8094073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Mutating the PKA-dependent phosphorylation site in the VACM-1 sequence (S730AVACM-1) prevents this inhibitory effect.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Dec 285(6) C1386-96",
                "id": "12917106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc17"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "the PKA activation induced by dbcAMP resulted in the down-regulation of PDE3B",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2000 Mar 1 346 Pt 2 337-43",
                "id": "10677351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dc05"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Glucagon receptor-mediated elevation of cAMP level results in activation of CREB and CREM, which activates PEPCK gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2003 Feb 24(1) 91-101",
                "id": "12588811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbf4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PTP activity participates in StAR protein induction and led us to attribute to the PKA-mediated PTP activation in steroidogenic systems a functional role, as mediator of StAR protein induction",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Res 2002 Nov 28(4) 413-7",
                "id": "12530643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbeb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "According to our data, N6Bz-cAMP treatment (150 uM) mimicked the protective effect of roflumilast, while H-89 reversed effects of N6Bz-cAMP (Fig. 3C).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 May 20(5) 803-14",
                "id": "18276108"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbe1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "Phosphorylation at Raf-1 S43 and S259 by PKA only weakly inhibited EGF activation of Raf-1 and ERK when cells maintained high Raf-1 S338 phosphorylation.  Raf-1 inhibition in suspension was not due to excessive negative regulation on inhibitory sites S43 and S259, as these serines were largely dephosphorylated in suspended cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jun 25(11) 4466-75",
                "id": "15899852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbd2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 Jan 1 377(Pt 1) 171-81",
                "id": "12974676"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbd0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "addition of ATP to rat liver cytosol increased supernatant protein factor activity by more than 2-fold and could be prevented by the addition of inhibitors of protein kinases A and C.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 5646-51",
                "id": "12454003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbbc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "from full text - Box1 - Known phosphorylation sites (kinase): Thr34 (cyclin-dependent kinase 1 (CDK1)); Thr117 (Aurora kinase B); Ser20 (protein kinase A (PKA)).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2008 Jan 8(1) 61-70",
                "id": "18075512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbb7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "# GeneRif: This evidence supports that the Hal gene is turned on by glucocorticoids and by glucagon either via PKC or PKA, but prefers the PKA pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Endocrinol Metab 2005 Jul 289(1) E172-9",
                "id": "15741241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dba6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Apr 3(4) 331-8",
                "id": "11283605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db94"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Dec 26 272(52) 32972-8",
                "id": "9407077"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db93"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "These results indicate that PKA phosphorylates CREB and so induces VEGF gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cells 2007 Feb 28 23(1) 23-9",
                "id": "17464208"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db84"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "AKAP121 induction stimulates PKA-dependent phosphorylation of the proapoptotic protein BAD at Ser(155), inhibits release of cytochrome c from mitochondria, and protects cells from apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 7 278(6) 4286-94",
                "id": "12427737"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Feb 20 273(8) 4734-9",
                "id": "9468536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Neuron 1996 Jun 16(6) 1179-88",
                "id": "8663994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db6e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1990 Dec 12 194(2) 541-7",
                "id": "2176601"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "The exact mechanism by which such an interaction occurs is not clear, but it may involve altered activity of the cGMP-inhibited PDE3 brought about by a change in the intracellular levels of cGMP by the inhibition of PDE5. This will in turn lead to increasing levels of cAMP, facilitating the interaction of cAMP with the PKA.",
              "citation": {
                "type": "PubMed",
                "name": "World J Urol 2004 Mar 26",
                "id": "15045518"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db62"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PRKA Family\") actsIn kin(p(SFAM:\"PRKA Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jul 21(14) 4626-35",
                "id": "11416140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "relation": "negativeCorrelation",
        "target": "cat(p(SFAM:\"PDE4 Family\"))",
        "directed": false,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") negativeCorrelation cat(p(SFAM:\"PDE4 Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "benwong1999",
          "edgeId": "52cb80aabf21ca05bcfa2494",
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") negativeCorrelation cat(p(SFAM:\"PDE4 Family\"))",
              "summary_text": "fibroblasts obtained from patients with COPD maintained inhibitory PGE2 signaling after PGE2 pretreatment. These data identify a PDE4-mediated attenuation of PGE2 inhibitory signaling in normal fibroblasts that appears to be altered in COPD fibroblasts. These alterations may contribute to COPD pathogenesis and could provide novel therapeutic targets.",
              "citation": {
                "type": "Other",
                "name": "Michalski J, Kanaji N, Liu X, Nogel S, Wang X, Basma H, Nakanishi M, Sato T, Gunji Y, Fahrid M, Nelson A, Muller KC, Holz O, Magnussen H, Rabe KF, Toews ML, Rennard SI.Am J Respir Cell Mol Biol. 2012 Dec;47(6):729-37. doi: 10.1165/rcmb.2012-0057OC. Epub 2012 Oct 4.",
                "id": "23043089"
              },
              "metadata": {
                "created_by": "benwong1999",
                "id": "52cb80aabf21ca05bcfa23f3"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "COPD",
                "cell": "Fibroblasts",
                "tissue": "Lung"
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"TGFB Family\")",
        "relation": "increases",
        "target": "a(SCHEM:Dinoprostone)",
        "directed": false,
        "label": "p(SFAM:\"TGFB Family\") increases a(SCHEM:Dinoprostone)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053271",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"TGFB Family\") increases a(SCHEM:Dinoprostone)",
              "summary_text": "AEC actively inhibit the proliferation of both normal and fibrotic fibroblasts via TGF-beta, which induces the prostaglandin E(2) synthesis in fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Allergy 2008 Aug 38(8) 1309-17",
                "id": "18503568"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df10"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Dinoprostone)",
        "relation": "increases",
        "target": "p(HGNC:PDE4A)",
        "directed": false,
        "label": "a(SCHEM:Dinoprostone) increases p(HGNC:PDE4A)",
        "metadata": {
          "casual": false,
          "createdBy": "tndror",
          "edgeId": "52ef5ea189e3620e445e995f",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Dinoprostone) increases p(HGNC:PDE4A)",
              "summary_text": "PGE2 significantly stimulated PDE4A and -4C ( < 0.05) expression",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "24227907"
              },
              "metadata": {
                "created_by": "tndror",
                "id": "52ef5ea189e3620e445e98b7"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "fibroblast",
                "tissue": "lung"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Dinoprostone)",
        "relation": "increases",
        "target": "p(HGNC:PDE4C)",
        "directed": false,
        "label": "a(SCHEM:Dinoprostone) increases p(HGNC:PDE4C)",
        "metadata": {
          "casual": false,
          "createdBy": "tndror",
          "edgeId": "52ef5f2089e3620e445e9ea4",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Dinoprostone) increases p(HGNC:PDE4C)",
              "summary_text": "PGE2 significantly stimulated PDE4A and -4C ( < 0.05) expression",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "24227907"
              },
              "metadata": {
                "created_by": "tndror",
                "id": "52ef5f2089e3620e445e9dfa"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "fibroblast",
                "tissue": "lung"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:PTGES2))",
        "relation": "increases",
        "target": "a(SCHEM:Dinoprostone)",
        "directed": false,
        "label": "cat(p(HGNC:PTGES2)) increases a(SCHEM:Dinoprostone)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053274",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:PTGES2)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "Cell-specific prostaglandin synthases convert PGH2 into a series of prostaglandins, including PGI2, PGF2alpha, PGD2 and PGE2 (Fig. 1).   Fig. 1 Legend - Pathway of prostaglandin production. Arachidonic acid is liberated from membranes by phospholipase A2. The cyclooxygenase enzymes (COX-1 and COX-2) produce prostaglandin H2 (PGH2) from arachidonic acid. PGH2 is acted upon by prostaglandin synthases to produce PGI2, PGD2, PGE2 and PGF2alpha. PGD2 is metabolized to 15-deoxy-12,14-PGJ2 (15-d-PGJ2). ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2002 Mar 23(3) 144-50",
                "id": "11864843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e097"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PTGES2)) increases a(SCHEM:Dinoprostone)",
              "summary_text": "These data suggest that H2O2 stimulates CFTR Cl(-) channel-mediated Cl(-) secretion through cyclooxygenase- and mPGES-1-dependent release of PGE2 and subsequent activation of PKA.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2007 Nov 293(5) F1571-6",
                "id": "17699556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd83"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "renal medulla"
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"RAF Family\"))",
        "relation": "increases",
        "target": "kin(p(SFAM:\"MEK1/2 Family\"))",
        "directed": false,
        "label": "kin(p(SFAM:\"RAF Family\")) increases kin(p(SFAM:\"MEK1/2 Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c3405327b",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"RAF Family\")) increases kin(p(SFAM:\"MEK1/2 Family\"))",
              "summary_text": "It consists of the Raf protein (MAP3K) that phosphorylates MEK (MAP2K), which in turn phosphorylates ERK (MAPK), the latter influencing transcription of different target genes. (From full text)",
              "citation": {
                "type": "Other",
                "name": "Ottenhof NA, de Wilde RF, Maitra A, Hruban RH, Offerhaus GJ.Patholog Res Int. 2011 Mar 27;2011:620601. doi: 10.4061/2011/620601.",
                "id": "21512581"
              },
              "metadata": {
                "created_by": "benwong1999",
                "id": "52cc2ab0bf21ca0644029dd5"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(SFAM:\"RAF Family\")) increases kin(p(SFAM:\"MEK1/2 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dd1a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Dinoprostone)",
        "relation": "increases",
        "target": "a(SCHEM:\"cyclic AMP\")",
        "directed": false,
        "label": "a(SCHEM:Dinoprostone) increases a(SCHEM:\"cyclic AMP\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532b9",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Dinoprostone) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Treatment of EC with PGE2 and beraprost markedly increased intracellular cAMP levels (Figure 3A, upper panels) without significant changes in cGMP levels (Figure 3A, lower panels).",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddf1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Dinoprostone) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "3. On human washed platelet suspensions the PGE analogues, with the exception of butaprost,inhibited the rise in adenosine 3':5'-cyclic monophosphate (cyclic AMP) induced by cicaprost (8 nM).PGE2 produced a monophasic inhibition curve (IC50 = 5.4 nM, 92% inhibition at 600 nM). ",
              "citation": {
                "type": "PubMed",
                "name": "Br J Pharmacol 1993 Feb 108(2) 363-9",
                "id": "8448586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e35e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Dinoprostone) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "both Isoproterenol and PGE2 elevate and sustain increases in cyclic adenosine 3',5'-monophosphate (cAMP)",
              "citation": {
                "type": "PubMed",
                "name": "Gen Pharmacol 1998 Nov 31(5) 715-9",
                "id": "9809467"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Dinoprostone) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "PGE2 increased phosphorylation of Akt and endothelial nitric oxide synthase (eNOS), eNOS activity, and nitric oxide (NO) production by the activation of cAMP-dependent protein kinase (PKA) and phosphatidylinositol 3-kinase (PI3K). Dibutyryl cAMP (DB-cAMP) mimicked the role of PGE2 in angiogenesis and the signaling pathway, suggesting that cAMP is a down-stream mediator of PGE2",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2005 Dec 31 37(6) 588-600",
                "id": "16391520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dbb4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Dinoprostone) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Thrombin and U46619-induced platelet aggregation, as well as basal and prostaglandin E2 (PGE2)-stimulated platelet cyclic adenosine monophosphate (cAMP) levels were unchanged after ingestion of either agent. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cardiovasc Pharmacol 1999 Jan 33(1) 12-8",
                "id": "9890391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Dinoprostone) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Addition of prostaglandin E2 or other agents that elevate cAMP levels resulted in inhibition of DNA synthesis",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1993 May 25 268(15) 10789-95",
                "id": "8388375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:Dinoprostone) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Both PGs caused cAMP-mediated activation of PKA-, Epac/Rap1- and Tiam1/Vav2-dependent pathways of Rac1 activation",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jul 1 313(11) 2504-20",
                "id": "17493609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e196"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "a(SCHEM:Dinoprostone) increases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "An increase of intracellular cAMP mediated by prostaglandin E2 (PGE2) has been shown to delay spontaneous apoptosis of neutrophils.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2000 Aug 68(2) 187-93",
                "id": "10947062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407de85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:VIP)",
        "relation": "increases",
        "target": "cat(p(HGNC:VIPR1))",
        "directed": false,
        "label": "p(HGNC:VIP) increases cat(p(HGNC:VIPR1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053276",
          "evidences": [
            {
              "bel_statement": "p(HGNC:VIP) increases cat(p(HGNC:VIPR1))",
              "summary_text": "We synthesized a VIP analog that combines mutations that decrease the affinity for the VPAC1 receptor but maintain a high affinity for the VPAC2 receptor with an amino-terminal hexanoylation that increases the affinity for the VPAC2 receptor with a limited decrease in the affinity of the VPAC1 receptor. ",
              "citation": {
                "type": "PubMed",
                "name": "Peptides 2004 Feb 25(2) 275-8",
                "id": "15063009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e35c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:celecoxib)",
        "relation": "directlyDecreases",
        "target": "cat(p(HGNC:PTGS2))",
        "directed": false,
        "label": "a(CHEBI:celecoxib) directlyDecreases cat(p(HGNC:PTGS2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053272",
          "evidences": [
            {
              "bel_statement": "a(CHEBI:celecoxib) directlyDecreases cat(p(HGNC:PTGS2))",
              "summary_text": "was able to prevent the development of N-methylnitrosurea-induced prostate and mammary carcinomas in rats by 50% (REF. 38). Celecoxib, an inhibitor of the inducible prostaglandin G/H synthase COX2, was able to reduce the number of colorectal polyps in patients with familial adenomatous polyposis (FAP). Patients with FAP are at high risk of developing colorectal neoplasias39.COX2 inhibitors are anti-inflammatory agents with anti-angiogenic activities that downregulate the expression of the pro-angiogenic factors FGF and VEGF40.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Jun 3(6) 401-10",
                "id": "12778130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407db9c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(CHEBI:celecoxib) directlyDecreases cat(p(HGNC:PTGS2))",
              "summary_text": "JAK/STATs C225 Phase I treatment (47) AG490 Preclinical treatment (48-51) #----------------------------------------------------------------- Table II. Chemopreventive Agents for Targeting Signal Transduction Pathways Target Drug Phase of Testing Reference Cox-2 Celecoxib Preclinical treatment (164,174-177) and prevention Nimesulide, Valdecoxib, Preclinical treatment (178) Parecoxib, Etoricoxib, Lumaricoxib Sulindac Phase II treatment (179-181) Exisulind Phase I treatment",
              "citation": {
                "type": "PubMed",
                "name": "J Mammary Gland Biol Neoplasia 2003 Jan 8(1) 45-73",
                "id": "14587863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407df86"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAPGEF3)",
        "relation": "negativeCorrelation",
        "target": "p(HGNC:CXCL8)",
        "directed": false,
        "label": "p(HGNC:RAPGEF3) negativeCorrelation p(HGNC:CXCL8)",
        "metadata": {
          "casual": false,
          "createdBy": "pirxtrurl",
          "edgeId": "5511865c89e3620b9c6acab2",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAPGEF3) negativeCorrelation p(HGNC:CXCL8)",
              "summary_text": "In results, read the section \"cAMP signalling attenuates CSE-induced IL-8 release from human ASM cells.\"\nRemember that Epac is an alias of RAPGEF3 (http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:16629)",
              "citation": {
                "type": "Other",
                "name": "Oldenburger, A., S. S. Roscioni, E. Jansen, M. H. Menzen, A. J. Halayko, W. Timens, H. Meurs, H. Maarsingh, and M. Schmidt. 2012. \"Anti-inflammatory role of the cAMP effectors Epac and PKA: implications in chronic obstructive pulmonary disease.\" PLoS One no. 7 (2):e31574. doi: 10.1371/journal.pone.0031574.",
                "id": "22363678"
              },
              "metadata": {
                "created_by": "pirxtrurl",
                "id": "5511865c89e3620b9c6ac9f9"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "COPD",
                "cell": "human ASM cells",
                "tissue": "Human lung tissue"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(SFAM:\"PDE4 Family\"))",
        "relation": "directlyDecreases",
        "target": "a(SCHEM:\"cyclic AMP\")",
        "directed": false,
        "label": "cat(p(SFAM:\"PDE4 Family\")) directlyDecreases a(SCHEM:\"cyclic AMP\")",
        "metadata": {
          "casual": false,
          "createdBy": "benwong1999",
          "edgeId": "52cb7d81bf21ca05bcfa1db1",
          "evidences": [
            {
              "bel_statement": "cat(p(SFAM:\"PDE4 Family\")) directlyDecreases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "PDE4 enzymes are expressed in distal human PASMCs and the effects of cAMP-stimulating agents on DNA synthesis, proliferation and MMP production is dependent, at least in part, on PDE4 activity. PDE4 inhibition may provide greater control of cAMP-mediated anti-proliferative effects in human PASMCs",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "16423283"
              },
              "metadata": {
                "created_by": "lvfedorova3",
                "id": "52fe84a689e3620ba47e536e"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": "pulmonary artery smooth muscle cells"
              }
            },
            {
              "bel_statement": "cat(p(SFAM:\"PDE4 Family\")) directlyDecreases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "These data identify a PDE4-mediated attenuation of PGE2 inhibitory signaling in normal fibroblasts that appears to be altered in COPD fibroblasts. These alterations may contribute to COPD pathogenesis and could provide novel therapeutic targets.",
              "citation": {
                "type": "Other",
                "name": "Michalski J, Kanaji N, Liu X, Nogel S, Wang X, Basma H, Nakanishi M, Sato T, Gunji Y, Fahrid M, Nelson A, Muller KC, Holz O, Magnussen H, Rabe KF, Toews ML, Rennard SI. Am J Respir Cell Mol Biol. 2012 Dec;47(6):729-37. doi: 10.1165/rcmb.2012-0057OC. Epub 2012 Oct 4",
                "id": "23043089"
              },
              "metadata": {
                "created_by": "benwong1999",
                "id": "52cb7d81bf21ca05bcfa1d13"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": "Lung"
              }
            },
            {
              "bel_statement": "cat(p(SFAM:\"PDE4 Family\")) directlyDecreases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "These data suggest that ROS-mediated lung inflammation could be mediated at least in part by calcium and elevated PDE activity associated with decreased cAMP in both macrophages and epithelial cells. Inhibition of these pathways may provide a route for treatment of inflammatory lung diseases.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "17129690"
              },
              "metadata": {
                "created_by": "lvfedorova3",
                "id": "52fe8c4f89e3620ba47e5c27"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "lung macrophages, epithelial cells"
              }
            },
            {
              "bel_statement": "cat(p(SFAM:\"PDE4 Family\")) directlyDecreases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Enhanced epithelial cAMP levels, induced by forskolin and PDE4 inhibition, increased formation of prostaglandin E2 (PGE2), but not of interleukin (IL)-8 or 15-hydroxyeicosatetraenoic acid (15-HETE) in airway epithelial cells.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "9922221"
              },
              "metadata": {
                "created_by": "lvfedorova3",
                "id": "52fe89c589e3620ba47e59fb"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": "airway epithelial cells"
              }
            },
            {
              "bel_statement": "cat(p(SFAM:\"PDE4 Family\")) directlyDecreases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Only two forms of the cAMP-specific PDE4 were found to be sensitive to physiologically relevant phosphatidic acid (PA) concentrations. ...The PDE4-peak 2 form was inhibited only by PA with saturated fatty acyl groups. ...These results suggest that PA may contribute to the lowering of cAMP level required in the early steps of a lympho-proliferative response, thus regulating immune functions through PDE4 activation.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "9023016"
              },
              "metadata": {
                "created_by": "lvfedorova3",
                "id": "52fe82ad89e3620ba47e5105"
              },
              "experiment_context": {
                "species_common_name": "rat",
                "disease": "",
                "cell": "",
                "tissue": "thymocytes"
              }
            },
            {
              "bel_statement": "cat(p(SFAM:\"PDE4 Family\")) directlyDecreases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Analysis of PDE activity of our AEC-II preparations revealed that PDE4 is the major cAMP hydrolysing PDE in human adult AEC-II.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "22815690"
              },
              "metadata": {
                "created_by": "lvfedorova3",
                "id": "52fe88bb89e3620ba47e57d0"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": "alveolar epithelial"
              }
            },
            {
              "bel_statement": "cat(p(SFAM:\"PDE4 Family\")) directlyDecreases a(SCHEM:\"cyclic AMP\")",
              "summary_text": "Whereas PDE1 and PDE3 activities were augmented, PDE4 activity, which represented the major cyclic AMP-hydrolysing activity of peripheral blood monocytes, rapidly declined.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "9154331"
              },
              "metadata": {
                "created_by": "lvfedorova3",
                "id": "52fe883389e3620ba47e55e7"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": "monocytes"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:VAV2))",
        "relation": "directlyIncreases",
        "target": "gtp(p(HGNC:RAC1))",
        "directed": false,
        "label": "cat(p(HGNC:VAV2)) directlyIncreases gtp(p(HGNC:RAC1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c340532a4",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:VAV2)) directlyIncreases gtp(p(HGNC:RAC1))",
              "summary_text": "The extraction was prevented when Rac1 was activated to its GTP-bound state by Rac-specific guanine nucleotide exchange factors (GEFs), such as Vav2, Dbl, Tiam1, P-Rex1 and TrioN, and bound by the downstream effector Pak1",
              "citation": {
                "type": "Other",
                "name": "PLoS One. 2014 Jul 11;9(7):e102425. doi: 10.1371/journal.pone.0102425. eCollection 2014.\nLiposome reconstitution and modulation of recombinant prenylated human Rac1 by GEFs, GDI1 and Pak1.\nZhang SC1, Gremer L2, Heise H3, Janning P4, Shymanets A5, Cirstea IC6, Krause E7, Nrnberg B5, Ahmadian MR1.",
                "id": "25014207"
              },
              "metadata": {
                "created_by": "mberra",
                "id": "551c131089e3620bbc3dc64c"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:VAV2)) directlyIncreases gtp(p(HGNC:RAC1))",
              "summary_text": "First, we determined that RhoG was regulated by guanine nucleotide exchange factors that also activate Rac and/or Cdc42. Vav2 (which activates RhoA, Rac1, and Cdc42) and to a lesser degree Dbs (which activates RhoA and Cdc42) activated RhoG in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47810-7",
                "id": "12376551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407dfca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:VAV2)) directlyIncreases gtp(p(HGNC:RAC1))",
              "summary_text": "Vav2 phosphorylation observed in these experiments reflects the activation of Rac-specific Vav2 nucleotide exchange activity (Aghazadeh et al., 2000).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2008 Jun 215(3) 715-24",
                "id": "18064650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407ddb0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PTGES2)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:PTGES2))",
        "directed": false,
        "label": "p(HGNC:PTGES2) actsIn cat(p(HGNC:PTGES2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b351ad3fbfd4c34053273",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PTGES2) actsIn cat(p(HGNC:PTGES2))",
              "summary_text": "Cell-specific prostaglandin synthases convert PGH2 into a series of prostaglandins, including PGI2, PGF2alpha, PGD2 and PGE2 (Fig. 1).   Fig. 1 Legend - Pathway of prostaglandin production. Arachidonic acid is liberated from membranes by phospholipase A2. The cyclooxygenase enzymes (COX-1 and COX-2) produce prostaglandin H2 (PGH2) from arachidonic acid. PGH2 is acted upon by prostaglandin synthases to produce PGI2, PGD2, PGE2 and PGF2alpha. PGD2 is metabolized to 15-deoxy-12,14-PGJ2 (15-d-PGJ2). ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2002 Mar 23(3) 144-50",
                "id": "11864843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e126"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGES2) actsIn cat(p(HGNC:PTGES2))",
              "summary_text": "LPS upregulated COX-2 expression 2.8-fold and alpha(v) integrin expression twofold. The COX-2 inhibitor celecoxib increased alpha(v) integrin mRNA expression twofold. Both exogenous PGE(2) and the specific EP(3) receptor agonist, MB28767, reduced constitutive alpha(v) integrin mRNA expression to half normal values",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Pathol 2004 May 57(5) 553-5",
                "id": "15113870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e2ae"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PTGES2) actsIn cat(p(HGNC:PTGES2))",
              "summary_text": "These data suggest that H2O2 stimulates CFTR Cl(-) channel-mediated Cl(-) secretion through cyclooxygenase- and mPGES-1-dependent release of PGE2 and subsequent activation of PKA.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2007 Nov 293(5) F1571-6",
                "id": "17699556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b352ad3fbfd4c3407e0cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "renal medulla"
              }
            }
          ]
        }
      }
    ]
  }
}
